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Abstract
The cellular mechanisms responsible for the versatile properties of CHO cells as the major
production cell line for biopharmaceutical molecules are not entirely understood yet, although
several ’omics’ data facilitate the understanding of CHO cells and their reactions to envi-
ronmental conditions. However, genome-wide studies of epigenetic processes such as DNA
methylation as a crucial epigenetic modification and an important element in mammalian
genome regulation and development are still limited.
In order to study DNA methylation phenomena in CHO cell cultures, whole-genome bisulfite
sequencing was implemented for CHO DP-12 cells that produce a recombinant human anti-
IL-8 antibody. Methylome data generated for this cell line allowed for the characterization
of the CHO DP-12 DNA methylation landscape as well as for the analysis of differential
DNA methylation upon butyrate addition. The combination with gene expression studies
by DNA-microarrays enabled an assessment of potential phenotypic effects and functional
significances.
As a DNA methylation map of a CHO cell line did not exist before, the analysis of the CHO
DP-12 cell DNA methylation landscape was of special importance. CHO DP-12 cells were
found to exhibit global hypomethylation compared to a majority of mammalian methylomes
and hypermethylation of CpG-dense regions at gene promoters called CpG islands. Also,
partially methylated domains were observed that covered 62% of the CHO DP-12 cell genome
and contained functional clusters of genes. Gene expression analysis showed these clusters to
be either highly or weakly expressed with regard to CHO-specific characteristics. Generally,
the results showed that DNA methylation might significantly contribute to CHO phenotypes
and allowed for a deeper understanding of CHO cell properties.
Whole-genome bisulfite sequencing and DNA-microarray analyses were next used to analyze
the time course of cellular reactions upon butyrate addition in CHO DP-12 cells, as supple-
mentation of butyrate is known to enhance cell specific productivities and leads to alterations
of epigenetic silencing events. Gene expression and DNA methylation analyses showed that
the central cellular pathways cell cycle, apoptosis and RNA processing, as well as pathways
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potentially associated with increased cell specific productivity such as energy metabolism
and protein biosynthesis were affected by butyrate. Differentially methylated regions were
furthermore found to contain binding-site motifs of specific transcription factors and were
hypothesized to represent regulatory regions closely connected to the cellular response to
butyrate. The experiment underlined the benefit of integrating DNA methylation and gene ex-
pression data, as it provided potential novel candidate genes for rational cell line development
and allowed for new insights into the butyrate effect on CHO cells.
Whole-genome bisulfite sequencing was finally compared to the analysis of DNA methylation
changes upon butyrate addition by a recently designed CHO-specific microarray. 32 % of
the genes detected as differentially methylated by CpG island microarrays were also found
by whole-genome bisulfite sequencing. Gene-specific analyses for verification of microarray
results did not show significant differences between the methods. Furthermore, hybridization
experiments for control of experimental parameters indicated that CpG island microarray
analyses were only biased by variations in DNA extraction, which led to false positive calls at
0.15 % of the probes. Therefore, CpG island microarrays were considered suitable tools for
the analysis of DNA methylation in CHO cells in a medium-throughput format. As both the
whole-genome bisulfite sequencing and CpG island microarray data sets indicated a potential
involvement of DNA methyltransferase 3a (DNMT3A) in the butyrate-response, DNMT3A
was functionally analyzed in transient knockdown experiments which indicated that reduced
levels of the enzyme might be associated with increased cell specific productivity.
2
1
Introduction
More than 200 biopharmaceutical molecules have been produced by means of mammalian
expression systems since the first recombinant protein, Tissue plasminogen activator (tPA),
was approved by the Food and Drug Administration (FDA) in 1986 (Walsh 2010). About 70 %
of these products are made in Chinese hamster ovary (CHO) cells, which provide proteins
with proper foldings and posttranslational modifications and account for the production of six
out of the ten top-selling biopharmaceuticals in 2013. These comprised e.g. Humira (AbbVie),
Rituxan (Biogen-IDEC) or Avastin (Roche; Walsh 2014).
Even though CHO cells were extensively used over the last three decades, still little is known
about the molecular basis for their versatile properties regarding robustness, adaptability and
productivity. For this reason several techniques have been applied to unravel the molecular
mechanisms in CHO-based production processes and a plethora of ’omics’ data sets was
generated. These data include the CHO K1 genome sequence which serves as a CHO reference
genome and facilitates genome-scale studies on multiple levels (Xu et al. 2011). The CHO
K1 genomic data was furthermore assigned to Chinese hamster chromosomes, which enables
the analysis of chromosomal rearrangements and genome stability (Brinkrolf et al. 2013).
The CHO cell transcriptome was sequenced and published (Becker et al. 2011) and several
transcriptomics studies were conducted to analyze the reactions of CHO cells to specific
environmental conditions or to compare CHO clones with differences in productivity. For
example, differential gene expression in CHO cells was analyzed upon treatment with the
productivity-enhancing substance butyrate, which was shown to affect expression of genes
related to protein secretion (Kantardjieff et al. 2010). It was furthermore shown that CHO
Chapter 1. Introduction
cell productivity increased due to temperature downshifts and that this was accompanied by a
significant upregulation of genes related to energy metabolism (Bedoya-López et al. 2016).
Additionally, several proteomic and metabolomic studies of CHO cells were performed,
which, e.g., showed that high passage numbers correlated with increased robustness due to
differential expression of anti-stress proteins (Beckmann et al. 2012). When extracellular
metabolites in CHO cell fed-batch cultures were examined, an accumulation of detrimental
metabolites over the cultivation process was found, which was accompanied by depletion of
media components despite the addition of feed medium (Chong et al. 2009).
Despite the immense effort to explain CHO cell characteristics by ’omics’ experiments, nu-
merous open questions remain and biopharmaceutical production processes are still largely
empirical. For example, when the correlation between lactate accumulation and its consump-
tion and the outcomes of production-scale cultures were examined using a large amount of
bioprocess data (243 bioreactor runs including inoculum trains and subsequent production
processes), it was shown that the rate of lactate formation and the switch to its consumption
varied even between cultures of the same strain under the same conditions. The hypothesis
was raised that this finding was a hint towards a predetermination of metabolic characteristics
in early stages of culturing (Le et al. 2012).
An explanation to such unanswered questions might arise from epigenomics studies in CHO
cells, which represent one missing link between the above-mentioned cellular levels and are
facilitated by recent developments in analysis techniques. The following sections provide an
overview of the history of epigenetic research, definitions and the relevance of epigenomic
studies.
1.1. A brief history of epigenetics
Until the middle of the 20th century developmental biologists took little account of genes and
gene action to answer the question of how a single fertilized egg can give rise to a complex
organism consisting of various specialized cell types. Instead, they focused on the roles
of nucleus and cytoplasm in the developmental process and either believed that preformed
elements in a cell enlarged during development (’preformationism’) or that chemical reac-
tions occurred among cellular components that executed a developmental plan (’epigenesis’;
Felsenfeld 2014). As time went on, it became apparent that certain fundamental features of
development were not explainable by either of these theories, e.g. the ability of differentiated
cells to maintain their phenotypes through cell division. However, a combination of both
theories provided a possible explanation, with preformation representing the static nature
of the gene and epigenesis representing the dynamic nature of gene expression (Deans and
Maggert 2015). Believing in this complementarity, the embryologist Conrad Waddington
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coined the term ’epigenetics’ in 1942, which he defined as ’the branch of biology that studies
the causal interactions between genes and their products which bring the phenotype into
being’, or, briefly, as changes in phenotype without changes in genotype (Waddington 1942;
Holliday 2006; Allis and Jenuwein 2016). At that time the gene was being accepted as the unit
of inheritance without knowledge about its biochemical nature (Deans and Maggert 2015).
1.1.1. The relationship between DNA methylation and gene regulation
During the following decades the work of Avery at al., Hershey and Chase and, obviously,
Watson and Crick proved that a protein-free DNA molecule could carry and inherit the genetic
information (Avery, Macleod, and McCarty 1944; Hershey and Chase 1952; Watson and
Crick 1953). As it was furthermore shown that the specialized gene expression potential in
differentiated cells was not due to mutations of the germline DNA sequence, mechanisms were
proposed in which information was superimposed on DNA sequences (Laskey and Gurdon
1970; Felsenfeld 2014). In 1975 two independent groups proposed that DNA methylation
at cytosine residues could act as an epigenetic mark that could be transmitted to the next
generation if methylation sites were palindromic and if a maintenance methyltransferase
existed that could bind to hemimethylated DNA (Riggs 1975; Holliday and Pugh 1975). This
hypothesis was confirmed by experiments using methylation-sensitive restriction enzymes
that showed a strong effect of DNA methylation at CpG sites on gene expression (Doerfler
1983; Bird and Southern 1978).
Further evidence for the involvement of DNA methylation in the control of gene expression
came from experiments using 5-azacytidine, which is a cytosine analog that is incorporated
into DNA and deactivates DNA methyltransferases (Holliday 2006; Jones and Taylor 1980). It
was shown that 5-azacytidine reactivated silent genes in many cases, e.g. the Phosphoglycerate
kinase 1 (Pgk1) gene that is linked to the inactive human X chromosome in hamster-human
cell hybrids (Hansen and Gartler 1990) or genes of the herpes simplex virus (HSV) that were
silenced in mammalian cells (Clough, Kunkel, and Davidson 1982).
These findings led to a revised definition of epigenetics as ’the study of changes in gene
function that are mitotically and/or meiotically heritable and that do not entail change in DNA
sequence’ (Wu and Morris 2001). In the following years several studies focused on patterns
of DNA methylation in different organisms or cell types, the impact of DNA methylation on
gene expression or the identification of enzymes responsible for de novo and maintenance
DNA methylation. These studies were immensely accelerated by the advent of next generation
sequencing technologies.
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1.1.2. The impact of histone modifications on chromatin structure
As transmission of gene activity states during cell division was shown in organisms such as
Drosophila that exhibit extremely low levels of DNA methylation, it was clear that DNA
methylation could not be the only epigenetic mechanism (Felsenfeld 2014). In fact, another
epigenetic mechanism was discovered in 1964, when Allfrey and co-workers showed that
histones are posttranslationally acetylated and methylated (Allfrey, Faulkner, and Mirsky
1964). Their speculation that histone acetylation might be correlated with chromatin structure
and, thereby, gene activation, was confirmed by the findings that DNA was packaged into
nucleosomes containing histone octamers (Thomas and Kornberg 1975) and that amino-
terminal tails of histones were essential for transcriptional regulation (Durrin et al. 1991). Fig.
1.1 summarizes the basic concept of chromatin organization.
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Figure 1.1.: Chromatin organization and histone tail modifications (modified from Marmorstein 2001).
A Histone octamers are depicted as yellow cylinders, histone tails are shown in red and
DNA in black. Nucleosomes comprise 145–147 bp of DNA wrapped around a core of
each two molecules of histones H2A, H2B, H3 and H4. Each core histone contains
a flexible, basic tail region which is the site for posttranslational modifications. As a
result of these modifications nucleosomes can either be tightly associated (condensed
heterochromatin) or relaxed (permissive euchromatin, ’beads-on-a-string’). B Histone H3
tail region with gene regulatory modifications acetylation (A), phosphorylation (P) and
methylation (M). Acetylation is associated with transcriptional activation, methylation and
phosphorylation are associated with both transcriptional activation and silencing. C High
resolution structure of a nucleosome core particle. DNA is shown in blue, the histone H2A
dimer in aqua, H2B in purple, H3 in red and H4 in green.
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The question of how specific chromatin sites are chosen for modification was answered by the
discovery of DNA-binding proteins such as the helix-loop-helix myogenic regulatory factor
MyoD (which is involved in skeletal muscle development; Berkes and Tapscott 2005) that
recruit cofactors like histone modification complexes (Lassar et al. 1989; Felsenfeld 2014).
Chromatin Isolation by RNA Purification sequencing (ChIRP-seq) experiments furthermore
showed that long non-coding RNAs (lncRNAs) can bind to DNA in a sequence-specific way
and are able to recruit histone modifying complexes (Chu et al. 2011). However, it is still
not clear how chromatin states can be transmitted through cell divisions. Different kinds
of mechanisms for propagation of histone marks have been suggested though, which are
rather based on variants of histones and not on histone modifications (Felsenfeld 2014). For
example, histone variant H3.3 (exhibiting four different amino acids compared to histone
H3) was shown to accumulate in active chromatin, while histone H3 is only incorporated
during DNA replication. Histone H3.3 was suspected to maintain gene activity through cell
division and to lead to replacement of histone H3, which is incorporated during this process.
Thereby, transmission of the active state of chromatin into the next generation would be
possible (McKittrick et al. 2004; Felsenfeld 2014).
1.1.3. Small RNA-mediated epigenetic regulation
A third component of the epigenetic system is a class of single-stranded, small non-coding
RNAs with a length of about 22 nucleotides, called microRNAs (miRNAs). MiRNAs were
discovered in C. elegans in 1993 (Lee, Feinbaum, and Ambros 1993) and regulate gene
expression on the posttranscriptional level by base-pairing with target mRNAs that leads
to translational repression or mRNA decay (Ha and Kim 2014). Although many of the
miRNA promoters have not been characterized yet, miRNA genes appear to be regulated
similarly to protein-coding genes by transcription factors and epigenetic mechanisms (Vrba
et al. 2013). For example, cell-type specific miRNA expression in human mammary epithelial
and fibroblast cells was shown to be regulated by DNA methylation and histone 3 lysine
27 trimethylation (H3K27me3; Vrba et al. 2011). Other miRNAs were shown to regulate
the expression of epigenetic mediators such as DNA methyltransferases (DNMTs, e.g. miR-
29) and Histone deacetylases (HDACs, e.g. miR-449a) themselves (Garzon et al. 2009;
Noonan et al. 2009). In fact, several publications describe a dynamic interplay between DNA
methylation events and microRNAs. For example, in fibrotic lung tissue expression of the miR-
17-92 cluster targeting DNMT1 was found to be decreased, while DNMT1 expression and
methylation of the miR-17-92 promoter itself were increased, thereby suggesting a negative
feedback-loop (Sun et al. 2013). Fig. 1.2 summarizes the epigenetics-miRNA regulatory
circuit (Sato et al. 2011). Generally, miRNAs are suspected to play a key role within the gene
regulatory network and could furthermore be able to transmit epigenetic signals by moving
from one cell to another (Holliday 2006).
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Figure 1.2.: Regulatory epigenetic-miRNA circuit (Sato et al. 2011). MiRNA genes can contain CpG
islands in their promoter regions and are transcribed by RNA polymerase II as primary
micro RNAs (pri-miRNAs) that are processed to mature miRNAs by the Drosha/DGCR8
complex and Dicer. The mature, single-stranded miRNAs mediate post-transcriptional
repression (mRNA cleavage, translational repression or deadenylation and destabilization
of target mRNAs) of target genes as part of the RNA induced silencing complex (RISC).
Amongst others, epigenetic regulators and transcription factors are targeted by RISC
complexes, which can lead to modification of chromatin structures and thereby (feedback)
regulation of miRNA genes themselves. RLC = RISC loading complex, PABP = Poly A
binding protein, TRBP = Tar RNA binding protein.
1.1.4. ENCODE and the Roadmap Epigenomics Project
It is understood today that gene expression is largely regulated by the epigenome, which
provides information about DNA methylation, histone and chromatin modifications as well as
other regulatory factors not encoded within the DNA such as non-coding RNAs. The impor-
tance of mapping and cataloging epigenomic structures is underlined by the immense efforts
of the Encyclopedia of DNA Elements (ENCODE) and Epigenomics Roadmap Projects that
followed the unraveling of the human genome. When the first sequencing of the complete
human genome was finished in 2001 (Lander et al. 2001), the ENCODE Project, an interna-
tional consortium of computational and laboratory-based scientists, was launched to identify
all functional elements comprised within it. The aim of the consortium was to generate a
comprehensive catalog of the structural and functional components, including epigenetic fea-
tures, encoded in the human genome in order to understand the biology of human health and
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disease (The ENCODE Project Consortium 2004). In a pilot phase (2004–2007) 44 genomic
target regions, which represented 1 % of the human genome, were manually selected and
analyzed regarding the identification of genes, promoters, enhancers, origins of replication,
transcription factor binding sites, histone modifications and Desoxyribonuclease I (DNase I)
hypersensitive sites (i.e. chromatin accessibility) by tiling arrays and genomic sequencing
(Birney et al. 2007). In the next step the ENCODE production phase was launched, which
aimed to analyze the entire genome of human cells grown in culture. The realization of this
project was eased by the advances in low-cost, rapid DNA-sequencing technologies and the
project was supposed to provide information about DNA methylation, histone modifications,
chromatin accessibility and interactions, transcription factor binding sites, the location and
sequence of gene-regulatory DNA elements as well as sequences and quantities of RNAs
transcribed from non-coding and protein-coding regions. The results of an initial analysis
of 1.640 data sets were published in a total of 30 papers in 2012, resulting in the conclusion
that 80 % of the human genome is transcribed and therefore considered as being functional
(Ecker et al. 2012). It has to be noted that this final conclusion is regarded very critically
within the scientific community (Graur et al. 2013; Eddy 2012). However, the ENCODE data
were used as a basis for the follow-up Roadmap Epigenomics Project which aimed to analyze
samples taken directly from human tissues and cells under diverse conditions and generated
epigenomic data for 127 tissues and cell types until the first release of a package of papers in
2015 (Romanoski et al. 2015). The data generated in this way are e.g. used to identify fresh
entry points for treatment of diseases like Alzheimer’s (Gjoneska et al. 2015).
According to the above-mentioned advances in epigenomic research in human cells and
tissues that followed the sequencing of the human genome, the relevance of similar studies in
biotechnologically important cell lines such as CHO cells is evident. Such studies will enable
a deeper understanding of gene regulation in the production of biopharmaceuticals, especially
in response to environmental conditions, and will finally enable rational design of better
production cell lines. As this thesis focused on the analysis of DNA methylation patterns in
CHO cells and the effect on environmental conditions on dynamic DNA methylation, the
following sections aim to provide a detailed overview of the current knowledge about this
epigenetic mechanism.
1.2. Biological processes involving DNA methylation events
In humans, the greatest changes in overall DNA methylation are observed during early
embryonic development, when the fertilized egg undergoes cleavage divisions and develops
into a morula and then a blastocyst (Marcho, Cui, and Mager 2015). In this period of
time DNA methyl groups in the paternal and maternal pronuclei are largely erased by active
demethylation (Fig. 1.3; Reik 2007). DNA methylation marks present at some genes, however,
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escape the overall demethylation events. The underlying mechanism is not entirely understood
yet, but it is speculated that specific proteins actively protect certain genomic regions from
demethylation (Reik 2007; Lane, Robker, and Robertson 2014). At the time of implantation
the whole genome is again methylated by the de novo DNA methyltransferases DNMT3A
and DNMT3B (see section 1.3.1.2), which establish a bimodal pattern of methylation for
a majority of mammalian genomes. This means that highly methylated regions alternate
with unmethylated regions, which mostly exhibit a specific base composition with a high
G+C content (CpG islands; see section 1.4; Cedar and Bergman 2012). These patterns are
maintained over cell divisions by the maintenance methyltransferase DNMT1 (see section
1.3.1.1). Following implantation, additional changes in methylation are possible, but mostly
affect tissue-specific genes or other specific loci, and overall DNA methylation landscapes
remain stable. Accordingly, a study examining 42 whole-genome methylation data sets
including diverse human cell and tissue types showed that only 21.8 % of autosomal CpG
dinucleotides are dynamically regulated within normal development (Ziller et al. 2013).
Figure 1.3.: Regulatory epigenetic processes during development (Reik 2007). When DNA methy-
lation is erased early in development, pluripotency-associated genes are expressed and
developmental genes are repressed by Histone H3 lysine 27 (H3K27) methylation. When
differentiation sets in, pluripotency-associated genes become repressed by increasing DNA
methylation which is paralleled by an increase in H3K4 methylation. During germ cell
development DNA methylation marks are erased in large parts and pluripotency-related
genes are re-expressed. Afterwards developmental genes are expressed again.
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DNA methylation has been shown to be responsible for processes such as X chromosome
inactivation (Herzing et al. 1997), imprinting (Feil and Berger 2007) or silencing of retrotrans-
posons and repetitive elements (Ndlovu, Denis, and Fuks 2011). Changes in DNA methylation
patterns are furthermore associated with a plethora of diseases like cancer (Kulis and Esteller
2010), diabetic nephropathy (Bell et al. 2010), artherosclerosis (Hai and Zuo 2016) or Parkin-
son’s (Wüllner et al. 2016) and it was shown that aberrant changes in epigenetic pathways
are often linked to environmental factors such as nutrients or the exposure to chemicals
(Ruiz-Hernandez et al. 2015). For example, changes in maternal diets during pregnancy
(regarding abnormal concentrations of folate, choline or docosahexaenoic acid) influence
the risk of developing metabolic and cardiovascular diseases in adulthood by induction of
aberrant DNA methylation, which is associated with differential expression of genes involved
in hormonal regulation or inflammation (Lee 2015; Jiang et al. 2012; Lee et al. 2013). Recent
evidence proves that it is even possible to transmit acquired DNA methylation marks to
the next generation, a process which is described by the term ’transgenerational epigenetic
inheritance’ (Prokopuk, Western, and Stringer 2015). It was for example shown in mice that
preconceptional feeding of a zinc deficient diet for 3 to 5 days disrupts chromatin methylation
and preimplantation development in oocytes (Tian and Diaz 2013). DNA methylation levels
(and, also, histone H3K4 trimethylation) were found to be decreased and associated with
differential expression of repetitive elements and oocyte specific genes, which led to impaired
fertilization potential and reduced blastocyst formation. Fertilization potential could in parts
be restored by supplementation with a methyl group donor. Another, yet controversial, ex-
ample was provided by Dias et al. in 2014, who showed that parental olfactory experience
influences behavior and neuronal structure of subsequent generations (Dias and Ressler 2014).
In this study F0 mice were subjected to odor fear conditioning before conception. It was
shown that F1 and F2 generations were similarly sensitive to the F0-conditioned odor without
ever being exposed to it. Sperm DNA from conditioned F0 males and F1 offspring showed
differential DNA methylation of a gene involved in olfactory pathways.
1.3. Setting and removing DNA methylation marks
The following section provides an overview of the structures and catalytic activities of the
above-mentioned enzymes responsible for setting and removing DNA methylation marks,
including DNA methyltransferase 1 (DNMT1), which mediates maintenance DNA methy-
lation during cell divisions and DNMT3A and DNMT3B as de novo methyltransferases.
Furthermore, the methylcytosine dioxygenase family of enzymes (TET1, TET2, TET3) is
described, which conveys the removal of methyl groups.
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1.3.1. DNA methyltransferases
Three DNA methyltransferases (DNMT1, DNMT3A, DNMT3B) and one related protein
without catalytic activity (DNMT3L) exist that consist of an N-terminal part responsible for
localization of the enzymes and a C-terminal, catalytically active part exhibiting a common
core structure for all DNMTs (see domain structure in Fig. 1.4). In comparison to DNMT1
the members of the DNMT3 family of proteins contain shorter N-terminal domains, which
do not possess a nuclear localization signal (NLS), PCNA and DNA replication foci binding
domains (PBD and TS) as well as the polybromo-1 homology domain (PBHD). All of these
domains mediate DNMT1-association with DNA replication sites. Instead, the DNMT3
family members possess PWWP domains for unspecific DNA binding as well as ATRX-
DNMT3-DNMT3L (ADD) domains for interaction with histone tails.
Mechanistically, DNMTs flip their target base out of the double helix and bury it in the active
center, thereby forming a covalent bond with it, which increases the negative charge at the C5
atom and leads to addition of a methyl group from the donor molecule S-adenosyl-methionine
(SAM or AdoMet; Jurkowska, Jurkowski, and Jeltsch 2011). The following subsections
provide a more detailed view on the maintenance methyltransferase, DNMT1, and the de
novo methyltransferases DNMT3A and DNMT3B.
Figure 1.4.: Schematic representation of the domain structure of mammalian DNA methyltransferases
(DNMTs; Jurkowska et al. 2011). PBD = PCNA binding domain, NLS = nuclear
localization signal, PBHD = polybromo-1 homology domain, CXXC = binding domain
for unmethylated CpGs, BAH = bromo-adjecent homology, PWWP = unspecific DNA
binding domain domain, ADD = ATRX-DNMT3-DNMT3L domain (histone interaction
domain).
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1.3.1.1. Maintenance DNA methylation
The hypothesis that maintenance of DNA methylation patterns through cell division could
be mediated by a methyltransferase with a strong preference for hemimethylated DNA was
confirmed in 1982, when Gruenbaum et al. studied enzymatic DNA methylation activity
in crude extracts from somatic cells. They showed that hemimethylated DNA, in contrast
to completely unmethylated DNA, was a better substrate for methylation with a 100-fold
higher Km value (Gruenbaum, Cedar, and Razin 1982). It was subsequently shown that the
enzyme DNA methyltransferase I (DNMT1) is permanently localized to replication foci and
mediates maintenance DNA methylation (Li, Bestor, and Jaenisch 1992; Leonhardt et al.
1992). DNMT1 is recruited to replication foci by a protein complex containing Ubiquitin-like
PHD and RING finger domain-containing protein 1 (UHRF1). Deletion of UHRF1 was shown
to drastically decrease DNA methylation in mouse embryonic stem cells and UHRF1 was
shown to co-localize with DNMT1 at replication foci during S phase (Bostick et al. 2007).
Another protein involved in this regulatory complex is Proliferating cell nuclear antigen
(PCNA), which dynamically binds to DNMT1 and increases its methylation efficiency by
100 %. However, this interaction was found to be not strictly required for maintaining global
methylation (Schermelleh et al. 2007).
The multimodular protein DNMT1 with its C-terminal methyltransferase domain and the
N-terminal regulatory region, which is composed of the replication foci targeting sequence
(RFTS) domain, the CXXC zinc finger domain and the pair of bromo adjacent homology
(BAH) domains (see Fig. 1.4 and ribbon representation in Fig. 1.5A) is recruited to replication
foci by the RFTS domain and interaction with UHRF1 (Leonhardt et al. 1992; Berkyurek
et al. 2014). Furthermore, the RFTS domain interacts with the methyltransferase domain in an
autoinhibitory mechanism, which is proposed to be responsible for occlusion of unmethylated
CpGs from the active site of the enzyme in order to ensure that only hemimethylated DNA is
methylated (Song et al. 2011). The association of the RFTS and methyltransferase domains
is strengthened by the helical linker between the CXXC and BAH1 domains. Binding of
the CXXC domain to CpG dinucleotides in unmethylated DNA results in positioning of the
CXXC-BAH1 domain linker into the calalytic site of the methyltransferase domain, thereby
generating a second variant of autoinhibitory conformation. When hemimethylated DNA is
bound, DNMT1 inhibition is released (Fig. 1.5B; Zhang et al. 2015). The BAH domains of
DNMT1 are suspected to serve as a platform for interaction with other proteins (Song et al.
2011).
1.3.1.2. De novo DNA methylation
DNMT3A, DNMT3B and DNMT3L belong to the DNMT3 family of methyltransferases,
with DNMT3A and DNMT3B being responsible for the de novo establishment of DNA
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Figure 1.5.: Structural overview of human DNMT1 bound to S-adenosyl homocysteine (AdoHcy) and
schematic representation of the autoinhibitory mechanism (Zhang et al. 2015). A Ribbon
representation with color-coding of RFTS, CXXC, BAH1, BAH2 and methyltransferase
domains as well as domain linkers (silver) and zinc ions (purple). B Conformational
transitions of DNMT1 upon binding to different DNA substrates with a key role of the
CXXC-BAH1 linker. TRD = Target Recognition Domain of the methyltransferase.
methylation patterns and DNMT3L as a catalytically inactive regulatory factor for de novo
methylation (Jurkowska, Jurkowski, and Jeltsch 2011). DNMT3L was found to co-localize
and co-immunoprecipitate with DNMT3A and DNMT3B (Hata et al. 2002) and to enhance
their de novo methylation potential (Chedin, Lieber, and Hsieh 2002). Two monomers of
DNMT3A (or DNMT3B) form a 16 nm long, tetrameric complex with two monomers of
DNMT3L (Fig. 1.6A). In this complex DNMT3L stabilizes the active site of DNMT3A and
thereby promotes methylation activity. The ADD domains present in both proteins mediate
association of the complex to nucleosomes (which exhibit a diameter of 11 nm) by binding to
unmethylated histone tails, which induces de novo methylation of DNA (Fig. 1.6B; Cheng
and Blumenthal 2008; Ooi et al. 2007). Accordingly, histone methylation was shown to
protect promoters from de novo methylation (Appanah et al. 2007). Recently it was shown
that the ADD domain of DNMT3A also interacts with the catalytic domain and blocks its
activity in an autoinhibitory conformation that is disrupted by histone H3 (and not H3K4me)
binding (Guo et al. 2015b).
1.3.2. DNA demethylation
The question of how DNA methylation marks might be removed from DNA strands was
answered in 2009, when a methylcytosine dioxygenase family of enzymes (TET1, TET2 and
TET3) was discovered and shown to be able to modify 5-methylcytosine through oxidation
to 5-hydroxymethylcytosine (5hmC; Tahiliani et al. 2009). In following experiments TET
enzymes were furthermore shown to be capable of iterative oxidation of 5hmC that results in
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Figure 1.6.: DNMT3A/3L interaction (modified from Cheng and Blumenthal 2008). A DNMT3A/3L-
tetramer with a DNA molecule (red) that covers two active sites. B DNMT3A/3L-tetramer
interaction with a nucleosome. DNMT3A is shown in green, DNMT3L in grey. The
DNMT3L molecules is capable of binding both histone tails if the DNMT3A/DNMT3L-
teramer is wrapped around the nucleosome. The amino-proximal part of DNMT3A is
shown as a cartoon (with N = variable region at amino terminus, PWWP = region involved
in unspecific DNA binding and CXXC = unmethylated CpG binding region) and might
interact with histone tails from neighboring nucleosomes through the CXXC domain.
the formation of 5-formylcytosine (5fC) and 5-carboxylcytosine (5caC; Fig. 1.7A; Ito et al.
2011). Notably, all three modifications are chemically distinct and could therefore function as
substrates for different enzymes.
Three mechanisms of possible roles of these modifications in the regeneration of unmodified
cytosine bases were proposed (Kohli and Zhang 2013): In the first scenario, oxidized bases
could be diluted in a DNA-replication dependent manner (’AM-PD’ in Fig. 1.7A). In a
second hypothetical scenario, a direct removal of the C5-position substituent is proposed.
Accordingly, it was shown that decarboxylation of 5caC could restore unmodified cytosine
- however, a decarboxylase responsible for this process has yet to be identified (Schiesser
et al. 2012). Furthermore, DNMTs were shown to function in demethylation events when
their methyl-group donor S-adenosyl-methionine (SAM) was missing, suggesting a ’reverse’
DNMT reaction that remains to be further explored as well (Kohli and Zhang 2013). The
third pathway to restore unmethylated cytosine, which is considered most reliably confirmed
yet, is based on active cytosine restoration by involvement of enzymes of the base excision
repair (BER) pathway, that has been shown to be linked to genome-wide changes in DNA
methylation, e.g. in mouse germ cells or zygotes (Hajkova et al. 2010; Wossidlo et al. 2010).
In fact, Thymine DNA glycosylase (TDG), that also functions as a DNA repair enzyme
capable of removing thymines from T-G-mismatches, was shown to exhibit base excision
activity on 5fC and 5caC in vitro (Maiti and Drohat 2011). This specificity could be due to
15
Chapter 1. Introduction
A B
Figure 1.7.: Pathway of dynamic cytosine methylation and proposed functions of 5hmC (modified
from Kohli and Zhang 2013). A Pathway of dynamic cytosine modifications. Cytosine
methylation is mediated by DNMTs. 5-methylcytosine (5mC) can be iteratively oxidized
to 5hmC, 5fC and 5caC. Oxidation products can either be passively diluted in a replication-
dependent manner (’active modification-passive dilution’ (AM-PD) pathway) or actively
restored (AM-AR) by TDG-mediated excision during the base excision repair (BER)
process. B Representation of individual reactions.
the fact that 5fC and 5caC have destabilized N-glycosidic bonds compared to unmethylated
cytosine, 5mC and 5hmC (Williams and Wang 2012).
TET-mediated oxidation of 5mC followed by both passive dilution and active removal by
TDG/BER plays a key role in the drastic DNA methylation changes during early development
(Messerschmidt, Knowles, and Solter 2014). In somatic cells, TET enzymes have furthermore
been associated with locus-specific demethylation events, e.g. in hormonal or cytokine-
mediated regulation. This suggests a general role of this pathway in the modulation of
transcriptional control without the necessity of DNA replication taking place (Kohli and
Zhang 2013).
1.4. DNA methylation and transcriptional regulation
The following section describes how DNA methylation influences gene expression. It also
underlines the fact that many aspects of this relationship are still unknown. For example,
methylation of specific genomic regions with a high density of CpG dinucleotides (so-called
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CpG islands) is related to transcriptional repression in some cases of long-term silencing (see
e.g. Herzing et al. 1997), but CpG island methylation does not change in many other cases
despite of changes in transcriptional activity of linked genes (Schübeler 2015). Furthermore,
although DNA methylation at genomic regions outside of CpG islands was shown to be
related to gene regulation (Stadler et al. 2011), it is not entirely clear if DNA methylation at
these sites is instructive or a result of transcription factor binding.
1.4.1. CpG islands
The largest part of the mammalian genome exhibits comparatively low levels of CpG dinu-
cleotides, as these are prone to spontaneous deamination when they are methylated, resulting
in the formation of thymine (’C to T transition’; Lander et al. 2001; Walser, Ponger, and
Furano 2008). Due to inefficient base-excision repair processes this led to CpG depletion over
evolutionary time (Schübeler 2015). An exception to this finding are genomic regions with a
high density of CpG dinucleotides that are called CpG islands (CGIs). CGIs were discovered
in experiments using the methylation-sensitive restriction enzyme HpaII to digest genomic
DNA, which showed that about 1 % of the genomes of all analyzed tissues were detectable
as separate fractions with a high number of HpaII restriction sites (i.e. unmethylated CpG
positions) in a gel (Bird et al. 1985). This discovery led to the annotation of about 26,300 CGIs
in the human genome that were defined by a length of at least 200 bp, a G+C content of at
least 50 %, and a ratio of observed to expected CpGs of at least 0.6 (Antequera and Bird 1993;
Illingworth and Bird 2009; Gardiner-Garden and Frommer 1987). These parameters are still
used to predict CGIs within DNA sequences. To reduce the risk of identifying false positive
sequences such as Alu elements (the most abundant repetitive element in primate genomes;
Zhang, Chen, and Zhao 2015) which resemble CGIs regarding their base composition, Takai
and Jones proposed in 2002 to raise the minimal required length to 500 bp, the G+C content
to 55 % and the observed-to-expected ratio to 0.65 (Takai and Jones 2002).
70 % of all CGIs in the human genome are associated with promoter regions of annotated
genes, including all constitutively expresses genes (Bird 2002). CGI-associated promoters
often allow for transcription initiation from different positions, whereas most promoters
without CpG islands initiate transcription from a single position (’broad type’ and ’sharp type’
promoters; Sandelin et al. 2007). However, not all CpG islands co-localize with annotated
transcription start sites - so-called ’orphan CGIs’ are suspected to either be associated with
tissue-specific transcription or to represent sites of unknown transcripts or non-coding RNAs
(Ndlovu, Denis, and Fuks 2011).
In most human and murine genomes the majority of CGIs is unmethylated, whereas the
remainder of the genome is highly methylated. For this reason most mammalian genomes
show a bimodal distribution of DNA methylation. Only a minority of CpG islands (about 10 to
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25 %) becomes methylated during embryonic development (Eckhardt et al. 2006; Zeschnigk
et al. 2009). CGI methylation can cause stable transcriptional repression of linked genes and
has been reported in all cases of long-term silencing such as X chromosome inactivation and
genomic imprinting (Schübeler 2015). In some cases CGI methylation events are furthermore
associated with malignant transformations. For example, genes of the Melanoma antigen
encoding gene (MAGE) family are, in germ cells, associated with unmethylated CGIs which
become methylated during differentiation. In some kinds of cancer cells MAGE methylation
is lost and the genes are expressed again (Honda et al. 2004). However, in many cases inactive
CGI promoters are linked to methylation of lysine 27 of histone H3 (H3K27me3) instead of
acquiring DNA methylation, whereas inactive promoters with low CpG-contents are often
found to be methylated (Schübeler 2015; Fig. 1.8).
CGI
promoter
CG-poor 
promoter
Transcription
factor Promoter
Repeats Enhancer Active gene Inactive gene
Figure 1.8.: Schematic representation of bimodal DNA methylation in a typical mammalian genome
and its correlation with transcription of associated genes (modified from Schübeler 2015).
Whereas methylation levels are high at intergenic, repeat and intragenic regions, promoter
and enhancer regions often overlap with CGIs which generally remain unmethylated, no
matter if the associated gene is active or not. Inactive CpG-poor promoters are generally
methylated.
1.4.2. DNA methylation changes at CpG-poor genomic regions
A general decrease of DNA methylation levels associated with binding of transcription factors
was described for CpG-poor, regulatory genomic regions, and such variable DNA methylation
at CpG-poor regions was proposed to closely reflect on-going gene activity (Schübeler
2015). However, it is still unclear if DNA methylation has a generally repressive effect by
facilitation or inhibition of binding of transcription factors, or if DNA methylation changes
occur downstream of transcription factor binding. Fig. 1.9 shows proposed scenarios for
the interaction between transcription factors and DNA methylation, which include reduction
of methylation levels by binding of methylation-insensitive transcription factors, specific
binding of transcription factors to methylated genomic regions and repulsion of metylation-
sensitive transcription factors by methylation of genomic regions. Furthermore, methyl-CpG-
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binding domain (MBD) proteins might inhibit transcription factor binding by interaction with
methylated regions that exhibit a high density of CpG dinucleotides (shading in Fig. 1.9D).
Finally, methylation insensitive transcription factors might create sites of reduced methylation
for methylation-sensitive transcription factors (Schübeler 2015). It has been shown that
transcriptional regulators can trigger demethylation events of endogenous genes in cultured
cells, which underlines the hypothesis that DNA methylation changes occur downstream of
transcription factor binding (Kress, Thomassin, and Grange 2006).
Methylation-insensitive
transcription factor
5mC
Transcription factor
Methylation-sensitive
transcription factor
A B C D E
Figure 1.9.: Proposed interactions between transcription factors and DNA methylation at CpG-poor
genomic regions (modified from Schübeler 2015). A Methylation levels might be reduced
by binding of methylation-insensitive transcription factors. B,C Methylated genomic
regions might either attract or repulse specific transcription factors. D Methyl-CpG-
binding domain (MBD) proteins might inhibit transcription factor binding by interaction
with methylated regions that exhibit a high density of CpG dinucleotides (shading). E
Methylation-insensitive transcription factors might mediate changes in DNA methylation
levels that enable binding of methylation-sensitive factors.
1.5. Methods for the analysis of DNA methylation
Methyl groups are removed from DNA molecules when these are subjected to methods
of molecular biology such as PCR and cloning, and are not detectable by hybridization
methods as well. Therefore, the detection of methyl-groups at cytosine bases requires
one of three general methods, which are based on (i) the digestion of genomic DNA with
methylation-sensitive restriction enzymes, (ii) the conversion of unmethylated cytosines to
uracil by treatment of DNA with bisulfite or (iii) the enrichment of either unmethylated or
methylated DNA by using proteins with specific binding domains. Each of these methods
can be combined with gene specific analyses or genome-wide detection of DNA methylation
patterns by microarrays or next generation sequencing techniques.
1.5.1. Utilization of methylation-sensitive restriction enzymes
The first group of methods that is based on digestion of native genomic DNA with methylation-
sensitive restriction enzymes such as HpaII, led to the identification of CpG islands, which
appeared as a distinct fraction of DNA fragments in a gel (see section 1.4; Bird et al. 1985).
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The technique Methylation-Sensitive Restriction Enzyme Digestion PCR (MSRE-PCR) is
also based on digestion of genomic DNA with methylation-sensitive restriction enzymes.
DNA digestion is followed by multiplexed PCR to enable determination of the methylation
status of several promoter regions in the same sample (Melnikov et al. 2005). Direct diges-
tion of genomic DNA is furthermore used for the microarray-based technique Differential
Methylation Hybridization (DMH; Yan et al. 2002). For DMH, genomic DNA is first cut with
MseI which leaves CpG islands intact and cuts bulk DNA into small fragments. CpG islands
are then ligated to linkers and cut with methylation-sensitive restriction enzymes. Only CpG
islands that remain intact and keep their linkers can subsequently be amplified and hybridized
to a microarray.
1.5.2. Bisulfite-mediated conversion of unmethylated cytosines
The second group of methods is based on bisulfite conversion of DNA. Treatment of genomic
DNA with sodium bisulfite results in conversion of unmethylated cytosine bases to uracil
(Frommer et al. 1992). Bisulfite-mediated deamination of cytosine takes place by reversible
addition of HSO3-, followed by liberation of NH3 by hydrolysis and a subsequent release of
HSO3-, which results in the formation of uracil (Fig. 1.10; Hayatsu 2008). Several analysis
methods can subsequently be performed which employ the fact that the newly generated uracil
bases are amplified as thymines when bisulfite-treated DNA is subjected to a PCR reaction.
Most commonly, bisulfite-treated DNA is either subjected to amplification of genomic regions
of interest followed by subcloning and Sanger sequencing (Frommer et al. 1992) or generation
of sequencing libraries for genome-wide analysis of DNA methylation patterns by next
generation sequencing (Bock 2012; Ziller et al. 2013; Lou et al. 2014; Rauch et al. 2012).
It is furthermore possible to interrogate the methylation status of specific loci by PCR
using primers designed for either unmethylated or methylated DNA (Methylation-Specific
PCR (MSP); Herman et al. 1996) or by Real-Time PCR-based analysis of differences in
melting temperatures (Methylation-Sensitive High-Resolution Melting (MS-HRM); Wojdacz,
Dobrovic, and Hansen 2008). Another method applied to analyze bisulfite-treated genomic
DNA is Combined Bisulfite Restriction Analysis (COBRA). COBRA is based on the fact
that, due to the methylation-dependent conversion of cytosines, specific restriction enzyme
recognition sites are formed or lost in the resulting PCR products (Xiong and Laird 1997;
Bilichak and Kovalchuk 2017). Common enzymes used for digestion of such PCR products
are TaqI (T|CGA) or BstUI (CG|CG).
Bisulfite treated DNA can also be analyzed by specific microarrays such as Illuminas Infinium®
HumanMethylation450 BeadChip which was designed to cover 450,000 methylation sites in
the human genome at single-nucleotide resolution. For this assay, genomic DNA is treated
with bisulfite followed by whole genome amplification (WGA). Each CpG site is covered by
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Figure 1.10.: Conversion of cytosine to uracil by bisulfite-treatment (Hayatsu 2008).
two types of beads present on the array, one corresponding to the methylated variant of the
respective locus and the other corresponding to the unmethylated variant. Depending on the
methylation status DNA fragments anneal to one of these two bead types and fluorescence
detection allows for identification of the bead type (Bibikova et al. 2009). The Infinium®
HumanMethylation450 BeadChip assay is widely used in epigenome-wide association studies
(EWAS; see e.g. Rakyan et al. 2011) and in studies within the scope of the efforts of the
Human Epigenome Consortium (Morris and Beck 2015).
1.5.3. Enrichment of methylated or unmethylated DNA
Using the third detection principle for cytosine methylation, methylated DNA fragments
can be enriched from a pool of sheared, untreated genomic DNA using an antibody against
methylated DNA (Methylated DNA Immunoprecipitation (MeDIP)) or a Methyl-CpG binding
domain (MBD) protein (Weber et al. 2005; Rauch et al. 2006a; Bock 2012). When both
methods were compared, the 5mC-antibody was shown to exhibit a higher affinity towards
DNA sequences with a low CpG density, whereas MBD-based enrichment favored regions
with a higher density of CpGs. Accordingly, by using an MBD protein the highest proportion
of CpG islands could be enriched (Nair et al. 2011). It is furthermore possible to specifically
enrich unmethylated DNA fragments by using zinc finger CXXC-domain containing proteins
like DNMT1, which physiologically recruit chromatin-modifying complexes to unmethylated
DNA (Blackledge et al. 2011; Long, Blackledge, and Klose 2013). Enriched fractions can
subsequently be analyzed by microarray hybridization (Rauch et al. 2006b) or next generation
sequencing (Li et al. 2010).
1.5.4. State-of-the-art DNA methylation analysis and its limitations
Due to technological advances and reduced costs of whole-genome sequencing experiments,
DNA methylation analyses shifted from gene-specific to genome-scale approaches. Whole-
genome bisulfite sequencing is considered the current ’gold standard method’ as it enables a
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higher genome coverage than microarrays and provides DNA methylation data in the highest
possible resolution. However, as this method still requires a sufficient sequencing depth and is
not feasible for large numbers of samples (e.g. patient cohorts), methylation microarrays such
as the Infinium® HumanMethylation450 BeadChip are popular as well. By such experiments,
a variety of DNA methylation maps was generated which revealed several interesting, yet
not completely understood, insights into an overall effect of DNA methylation on certain
phenotypes. For example, inter-individual variability of drug metabolizing enzymes was
shown to be associated with DNA methylation-dependent control of alternative splicing events
(Habano et al. 2015). In human placenta tissue, global DNA methylation analyses resulted in
the identification of apparently unstructured, partially methylated domains (PMDs) that could
be associated with specific functional groups of genes related to developmental processes
(Schroeder and LaSalle 2013). DNA methylation marks were furthermore shown to represent
suitable biomarkers. For example, promoter methylation of the Fragile X mental retardation
1 (Fmr1) gene was shown to be associated with differences in the response of patients to a
specific antagonistic drug (Jacquemont et al. 2011).
However, there are still some limitations to each method. Incomplete bisulfite conversions and
bisulfite PCR errors are considered to be sources of bias in DNA methylation analyses by next
generation sequencing as well as bisulfite-based microarray experiments. These microarrays
can also be biased by cross-hybridizations (Laird 2010). As the Infinium® HumanMethyla-
tion450 BeadChip assay is a tool which is used frequently (De Meyer et al. 2015; Yue et al.
2016; Smith et al. 2016), several studies exist that analyze its performance in general and
also in comparison to sequencing-based methodologies. In these studies it was shown that
SNPs present in the analyzed genomes may lead to false interpretations of methylation signal
differences (Daca-Roszak et al. 2015) and that cross-reactive probes and polymorphic CpGs
exist on this array (Chen et al. 2013). According to this multitude of potential biases that exist
for each individual method, a comparison of the Infinium® HumanMethylation27 BeadChip
assay (the predecessor of the HumanMethylation450 BeadChip) to different genome-wide
sequencing-based methods showed that only about one-fifth of the differentially methylated
regions identified by whole-genome sequencing approaches were detected by the microarray-
based method (Bock et al. 2010). Between sequencing-based methods, differences in the
detection of differentially methylated regions (DMRs) were shown in this publication as well,
although the results of these methods were generally shown to overlap to a larger extent
(Walker et al. 2015).
1.5.4.1. Novel technologies
When the methylcytosine dioxygenase family of TET enzymes was discovered in 2009 and
5mC was shown to be actively modified to 5hmC, 5fC and 5caC, followed by cytosine
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restoration by the TDG enzymes (Tahiliani et al. 2009), methods were developed to map these
modifications in single-base resolution on a genome-scale. Booth et al. developed the method
Oxidative Bisulfite Sequencing (oxBS-Seq) to discriminate 5mC and 5hmC, as both modified
bases are protected from bisulfite conversion. OxBS-Seq is based on the conversion of 5hmC
to 5fC, which is converted to uracil by bisulfite treatment and is therefore read as thymine in
sequencing. By combination of bisulfite sequencing and oxBS-Seq data the identification of
5hmC sites is possible (Fig. 1.11, left; Booth et al. 2012). 5fC maps could be generated using
Reduced Bisulfite Sequencing (redBS-Seq; Fig. 1.11 right). This method employs the fact
that 5fC is reduced to 5hmC through treatment of DNA with sodium borohydride, and 5hmC,
when treated with bisulfite, is resistant to the bisulfite conversion reaction. Alignment of
bisulfite reads from reduced and non-reduced DNA allows for single-base mapping of 5fmC
(Booth et al. 2014).
Figure 1.11.: Principle of Oxidative Bisulfite Sequencing (oxBS-Seq) and Reduced Bisulfite Sequenc-
ing (redBS-Seq; Booth et al. 2014).
5caC detection was shown to be possible by Chemical Modification-Assisted Bisulfite Se-
quencing (CAB-Seq), which is based on chemical labeling of 5caC and changed behavior of
the modified base during bisulfite conversion (Lu et al. 2013). Thereby, it was e.g. shown
that 5fC and 5caC accumulated at hypomethylated promoters in embryonic stem cells (Neri
et al. 2015). Bachman et al., as another example, analyzed temporal dynamics of 5fC levels
in mouse DNA and found them to be stable and not correlated to the levels of the precursors
5mC and 5hmC (Bachman et al. 2015). As 5fC has a genomic profile distinct from the ones
of its precursors and was shown to alter the DNA structure, the authors hypothesized that 5fC
is not only a demethylation intermediate, but influences gene regulation distinctly to 5mC.
In parallel to the development of novel technologies for mapping of 5mC intermediates,
bisulfite sequencing of single cells is attracting increasing attention, as the current whole-
genome approaches require millions of cells and do not allow for studies of cell populations
or cell-to-cell heterogeneity. Recently published protocols for single-cell methylomics were
already tested in different biological systems (see e.g. Farlik et al. 2015) and will eventually
enable the elucidation of phenomena such as the above-mentioned partially methylated
domains.
23
Chapter 1. Introduction
1.6. Epigenetic studies in the production of
biopharmaceuticals
While epigenomics in human cells and tissues got into the focus of scientists after completion
of the Human Genome Project in 2001, it took about a decade longer for the biotechnological
community to address epigenetic phenomena in the production of biopharmaceuticals on
a genome-scale. This is in parts due to the fact that the CHO genome and transcriptome
sequences are only available since 2011 (Xu et al. 2011; Becker et al. 2011). Therefore, most
of the current studies focus on recombinant genes and regulatory elements. Most recently,
a first report on epigenetically engineered CHO cell lines was published, underlining the
increasing amount of evidence for the importance of epigenetic phenomena in these cells
(Tastanova et al. 2016).
1.6.1. Analysis of single recombinant genes and promoters
Several studies were conducted that analyzed recombinant genes or promoters. Amongst them,
many were specifically interested in methylation changes of the cytomegalovirus (CMV)
promoter. Kim and co-workers, for example, analyzed monoclonal antibody producing
CHO cell lines during extended sub-culture in the presence of selective pressure (Kim et al.
2011). A detailed examination of CMV promoter methylation (29 CpG sites) was performed
using bisulfite sequencing and revealed that the instable and low generation number cell
lines were affected by pCMV methylation that strongly increased during sub-culturing. The
correlation between pCMV methylation, instability of productivity and its potential to be
used as a biomarker was also addressed by Osterlehner et al., who established a qPCR-based
screening method allowing for enrichment of stable producers early in cell line development
(Osterlehner, Simmeth, and Göpfert 2011). In a follow-up study that aimed to identify further
markers of production stability, histone modifications in the vicinity of the CMV promoter
were analyzed and proved to be even more indicative of stability than DNA methylation.
Enrichment of stable producer cells was shown to be able by selecting those clones with
the highest levels of histone H3 acetylation (Moritz et al. 2016). Adding to this is a study
which examined DNA methylation and chromatin modifications along the human Eukaryotic
translation elongation factor 1 alpha 1 (EEF1A1) promoter as part of an antibody expression
cassette in CHO cells (Veith et al. 2016). Here, also, histone acetylation was associated
with high expression levels and was found to be more predictive than DNA methylation. As
a consequence of these findings, Saunders et al. assessed different chromatin modifying
elements for their potential to negate negative effects of the insertion sight and maintain
transgene expression. The elements were integrated either between sequences coding for
heavy and light antibody chains or in flanking positions. The A2UCOE (Ubiquitously acting
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chromatin-opening element derived from the human HNRPA2B1-CBX3 locus) element was
shown to be able to increase antibody yields about 6.5-fold, to mitigate the reduction of
antibody production over 120 generations and to reduce transgene promoter methylation
(Saunders et al. 2015).
Besides promoter regions, recombinant genes were also analyzed regarding their potential
to influence gene expression by induction of epigenetic mechanisms. In 2010 Bauer and
colleagues analyzed the impact of intragenic CpG content on gene expression in transiently
and stably transfected CHO cells (Bauer et al. 2010). By modulation of the codon usage of
green fluorescent protein (GFP), the group created a CpG-depleted version of the reporter
and observed a promoter-independent and severe decrease in mRNA and protein abundance
upon CpG depletion. The decrease in gene expression was shown to be due to reduced
de novo transcription in nuclear run-on assays, and it was speculated that this indicated an
influence of CpG content on the chromatin structure along the open reading frames. In a
similar but extended study, the same comparison between the original GFP gene and a poorly
expressed, CpG depleted version, was performed using various promoters (CMV, EF-1alpha
and A2UCOE) and different cell systems (CHO and embryonic pluripotent carcinoma cells).
CpG depletion was shown to increase local chromatin density, and usage of the CMV promoter
led to silencing of recombinant genes irrespective of CpG content. In contrast, the EF-1alpha
promoter enabled high expression levels and delayed silencing. Silencing phenomena could
be prevented completely by using the A2UCOE promoter, which was hypothesized to be due
to its chromatin-opening abilities (Krinner et al. 2015).
1.6.2. Epigenetic engineering
A first report of epigenetic engineering in the context of recombinant protein production
was published by Tastanova et al., who screened 29 polycomb proteins for their potential to
enhance recombinant gene expression in CHO cells (Tastanova et al. 2016). Upon binding,
polycomb proteins are known to recruit chromatin-remodeling proteins and modify the
chromatin (both locally and globally) surrounding regulatory elements. Thereby, they regulate
key developmental genes (Entrevan, Schuettengruber, and Cavalli 2016). In the screening
experiment, the Yin yang 1 (YY1) protein had the greatest impact on the expression of
several product genes and CHO cell lines stably expressing YY1 in moderate amounts showed
6-fold higher antibody titers. Interestingly, higher levels of YY1 had the opposite effect
on recombinant gene expression. This is in accordance with a previous study that shows a
repressive effect of YY1 on the CMV promoter in CHO cells (Brown et al. 2015). The switch
between the activating role of moderate YY1 levels and the repressive effect of YY1 over
expression was shown in other contexts as well (Deng et al. 2009) and is referred to as a
so-called ’squelching effect’ (Gill and Ptashne 1988).
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1.6.3. Genome-scale epigenomics in long-term cultured cells
In contrast to the multitude of publications about global DNA methylation phenomena in
human and mouse, only one estimation of global DNA methylation in long-term cultured
cells existed previously to the beginning of this thesis and one study of global epigenetic
characteristics of CHO cells was published in 2016, when the major experiments of the study
presented here were already performed and published.
This first estimation of global DNA methylation in long-term cultured cells was made in 1990,
when Antequera et al. showed that CpG island methylation has a pivotal role in permanent
inactivation of genes in cultured cells. They hypothesized that transcriptional repression was
often falsely related to mutations (Antequera, Boyes, and Bird 1990) based on experiments
using permanent human and murine cell lines which exhibited unexpectedly high numbers of
methylated CpG islands. These were mostly associated with genes unnecessary in culture.
High methylation levels were e.g. detected for the Alpha-globin gene. Housekeeping genes
were not associated with methylated CpG islands, nor were genes relevant for the selection
process (Dihydrofolate reductase gene, Dhfr; first shown by Stein et al. 1983). As similar cell
lines showed comparable methylation patterns, the authors hypothesized that about 50 % of
all CpG islands become methylated in long-term cultured cells.
In 2016, Feichtinger et al. analyzed six related CHO cell lines regarding their genome
sequences and DNA methylation patterns as well as global histone modifications under
different culture conditions, in different media and after subcloning (Feichtinger et al. 2016).
Generally, all CHO cell lines showed a bimodal distribution of either hypo- or hypermethylated
CpGs with overall methylation levels of 55–65 %. The numbers of differentially methylated
regions between the cell lines were shown to be low in response to passaging and during
batch cultivation, and high as a consequence of several rounds of subcloning and selection
of a certain phenotype or in response to media changes. In contrast, histone modifications
were found to significantly change during a batch culture and growth phases could clearly be
distinguished. The authors hypothesized that DNA methylation changes play a major role in
defining CHO cell phenotypes, while short term changes in gene expression, like those related
to different nutrient availabilities in batch cultures, are rather associated with alterations in
histone marks.
1.7. Butyrate: Physiological effects and biotechnological
application
Butyrate is a short chain fatty acid (SCFA; Fig. 1.12) which is generated in high levels (mM
range) during fermentation of carbohydrates in the colon (Steliou et al. 2012).
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Figure 1.12.: Chemical structure of butyrate.
It was shown to be the primary energy source and an anti-inflammatory agent for normal
colorectal epithelium and, simultaneously, to prevent growth of colorectal cancer cells by
inhibiting Histone deacetylases (HDACs), thereby altering the expression of genes with
functions in proliferation, apoptosis and differentiation. On the contrary, butyrate stimulates
growth of normal colon cells. This phenomenon is referred to as ’the butyrate parodox’
(Fleming et al. 1991; Hamer et al. 2008; Zhang et al. 2010; Donohoe and Bultman 2012).
1.7.1. Cells respond differently to butyrate due to the Warburg effect
What are putative reasons for the ’butyrate paradox’? In 2012 Donohoe et al. provided proof
that the differences in cell metabolism that lead to the contradicting behavior of normal and
transformed cells in response to butyrate are due to the Warburg effect (Donohoe and Bultman
2012) This effect describes the phenomenon of aerobic glycolysis being the predominant
process of energy generation in cancer cells (and not oxidative metabolism; Vander Heiden,
Cantley, and Thompson 2009). Donohoe et al. suggested that in cancer cells butyrate
is not metabolized in the mitochondria, but accumulates in the cell and inhibits histone
deacetylases, thereby regulating genes that inhibit proliferation and induce apoptosis (Fig.
1.13). Accordingly, Cyclin-dependent kinase inhibitor 1 (p21), Nuclear factor kappa B (NFkB)
and components of the Mitogen-activated protein kinase (MAPK) pathway have previously
been shown to be affected by butyrate (Archer et al. 2005; Lührs et al. 2002; Scott, Longpre,
and Loo 2008; Kolar et al. 2007). In their experiment, Donohoe et al. prevented the Warburg
effect from occuring in cancer cells and showed that this was sufficient to induce butyrate-
mediated induction of growth. When higher doses of butyrate were used, proliferation was
inhibited nevertheless, as the cellular capacities for oxidation of the SCFA were used up. The
study also showed that butyrate not only functions as an HDAC inhibior - a butyrate function
that has long been known (Boffa et al. 1978) - but also as a histone acetyltransferase (HAT)
activator due to its contribution to acetyl-CoA production when it is oxidatively metabolized
(Donohoe and Bultman 2012; Donohoe, Curry, and Bultman 2013).
1.7.2. Effects of butyrate on DNA methylation
Although research on butyrate-induced effects has mainly focused on its role as an HDAC
inhibitor yet, several lines of evidence also hint towards a contribution of butyrate-induced
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Figure 1.13.: Differences in cellular metabolism between normal and cancer cells result in opposing
effects upon butyrate addition (figure based on Donohoe et al. 2013).
changes in DNA methylation to its overall effect. A striking hint on a putative major influence
of butyrate on DNA methylation came from research on honey bees. Fertile queens and
sterile worker bees have identical genetic backgrounds and queen development is induced
by feeding a substance called royal jelly. When the effect of RNA interference-mediated
knockdown of DNMT3 was analyzed in honey bee larvae, a majority of these larvae emerged
as queens and exhibited fully developed ovaries. This suggested that the major phenotypic
difference between queen and worker bees is established by nutritional input (Kucharski et al.
2008). Although it is not fully clear yet what components of royal jelly indeed have such a
great impact on the epigenetic system, it is speculated that a substance similar to butyrate,
phenylbutyrate, which is also a known HDAC inhibitor, primarily contributes to this effect
(Chittka and Chittka 2010; Lyko et al. 2010).
Several other key enzymes responsible for setting and removing DNA methylation marks
were shown to be affected by butyrate. In a study examining the relationship between
butyrate (which is also used as an antidepressant) and DNA methylation in brain tissue, lower
expression levels of TET1 were found that were associated with increased hydroxymethylation
of a gene relevant for neurogenesis and synaptic plasticity (Wei et al. 2015). As another
major regulator of DNA methylation, DNMT1 was also found to be influenced by butyrate.
It was shown that butyrate repressed MAP kinase I (ERK) activation, which was linked
to downregulation of DNMT1 protein levels and subsequent changes in DNA methylation
(Sarkar et al. 2011). Furthermore, butyrate was shown to influence the expression of Growth
arrest and DNA damage inducible protein (GADD45) isoforms which are suspected to
contribute to DNA demethylation by DNA damage repair (Chen et al. 2002; Rai et al. 2008).
Several studies furthermore report changes of gene-specific DNA methylation levels in
response to butyrate treatment. For example, butyrate-induced promoter demethylation of
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Secreted frizzled-related protein (SFRP) proofed to be related to changes in SFRP gene
expression and subsequent inhibition of WNT signaling in gastric cancer (Shin et al. 2012).
It was also shown that butyrate exposure resulted in histone acetylation and decreased DNA
methylation of Gamma-globin genes upon pharmacological, butyrate-depended induction of
fetal hemoglobin (Fathallah et al. 2007).
1.7.3. The effect of butyrate on CHO cell cultures
The first report of an effect of butyrate addition on morphology and growth of Chinese
hamster cells was published in 1973 (Wright 1973). Only few years later, this effect was
related to cellular energy processes, and in 1980 it was shown that butyrate influences cell
cycle progression by induction of G1 phase arrest and histone acetylation in CHO cells
(Storrie, Puck, and Wenger 1978; D’Anna, Tobey, and Gurley 1980). Okabayashi et al.
were amongst the first to report of an effect of butyrate addition on the production of a
recombinant gene in CHO cells. They expressed a Preprourokinase gene in CHO-K1 cells
under the control of the Simian virus 40 early region (SV40) promoter. Addition of 5 mM
butyrate led to an increase in productivities of 2-3-fold (Okabayashi, Kanéda, and Arimura
1989). Since then, many publications proved the productivity enhancing effect of butyrate
on CHO cells expressing recombinant proteins. The effect was shown for proteins such as
Tissue plasminogen activator, Thrombopoietin, Glycosyltransferases or several monoclonal
antibodies, and it was observed for both the CMV and the SV40 promoter (Palermo et al.
1991; Jiang and Sharfstein 2008; Klausing, Krämer, and Noll 2011; Sung et al. 2004; Choi
et al. 2005).
The positive effect of butyrate addition on CHO cells are not only accompanied by detrimental
effects such as growth inhibition and apoptosis. It was furthermore reported that the quality
and bioactivity of glycoproteins can be influenced by butyrate, as butyrate treatment resulted
in changed galactosylation of monoclonal antibodies (Hong et al. 2014). Lee et al. also proved
a correlation of butyrate addition and glycosylation. They showed that butyrate treatment led
to a reduction of the relative proportion of the sialic acid content of a recombinant glycoprotein
that was accompanied by altered expression of several genes related to glycosylation. These
included UDP-glucose pyrophosphorylase or Sialidase-2 (Lee et al. 2014). However, another
study examining an effect of butyrate treatment on protein quality with respect to glycosylation
did not show significant changes in sialic acid content or antibody activity (Chen et al. 2011).
As butyrate addition apparently did not change product qualities in some cases, several
attempts have been made to reduce the detrimental side-effects regarding growth inhibition
and induction of apoptosis and enhance the positive effect of butyrate on productivities. For
example, a combination of supplementation of 2 mM butyrate and a cultivation temperature of
30 °C was shown to prolong the culture duration and increase the final antibody concentration
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(Chen et al. 2011). Suppression of apoptotic pathways by overexpression of Apoptosis
regulator Bcl-2 (BCL2) or X-linked inhibitor of apoptosis (XIAP) was also shown to have a
positive effect (Sung and Lee 2005; Kim, Leeds, and Chuang 2009). Further studies showed
that apoptosis-inhibitory antioxidants such as N-acetylcystein were capable of maintaining
long-term survival and enhance production of recombinant Interferon-beta-1a, or that CHO
cells deficient in the pro-apoptotic Apoptosis regulator BAX (BAX) and Bcl-2 homologous
antagonist/killer (BAK) proteins were able to withstand butyrate-induced apoptosis (Oh et al.
2005; Misaghi et al. 2013).
As knowledge about the mechanism underlying the butyrate effect promises to enable rational
cell line development in terms of employing the positive butyrate effects while omitting the bad
ones, several ’omics’ studies aimed to analyze the effect of butyrate addition on the CHO cell
transcriptome or proteome. De Leon Gatti et al., e.g., could show that butyrate affected histone
modifications, lipid metabolism and protein processing as well as the expression of chaperone
genes (De Leon Gatti et al. 2007). In a study performed by Kantardjieff et al. butyrate was
shown to affect expression of genes related to protein secretion and signaling (Kantardjieff
et al. 2010). Klausing et al. could furthermore show that genes related to carbohydrate, lipid,
amino acid and glycan metabolism were upregulated upon butyrate addition, whereas genes
associated with cell growth and apoptosis were downregulated (Klausing, Krämer, and Noll
2011). Yee at al. could also show that butyrate increased the expression of genes involved
in protein secretion and redox activity and decreased the expression of genes related to cell
cycle and apoptosis (Yee et al. 2008).
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Research objective
Chinese hamster ovary (CHO) cells represent the major mammalian production cell line
for therapeutic proteins. Several aspects of the molecular mechanisms underlying their
unique properties remain poorly understood, although a variety of ’omics’ studies was
performed that analyzed the CHO cell genome (Xu et al. 2011), transcriptome (Becker et al.
2011; Kantardjieff et al. 2010) or proteom (Beckmann et al. 2012; Nissom et al. 2006).
A cellular level that has attracted less attention yet is the CHO cell epigenome. The term
’epigenome’ summarized mechanisms which regulate gene expression without altering the
DNA sequence and includes methylation of DNA, posttranslational modifications of histones
and posttranscriptional gene silencing by small RNAs. DNA methylation in CHO cells has
mostly been studied in experiments focusing on single recombinant genes or promoters before.
Here, genome-wide DNA methylation and its effect on gene expression was supposed to be
analyzed in an exemplary, antibody-producing CHO cell line.
The detection of methyl-groups at cytosine bases can be performed employing the conversion
of unmethylated cytosines to uracil by treatment of DNA with bisulfite and subsequent analysis
by next generation sequencing. In comparison to other methods for DNA methylation analysis,
this technique allows for the generation of DNA methylation data with the highest genome
coverage and resolution. Therefore, whole-genome bisulfite sequencing was supposed to be
implemented for CHO DP-12 cells that produce a recombinant human anti-IL-8 antibody.
Furthermore, whole-genome DNA methylation data were supposed to be combined with gene
expression measurements to allow for an assessment of potential phenotypic effects of DNA
methylation and functional significance.
Chapter 2. Research objective
Whole-genome bisulfite sequencing and gene expression studies were supposed to be applied
to shed light on the DNA methylation landscape of CHO DP-12 cells. As a DNA methylation
map for CHO cells did not exist before, this was considered an important step towards under-
standing CHO cell characteristics. Data generated in this way for several other mammalian
cell types offered for example new explanations regarding causalities of diseases such as
cancer or could be used to identify diagnostic biomarkers. In a second application the effects
of the productivity enhancing short chain fatty acid butyrate on DNA methylation and gene
expression were supposed to be analyzed in a time course approach, as supplementation of
butyrate is known to enhance cell specific productivities and leads to alterations of epigenetic
silencing events.
As another tool for DNA methylation analysis in CHO cells, a specifically designed CpG
island microarray, already existed (Wippermann 2012; Wippermann et al. 2013), CpG island
microarray performance was supposed to be compared to whole-genome bisulfite sequencing
regarding the butyrate effect on DNA methylation. CpG island microarray experiments
were supposed to be verified by gene-specific analysis of DNA methylation and control
hybridization experiments. Finally, putative central mediators of the butyrate effect were
supposed to be identified based on the comparative data analysis and functionally analyzed in
transient knockdown experiments by RNA interference.
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3.1. Cell culture and cultivation process analysis
3.1.1. CHO cell lines
For analysis of the CHO cell DNA methylation landscape and differential DNA methyla-
tion upon butyrate treatment CHO DP-12 cells were used. The effect of siRNA-mediated
knockdown of DNMT3A was analyzed in CHO DP-12 cell cultures, too. The strength of
endogenous CHO promoters was measured using both CHO DP-12 and CHO K1 cell lines.
The comparative analysis of CHO clones with differences in their production stability was
performed usind CHO-XL99 cell clones.
The CHO K1 cell line (ATCC CCL-61) was derived as a subclone from the parental CHO cell
line that was established by Theodor Puck in 1957 (Puck 1958).
Anti-Interleukine-8-antibody-producing CHO DP-12 cells (clone#1934, ATCC CRL-12445)
were derived by co-transfection of CHO DP-12 cells with the vectors p6G4V11N35A.choSD.9
and p6G4V11N35E.cho-SD.10 (U.S. patent 6,025,158) that enable the expression of variable
heavy and light regions of two variants of the murine 6G4.2.5 monoclonal antibody. Both
vectors were generated based on a dicistronic DHFR expression vector that produces the
selectable marker and recombinant cDNAs of the heavy and light chain from a single primary
transcript by differential splicing (Lucas et al. 1996). The SV40 promoter was used for recom-
Chapter 3. Materials and methods
binant gene expression. CHO DP-12 cells were transfected by lipofection and methotrexate
was used for gene amplification.
CHO-XL99 cells were kindly provided by the Australian Institute for Bioengineering and
Nanothechnology (AIBN). The CHO-XL99 clones used here were CHO K1 derivatives (from
the original ATCC-61 vial) that have been adapted step-wise to chemically defined conditions.
They produce a therapeutic IgG1 antibody. For this thesis CHO-XL99 clones were used that
showed differences in the stability of IgG1 production depending on the presence of selection
pressure by puromycin.
3.1.2. Cultivation conditions
CHO K1 and CHO DP-12 cells were cultivated in chemically defined, animal component-free
medium CHOMACS® CD (Miltenyi Biotec, Bergisch Gladbach, Germany) supplemented
with 6 mM L-glutamine (Fagron GmbH&Co.KG, Barsbüttel, Germany). For cultivation of
CHO DP-12 cells 200 nM Methotrexate (MTX; Wyeth, Madison, New Jersey) and 0.1 mg/L
Insulin-like growth factor (Long R3 IGF-I; Sigma-Aldrich, Munich, Germany) were added to
the media. Cells were cultivated in 250 mL shaker flasks (Corning Inc., Corning, New York)
with a culture volume of 70 mL and a seeding cell density of 3×105 cells/mL. Culture flasks
were kept at 37 °C, 80 % humidity and 5 % CO2 on a shaking platform at 185 rpm (50 mm
diameter rotation). Batch cultivation of CHO-XL99 cells was performed at the Australian
Institute for Bioengineering and Nanotechnology.
3.1.3. Cryopreservation and thawing
To preserve CHO cells, 1×107 cells from the exponential growth phase were centrifuged
for 5 min at 800 rpm (Megafuge 1.0, Thermo Fisher Scientific) and resuspended in ice cold
freezing medium (10 % DMSO, 90 % CHOMACS® CD, 6 mM glutamine). 1.5 mL resus-
pended cells were transfered to cryo vials (Nalgene Cryoware Cryogenic Vials, ThermoFisher
Scientific) that were placed into freezing containers at -80 °C (Mr. Frosty™ Freezing Con-
tainer, Thermo Scientific) to achieve a rate of cooling of -1 °C/min. 24 h later the tubes were
transfered to the nitrogen tank (Chronos Biosafe 150). After thawing cryopreserved cells were
washed with ice cold PBS (137 mmol/L NaCl, 2.7 mmol/L KCl, 10 mmol/L Na2HPO4, 1.8
mmol/L KH2PO4), centrifuged at 200×g and resuspended in pre-warmed culture medium.
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3.1.4. Measurement of cell count and viability
Measurements of cell densities and viabilities were performed on a Cedex AS20 cellcounter
(Innovatis AG, Bielefeld, Germany) in triplicates. Viabilities were determined by utilization
of the Trypan Blue exclusion method. The required sample volume was 300 µL. Samples
were diluted 1:2 with phosphate buffered saline (PBS) buffer (155.2 mM NaCl, 1.5 mM
KH2PO4, 5.1 mM Na2HPO4, pH 7.2).
3.1.5. Measurement of glucose and lactate concentrations
Glucose and lactate concentrations were measured using the YSI 2700 Select Analyzer,
which employs immobilized enzymes (Glucose Oxidase and L-Lactate Oxidase) to oxidate
glucose and lactate, repectively, and produce hydrogen peroxide that generates a probe signal
current (Yellow Springs Instruments Inc., Yellow Springs, Ohio, USA). Cell suspensions were
centrifuged for 5 min at 200×g and the culture supernatants were diluted 1:5 with PBS prior
to the mesurement.
3.1.6. Measurement of IgG concentrations
IgG concentrations were measured with a HPLC method on protein A columns according
to the manufacturer’s protocol (Poros A, Applied Biosystems, Foster City, California). Cell
suspensions were centrifuged for 5 min at 200×g. Subsequently, 120 µL supernatant were
centrifuged for 5 min at 16,000×g through a 0.2 µm filter (VWR, Radnor, Pennsylvania,
USA). 100 µL were used for each measurement. Quantification of peak areas to determine
antibody concentrations was performed in comparison to internal standards.
3.1.7. Transient tansfection of CHO cell cultures
For RNA interference experiments shRNA-expression plasmids were delivered to CHO DP-12
cell cultures by transient transfection. Also, the strength of endogenous CHO promoters was
analyzed in transiently transfected CHO DP-12 and K1 cultures. Transfection of promoter-
reporter constructs was performed on a Nucleofector® 2b (Lonza, Basel, Switzerland) using
the Amaxa® Cell Line Nucleofector® Kit L (Lonza, Basel, Switzerland). For each transfection
reaction 1×106 cells were harvested by centrifugation at 200×g for 5 min and resuspended
in 100 µL Nucleofector® solution (supplied supplement added at a ratio of 4.5:1) that was
than combined with 6 µg of plasmid DNA. The mixture was transfered to a Nucleofector®
cuvette and Nucleofector® program X-001 was applied. Immediately 500 µL pre-warmed
culture medium were added and the cells were transfered into a 12-well plate containing
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1.5 mL pre-warmed medium. The transfected cells were incubated for 24 h at 125 rpm, 37 °C
and 5 % CO2 before they were harvested.
3.2. Microbiological methods
3.2.1. Bacterial culture
Microbiological experiments were performed using OneShot® TOP10 Chemically Competent
E. coli cells (Invitrogen, Carlsbad, California, USA. Genotype: F- mcrA ∆( mrr-hsdRMS-
mcrBC) Φ80lacZ∆M15 ∆ lacX74 recA1 araD139 ∆( araleu)7697 galU galK rpsL (StrR)
endA1 nupG). Bacteria were cultivated in LB medium (5 g/L yeast extract, 10 g/L tryptone,
10 g/L NaCl; autoclaved) or on LB agar plates (LB medium, 12 g/L agar; autoklaved) at
37 °C on a benchtop shaker at 200 rpm under an incubation hood (Certomat® MO II and
Certomat H, Sartorius, Göttingen, Germany) and in an incubator (Function Line, Heraeus
Instruments, Hanau, Germany), respectively. Transformants were selected by antibiotics
resistance. All plasmids used in this work contain an ampicillin resistance gene and ampicillin
was added to the cultivation media in a concentration of 100 µg/L.
3.2.2. Preparation of competent E. coli cells using calcium chloride
Chemically competent E. coli cells were generated using calcium chloride according to
Sambrook and Russell (Sambrook and Russell 2006). 50 µL of an E. coli overnight preculture
were added to 100 mL LB medium. The culture was incubated at 37 °C and 200 rpm while
its growth was monitored by measuring the optical density at 600 nm (OD600) every 15-20
min. When the OD600 reached 0.35 the culture was harvested by cooling it for 10 min on ice
in 50 mL tubes (Corning Inc., Corning, New York, USA) and a following centrifugation at
2,700×g for 10 min at 4 °C (Rotina 420R, Hettich Lab Technology, Tuttlingen, Germany).
The pellet was resuspended in 30 mL ice-cold MgCl2-CaCl2 solution (80 mM MgCl2, 20 mM
CaCl2; sterile filtered) followed by centrifugation for 10 min at 4 °C. Subsequently, the pellet
was again resuspended, this time in 2 mL ice-cold 0.1 M CaCl2, and dispensed into aliquots
of 50 µL that were either directly used for transformation or stored at -80 °C.
3.2.3. Transformation of competent E. coli cells
For transformation DNA was added to the competent cells and the mixture was stored on ice
for 30 min followed by a heat shock at 42 °C for 1 min. After the heat shock the cells were
rapidly transfered to ice and 800 µL SOC medium (20 g/L tryptone, 5 g/L yeast extract, 10
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mM NaCl, 2,5 mM KCl, 10 mM MgSO2, 10 mM MgCl2, 20 mM glucose; autoclaved) were
added. The cells were incubated at 37 °C on a shaking platform (ThermoMixer®, Eppendorf,
Hamburg, Germany) for 45 min. Cells were then collected by centrifugation for 2 min at room
temperature in a benchtop centrifuge (MiniSpin, Eppendorf), resuspended in SOC medium
and plated on LB agar.
3.2.4. Plasmid preparation
Preparation of up to 20 µg plasmid DNA from culture volumes of 5 mL was performed using
the GeneJet Plasmid Miniprep Kit (ThermoFisher Scientific Inc., Waltham, Massachusetts,
USA) according to the manufacturer’s instructions. For minipreparations, E. coli clones from
selection LB agar plates were inoculated into selective LB medium and grown overnight at
37 °C and 200 rpm. Large scale isolation of plasmid DNA (up to 200 µg) was performed
using the GeneJet Plasmid Midiprep Kit (ThermoFisher Scientific Inc.) according to the
manufacturer’s instructions. For midipreparations, a 5 mL preculture of the respective clone
was prepared and incubated for 8 h at 37 °C and 200 rpm. The pre-culture was then diluted
1:10 and incubated for 12-16 h.
3.3. Molecular biology methods
3.3.1. Preparation and analysis of DNA
For DNA preparation by phenol chloroform or columns CHO cells were washed twice with
PBS and the cell pellets were stored at -80 °C. Phenol chloroform extraction was used for gene
specific experiments and CpG island microarrays. For Illumina sequencing and generation
of the CHO cell methylome, DNA was isolated from washed cell pellets using the Qiagen
Genomic-tip 100/G system (Qiagen, Hilden, Germany) according to the manufacturer’s
instructions.
3.3.1.1. Isolation of DNA from CHO cells using Proteinase K and phenol
Cell pellets were resuspended in 600 µL Tris ethylenediaminetetraacetic acid (EDTA) buffer
(TE buffer; 10 mM Tris, 1 mM EDTA, pH 8.0). 2 mL lysis buffer (0.5 % SDS in TE buffer,
100 µg/mL Proteinase K, 20 µg/mL RNase A) were added. The sample was carefully mixed
by pipetting and incubated at 37 °C for 1 h, followed by an incubation at 50 °C for 4 h.
Subsequently, 1 volume of phenol chloroform isoamyl alcohol (PCI, ratio 25:24:1, pH 7.5-
8.0) was added and the sample was mixed for 10 min on a rotating mixer (VWR® Tube Rotator,
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VWR, Radnor, Pennsylvania, USA). Phase separation was performed by centrifugation at
maximum speed for 10 min (Rotina 420R, Hettich Lab Technology, Tuttlingen, Germany).
The upper aqueous phase was carefully removed and PCI extraction was repeated until
no white precipitate was visible within the interphase any more. The aqueous phase was
then extracted with one volume of chloroform isoamyl alcohol (CI, ratio 24:1) followed
by centrifugation for 1 min. To precipitate the DNA from the aqueous phase 0.5 volumes
NH4OAc (4.4 mM) and 2.5 volumes of 100 % ethanol were added and the sample was
placed into the freezer (-20 °C) overnight. The precipitate was collected by centrifugation at
maximum speed and 4 °C for 30 min. The supernatant was removed, the pellet was washed
with 70 % ethanol and resuspended in 1 mL TE buffer. To achieve complete dissolution of
the DNA, the tube was placed on a rocking platform (ThermoMixer®, Eppendorf, Hamburg,
Germany) for 2 h at 50 °C. DNA integrity was checked on 0.6 % agarose gels.
3.3.1.2. Agarose gel electrophoresis of DNA
Agarose gels (SeaKem LE-Agarose, Lonza, Switzerland) were prepared at concentrations of
0.6 % (w/v), 1 % (w/v) and 2 % (w/v) for separation of high molecular weight DNA, DNA
fragments and plasmids ≥ 500 bp, and DNA fragments ≤ 500 bp. Gels were cast and run
using Tris acetate EDTA (TAE) electrophoresis buffer (40 mM tris acetate, 1 mM EDTA).
DNA samples were mixed with 6-fold gel-loading buffer (0.25 % (w/v) bromophenol blue,
0.25 % (w/v) xylene cyanol FF, 30 % (v/v) glycerol in water). A voltage of 5 V/cm was
applied until the loading dye reached the desired position within the gel. Gels were stained
with GelRed (Biotium, Hayward, California, USA) for 10 min on a shaking platform and
detection of fluorescence signals was performed using a Fusion FX-7 system (Vilber-Lourmat,
Eberhardzell, Germany). DNA fragment size was determined by comparison with DNA
ladders (Fig. 3.1).
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Figure 3.1.: DNA ladders (Thermo Scientific) used for determination of DNA fragment sizes.
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3.3.1.3. DNA extraction from agarose gels
DNA was extracted from agarose gels using the GeneJet Gel Extraction Kit (ThermoFisher
Scientific, Waltham, Massachusetts, USA) according to the manufacturer’s instructions. DNA
was eluted in varying volumes of elution buffer depending on the subsequent application.
3.3.1.4. Analysis of DNA quantity and quality
For quantitative PCR, gene specific DNA methylation analyses and CpG island microarray
experiments, DNA quantity and quality (OD260/OD280) were determined using a NanoPho-
tometer with a LabelGuard™Microliter Cell (Implen, München, Germany). For Illumina
sequencing of the CHO cell methylome, DNA concentrations were determined using a Quant-
iT PicoGreen® dsDNA Assay Kit (Invitrogen, Carlsbad, USA) on a Microplate Reader Tecan
Infinite 200 (Tecan, Männedorf, Switzerland). Sequencing libraries were quantified with a
High-Sensitivity Chip on a Bioanalyzer (Agilent, Böblingen, Germany).
3.3.1.5. Sanger sequencing
To analyze site-specific DNA methylation in single-base resolution, PCR products amplified
from bisulfite-treated DNA were cloned into pJet1.2/blunt cloning vector in order to enable
sequencing of individual molecules (see section 3.4). Also, constructs for siRNA-mediated
knockdown of Dnmt3a (section 3.3.5.3; vector pLVX-shRNA1) and for the analysis of the
strength of endogenous CHO promoters (section 3.3.5.3; vector pMCS-Green Renilla Luc)
were controlled by Sanger sequencing in regard to the potential presence of mutations and
the completeness of the cloned oligonucleotides. DNA sequences were determined by the
MPIZ DNA core facility on Applied Biosystems Abi Prism 377, 3100 and 3730 sequencers
(Weiterstadt, Germany) using BigDye-terminator v3.1 chemistry. Premixed reagents were also
obtained from Applied Biosystems. Per sequencing reaction 10 µL plasmid DNA in elution
buffer at a concentration of 250 ng/µL and 1 µL primer at a concentration of 10 pmoL/µL
were required. Table 3.1 shows the primers used for sequencing. For sequencing reactions
with pJet1.2/blunt as a template, only the reverse primer was used, as no reliable sequencing
results were obtained using a forward primer.
3.3.2. Polymerase chain reaction (PCR)
Polymerase chain reactions (PCRs) were performed to amplify regions of interest from
bisulfite treated DNA or to amplify endogenous CHO promoter sequences from genomic
CHO K1 DNA. PCR products amplified from bisulfite treated DNA were either analyzed by
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Table 3.1.: Primers used for sequencing of DNA fragments inserted into pJet1.2/blunt cloning vector,
pMCS-Green Renilla Luc and pLVX-shRNA1.
Vector Primer Sequence (5’→ 3’)
pJet1.2/blunt pJet rev AAGAACATCGATTTTCCATGGCAG
pMCS-Green Renilla Luc
pMCS_LUC_for GGATAACCGTATTACCGCCATG
pMCS_LUC_rev CTGTCCAGCACGTTCATCTG
pLVX-shRNA1
pLVX-shRNA1-fwd TTTCTTGGGTAGTTTGCAGTTTT
pLVX-shRNA1-rev GCCAGAGGCCACTTGTGTAG
Combined Bisulfite Restriction Analysis (COBRA, see 3.4.2) or subcloned into pJet1.2/blunt
cloning vector for sequencing (see 3.3.1.5). Endogenous CHO promoter sequences were used
to generate reporter-promoter constructs for dual luciferase assays (see 3.5.2).
3.3.2.1. Amplification from bisulfite-treated DNA
An EpiMark® Hot Start Taq DNA Polymerase (NEB) was used to amplify regions of interest
from bisulfite treated DNA. Reactions were set up in a volume of 25 µL according to the
manufacturer’s recommendations. Generally, 2 µL purified, bisulfite treated DNA were used
as a template. Table 3.2 shows the cycling program used for PCRs with EpiMark® Hot Start
Taq DNA Polymerase. Table 3.3 lists the primers that were used.
Table 3.2.: Cyling program used for amplification of regions of interest from bisulfite treated genomic
DNA with EpiMark® Hot Start Taq DNA Polymerase. Annealing temperatures specific for
each pair of primers are listed in Table 3.3.
Time Temperature Cycles Comment
30 sec 95 °C 1 Initial denaturation
15 sec 95 °C
35-40
Denaturation
30 sec variable Annealing
1 min/kb 68 °C Elongation
5 min 68 °C 1 Final extension
∞ 12 °C 1 Hold
3.3.2.2. Amplification from native DNA
Genomic regions that were analyzed regarding their potential to initiate the expression of
recombinant genes by dual luciferase reporter assays were amplified from CHO K1 DNA
using a Q5® High-Fidelity DNA Polymerase (NEB) that exhibits a more than 100-fold lower
error rate than Taq polymerases. Reactions were set up in a volume of 25 µL according to the
manufacturer’s recommendations without 5 ×Q5® GC enhancer. About 50 ng of genomic
DNA were used as a template. Table 3.4 shows the cycling program used for PCRs with Q5®
High-Fidelity DNA Polymerase. Table 3.5 lists the primers that were used.
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Table 3.3.: Primers used for amplification of regions of interest from bisulfite treated CHO DNA. TA =
annealing temperature.
Name Sequence (5’→ 3’) Gene Amplificate [bp] TA [°C]
pBca1 for GGGTGTTAGGAATTAAATTTTTAATT
Bcat1 373 57
pBca1 rev CACAATAACTTTCTCTAAAACTCCC
pβActin for GGTAAGTAGGGATAATAGGTTTAGT
Actb 318 57
pβActin rev CCCCCAAAATAAACAAATAC
dvl1_for_BS TTTTAGTTAGGAGTTAAAAGTTGTATAATG
Dvl1 594 56
dvl1_rev_BS TAAATCAAATCTCAAATTAAAATACATCC
frizzled7_for_BS for GTAGGGTATTAAGAAGGAGGGTTGTAT
Fzd7 723 56
frizzled7_rev_BS ATAACTACAAAATCTTACCAAACCAAATC
myc_for_BS ATTTGGAAGGATAGTAAGTATATTGGAAG
Myc 541 56
myc_rev_BS AAATAAAACTCTAACTCACCATATCTCCT
dnmt3a_for TTTAGATTAAGAGTGGGAAAATATTTGA
Dnmt3a 407 53
dnmt3a_rev TTTTTCTCCTTAAAACTCCAAAATAAC
Table 3.4.: Cyling program used for amplification of promoter regions from CHO genomic DNA with
Q5® High-Fidelity DNA Polymerase. Annealing temperatures specific for each pair of
primers are listed in Table 3.5.
Time Temperature Cycles Comment
30 sec 98 °C 1 Initial denaturation
10 sec 98 °C
25-35
Denaturation
15 sec variable Annealing
20-30 sec/kb 72 °C Elongation
2 min 72 °C 1 Final extension
∞ 12 °C 1 Hold
3.3.2.3. Quantitative Real-Time PCR
Quantitative Real-Time PCR (qPCR) experiments for analysis of relative gene expression
or quality control of methylated DNA enrichment were performed on a LightCycler® 480
(Roche, Basel, Switzerland) using microtiterplates (White Multiwell Plate 96, Roche) and
Sealing Foil (Roche). For all experiments the Platinum® SYBR® Green qPCR SuperMix-UDG
Kit (ThermoFisher Scientific) was used. Per reaction 15 µL Platinum® SYBR® Green qPCR
SuperMix-UDG, 0.6 µL of both the forward and reverse primer (10 µM), 12.8 µL dH2O and
1 µL sample DNA were used. Sample analysis was performed in triplicates. Table 3.6 shows
the cycling conditions used for qPCR. Table 3.7 lists the primers that were used.
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Table 3.5.: Primers used for amplification of endogenous CHO promoter regions from CHO K1
genomic DNA. EcoRI and BamHI restriction endonuclease recognition sites are shown in
lowercase. TA = annealing temperature. NA = not assigned to any annotated gene.
Name Sequence (5’→ 3’) Gene Amplificate [bp] TA [°C]
P2_Eco_for GGACgaattcTTGGGGTGTGAAGAAAAGCC
NA 529 56
P2_Bam_rev GGACggatccCCACAAGCCAGGGATGGAT
P3_Eco_for GGACgaattcATACAGTTCCCCATGCTGTG
Hist1h4n 530 56
P3_Bam_rev GGACggatccTTTTCCAAGACCCTTACCGC
P5_Eco_for GGACgaattcATTCTCCAGCCTCCACCTCT
Rps3 339 56
P5_Bam_rev GGACggatccGTCCGAAATGCTTACCTTCCT
Table 3.6.: Cyling program for quantitative Real-Time PCR.
Time Temperature Cycles Comment
2 min 50 °C 1 UDG incubation
2 min 95 °C 1 Initial denaturation
15 sec 95 °C
40
Denaturation
30 sec 60 °C Annealing and elongation
0.11 °C/sec 45 °C to 95 °C 1 Melting curve
∞ 40 °C 1 Hold
3.3.3. Preparation and analysis of RNA
Total RNA was extracted for reverse transcriptase quantitative PCR (RT-qPCR) experiments
and for gene expression microarray analyses. RNA samples were permanently kept on ice.
3.3.3.1. RNA extraction
RNA extraction was performed using the Direct-zol™ RNA MiniPrep Kit (Zymo Research,
Irvine, California, USA) according to the manufacturer’s recommendations. RNA concentra-
tions were measured on a NanoPhotometer (Implen) that also enabled determination of RNA
purity by calculation of OD260/OD280 ratios. RNA samples were stored at -80 °C in aliquots
of 10 µL.
3.3.3.2. Quality control on denaturing agarose gels
Labeling of cDNA for gene expression microarray experiments requires RNA of high integrity.
Therefore, RNA integrity was checked on denaturing agarose gels prior to microarray analyses.
1 % agarose gels were prepared using 1×MOPS buffer (3-(N-morpholino)propanesulfonic
acid, 200 mM) with 6.5 % (v/v) formaldehyde (all work was performed under a fume hood).
Gels were pre-run in 1×MOPS buffer for 20 min at 5 V/cm to reach a temperature beneficial
for denaturation of the RNA molecules. 0.5 µg of total RNA were mixed with 6 µL 2× RNA
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Table 3.7.: Primers used for quantitative Real-Time PCR. gDNA = genomic DNA, cDNA = comple-
mentary DNA.
Name Sequence (5’→ 3’) Gene Amplificate [bp] Template
Bcat1-MIRA-for GCAGGGACGCTGTTTGGCCT
Bcat1 97 gDNA
Bcat1-MIRA-rev GGCTTTCCAGGGCTCTGCGT
Actb-MIRA-for CCGCGGAGCGGACACTTTCA
Actb 100 gDNA
Actb-MIRA-rev AGCGGGTCCACCGGTGTCTA
rtPCR_Dnmt3a_for TGATGAACGCACAAGAGAGC
Dnmt3a 97 cDNA
rtPCR_Dnmt3a_rev GGTGACATTGAGGCTTCCAC
rtPCR_Hdac1_for TTCGGGATATTGGGGCTGG
Hdac1 102 cDNA
rtPCR_Hdac1_rev TGACTGGCTTGAAAATGGCT
Aktin-fwd CACCCTGTGCTGCTCACC
Actb 100 cDNA
Aktin-rev_rev CGTACATGGCTGGGGTGT
loading buffer (ThermoFisher Scientific) and heated up for 10 min at 65 °C. Sample were
then chilled and loaded onto the gel that was run for about 70 min at 5 V/cm. RNA sample
integrity was evaluated regarding the presence of clear 28S and 18S rRNA bands, with the
28S rRNA band supposed to be about twice as intense as the 18S rRNA band.
3.3.3.3. Reverse transcription for generation of cDNA
Synthesis of first strand cDNA from RNA templates was performed using the RevertAid
First Strand cDNA Synthesis Kit (ThermoFisher Scientific) according to the manufacturer’s
instructions with 1 µg of template RNA.
3.3.4. Gene expression profiling by microarrays
To analyze the CHO DP-12 cell transcriptome in response to butyrate treatment, gene expres-
sion microarray analyses were performed using a CHO cell-specific microarray in a one-color
labeling approach (Becker et al. 2014). The microarrays were printed in a 4 × format (4
arrays per slide), which required defined buffer volumes and RNA amounts for hybridization.
The volumes and concentrations indicated in the following refer to this format and would need
to be adjusted for other array formats. Sample labeling and microarray hybridization was
performed according to the protocol One-Colour Microarray-Based Gene Expression Analysis
- Low Input Quick Amp Labeling (Agilent Technologies). The procedure is summarized in the
following sections.
3.3.4.1. Sample preparation
To include positive control transcripts into the gene expression microarray analysis the Agilent
One Colour RNA Spike-In Kit was used according to the manufacturer’s recommendations.
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The RNA Spike Mix Stock Solution was heated at 37 °C for 5 min and diluted for the total RNA
input amount of 50 ng. cRNA generation and labeling reactions were performed according to
the protocol and samples were stored at -80 °C overnight. Subsequently, the amplified and
labeled cRNA samples were purified using the RNeasy Mini Kit (Qiagen) according to the
manufacturer’s recommendations and eluted in 30 µL RNase-free water. The NanoPhotometer
was used to determine the yield and specific activity of each reaction by measuring the Cy3 dye
concentraion (pmol/µL), the RNA absorbance ratio (260/280 nm) and the cRNA concentration
(ng/µL). Equations 3.1 (yield) and 3.2 (dye activity) were used for the calculations.
µg of cRNA =
Concentration of cRNA×30 µL
1000
(3.1)
pmol Cy3 per µg cRNA =
Concentration of Cy3
Concentration of cRNA
(3.2)
The recommended yield for 4× microarrays is 1.65 µg of cRNA. The recommended specific
activity is ≥ 6 pmol Cy3 per µg cRNA.
3.3.4.2. Microarray hybridization and wash
1.65 µg of cRNA were used for hybridization of each microarray according to the man-
ufacturer’s recommendations. Slides were hybridized at 10 rpm and 65 °C for 17 h in a
Microarray Hybridization Oven (Agilent Technologies). The subsequent washing procedure
was performed according to the protocol. Slides were put into the slide holders for scanning
without an Agilent Ozone Barrier Slide, as ozon levels were considered to not exceed 50 ppb.
3.3.4.3. Scanning and feature extraction
After washing, microarray slides were scanned with a High-Resolution Microarray C Scanner
(Agilent Technologies) using the following settings: Green dye channel, scan resolution 5 µm,
Tiff file dynamic range 20 bit, green PMT gain 100 %. Data extraction from scan data was
then performed using the Agilent Feature Extraction Software. The grid template ’one-color’
was assigned to the extraction as well as the protocol ’GE1_107_Sep09’.
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3.3.5. Molecular cloning
3.3.5.1. Subcloning of PCR products amplified from bisulfite-treated DNA
To enable sequencing of amplificates from bisulfite treated DNA, PCR products were cloned
into pJet1.2/blunt cloning vector (see vector map in Fig. 3.2) using the CloneJet PCR Cloning
Kit (Thermo Scientific) according to the manufacturer’s recommendations. As amplification
was performed using the EpiMark®Hot Start Taq DNA Polymerase (NEB) which produces
3’-dA overhangs, PCR products were blunted prior to ligation.
Figure 3.2.: Vector map of pJet1.2/blunt cloning vector (Thermo Scientific).
3.3.5.2. Generation of promoter-reporter constructs for dual luciferase assays
Promoter-reporter constructs for dual luciferase assays were generated by cloning of 5 selected
endogenous CHO promoter sequences that were provided by Tobias Jakobi (Jakobi et al.
2014) into pMCS-Green Renilla Luc cloning vector (see vector map in Fig. 3.3 A) via the
EcoRI and BamHI restriction endonuclease recognition sites contained in its multiple cloning
site (MCS).
A B C
Figure 3.3.: Vector maps of pMCS-Green Renilla Luc, pCMV-Green Renilla Luc and pTK-Red Firefly
Luc (ThermoFisher Scientific).
Two promoters (promoters 1 and 5) were synthesized as complementary oligonucleotides by
Metabion (Tab. 3.8; Steinkirchen, Germany) and three promoters (promoters 2 to 4) were
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amplified from CHO K1 genomic DNA. Primers used for amplification of the promoters 2
to 4 are listed in Tab. 3.5. Restriction endonuclease sites were added to the ordered oligonu-
cleotides and primers to enable cloning into pMCS-Green Renilla Luc vector. Annealing
of 100 pmol per oligonucleotide was performed in annealing buffer (100 mM potassium
acetate, 30 mM HEPES-KOH, 2 mM magnesium acetate, pH 7.4) using a Thermocycler
(Eppendorf) with the oligonucleotide annealing program shown in Tab. 3.9. PCRs were
performed according to section 3.3.2.2.
Table 3.8.: Oligonucleotide sequences used for generation of promoter-reporter constructs by direct
cloning into pMCS-Green Renilla Luc vector. EcoRI and BamHI restriction endonuclease
recognition sites are shown in lowercase.
No. Gene Strand Sequence (5’→ 3’)
1 NA
forward GGACgaattcGCGGACTTCAGGAGAGGAAGCGGAAATGCGTGGCCGCTTTAAA-
GGCGTCGGCCCGCCCCGGCGCCCCTCTTTCCGTGTCCGGCCGCCGTGGGGAC-
AGGAGGTGAGTGCGGGCGTGCGAGCGGTCGGGGggatccGGAC
reverse GTCCggatccCCCCGACCGCTCGCACGCCCGCACTCACCTCCTGTCCCCACGG-
CGGCCGGACACGGAAAGAGGGGCGCCGGGGCGGGCCGACGCCTTTAAAG-
CGGCCACGCATTTCCGCTTCCTCTCCTGAAGTCCGCgaattcGTCC
5 Hist1h4n
forward GGACgaattcCCGCTCCTAGGGAATATAAGCTCTGGCTTGGGCGCACTGCATT-
GTAGTTCTCTCTTGTTTCTCTGCTGATTGTTTGTTCACCAggatccGGAC
reverse GTCCggatccTGGTGAACAAACAATCAGCAGAGAAACAAGAGAGAACTACA-
ATGCAGTGCGCCCAAGCCAGAGCTTATATTCCCTAGGAGCGGgaattcGTCC
Table 3.9.: Program for annealing of oligonucleotides in a Thermocycler.
Time Temperature
3 min 95 °C
2 min 72 °C
30 min Ramp cool to 37 °C
2 min 25 °C
hold 4 °C
3.3.5.3. Cloning of shRNA oligonucleotides into pLVX-shRNA1
ShRNA oligonucleotides for RNAi-mediated knockdown of DNMT3A were cloned into
pLVX-shRNA1 (Clontech, Mountain View, California, USA) which contains a human Pol
III-dependent U6 promoter upstream of the MCS for shRNA expression, an ampicillin
resistance gene for cloning and a puromycin resistance gene for selection of stably transfected
mammalian cells. pLVX-shRNA1 also contains several elements for packaging into viral
particles, which was not performed within this thesis (WPRE, cPPT/CTS and RRE in Fig.
3.4).
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Figure 3.4.: Vector map of pLVX-shRNA1 (Clontech).
3.3.6. ShRNA design for RNA interference experiments
For RNAi experiments siRNAs were designed using the Clontech RNAi Sequence Selector
and the following criteria for selection of shRNAs with high efficacies: A maximal melting
temperature of 45 °C, an optimal G+C content of 45 %, a higher melting temperature at
the 5’ end than at the 3’ end, a maximal length of homopolymeric sequences of 4 bases,
adenine bases at positions 3, 6, 18 or 19 and no guanine at position 13. A scrambled control
sequence was generated using the InvivoGen siRNA Wizard v3.1. All siRNA sequences
were mapped to the CHO genome sequence in GenDBE (Rupp et al. 2014) to avoid cross-
hybridizations. Subsequently, the Clontech shRNA Sequence Designer was used to generate
shRNA oligonucleotides that contained loop and terminator sequences as well as restriction
enzyme sites (BamHI and EcoRI) for cloning of annealed oligos into an expression vector.
ShRNA oligonucleotides (Tab. 3.10) were synthesized by Metabion. Annealing of shRNA
oligonucleotides was performed in annealing buffer in a Thermocycler (see annealing program
in Tab. 3.9). Annealed oligos were cloned into pLVX-shRNA1 (see section 3.3.5.3).
3.4. DNA methylation analysis
The following section describes the techniques that were used to analyze both site-specific and
genome-wide DNA methylation in the CHO cell genome. Analysis of single-base methylation
patterns of genomic regions with a maximum size of 600 bp was performed by bisulfite
Sanger sequencing. Combined Bisulfite Restriction Analysis (COBRA; Xiong and Laird
1997) was applied to confirm bisulfite sequencing results. Genome wide DNA methylation
analyses were performed using a CHO specific CpG island microarray and next generation
sequencing.
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Table 3.10.: shRNA sequences used for RNAi-mediated knockdown of DNMT3A. Indicated are exons
of the DNMT3A gene targeted by the three siRNAs as well as the shRNA oligonu-
cleotide sequences (uppercase) including added restriction enzyme sites (lowercase). sc =
scrambled control.
siRNA Dnmt3a-
Exon
Strand Sequence (5’→ 3’)
2 3 forward gatccGGTGGAAAGTAGTGACACATTCAAGAGATGTGTCACTACTTTCCACCTTTTTTg
2 3 reverse aattcAAAAAAGGTGGAAAGTAGTGACACATCTCTTGAATGTGTCACTACTTTCCACCg
3 8 forward gatccGTCGAGAAACTCATGCCACTTTCAAGAGAAGTGGCATGAGTTTCTCGATTTTTTg
3 8 reverse aattcAAAAAATCGAGAAACTCATGCCACTTCTCTTGAAAGTGGCATGAGTTTCTCGACg
9 20 forward gatccGTCTGGAACATGGCAGAATATTCAAGAGATATTCTGCCATGTTCCAGATTTTTTg
9 20 reverse aattcAAAAAATCTGGAACATGGCAGAATATCTCTTGAATATTCTGCCATGTTCCAGACg
sc - forward gatccGGGAGTACATCGTGAGAAATTCAAGAGATTTCTCACGATGTACTCCCttttttg
sc - reverse aattcaaaaaaGGGAGTACATCGTGAGAAATCTCTTGAATTTCTCACGATGTACTCCCg
3.4.1. Bisulfite Sanger sequencing of individual genomic loci
3.4.1.1. Primer design for bisulfite sequencing
As bisulfite treated DNA exhibits a low percentage of cytosine bases and many homopolymeric
regions, primer design for PCRs with bisulfite DNA as a template requires consideration
of certain parameters. Primers were designed with the online software MethPrimer (Li
and Dahiya 2002) using the following criteria: In order to avoid discrimination between
methylated and unmethylated DNA, primers should not contain any CpG dinucleotides. To
prevent amplification of unconverted sequences, 3’ ends were supposed to contain cytosines
from CpH (H = A, T, C) contexts. Primers should furthermore be longer than 25 nt to ensure
their specificity. Amplificates should not exceed 500 bp to 600 bp, as bisulfite treated DNA is
single stranded and therefore sensitive to shearing forces (Warnecke et al. 2002; Zhang et al.
2009). Primers were synthesized by Metabion.
3.4.1.2. Bisulfite conversion of genomic DNA
Bisulfite conversion of genomic DNA was performed using the Epimark Bisulfite Conver-
sion Kit (NEB, Ipswich, Massachusetts, USA) or the EZ DNA Methylation-Lightning™ Kit
(ZymoResearch, Freiburg, Germany) according to the manufacturer’s instructions and with a
total amount of 100 ng of DNA per reaction. Bisulfite treated DNA samples were stored at
-20° C in aliqouts of 10 µL.
3.4.1.3. Sequencing of amplificates from bisulfite treated DNA
Amplification of genomic regions from bisulfite treated DNA was performed using an Epimark
Taq Polymerase (NEB). PCR products were purified from 2 % agarose gels and cloned into
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pJet1.2/blunt cloning vector. 10 µL per ligation reaction were used for transformation of
chemically competent E. coli cells. At least 5 clones were randomly picked from selection
plates and plasmid DNA was isolated. Sequencing was performed according to 3.3.1.5.
Sequence analysis was performed using the online tool BiQ analyzer (Bock et al. 2005). Fig.
3.5 shows an exemplary sequencing result of good quality (regarding the conversion rate of
cytosines in non-CpG contexts and peak heights) in a comparison to the original sequence.
Figure 3.5.: Exemplary Sanger sequencing result. The region of interest was amplified from bisulfite
treated DNA, subcloned into pJet1.2/blunt cloning vector and Sanger sequenced. Top:
Original DNA sequence, bottom: sequence from bisulfite-treated DNA.
3.4.2. Combined Bisulfite Restriction Analysis (COBRA)
To confirm the results of bisulfite sequencing experiments, Combined Bisulfite Restriction
Analysis (COBRA) was used (Xiong and Laird 1997). For this experiment purified am-
plificates from bisulfite treated DNA were digested with TaqI (recognition site 5’-TCGA;
Promega, Madison, USA) and BstUI (recognition site 5’-CGCG; FastDigest®, Thermo
Scientific) according to the manufacturer’s recommendations. The technique is based on
the fact that the presence of restriction enzyme recognition sites depends on the methylation
status of cytosine bases within this sequences - i.e., if the cytosine within the TaqI site was not
methylated, the site reads 5’-TTGA-3’ after bisulfite conversion and amplification. Therefore,
TaqI would only cut fragments from DNA which carried a methyl group at the respective
position (see schematic representation of the COBRA principle in Fig. 3.6). DNA fragments
were separated on 2 % agarose gels. Undigested DNA fragments served as a control.
3.4.3. CpG island microarray analysis
The analysis of differential CpG island methylation was carried out using customized CHO
specific oligonucleotide CpG island microarrays (Wippermann et al. 2013; Wippermann
2012). The process of microarray design included prediction of promoter-associated and
intragenic CpG islands in the CHO genome based on the available genomic data from Xu
et al. 2011 and transcriptomic CHO data (Becker et al. 2011), and was performed according
to the algorithm of Takai and Jones (Takai and Jones 2002). A total of 43,318 CpG islands
in the CHO genome were identified, 21,993 of which could be associated with promoter
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Figure 3.6.: Principle of Combined Bisulfite Restriction Analysis (COBRA).
and intragenic regions. 27,466 individual probes were designed with average distances of
500 bp, in regard to the average DNA fragment lengths after sonication. Customized arrays
were printed by Agilent Technologies in an 8 x 60K (62,976 features) high density format.
Therefore, all probes are present at least twice per array, so that experiments with two arrays
(including a dye swap) result in 4 to 6 replicates per probe. The CHO-specific CpG island
microarray contains the ControlGrid IS-62976-8-V2_8by60K_LA_Genomic_20080924 with
the negative controls ’DarkCorner’, ’Structural Negative’ and ’Biological Negative’ (indicated
as DarkCorner, 3×SLv1 and NC1_00000002 in the .txt file after feature extraction). Negative
controls are used to measure the background signal intensity. DarkCorner and Structural
Negative controls form a hairpin that prevents hybridization. Biological Negative controls
were shown not to hybridize to any DNA sample tested. The microarray was assigned the
Agilent ID 040858.
3.4.3.1. Sonication of genomic DNA
Genomic DNA was sonicated to an average fragment size of 500 bp using a Branson Sonifier
450-A (Branson Ultrasonics, Danbury, Connecticut). Sonication was carried out 6 times in TE
buffer for 30 s with 40 % amplitude while cooling the tubes in icewater. Subsequently, 300 ng
DNA per sample were checked on 2 % agarose gels. Sonication was repeated depending on
the persistent presence of high molecular DNA.
3.4.3.2. Immunoprecipitation of methylated DNA
35 µg of fragmented genomic DNA per sample were used for enrichment of methylated DNA
by magnetic beads coupled MBD2-Fc protein (Epimark Methylated DNA Enrichment Kit,
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NEB, Ipswich, Massachusetts). Magnetic beads were resuspended by inverted rotation for
30 min. Per 1 µg of sheared DNA 1 µL beads and 0.1 µL MBD protein were used. The
required amount of beads was washed twice in 1× bind/wash buffer (3 minutes rotation
followed by removal of buffer). Subsequently, 200 µL buffer and the required amount of
MBD protein were added and the mixture was incubated by inverted rotation for 1 h. The
beads were washed twice again, resuspendend in 1× bind/wash buffer and added to the DNA
that was diluted in 1× bind/wash buffer. Samples were incubated for 1 h. Eight washing steps
were used to wash off unbound DNA. Methylated DNA was eluted by adding 100 µL dH2O
and incubation at 65 °C and 1000 rpm for 20 min on a ThermoMixer (Eppendorf). Removal
of MBD protein present in the supernatant was performed using a GeneJet PCR Purification
Kit (ThermoFisher Scientific). DNA was eluted in 13 µL dH2O and stored at -80 °C.
3.4.3.3. Fluorescence labeling of enriched methylated DNA
Enriched DNA samples were labeled with Cyanine 3- and 5-dUTP using the SureTag DNA
Labeling Kit (Agilent Technologies, Santa Clara, California). 2.5 µL random primer were
added to 13 µ L enriched methylated DNA and the samples were incubated for 5 min at 95 °C
in a Thermocycler (Eppendorf). After cooling to 4 °C 9.5 µL reaction master mix (5 µL
buffer, 2.5 µL 10× dNTPs, 1.5 µL Cy3-dUTP or Cy5-dUTP and 0.5 µL Exo-Klenow) were
added per sample. Incubation was performed at 37 °C for 120 min. The labeling reaction
was stopped by incubation at 65 °C for 10 min. For removal of unincorporated dye Amicon
30 kDa spin filters (Merck Millipore, Billerica, Massachusetts, USA) were used. Washing
was done with TE buffer. After vacuum concentration the samples were eluted in 6.3 µL TE
buffer. 1 µL per sample was used to measure the DNA and dye concentrations in order to
calculate the yield of fluorescently labeled DNA and the specific dye activity (see equations
3.3 and 3.4). 9 µg to 12 µg of labeled DNA was considered to be optimal yields. Optimal
dye activity values for Cy3 were 25–40 pmol/µg and for Cy5 20–25 pmol/µg. Samples were
stored overnight at -20 °C and used for microarray hybridization on the next day.
Specific activity [pmol dye/µg DNA] =
pmol per µL of dye
µg per µL DNA
(3.3)
Yield [µg] =
DNA concentration [ng/µL]×Sample volume [µL]
1000ng/µg
(3.4)
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3.4.3.4. Hybridization
Subsequently the Cy3- and Cy5-labeled samples were combined and 29 µL hybridization
mastermix (4.3 µL 10× blocking agent, 21.5 µL 2× hi-rpm buffer (Agilent Technologies,
Santa Clara, California), 8 % formamide (Carl Roth, Karlsruhe, Germany), 1.2 µL Mouse
Cot-1 DNA (Life Technologies, Darmstadt, Germany)) were added per tube. The mixture was
incubated for 3 min at 95 °C and subsequently for 30 min at 60 °C. 40 µL per sample were
used for hybridization to the microarrays by incubation at 67 °C with 20 rpm for 24 h.
3.4.3.5. Scanning and feature extraction
After washing and drying the slides by centrifugation, the arrays were scanned with a High
Resolution Microarray C Scanner (Agilent Technologies, Santa Clara, California) using
the following settings: Scanning profile ’Agilent G3_CGH’, channel ’R+G’, resolution
3 µm, 16 bit .tiff image. Data extraction from scan data was carried out using the Feature
Extraction Software (Agilent Technologies). The grid template that was automatically loaded
from Agilents Grid Template Broser was assigned to the extraction as well as the protocol
’ChIP_107_Sep09’.
3.4.4. Whole-genome bisulfite sequencing
In order to analyze the CHO DNA methylation landscape and to display the butyrate effect on
DNA methylation in single-base resolution, sequencing libraries were generated from bisulfite
treated DNA and subjected to next generation Illumina sequencing. As the CHO DP-12 cell
line as an exemplary production cell line was used for this experiment, unconverted CHO
DP-12 DNA was also sequenced to account for SNPs present between the CHO DP-12 and
the reference CHO K1 cell genomes.
3.4.4.1. Bisulfite conversion
50 ng of extracted DNA were spiked with 0.01 % (w/w) of Unmethylated cl857 Sam7
Lambda DNA (Promega, Madison, Wisconsin) that served as an unmethylated control and was
subjected to bisulfite treatment (ZymoResearch Methylation Lightning Kit; ZymoResearch,
Irvine, California). Bisulfite converted DNA was stored at -80 °C until library construction.
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3.4.4.2. Library generation and quality control
Library generation from bisulfite treated DNA and 10 ng of unconverted genomic DNA was
performed using the EpiGnome Methyl-Seq Kit (Epicentre, Madison, Wisconsin) according to
the manufacturer’s instructions. Briefly, bisulfite-treated DNA was randomly primed and DNA
molecules with 5’ tags were synthesized. Subsequently, the 3’ ends of the newly synthesized
molecules were tagged as well and dsDNA was amplified by PCR with barcoded primers
to allow for multiplexed sequencing of libraries from bisulfite treated and native DNA. For
this, EpiGnome™ Index PCR Primers (Epicentre) were used. The sequence of each Index
PCR primer is 5’-CAAGCAGAAGACGGCATACGAGAT N1-N6 GTGACTGGAGTTCA-
GACGTGTGCTCTTCCGATCT. N1-N6 represents the reverse complement of the index
sequence generated during sequencing (see Tab. 3.11). The quality of both libraries was
checked on High Sensitivity DNA Chips on the Bioanalyzer (Agilent Technologies, Santa
Clara, California).
Table 3.11.: Barcoding of individual libraries for DNA methylome analysis by next generation se-
quencing.
Sample No. of Index PCR Primer Index sequence
Genome 4 5’-TGACCA-3’
0 h 5 5’-ACAGTG-3’
6 h 2 5’-CGATGT-3’
12 h 10 5’-TAGCTT-3’
24 h 11 5’-GGCTAC-3’
36 h 8 5’-ACTTGA-3’
3.4.4.3. Illumina MiSeq sequencing
In order to estimate the behavior of sequencing libraries generated from bisulfite treated DNA,
samples were sequenced on an Illumina MiSeq desktop sequencer (Illumina) in a 2×76 bp
run according to the manufacturer’s instructions. Briefly, sequencing libraries (i.e. 0 h to
36 h) were pooled and denatured. The pool was then diluted to a concentration of 8.4 pM
for sequencing. PhiX Control v3 (Illumina) was added in a concentration of 2.1 pM. The
mixture was transferred into the reagent cartridge and sequencing was started after washing
and loading the flow cell.
3.4.4.4. Illumina HiSeq 1500 sequencing
Paired-end sequencing was performed on an Illumina HiSeq 1500 system in a 2×100 bp run
with 1 % PhiX Control v3 (Illumina) in each lane. One entire lane was used as a control to
sequence the unconverted CHO DP-12 genomic DNA library and to allow for phasing and
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pre-phasing. Lanes containing bisulfite libraries were additionally loaded with 10 % of the
unconverted DNA library. Tab. 3.12 contains the theoretical compositions of the sequencing
reactions.
Table 3.12.: Composition of Illumina HiSeq sequencing reactions for flow cells 1 and 2. Calculations
were based on a theoretical maximum output of 280 Gb per flow cell. The theoretical
coverages of both sequencing runs were 47-fold for the CHO DP-12 genome and 32-fold
for each library. Clusters were generated in a final concentration of 10 pM.
Sample Lane 1 Lane 2-8
Sequencing run 1
PhiX 1 % (0.35 Gb) 1 % (0.35 Gb)
CHO DP-12 genome 99 % (34.65 Gb) 10 % (3.5 Gb)
Bisulfite libraries – 89 % 0, 6, 12, 24 h (31.15 Gb)
Sequencing run 2
PhiX 1 % (0.35 Gb) 1 % (0.35 Gb)
CHO DP-12 genome 99 % (34.65 Gb) 10 % (3.5 Gb)
Bisulfite libraries – 12 % 0 h, 16 % 6, 12, 24 h, 40 % 36 h (31.15 Gb)
3.5. Protein biochemistry
Protein biochemical methods were used to determine the expression level of DNMT3A and
HDAC1 in butyrate-treated CHO DP-12 cells. For this purpose westernblot analyses were
used. Furthermore, dual luciferase assays were performed to analyze the gene expression
potential of endogenous CHO regulatory elements in promoter-reportergene assays employing
a firefly luciferase.
3.5.1. Westernblot analysis
3.5.1.1. Protein extraction
Cells were washed twice by centrifugation for 5 min at 1000 rpm in PBS buffer. Cell pellets
were resuspended in 500 µL ice cold lysis buffer (50 mM Tris-HCl pH 7.2, 150 mM NaCl,
2 mM EDTA, 0.1 % SDS, 1 % NP40, 1 mM phenylmethylsulfonyl fluoride (PMSF)) and
mixed. Samples were incubated for 5 min on ice, followed by 5 min of sonication with 40 %
amplitude at RT. After 30 min of incubation on ice, samples were centrifuged for 30 min at
13,000 rpm and 4 °C to remove cell debris from the supernatant that contained the extracted
protein.
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3.5.1.2. Protein quantification by Bradford assay
Protein quantifications were performed using the Coo Protein Assay Kit (Uptima-Interchim,
Montlucon, France). 5 µL per sample or standard dilution (BSA) were combined with 250 µL
Coomassie reagent (Uptima-Interchim) in 96-well plates. Plates were incubated for 1 min on
a rotating platform at RT. Absorption was measured within the next 15 min at 570 nm on a
plate reader (PowerWave HT Reader, BioTek Instruments Inc., USA). Protein concentrations
were calculated based on the standard curve.
3.5.1.3. SDS polyacrylamide gelelectrophoresis (SDS-PAGE)
Gels were cast as discontinuous systems consisting of an SDS-polyacrylamide-stacking gel
(4 %, pH 6.8) and an SDS-polyacrylamide-resolving gel (10 % for detection of both DNMT3A
and HDAC1, pH 8.8). For one stacking gel 130 µL Rotiphorese® Gel 30 (37.5:1, Carl Roth),
610 µL of MilliQ, 250 µL 1.3× gel buffer (pH 6.8, 0.5 M Tris-HCl, adjust pH with 6 M HCl)
and 10 µL SDS were used. For one resolving gel of 10 % 1650 µL Rotiphorese® Gel 30,
2050 µL MilliQ, 1250 µL 4× gel buffer (pH 8.8, 1.5 M Tris-HCl, adjust pH with 6 M HCl)
and 50 µL SDS were used. 5 µL 10 % APS and 1 µL TEMED per mL gel were added to induce
polymerization. Resolving gels were overlayed with isopropanol before polymerization for
45 min to assure even edges. Stacking gels were also allowed to polymerize for 45 min.
4× SDS sample buffer (8 % SDS, 250 mM TRIS, 40 % glycerol, 0.04 % bromophenol blue)
was added to 20 µg of total protein per sample to a final concentration of 1× and incubated
for 10 min at 70 °C and 400 rpm. Samples were centrifuged and loaded onto the gel that was
run at 175 volts in 1× SDS electrophoresis buffer (125 mM TRIS, 960 mM glycine, 0.5 %
SDS ) for 50 to 60 min. A PageRuler™ Prestained Protein Ladder (Fig. 3.7; ThermoFisher
Scientific) was used as a size standard.
Figure 3.7.: PageRuler™ Prestained Protein Ladder (ThermoFisher Scientific). kDa = kilodalton.
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3.5.1.4. Westernblot analysis
Transfer of proteins from the SDS-polyacrylamide gel to a polyvinylidene fluoride (PVDF)
membrane that was equilibrated in EtOH for 30 seconds was performed for 60 min at 35
volts in transfer buffer (20 times: 500 mM bicine, 500 mM bis-Tris, 20 mM EDTA. 1 times:
Addition of 10 % EtOH and 1 µL/mL NuPAGE antioxidant). The membrane was than
incubated overnight at 4 °C in 10 mL blocking solution (PBS buffer, 5 % milk powder, 0.3 %
Tween 20) on a shaking platform. After 2 washing steps incubation with the primary antibody
(1:1000 for both DNMT3A and HDAC1) was performed for 1 h on a shaking platform. The
primary antibody was removed by 3 washing steps (each 15 min; washing solution: PBS
buffer, 1 % milk powder, 0.3 % Tween 20). Subsequently, incubation with the cyanine dye
(Cy) coupled secondary antibody (1:300 for DNMT3A, which was detected with an Cy5-
coupled secondary antibody, and 1:500 for HDAC1, which was detected with an Cy3-coupled
secondary antibody) was performed for 1 h on a shaking platform followed by three washing
steps (each 15 min). As the secondary antibody was Cy-conjugated, gels were scanned using
an Ettan DIGE Imager with pixel size 100 µm and variable exposure times (depending on
signal intensities).
After scanning and data analysis, PVDF membranes were stained with Coomassie dye and
scanned to enable quantification of the total amount of protein that has been transferred. This
was used to normalize band intensities of the proteins that were analyzed.
3.5.2. Dual luciferase assay
In order to analyze the gene expression potential of endogenous CHO regulatory elements, 5
promoters were analyzed in promoter-reportergene assays employing a firefly luciferase. To
enable correction of the results for variability in CHO cell transfection a Renilla luciferase was
expressed as an internal control. Activities of both enzymes were simultaneously measured
using the Dual-Luciferase® Reporter (DLR™) Assay System (Promega) according to the
manufacturer’s recommendations. Fig. 3.8 shows the bioluminescent reactions the assay
system is based on. Central to the experiment is the fact that the amount of relative light
units (RLU) produced by Green Renilla Luciferase depends on the expression strength of
the endogenous CHO promoter, whereas the luminescence signal from the constitutively
expressed Tk promoter does not change regardless of any intrinsic regulations, but depends
on experimental conditions such as the transfection efficiency. For this reason, Tk promoter-
depended luciferase expression can be used for normalization in dual luciferase assays, which
are capable of measuring both luciferase activities sequentially from a single sample. In the
assay used here, Firefly luciferase activity was determined first by adding beetle luciferin and
coenzyme A, which results in a stable luminescence signal. The signal generated in this way
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is subsequently quenched and the substrate for Renilla Luciferase, coelenterate-luciferin, is
added (Dual Luciferase® Reporter Assay System protocol, Promega). Luminescence was
measured using a plate-reading luminometer (FLUOstar Galaxy; BMG LABTECH GmbH,
Ortenberg, Germany).
Figure 3.8.: Bioluminescent reactions employed for the Dual Luciferase® Reporter Assay System
(Promega).
3.6. Data analysis
Data generated by bisulfite sequencing of individual genomic regions were analyzed using
the BiQ Analyzer software (Bock et al. 2005). For evaluation of microarray data generated
by CHO CpG island and CHO gene expression microarrays, analyses were performed using
the Bioconductor limma package in the R programming environment (Ritchie et al. 2015).
Further CpG island microarray data evaluation was performed using the EMMA2 software
platform (Dondrup et al. 2009). Analysis of data generated by next generation sequencing
(NGS) was done in collaboration with Oliver Rupp from the Bioinformatics and Systems
Biology group at Justus Liebig University Giessen.
3.6.1. Analysis of gene-specific DNA methylation data
DNA methylation data generated for genomic regions of interest by Sanger sequencing
were analyzed using the BiQ Analyzer software tool (Bock et al. 2005). Sequence files and
sequences of the genomic regions of interest were imported in FASTA format. The software
aligns the in silico converted (as if fully unmethylated, i.e. complete C to T conversion)
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genomic sequence with the sequencing reads and applies different quality control measures.
First the conversion rate, which is defined as the number of correctly converted cytosines
outside of CpG contexts divided by all cytosines outside of CpG contexts, is calculated. The
software then suggests to exclude sequences that are likely to have originated from only a
few individual chromosomes. In a third step putative sequencing errors are analyzed and
BiQ Analyzer suggests to exclude sequences that exhibit a local sequence identity of less
than 80 %. The software finally generates a HTML documentation that includes sequence
alignments, statistics and methylation diagrams in ’lollipop’ style.
3.6.2. Analysis of data generated by CHO CpG island microarray
experiments
Data quality was explored using the Bioconductor limma package that enables visual in-
spection of experimental data to identify potential quality problems (Ritchie et al. 2015).
Such problems might arise during sample processing (e.g. due to differences in labeling
efficiencies) or microarray hybridization (e.g. due to minor differences in the composition of
the hybridization mixtures). For quality assessment of two-color microarray data boxplots
of red and green signals and red and green background signals were generated. To get an
overview of potential spatial artifacts, intensity plots for all four types of signals were gen-
erated. Furthermore, density plots were used to get an idea of the signal distribution across
each array. Supplementary listing B.1 shows the R script for installation of limma, import of
microarray data and generation of quality plots.
The microarray data was evaluated using the open source software platform EMMA2, which
has been designed for consistent storage and efficient analysis of microarray data (Dondrup
et al. 2009). Normalization was carried out using the LOWESS method (Yang et al. 2002).
Normalized data was subjected to Student’s t-tests to determine significantly regulated regions
with p-values below a threshold of 0.05. All p-values were corrected based on the method of
Benjamini and Hochberg (Benjamini and Hochberg 1995) to account for the multiple testing
situation.
3.6.3. Analysis of gene expression microarray data
Data analysis of gene expression microarray experiments was performed using the limma
package in R. In a first step, the signal ranges before normalization were compared between
the arrays. Data were than background corrected and quantile normalized. In order to
collect the subset of genes highly expressed in the samples, all genes with expression values
above the 75th percentile were defined as highly expressed (according to Schroeder et al.
2011). Furthermore, for each comparison between samples of interest, statistical parameters
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for differential expression were calculated. Genes with adjusted p values below 0.01 were
considered to be significantly differentially expressed. Supplementary listing B.2 shows the R
script for import of microarray data, normalization and calculation of statistical parameters
for comparisons between data sets of interest.
3.6.4. Analysis of next generation sequencing data
Parts of the analysis described in this section were performed in collaboration with Oliver
Rupp, who bioinformatically processed the sequencing data, integrated DNA methylation
profiles into the GenDBE genome browser and performed de novo discovery of DNA sequence
motifs in DMRs.
Paired-end reads were quality checked using FastQC (Andrews 2010) and trimmed using
Trimmomatic (Bolger, Lohse, and Usadel 2014). The reference CHO K1 genome (Xu et al.
2011) was corrected for single nucleotide polymorphisms (SNPs) within the CHO DP-12 cell
line. First the reads from the sequencing of unconverted CHO DP-12 DNA were mapped to
the CHO K1 genome with Bowtie2 (Langmead and Salzberg 2012). SNPs were then called
using the SAMtools mpileup algorithm and filtered using in house perl scripts. SNPs with a
minimal coverage of 4 reads and at least 25 % of the reads containing the SNP were used for
cell line correction using the vcfutils vcf2fq method (Li et al. 2009). The Smithlab Methylation
Data Analysis Pipeline (MethPipe; Song et al. 2013) was used for mapping of reads from
bisulfite treated libraries to the SNP-corrected reference genome, removal of duplicate reads,
calculation of single-site methylation levels, estimation of bisulfite conversion rates and
calculation of methylation levels in untranslated regions (UTRs), exons, introns and CGIs
(annotation of CGIs based on (Wippermann et al. 2013). For comparison of two methylomes,
the pipeline used a one-directional version of Fisher’s exact test to determine the significance
of differential methylation at individual CpGs. Differentially methylated regions (DMRs) were
determined by using differential methylation scores of single-CpGs. Methylation data tracks
were integrated into the in-house GenDBE genome browser (Rupp et al. 2014) to inspect
selected regions with known methylation patterns for accordance of whole-genome bisulfite
sequencing results. For this, Branched chain amino acid aminotransferase cytosolic-like gene,
Bcat1, served as a methylated control. The Beta-actin gene, Actb, served as an unmethylated
control. Partially methylated domains (PMDs) of more than 10 kb and methylation levels
below 70 % were identified using a sliding window approach according to Lister et al. (Lister
et al. 2009). For this, SNP-corrected CHO K1 scaffolds containing more than 100 CpGs were
included into the analysis (5,874 scaffolds comprising 96 % of the CHO genome). For PMDs
and hypermethylated domains (HMDs) with > 100 CpGs, average methylation levels, size
and coverage by coding sequence (CDS) were analyzed. Assignment of CHO DP-12 PMDs
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to the recently sequenced Chinese hamster (CH) chromosomes (Brinkrolf et al. 2013) was
based on read coverages.
3.6.5. Functional gene set analysis
Gene Ontology annotations were performed using the Database for Annotation, Visualization
and Integrated Discovery (DAVID) tool (Huang et al. 2009). Generally Applicable Gene-set
Enrichment analysis of significantly differentially expressed genes was performed using
GAGE (Luo et al. 2009). The STRING database was used to identify potential protein-protein
interaction networks (Szklarczyk et al. 2015). The Bioconductor Pathview package was
applied for pathway-based data integration and visualization of gene expression time courses
on KEGG pathways (Luo and Brouwer 2013; Kanehisa and Goto 2000). Heatmaps were
generated using the ComplexHeatmap package (Gu, Eils, and Schlesner 2016). The de
novo motif discovery for determination of putative transcription factor binding sites within
differentially methylated regions was performed using the motif discovery algorithm DREME,
which was designed to find short core motifs of eukaryotic transcription factors (Bailey 2011).
De novo discovered motifs were then subjected to a similarity search in transcription factor
databases using the Tomtom algorithm (Gupta et al. 2007).
3.6.6. Statistics applied for DNA methylation and gene expression
analysis
For comparison of two methylomes, a one-directional version of Fisher’s exact test according
to Altham (1971) was applied by using the default parameters of the MethPipe analysis
pipeline to determine the significance of differential methylation at individual CpGs. Differ-
entially methylated regions (DMRs) were determined by combining differential methylation
scores of single-CpGs and DMRs with ≥ 1 significantly differentially methylated CpG were
considered significant (Song et al. 2013). For gene expression analysis by CHO cDNA-
microarrays genes with a false discrovery rate ≤ 0.01 were considered to be significantly
differentially expressed. GAGE was also performed with a false discrovery rate ≤ 0.01 (Luo
et al. 2009). Gene ontology analyses using DAVID were performed with Expression Analysis
Systematic Explorer (EASE) scores ≤ 0.01 (Hosack et al. 2003; Huang et al. 2009). Signifi-
cant enrichment of sequence motifs in DMRs by DREME (Bailey 2011) was calculated using
the Fisher’s Exact Test in comparison to a ten-fold bigger set of randomly chosen sequences
with an equal length distribution and the default significance threshold of p ≤ 0.05. De novo
discovered motifs were subjected to a similarity search in transcription factor databases using
the Tomtom algorithm and uncorrected p values ≤ 0.0005 (Gupta et al. 2007).
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Chinese hamster ovary (CHO) cells represent the most commonly used production cell line for
therapeutic proteins. By recent genome and transcriptome sequencing a basis was created for
future investigations of genotype-phenotype relationships and for improvement of CHO cell
productivity and product quality. In this context information is missing about DNA cytosine
methylation as a crucial epigenetic modification and an important element in mammalian
genome regulation and development. For this reason this doctoral thesis aimed to analyze
DNA methylation in CHO DP-12 cells that produce a recombinant human anti-IL-8 antibody.
DNA methylation patterns in CHO cells were analyzed in general as well as changes of DNA
methylation in response to the fatty acid butyrate. To be able to assess the impact of both
the CHO DNA methylation landscape as well as differential DNA methylation upon butyrate
addition on gene expression, CHO-specific DNA-microarrays were applied and data were
analyzed in an integrative approach.
As another tool for DNA methylation analysis in CHO cells, a specifically designed CpG
island microarray, already existed (Wippermann 2012; Wippermann et al. 2013), CpG island
microarray performance was compared to whole-genome bisulfite sequencing regarding the
butyrate effect on DNA methylation. Exemplary results of the CpG island microarray experi-
ment were confirmed by gene-specific analysis of DNA methylation. Control hybridization
experiments were furthermore performed in order to be able to assess potential sources of
bias originating from the experimental procedure. Finally, putative central mediators of
the butyrate effect were identified based on the comparative data analysis and functionally
analyzed in transient knockdown experiments by RNA interference.
Chapter 4. Results and discussion
4.1. Integrative analysis of DNA methylation and gene
expression in CHO cells
For integrative analysis of DNA methylation and gene expression changes in CHO cells upon
butyrate treatment, samples were taken from batch cultivations of the exemplary antibody-
producing CHO DP-12 cell line. Gene expression profiling by DNA-microarrays was per-
formed as described previously (Becker et al. 2014), while whole-genome bisulfite sequencing
was newly implemented for this cell line. Sample generation and the implementation process
are described in the following sections.
4.1.1. Generation of samples
Replicate (n = 4) batch cultures of reference CHO DP-12 cells and cultures that were treated
with 3 mM butyric acid were monitored regarding viable cell density, viability, cell specific
productivity, glucose consumption and lactate formation (Fig. 4.1). The reference cultures
showed exponential cell growth with a maximum viable cell density of 1.2 × 107 cells/mL on
cultivation day 8 and high viabilities until day 9, while the maximum cell specific productivity
of 7.4 pg/cell × d was reached on day 4. When glucose was limited the reference cells started
to metabolize lactate.
CHO DP-12 cell cultures that were treated with butyrate reached a maximum viable cell
density of about 3 × 106 cells/mL and proliferation was reduced after butyrate addition. One
day post treatment, viabilities started to decrease. At the same time, the cultures started to
metabolize lactate. However, cell specific productivities of the butyrate-treated cells reached
a maximum of 17 pg/cell × d. Samples for integrative DNA methylation and gene expression
analysis were taken prior to butyrate addition as well as 6, 12, 24 and 36 hours post butyrate
treatment. The CHO DP-12 DNA methylation landscape was analyzed using the replicate
samples that were taken before butyrate addition. These samples furthermore served as the
reference for the analysis of differential DNA methylation and gene expression upon butyrate
addition.
4.1.2. Implementation of whole-genome bisulfite sequencing for CHO
DP-12 cells
The analysis and interpretation of DNA methylation data by whole-genome bisulfite sequenc-
ing generally includes the bisulfite-mediated conversion of unmethylated cytosines, library
generation, which leads to the amplification of converted cytosines as thymines, and next
generation sequencing. Subsequently, the sequencing data are aligned to a reference genome
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Figure 4.1.: Cell growth, IgG production, glucose and lactate concentrations of CHO DP-12 cell
cultures (Wippermann et al. 2016). Error bars represent standard deviations of four
replicate cultures. The vertical lines mark the sampling points for whole-genome bisulfite
sequencing and gene expression analysis. Butyrate was added immediately after the
first sampling. A Viable cell density (VCD) and mean viability (Viab) of reference and
butyrate-treated cultures. B Cell specific productivity (Qp) and mAb titer of reference and
butyrate-treated cultures. C Glucose (Glc) and lactate (Lac) concentrations of reference
and butyrate-treated cultures.
to enable calculation of absolute cytosine methylation levels. After single-base methylation
levels are determined, methylation data are visualized in a genome-browser, the distribution of
methylation levels across genomes is analyzed and differentially methylated regions (DMRs)
can be identified comparing individual methylomes. Combination of data generated in this
way with gene expression measurements allows for an assessment of potential phenotypic
effects and functional significance (Bock 2012).
The work flow of whole-genome bisulfite sequencing for determination of CHO DP-12 DNA
methylation patterns and its combination with gene expression data is summarized in Fig. 4.2.
Due to the fact that the CHO DP-12 genome is not yet publicly available, this procedure first of
all required correction of the reference genome CHO K1 (Xu et al. 2011) for single nucleotide
polymorphisms (SNPs) present between both genomes. Next generation sequencing data
from bisulfite-treated reference samples and samples taken after butyrate addition could
then be mapped to this customized genome (section 4.1.2). This allowed for the analysis
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of the genome-wide distribution of DNA methylation in CHO DP-12 cells and differential
DNA methylation could be determined between individual methylomes. Genome-wide DNA
methylation data were next combined with gene expression data to analyze the CHO DP-12
DNA methylation landscape (section 4.1.3) and differential DNA methylation upon butyrate
treatment in a time-course study including time points 6 h, 12 h, 24 h and 36 h post butyrate
addition (section 4.1.4).
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Figure 4.2.: Schematic representation of the work flow of integrating whole-genome bisulfite sequenc-
ing and CHO DNA-microarray data.
As the implementation of experimental methods requires utilization of controls, positive
and negative methylated and unmethylated control regions were employed that were pre-
viously identified in the promoters of Beta-actin (Actb) and Branched chain amino acid
aminotransferase cytosolic-like (Bcat1; Wippermann 2012). The methylation status of these
regions was determined by bisulfite Sanger sequencing of pooled DNA samples from CHO
DP-12 cells cultivated with and without butyrate addition. Fig. 4.3 summarizes the results
of this analysis and shows a schematic representation of the Actb and Bcat1 promoters with
indication of the CpG island regions that were analyzed. The ’lollipop’ plots below show
that the analyzed region of the Actb promoter was found to be completely unmethylated
(indicated by white circles), whereas the analyzed region of the Bcat1 promoter was found
to be completely methylated (indicated by black circles). Therefore, these regions served as
controls for whole-genome bisulfite sequencing experiments.
4.1.2.1. Quality control of DNA samples and bisulfite sequencing libraries
Quality control of bisulfite sequencing experiments mainly focuses on potential biases that
are introduced by the sample material (e.g. DNA quality and integrity) or incomplete bisulfite
conversion (Bock 2012). To account for these quality requirements DNA samples extracted
from CHO DP-12 cell cultures were checked photometrically for their purity by calculating the
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Actb
Bcat1
CDS
TSS
TSS
Figure 4.3.: Bisulfite sequencing results of parts of the CGIs of Beta-actin (Actb) and Branched chain
amino acid aminotransferase cytosolic-like (Bcat1). CGIs are indicated in black. The
arrows mark the transcription start sites (TSS) and the beginning of the coding sequence
(CDS) for Actb. Bisulfite Sanger sequencing results are shown as lollipop plots and black
circles represent a methylated CpG position, whereas white circles indicate unmethylated
CpG positions.
OD260/OD280 ratio and for their integrity by application of 0.6 % agarose gels (Supplementary
Fig. B.13) before they were subjected to bisulfite treatment.
The efficiency of bisulfite-mediated conversion of unmethylated cytosines was considered
to be the next critical step, as it is known to potentially be incomplete. This is due to the
fact that bisulfite conversion of unmethylated cytosines depends on complete denaturation
of DNA molecules, which can be difficult for intact chromosomal DNA. For this reason the
efficiency is controlled by spiking DNA samples with unmethylated lambda phage DNA. It
was hypothesized that bisulfite-mediated conversion of DNA might be more efficient when
the DNA was sheared before bisulfite treatment. However, sequencing libraries that were
generated from sheared, bisulfite-treated DNA turned out to be inhomogeneous regarding their
size distribution (Supplementary Fig. B.15). Therefore, five Illumina sequencing libraries
were generated from unsheared bisulfite-treated DNA for the reference and sampling points
’6 h’, ’12 h’, ’24 h’ and ’36 h’ by using barcoded PCR primers to allow for multiplexed
sequencing. Library qualities were checked for the correct distribution of fragment sizes
on a Bioanalyzer® (Supplementary Fig. B.14). The sequencing libraries generated from
bisulfite-treated DNA exhibited a mean size of about 360 bp.
In order to get an idea of library qualities, potential difficulties that might compromise
sequencing, and in order to be able to adjust reaction conditions in the subsequent HiSeq
sequencing runs if necessary, the libraries were pooled and subjected to a 2× 75 bp paired-end
run on an Illumina MiSeq system with comparably low sequencing output as a pre-test. Also,
the conversion rate of the unmethylated spike-in lambda DNA was controlled in this step,
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which was above 99 %. MiSeq sequencing resulted in 25.14 millions of reads. The pooled
libraries exhibited a base composition of 29 % adenine, 22 % guanine, 42 % thymine and
6 % cytosine (Fig. 4.4) up to sequencing cycle 80, as most cytosines outside of CpG contexts
are unmethylated in mammalian genomes (Schübeler 2015) and were therefore converted
to thymines by bisulfite treatment. After cycle 80 DNA fragments were read from the other
end. After this reversal and up to the end of the sequencing reactions guanine and adenine,
which are complementary to cytosine and thymine, exhibited the expected percentages of
6 % (as guanine is complementary to cytosine, which was reduced by bisulfite treatment) and
42 % (as adenine is complementary to thymines, which exhibited a higher percentage because
unmethylated cytosines were converted). Generally, the libraries were considered suitable for
sequencing and no adjustments were necessary in the subsequent HiSeq runs.
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Figure 4.4.: Percent base plot of MiSeq sequencing of pooled libraries from whole-genome bisulfite
sequencing.
4.1.2.2. Illumina HiSeq sequencing of libraries from native and bisulfite-treated CHO
DP-12 DNA and generation of the CHO DP-12 reference genome
Multiplexed sequencing was performed on an Illumina HiSeq 1500 system in two 2 × 100 bp
runs. Next to the libraries from bisulfite-treated DNA, a library generated from a pool of DNAs
from both reference and butyrate-treated cells was analyzed that was used for SNP-correction
of the CHO K1 genome later on. This native library (mean library size 446 bp) was sequenced
with a theoretical sequencing depths of 47-fold. Libraries from bisulfite-treated DNA of
reference and butyrate-induced cultures were sequenced with a theoretical coverage of 32-fold
per sample. In total, 489 Gb of sequence output were obtained by the two sequencing runs.
Tab. 4.1 shows the amount of sequence data per sample and the corresponding calculated
coverages. The CHO genome size of 2.5 Gb as determined by Xu et al. 2011 was used for
this calculation.
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Table 4.1.: Numerical summary of raw sequence output and calculated genome coverage from Illumina
HiSeq sequencing of libraries from native and bisulfite-treated (BS) CHO DP-12 DNA
before further data processing.
Sample BS treatment Output [Gb] Coverage [fold]
Pooled DNAs – 115.8 46.3
Reference
√
81.1 32.4
6 h
√
71.4 28.6
12 h
√
69.2 27.7
24 h
√
72.8 29.1
36 h
√
66.7 26.7
116 Gb of sequence information were obtained for the untreated pool of DNAs, whereas
67-81 Gb of sequence information were obtained for the bisulfite-treated samples. The
genomic coverages, which were calculated based on the amount of raw data, corresponded to
the theoretical coverages that were used for setting up the multiplexed sequencing reactions
only for the pool of DNAs as well as for the reference. For the samples ’6 h’ to ’36 h’ a mean
coverage of 28-fold instead of 32-fold was achieved.
To generate a CHO DP-12 reference genome by SNP-correction of the CHO K1 genome data,
sequencing reads from the library of pooled DNAs were trimmed and 95.8 Gb (575,986,927
reads) of sequence information remained. 84 % of these reads could be mapped to the CHO
K1 reference genome and 74 % were properly paired. SNP-detection showed 4,054,041 SNPs
with a coverage of ≥ 4 reads and at least 25 % of the reads containing the SNP between both
genomes. The mean coverage of the CHO K1 genome by reads from CHO DP-12 DNA after
trimming and mapping was 32-fold. In the following sections the customized CHO DP-12
reference genome is referred to as ’the SNP-corrected CHO K1 genome’.
4.1.2.3. Selection of a mapping algorithm for data analysis
The Smithlab Methylation Data Analysis Pipeline (MethPipe; Song et al. 2013) was chosen
for the analysis of data from whole-genome bisulfite sequencing experiments. However, prior
to data analysis the mapping tool integrated into the MethPipe analysis pipeline was compared
to the mapping tool BS-Seeker2 (Guo et al. 2013) in order to select the algorithm best suitable
for data analysis.
Therefore, reads generated by HiSeq sequencing from bisulfite-treated libraries of the ref-
erence cultures were mapped to exemplary parts of the SNP-corrected CHO K1 genome.
Generally, mapping tools for processing of reads from bisulfite-treated libraries employ one
of two different strategies. The MethPipe mapping tool uses a principle called ’wild-card’
alignment, which converts every C in the original sequence to the ’wild-card letter’ Y. Fig.
4.5A shows an exemplary alignment with a reference sequence at the top and bisulfite se-
quencing reads in the center (Fig. modified from Bock 2012). Generally, Cs and Ts present in
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the reads are allowed to map to Ys. If a read corresponds to multiple positions in the reference
sequence it is removed from the analysis (crossed out). Methylation levels are calculated
based on the number of Cs at each Y position. The BS-Seeker2 mapping tool, in contrast, uses
a ’three-letter’ alignment and converts each C in the reference sequence to an uppercase T
and each C in the reads to a lowercase t (Fig. 4.5B). During alignment, both T and t can map
to a T in the reference sequence and ambiguous reads are discarded. Methylation levels are
calculated based on the number of lowercase ts.
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Figure 4.5.: Comparison of mapping tool performance. Two pipelines for DNA methylation data
analysis were compared regarding the results for CHO cell genomic regions with known
methylation levels (Actb and Bcat1). A,B The MethPipe pipeline (Song et al. 2013) uses a
wild-card aligner, while BS-Seeker2 (Guo et al. 2013) employs a three-letter alignment
tool (figure based on Bock 2012). C Single-base methylation levels for the unmethylated
control region Actb. D Single-base methylation levels for the methylated control region
Bcat1.
The MethPipe mapping tool provided correct results for the internal CHO methylated (the
Bcat1 CpG island) and unmethylated (the 5’ UTR-associated CpG island of Actb) controls,
whereas the BS-Seeker2 results only gave an impression of the methylation status, as it
generated a high background noise (Fig. 4.5C, D). CpG island regions suspected to be
unmethylated were inspected as well and identically noisy signals were found to be generated
by BS-Seeker2 (see Supplementary Fig. B.16 for exemplary results). Therefore, the internal
MethPipe mapping algorithm was used for data processing, which included the removal of
duplicate reads as well as calculation of single-site methylation levels, mean methylation of
genomic regions, and differential methylation between methylomes.
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4.1.2.4. Processing of whole-genome bisulfite sequencing data
In the first step of data analysis, absolute methylation levels for each CpG dinucleotide within
the genomes of reference and butyrate-treated samples were determined by calculating the
ratio of mapped thymines and cytosines at individual CpG positions of the SNP-corrected
CHO K1 genome.
Table 4.2.: Numerical summary of whole-genome bisulfite sequencing results after mapping to the
SNP-corrected CHO K1 genome.
Sample Mean methylation [%] CpG sites covered [%] Mean coverage [fold] Total reads
Reference 61.09 94.04 14.30 398,995,016
6 h 59.89 93.86 13.62 353,379,241
12 h 59.55 93.86 13.24 342,468,374
24 h 60.06 94.03 14.02 364,018,688
36 h 61.23 93.39 11.01 329,546,415
Tab. 4.2 shows that mapping resulted in an average sequencing depth of 11- to 14-fold. This
means that, per sample, about 50 % of the reads from bisulfite-treated DNA could be mapped
to the SNP-corrected CHO K1 genome. About 94 % of all CpG sites known in the CHO
genome were covered by each library (i.e. about 15.3 million CpGs in each genome were
analyzed). Furthermore, butyrate treatment was found to induce a maximum decrease in
genome-wide mean methylation levels from 61.09 % in the reference samples to 59.55 % at
sampling point ’12 h’.
4.1.2.5. Integration of whole-genome DNA methylation data into GenDBE and
inspection of exemplary genomic regions
Next, DNA methylation data of reference and butyrate-treated CHO DP-12 cells were inte-
grated into the genome browser GenDBE, which is a web-based tools for browsing eukaryotic
genomes (Rupp et al. 2014). First, overall DNA methylation patterns were compared between
the sampling points and proved to be very consistent (see exemplary genomic region in
Supplementary Fig. B.17). To control the correctness of data integration, the control promoter
regions of Actb and Bcat1 were inspected (Fig. 4.6A; data are only shown for the reference,
as no differences were observed between the individual samples). The 5’ UTR-associated
CpG island of Actb was found to be completely unmethylated, whereas the Bcat1 CpG island
was found to exhibit methylation levels of nearly 100 %.
Assuming that CHO DP-12 cells exhibited a DNA methylation profile similar to other
mammalian cells, promoter-associated CpG islands of CHO housekeeping genes (according
to Bahr et al. 2009) were checked for their methylation status as another measure of data
quality (Fig. 4.6B). All CpG island regions of the CHO housekeeping genes Component of
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Figure 4.6.: Methylation data tracks were loaded into the GenDBE genome browser (Rupp et al. 2014)
to visually inspect selected genomic regions. Exons are indicated by red rectangles,
CpG islands by blue rectangles and UTRs by yellow rectangles. Methylation levels for
each CpG are represented by green bars. A Promoter regions of Branched chain amino
acid aminotransferase cytosolic-like gene (Bcat1) and 5’ UTR of Beta-actin gene (Actb).
Regions of the CHO DP-12 genome with known methylation levels are marked by a red
box. B Visual inspection of CpG islands at housekeeping gene promoters. Inspected were
the genes Cog1, Rpb1, B2m, Pabpn1 and Pms2.
oligomeric golgi complex 1 (Cog1), DNA-directed RNA polymerase II subunit RPB1 (Rpb1),
Beta-2-microglobulin (B2m), Poly(A) binding protein, nuclear 1 (Pabpn1) and Mismatch
repair endonuclease PMS2 (Pms2) were found to be unmethylated.
4.1.2.6. Discussion: Generation of genome-scale DNA methylation data for CHO
DP-12 cells
In order to analyze genome-wide DNA methylation in CHO DP-12 cells by whole-genome
bisulfite sequencing, a customized reference genome was generated for CHO DP-12 cells.
Reads from bisulfite-treated CHO DP-12 DNA, which proved to be fully converted based
on the complete conversion of spike-in lambda DNA, could be successfully mapped to it
using the MethPipe data analysis pipeline. The BS-Seeker2 mapping algorithm was excluded,
as the results exhibited a high background noise. The observation that the two mapping
algorithms that were tested performed very differently can be explained by the fact that the
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three-letter aligner BS-Seeker2 removes all remaining Cs from the sequencing reads, thereby
further reducing the sequence complexity and increasing the number of ambiguous alignment
positions (Bock 2012). Absolute methylation levels for each CpG dinucleotide within the
CHO DP-12 genome were therefore generated using the internal MethPipe mapping algorithm.
Single-site methylation data were then integrated into the GenDBE genome browser (Rupp
et al. 2014) for visual inspection of genomic regions with known methylation levels as well
as promoter CpG islands of CHO housekeeping genes. The inspected regions exhibited the
expected methylation levels.
Recent publications show similar approaches of mapping genome-scale DNA methylation
data from bisulfite sequencing experiments using the MethPipe analysis pipeline. For example,
Lin et al. compared the methylomes of different breast cancers to normal human breast tissue
and analyzed the data using the MethPipe suite (Lin et al. 2015). Similarly to the results of the
mapping that was performed within the scope of the experiment in this thesis, they could map
79 % of the bisulfite reads to the Homo sapiens reference genome and obtained a sequencing
depth of about 19-fold, with 91 % of all CpG sites covered and a bisulfite conversion rate
of at least 99 %. The authors did not include data about quality control by visual inspection
of selected genomic regions. The MethPipe analysis pipeline was also used in a study that
analyzed the epigenomes of human primordial germ cells. Progressive genome-wide DNA
demethylation to basal levels was shown for these cells during early development, with some
genomic regions being resistant to overall demethylation (Tang et al. 2015). The authors also
reported a bisulfite conversion rate of at least 99 % and mapping efficiencies of a of maximum
58 %.
4.1.2.7. Conclusion: Implementation of whole-genome DNA methylation analysis
enables characterization of epigenetic phenomena
Taken together, whole-genome bisulfite sequencing was successfully implemented for CHO
DP-12 cells and enabled generation of methylome data for reference and butyrate-treated
samples. In combination with gene expression studies by DNA-microarrays this promised
to enable the characterization and functional analysis of the CHO DP-12 DNA methylation
landscape, which was considered necessary for a comprehensive understanding of epigenetic
effects linking genotype and phenotype in the production of biopharmaceuticals. The CHO DP-
12 DNA methylation landscape and corresponding gene expression data were analyzed both
in a comparison to published mammalian methylomes and with regard to CHO phenotypic
properties. In a second step, the effects of the productivity enhancing substance butyrate on
DNA methylation and gene expression were analyzed regarding affected pathways, putative
dynamic effects and time courses of induced changes. Both cellular levels were analyzed
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separately as well as in combination to display the cellular reaction to butyrate addition as
detailed as possible.
4.1.3. The CHO DP-12 DNA methylation landscape
As a DNA methylation map of a CHO cell line did not exist before, the analysis of the CHO DP-
12 cell DNA methylation landscape was of special importance. To be able to assess the impact
of the CHO DP-12 DNA methylation landscape on CHO phenotypic properties, this analysis
was combined with gene expression data generated by DNA-microarrays. For gene expression
microarray analysis four replicate DNA-microarrays were hybridized. Data analysis was
performed using the limma package in R (Smyth 2005) after background correction and
quantile normalization across the technical replicates. As the subset of genes highly expressed
in the samples was supposed to be correlated with the DNA methylation data, all genes with
expression values above the 75th percentile were defined as highly expressed (according to
Schroeder et al. 2011).
4.1.3.1. Global assessment of the CHO DP-12 DNA methylation landscape
To assess the levels and patterning of DNA methylation across the CHO DP-12 cell genome,
a general analysis was performed first. Mean CpG methylation levels were calculated and
CHO DP-12 cells were found to exhibit an average methylation level of 61 % (see section
4.1.2.4). As global methylation levels of > 70 % were reported for a wide variety of cells (e.g.
82 % methylation for HUES64 cells or 78 % methylation for fetal brain cells; Ziller et al.
2013), this finding suggests hypomethylation for the samples analyzed. A global analysis
of DNA methylation on the level of single CpG dinucleotides showed a generally bimodal
distribution of methylation with 52 % of all CpGs being largely methylated (> 70 % of
reads showing methylation) and 30 % of unmethylated CpGs (≤ 10 % of reads showing
methylation; Fig. 4.7A). The remainder of CpG dinucleotides showed partial methylation.
The DNA methylation data were also searched for methylation in a non-CpG context. Overall,
such cytosines exhibited a mean methylation of 3.4 %. When the number of non-CpG
cytosines that were covered by more then 4 reads and exhibited a methylation level of ≥ 70 %
was calculated, only 0.1 % of all cytosines were found to be methylated. This indicated that
non-CpG methylation might by irrelevant in CHO DP-12 cells, as high levels of non-CpG
methylation were for example found in brain tissue, which was shown to exhibit a mean level
of non-CpG methylation of about 25 % (Guo et al. 2014). Due to the very low number of
non-CpG methylation in the CHO DP-12 genome, this type of methylation was considered to
be irrelevant and potentially due to sequencing bias.
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Figure 4.7.: Global distribution of DNA methylation levels in reference CHO DP-12 cultures Wipper-
mann et al. 2015). A Percent methylation of CpG dinucleotides. B Percent methylation of
20 kb, non-overlapping windows tiled through the CHO DP-12 genome. C Percent methy-
lation of CpG islands (CGIs), untranslated regions (UTRs), coding sequences (CDSs) and
introns. Lightgrey bars mark the percentage of regions with methylation levels below
10 %. Also indicated is the average methylation level of each genomic feature.
To get an initial overview of the CHO DP-12 cell DNA methylation landscape, it was examined
whether the observed overall hypomethylation was due to a uniform distribution of CpGs
with low and high methylation levels or if there were local differences in average methylation
between genomic regions. Therefore, the distribution of average methylation levels for non-
overlapping 20 kb windows tiled through the genome was analyzed (according to Schroeder
et al. 2011; Fig. 4.7B). Windows containing less than 100 CpGs were excluded from the
analysis. The purpose of this calculation was to diminish the effect of putatively unmethylated
CpG islands. This analysis showed a very broad methylation spectrum between 20 % and
80 % methylation with a peak at 60 %, indicating a high degree of heterogeneity in local CHO
DP-12 DNA methylation.
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To further characterize the CHO DP-12 cell methylome with regard to the methylation of
annotated genomic features, DNA methylation levels for CGIs, untranslated regions (UTRs),
coding sequences (CDSs) and introns (CDS and introns also referred to as gene-bodies) were
determined (Fig. 4.7C). 45 % of all CGIs in the CHO DP-12 cell genome proved to be
unmethylated and, generally, CGIs showed a mean methylation level of 45 %. UTRs showed
a mean methylation of 56 %, with 26 % of them being unmethylated. CDSs and intronic
regions exhibited mean methylation levels of 76 % and 68 %, respectively, a low percentage
of unmethylated regions (9 % and 7 %) and a high frequency of highly methylated regions.
In summary, CHO DP-12 cells showed global hypomethylation and evidence for local
differences in average methylation levels. In accordance with previously described DNA
methylomes, CGIs proved to have the lowest methylation levels, although a larger fraction of
them was methylated as e.g. in comparison to CGIs in human tissues (9 % of hypermethylated
CGIs; Eckhardt et al. 2006). Gene-bodies in CHO DP-12 cells exhibited a higher level of
DNA methylation than UTRs.
4.1.3.2. Evidence for partially methylated domains in the CHO DP-12 genome
As indications of heterogeneous DNA methylation patterns in the CHO DP-12 cell genome
were found, methylation levels were plotted along the SNP-corrected CHO K1 scaffolds
to visualize their distribution. In this analysis heterogeneous patterns of DNA methylation
with regions showing a high degree of methylation and neighboring regions with partial
methylation were observed (an example is shown in Fig. 4.8 and Supplementary Fig. B.23).
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are exons and CpG islands (CGI) in black. Regions identified as CHO DP-12 PMDs
are marked by green bars. Complete scaffolds JH000001 to JH000009 are shown in
Supplementary Fig. B.23.
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Similar patterns of alternating methylation domains were e.g. also found in colorectal cancer,
breast cancer, fibroblast cultures, SH-SY5Y neuronal cells and placenta. Regions with partial
methylation in these cells and tissues were termed partially methylated domains (PMDs)
(Schroeder et al. 2011; Schroeder et al. 2013; Gaidatzis et al. 2014; Lister et al. 2009; Hon
et al. 2012; Berman et al. 2012). According to the properties of these known PMDs, regions
with a minimum size of 10 kb and a methylation level below 70 % were classified as CHO
DP-12 PMDs. Calculation of the PMD-coverage of all SNP-corrected CHO K1 scaffolds with
more than 100 CpGs (4,874 scaffolds comprising 96 % of the CHO genome) showed that
62 % of the analyzed scaffolds were partially methylated. Accordingly, 38 % of the CHO
DP-12 cell genome were covered by highly methylated domains (HMDs).
As it was shown that X chromosome inactivation complicates PMD analyses (Schroeder
et al. 2013) and due to the fact that CHO cells originate from a female donor, the next
question was whether CHO DP-12 PMDs showed differences in their distribution on the
single chromosomes. This possibility was checked by mapping the whole-genome bisulfite
sequencing reads to the Chinese hamster (CH) chromosomes sequenced and annotated by
Brinkrolf et al. (Brinkrolf et al. 2013). Normalized to chromosome size, 18.4 PMDs/Mb
on average and a very significant difference in PMD count per Mb for chromosome X were
detected, which was much higher with 26.4 PMDs/Mb (Fig. 4.9). A similar finding was
reported by Lister et al. for IMR90 PMDs (Lister et al. 2009). Therefore, PMDs on the X
chromosome were omitted from further analyses of PMD and HMD size, methylation level
and coding sequence (CDS) coverage.
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Figure 4.9.: PMD count per Mb for CHO DP-12 PMDs based on Illumina read coverage assigned to
Chinese hamster chromosomes (Wippermann et al. 2015). One standard deviation of the
mean is indicated by one, two standard deviations by two asterisks.
CHO DP-12 PMDs exhibited 54 % methylation on average, a mean size of 64 kb and a
maximum size of 2,990 kb (Fig. 4.10A-B). In contrast, HMDs showed a mean methylation
of 77 %, a mean size of 34 kb and a maximum size of 450 kb. Next, the coverage of CHO
DP-12 PMDs and HMDs by coding sequence was calculated (Fig. 4.10C). CHO DP-12
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PMDs showed a mean CDS coverage of 1.8 % and a maximum coverage of 65 %, whereas
HMDs exhibited a mean CDS coverage of 3.4 % and a maximum coverage of 90 %. In order
to furthermore obtain the number of CHO DP-12 PMD-localized genes, all annotated CHO
genes were categorized according to their genomic position within or outside of a CHO DP-12
PMD. Genes with partial PMD coverage were excluded. 4,265 unique genes co-localized
with a CHO DP-12 PMD, representing only 18 % of the total of 24,383 genes predicted for
the CHO K1 cell line (Xu et al. 2011). In summary, CHO DP-12 PMDs proved to be larger
but also showed clear evidence for containing fewer genes than CHO DP-12 HMDs.
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ray analysis enabled assessment of the expression levels of 16,693 genes. Of these, 3120
were highly expressed. 1261 of the highly expressed genes also co-localized with CHO
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4.1.3.3. Functional classification of CHO DP-12 PMD-localized by DNA-microarray
analysis
In a next step, PMD-gene expression was analyzed using a CHO-specific DNA-microarray
(Becker et al. 2014), as a known characteristic of PMDs is transcriptional repression of
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co-localized genes. The DNA-microarray enabled the analysis of 16,693 unique gene clusters
and covered 85 % of the identified CHO DP-12 PMD-genes. The remaining (635) PMD-
genes were not present on the microarray and were therefore not analyzed (Fig. 4.10D). As
a one-color labeling protocol was applied, an estimation of gene expression strengths was
possible by this experiment and allowed for the identification of the subset of genes that were
highly expressed. By this means, 3120 highly expressed genes were identified. 1261 of them
were amongst the CHO DP-12 PMD-localized genes (3621 genes in total). This means that
about 65 % of the PMD-localized genes were not highly expressed.
Table 4.3.: Gene ontology (GO) classification of total CHO DP-12 PMD-genes (4265; Wippermann et
al. 2015).
GO ID GO term Count p value
GO:0006455 Translational elongation 81 5.59 × 10-29
GO:0006412 Translation 169 1.96 × 10-22
GO:0007608 Sensory perception of smell 202 5.95 × 10-21
GO:0007606 Sensory perception of chemical stimulus 214 3.16 × 10-19
GO:0050877 Neurological system process 427 1.31 × 10-13
GO:0050890 Cognition 334 2.90 × 10-13
GO:0007600 Sensory perception 302 6.29 × 10-13
GO:0008277 G-protein coupled receptor protein signaling pathway 376 8.68 × 10-09
GO:0042254 Ribosome biogenesis 60 9.95 × 10-08
GO:0022613 Ribonucleoprotein complex biogenesis 77 1.67 × 10-06
GO:0034470 ncRNA processing 78 4.47 × 10-06
GO:0006364 rRNA processing 45 5.89 × 10-06
GO:0034660 ncRNA metabolic process 91 8.94 × 10-06
GO:0016072 rRNA metabolic process 45 2.28 × 10-05
GO:0000375 RNA splicing, via transesterification reactions 64 3.19 × 10-05
GO:0000377 RNA splicing, via transesterification reactions with bulged adeno-
sine as nucleophile
64 3.19 × 10-05
GO:0000398 Nuclear mRNA splicing, via spliceosome 64 3.19 × 10-05
GO:0006396 RNA processing 182 1.25 × 10-04
GO:0042274 Ribosomal small subunit biogenesis 10 1.80 × 10-04
GO:0007166 Cell surface receptor linked signal transduction 549 1.95 × 10-04
GO:0042273 Ribosomal large subunit biogenesis 9 5.70 × 10-04
GO:0030005 Cellular di-, tri-valent inorganic cation homeostasis 82 8.27 × 10-04
Tab. 4.3 shows the gene ontology (GO) analysis of the 4265 genes that were in total associated
with CHO DP-12 PMDs and were found to be significantly enriched in two different general
categories. These genes were on the one hand related to gene expression and RNA splicing,
e.g. represented by the GO terms ’translational elongation’ (81 genes), ’translation’ (169
genes) or ’ribosome biogenesis’ (60 genes) as well as ’RNA processing’ (182 genes). On the
other hand, genes related to neurological processes were enriched, e.g. represented by the
specific GO terms ’sensory perception of smell’ (202 genes), ’neurological system process’
(427 genes) or ’cognition’ (334 genes).
Next, separate gene ontology annotations were performed for the highly expressed PMD-
genes (1261) and the weakly or not expressed PMD-genes (2360), respectively. Interestingly,
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Table 4.4.: Separate gene ontology (GO) classifications for highly expressed (1261) and weakly or not
expressed (2360) CHO DP-12 PMD-genes (Wippermann et al. 2015). Displayed are the
top 20 GO terms for both groups according to p values. Complete lists of gene ontology
annotations can be found in Supplementary Tabs. B.5 and B.6.
GO ID GO term Count p value
Highly expressed CHO DP-12 PMD-genes
GO:0006412 Translation 147 4.54 × 10-76
GO:0006414 Translational elongation 77 7.25 × 10-64
GO:0006396 RNA processing 117 6.47 × 10-25
GO:0042254 Ribosome biogenesis 50 1.14 × 10-23
GO:0022613 Ribonucleoprotein complex biogenesis 60 6.73 × 10-23
GO:0000398 Nuclear mRNA splicing, via spliceosome 50 9.30 × 10-19
GO:0000375 RNA splicing, via transesterification reactions 50 9.30 × 10-19
GO:0000377 RNA splicing, via transesterification reactions with bulged adeno-
sine as nucleophile
50 9.30 × 10-19
GO:0006364 rRNA processing 37 2.61 × 10-17
GO:0008380 RNA splicing 68 2.84 × 10-17
GO:0016072 rRNA metabolic process 37 1.31 × 10-16
GO:0006397 mRNA processing 70 2.09 × 10-15
GO:0006119 Oxidative phosphorylation 36 2.32 × 10-15
GO:0034660 ncRNA metabolic process 56 1.47 × 10-14
GO:0006091 Generation of precursor metabolites and energy 66 7.95 × 10-14
GO:0016071 mRNA metabolic process 73 1.12 × 10-13
GO:0034470 ncRNA processing 47 7.37 × 10-13
GO:0015985 Energy coupled proton transport, down electrochemical gradient 18 1.61 × 10-09
GO:0015986 ATP synthesis coupled proton transport 18 1.61 × 10-09
GO:0042274 Ribosomal small subunit biogenesis 10 4.30 × 10-09
GO:0000278 Mitotic cell cycle 62 8.82 × 10-09
Weakly or not expressed CHO DP-12 PMD-genes
GO:0022610 Biological adhesion 150 3.53 × 10-10
GO:0007155 Cell adhesion 149 6.01 × 10-10
GO:0007268 Synaptic transmission 72 2.02 × 10-07
GO:0019226 Transmission of nerve impulse 81 2.25 × 10-07
GO:0007610 Behavior 98 1.70 × 10-06
GO:0007204 Elevation of cytosolic calcium ion concentration 34 2.23 × 10-06
GO:0055074 Calcium ion homeostasis 49 2.45 × 10-06
GO:0050877 Neurological system process 212 2.48 × 10-06
GO:0006874 Cellular calcium ion homeostasis 48 2.61 × 10-06
GO:0030005 Cellular di-, tri-valent inorganic cation homeostasis 55 5.97 × 10-06
GO:0006875 Cellular metal ion homeostasis 49 8.43 × 10-06
GO:0009611 Response to wounding 105 8.63 × 10-06
GO:0051480 Cytosolic calcium ion homeostasis 34 1.18 × 10-05
GO:0055082 Cellular chemical homeostasis 80 1.27 × 10-05
GO:0006873 Cellular ion homeostasis 79 1.28 × 10-05
GO:0055065 Metal ion homeostasis 50 1.38 × 10-05
GO:0055066 Di-, tri-valent inorganic cation homeostasis 56 1.39 × 10-05
GO:0007267 Cell-cell signaling 113 3.90 × 10-05
GO:0030003 Cellular cation homeostasis 57 4.26 × 10-05
GO:0044057 Regulation of system process 66 5.03 × 10-05
GO:0051345 Positive regulation of hydrolase activity 43 8.70 × 10-05
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the highly expressed PMD-genes proved to belong to the same GO classes related to gene ex-
pression and RNA processing as generally enriched in CHO DP-12 PMD-localized genes (Tab.
4.4 and Supplementary Tab. B.5). Additionally, genes contributing to energy metabolism
(’generation of precursor metabolites and energy’, 66 genes) and cell cycle control (’mitotic
cell cycle’, 62 genes) were found to be significantly enriched in this group. Within the weakly
or not expressed PMD-genes those contributing to neurological processes were overrepre-
sented, e.g. including GO terms like ’synaptic transmission’ (81 genes) or ’neurological
system process’ (212 genes; Tab. 4.4 and Supplementary Tab. B.6). Also, genes with func-
tions in cellular adhesion (’biological adhesion’, 150 genes) and calcium ion homeostasis
(’cellular calcium ion homeostasis’, 48 genes) were significantly enriched in this group.
4.1.3.4. Discussion: General characterization of the CHO DP-12 cell DNA methylome
Whole-genome bisulfite sequencing and gene expression microarray analyses showed that
the CHO DP-12 cell genome is hypomethylated (61 % CpG methylation) compared to most
mammalian cell types like embryonic stem (ES) cells, their derivatives and primary cells
that exhibit global methylation levels of >70 % (Ziller et al. 2013). Global hypomethylation
has been reported for cancers such as colon tumors and also for long-term cultured cells like
IMR90, foreskin fibroblasts and HepG2 cells and proved to be either related to a uniform or a
locally concentrated distribution of hypomethylated regions (Ziller et al. 2013; Laurent et al.
2010; Berman et al. 2012; Schroeder and LaSalle 2013).
The analysis of methylation of genomic features showed that CGIs and UTRs in CHO DP-12
cells are less frequently methylated than so-called gene bodies (coding sequences and introns)
that are predominantly methylated. This is in accordance with previously described DNA
methylomes that show higher levels of DNA methylation in gene-bodies compared to UTRs
and was e.g. shown in bovine muscle tissue (Huang et al. 2014). For multiple species a
genome-wide negative correlation between promoter methylation and gene expression was
described, whereas gene-body methylation has been reported to be positively correlated with
gene expression (Deaton and Bird 2011; Jjingo et al. 2012). The meaning of evolutionary
conserved gene-body methylation is not completely understood yet, but studies indicate that
intragenic DNA methylation modulates alternative RNA splicing (Maunakea et al. 2013).
CGIs proved to have the lowest overall methylation levels in CHO DP-12 cells, although a
larger fraction of them is methylated compared to human tissues, mouse embryonic stem cells
or differentiated mouse cells (Eckhardt et al. 2006; Meissner et al. 2008; Stadler et al. 2011).
This finding is in contrast to the concept of CGIs being usually characterized by their lack of
DNA methylation, but in accordance with the hypothesis that a great number of CGIs become
methylated in permanent cell lines (Antequera, Boyes, and Bird 1990). Cancer cells are also
known to exhibit global hypomethylation that accompanies aberrant hypermethylation of CGIs
79
Chapter 4. Results and discussion
(Sproul and Meehan 2013). In many of these cases hypermethylation of promoter CGIs can
be related to silencing of tumor suppressor genes regulating cell growth, differentiation and
apoptosis (Yang and Zheng 2014; Liu et al. 2014). Hu et al., e.g., identified novel candidate
tumor suppressor genes in natural killer cell lymphoma (NKCL) by promoter methylation
analysis and gene expression profiling, including Bcl-2-like protein 11 (BCL2L11; Hu et al.
2015). Ectopic BCL2L11 expression led to increased apoptosis in natural killer cell lines. A
similar approach could be applied to find key regulators of growth and apoptosis in CHO cells
useful for cell line engineering.
One study exists that can be used for direct comparison of results from whole-genome bisulfite
sequencing studies in CHO cells. In 2016, Feichtinger et al. analyzed six related CHO
K1-derived cell lines regarding their genome sequences and DNA methylation landscapes
under different culture conditions, in different media and after subcloning (Feichtinger et
al. 2016). They showed the numbers of differentially methylated regions between the cell
lines to be low in response to passaging and during batch cultivation. High numbers of
differentially methylated regions were only found to be high as a consequence of several
rounds of subcloning and selection of a certain phenotype. DNA methylation was furthermore
found to change significantly in response to media changes. Generally, this study confirmed
the results of the one performed here, as all CHO cell lines analyzed by Feichtinger et
al. showed a bimodal distribution of either hypo- or hypermethylated CpGs with overall
methylation levels of 55 – 65 % and a proportion of CpG dinucleotides with intermediate
methylation levels. Differences between CHO K1 and CHO DP-12 cells could be found
regarding the proportions of unmethylated and methylated CpGs, as in CHO DP-12 cells 30 %
of all CpGs were unmethylated and in CHO K1-derived cells only about 18 % of all CpGs. On
the contrary, CHO K1 cells were shown to exhibit higher numbers of methylated CpGs (60 %
compared to 30 % methylated CpGs in CHO DP-12). CHO DP-12 cells had, accordingly, a
higher proportion of CpG dinucleotides with intermediate methylation levels. Feichtinger et
al. did not analyze the overall distribution of DNA methylation across individual genomes
in more detail, but rather focused on the comparisons between methylomes. Therefore, no
general conclusions regarding the DNA methylation landscapes of the CHO K1-derived cells
could be deduced from this study.
4.1.3.5. Discussion: Partially methylated domains in the CHO DP-12 cell DNA
methylome
The global characterization of DNA methylation in the CHO DP-12 cell genome indicated a
heterogeneous arrangement of hypomethylated regions instead of an even distribution. When
methylation levels were plotted along the SNP-corrected CHO K1 scaffolds, large genomic
regions with partial methylation were observed. Methylation levels of 54 % on average could
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be assigned to these regions which clearly separated them from the neighboring regions with
a mean methylation of 77 %. These regions were termed CHO DP-12 PMDs according to the
PMDs found in colorectal cancer, breast cancer, fibroblast cultures, SH-SY5Y neuronal cells
and placenta (Schroeder et al. 2011; Schroeder et al. 2013; Gaidatzis et al. 2014; Schroeder
and LaSalle 2013; Lister et al. 2009; Hon et al. 2012; Berman et al. 2012). PMDs correspond
to genomic domains of an average size of 135 kb that cover approximately 40 % of the
above-mentioned genomes and have lower levels of DNA methylation than the neighboring
genomic regions (Gaidatzis et al. 2014; Schroeder and LaSalle 2013). For CHO DP-12 PMDs
a mean size of 64 kb was detected, which is probably due to the current draft status of the
CHO K1 genome. A coverage of all analyzed SNP-corrected CHO K1 scaffolds by CHO
DP-12 PMDs of 62 % was observed.
Another characteristic of PMDs is transcriptional repression of genes localized within these
regions that are generally gene-poor (Schroeder et al. 2013). Accordingly, only 18 % (4,265)
of all genes were located within CHO DP-12 PMDs. However, gene expression analysis
showed that 30 % (1261) of the CHO DP-12 PMD-localized genes were highly expressed,
contradicting the notion of generally repressed gene expression by PMDs. In agreement
with the differences in expression, GO analysis of all genes located within CHO DP-12
PMDs showed a significant enrichment in two different functional groups that were related to
gene expression on the one hand and to neurological processes on the other hand. When a
separate GO analysis was performed for the highly expressed PMD-genes, a significant over-
representation was found for those genes with functions in gene expression and, additionally,
in energy metabolism and cell cycle, thus representing functions vital for CHO cell growth and
productivity. Several reports have shown strong expression of genes related to transcription,
translation, chromatin modification and energy metabolism in CHO cell cultures, too (Carlage
et al. 2009; Meleady et al. 2011; Nissom et al. 2006).
Weakly or not expressed CHO DP-12 PMD-localized genes were significantly enriched for
the functions related to neurological processes such as synaptic transmission and also to cell
adhesion and calcium ion homeostasis. It is known that PMDs often contain repressed genes
with tissue-specific functions unrelated to the tissue of origin (Schroeder and LaSalle 2013).
Neurological processes clearly are unnecessary functions in CHO cells. These processes are
strongly related to the cellular calcium homeostasis, as intracellular calcium plays a critical
role in neuron development (Gomez and Zheng 2006). It is striking that reduced capacity
of cellular adhesion is relevant for adaption of CHO cells to suspension culture, which is a
CHO cell property necessary for scalability of industrial processes. It is also strongly related
to the conversion of benign tumors to aggressive cancers (Tokuda et al. 2014). Interestingly,
PMDs in placenta tissue, SH-SY5Y and IMR90 cells are most significantly enriched in genes
contributing to neurological processes, too (Schroeder et al. 2013). This finding is supported
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by the fact that methylation patterns in PMDs were shown to be conserved across cell types
(Gaidatzis et al. 2014).
4.1.3.6. Conclusion: The first map of a CHO cell DNA methylation landscape
The results presented here represent a first global analysis of the CHO DNA methylation
landscape. The CHO DP-12 cell methylome was shown to exhibit general properties that are
typical for mammalian cells, although it also turned out to be heterogeneous and characterized
by global hypomethylation and hypermethylation of CpG islands. It furthermore shows strong
evidence of partially methylated domains. Similar epigenomic features are observed for
many cancer types and also for placenta (Schroeder and LaSalle 2013). In fact, placental
trophoblastic and malignant cells share features such as high proliferation or their lack of
cell-contact inhibition and it was shown that a subset of malignant tumors activate ectopic
expression of germline and placental genes (Ferretti et al. 2006; Rousseaux et al. 2013). CHO
cells are, similarly to cancer and placental trophoblast cells, characterized by their proliferative
properties and deregulated apoptotic pathways. Here, it was additionally shown that CHO
DP-12 cells not only exhibit epigenomic features similar to cancer and placenta cells, but that
there is evidence of these features being involved in the repression of tissue-specific genes,
as it was shown for placenta PMDs, too. Interestingly, the repressive effect of CHO DP-12
PMDs does not affect genes relevant to CHO cell properties.
To fully understand this relationship, it still needs to be elucidated how PMDs evolved, if
they are generated in a dynamic manner and what they look like on the cellular level. A
comparison of different CHO cell lines with respect to the presence and location of PMDs
is also required. However, these findings show that DNA methylation might significantly
contribute to CHO phenotypes and allow for a deeper understanding of CHO cell properties.
As a consequence, future experiments to identify targets for rational design of CHO cell lines
with improved production characteristics should not only address gene expression changes,
but also the underlying epigenetic patterns. The presence of PMDs in the CHO DP-12 cell
genome for example underlines the necessity of site-specific integration of recombinant genes
in order to avoid potentially unfavorable epigenetic environments leading to low expression
levels.
4.1.4. DNA methylation dynamics and differential gene expression in
response to butyrate
In the second part of the integrative analysis of DNA methylation and gene expression in
CHO DP-12 cells, the butyrate effect on DNA methylation dynamics and differential gene
expression was analyzed in a time-course study. Butyrate is known to enhance cell specific
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productivity and was shown to influence epigenetic processes both on the levels of histones
and DNA methylation (Choi et al. 2005; Jiang and Sharfstein 2008; Klausing, Krämer, and
Noll 2011; Sung et al. 2004; Kucharski et al. 2008; Donohoe and Bultman 2012). However,
the positive effect of butyrate addition on CHO cells is also accompanied by detrimental
effects such as growth inhibition and apoptosis. It was furthermore reported that the quality
and bioactivity of glycoproteins can be influenced by butyrate addition (Hong et al. 2014; Lee
et al. 2014). Knowledge of the mechanism underlying the butyrate effect promises to enable
rational cell line development in terms of employing only the positive aspects. For this reason,
several studies aimed to analyze the effect of butyrate addition on the CHO cell transcriptome
and proteome. It was for example shown that butyrate affected histone modifications, lipid
metabolism and protein processing as well as the expression of chaperone genes (De Leon
Gatti et al. 2007). Additionally, Kantardjieff et al. reported that butyrate affected expression
of genes related to protein secretion and signaling (Kantardjieff et al. 2010). Klausing et
al. could show that genes related to carbohydrate, lipid, amino acid and glycan metabolism
were upregulated upon butyrate addition, whereas genes associated with cell growth and
apoptosis were downregulated (Klausing, Krämer, and Noll 2011). It was furthermore shown
that butyrate increased the expression of genes involved in protein secretion and redox activity
and decreased the expression of genes related to cell cycle and apoptosis (Yee et al. 2008).
Here, genome-wide butyrate-induced changes of DNA methylation and gene expression were
analyzed. DNA methylation and gene expression data were integrated regarding functional
annotations of differentially methylated and expressed genes and potential correlations of
DNA methylation and gene expression profiles over the time course of sampling. A de
novo sequence motif discovery was applied furthermore to assess an involvement of specific
transcription factors.
4.1.4.1. Gene expression changes upon butyrate addition
Samples for integrative DNA methylation and gene expression analysis were taken from
CHO DP-12 batch cultivations prior to butyrate addition as well as 6, 12, 24 and 36 hours
post butyrate treatment (please refer to section 4.1.1 for details). The replicate samples
taken before butyrate addition served as the reference for the analysis of differential DNA
methylation and gene expression upon butyrate addition. RNAs extracted from these samples
were checked for integrity (Supplementary Fig. B.18) and pooled before cDNA was generated
by reverse transcription. 1.65 µg of each cDNA was used for microarray hybridization. Four
DNA-microarrays were hybridized for the reference and each 3 DNA-microarrays for the time
points 6, 12, 24 and 36 hours post butyrate treatment (see quality plots in Supplementary Fig.
B.19). Data analysis was performed using the limma package in R. In a first step, the signal
ranges before normalization were compared between the arrays, which proved to be very
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similar even before further processing. Data were then background corrected and quantile
normalized (Supplementary Fig. B.20). For each comparison between samples of interest,
statistical parameters for differential expression were calculated. Genes with adjusted p values
below 0.01 were considered to be significantly differentially expressed.
To get a first impression of differential gene expression, the top 10 up- and downregulated
genes were examined regarding their functions and the extent of differential expression. Table
4.5 shows each of the top 10 up- and downregulated genes 36 hours post butyrate addition
with indication of M-values for all four sampling points. M-values represent the log2-ratio
of the experimental sample to the reference. Accordingly, M-values of 1.0 indicate a two-
fold increase in gene expression in the experimental sample relative to the reference culture
(fold change 2). An M-value of -1.0 indicates a decrease in gene expression of 50 % in the
experimental sample relative to the reference culture (fold change 0.5). The table also shows
key protein functions retrieved from the UniProt database (The UniProt Consortium 2014).
Table 4.5.: Expression time courses of the top 10 up- and downregulated genes 36 hours post butyrate
addition (p ≤ 0.01). M-values ≤ -1.0 are associated with downregulated genes. M-
values ≥ 1.0 are associated with upregulated genes. Key protein functions were retrieved
from the UniProt database (The UniProt Consortium 2014).
Abbr. Name Gene expression [M-value] Function
6 h 12 h 24 h 36 h
Downregulated genes
PRRX1 Paired mesoderm homeobox protein 1 -0.77 -2.07 -2.52 -2.34 Development
EMPL Epithelial membrane protein 1 -0.58 -1.77 -2.38 -2.24 Apoptosis, growth
IL1RL1 Interleukin-1 receptor-like 1 -0.96 -1.76 -1.99 -2.11 Receptor, growth
PTHLH Parathyroid hormone-related protein -1.99 -2.12 -2.11 -1.97 Growth, development
FBXO4 F-box only protein 4 -0.84 -1.95 -2.32 -1.94 Ubiquitination
NUPR1 Nuclear protein 1 0.00 -0.66 -1.53 -1.86 Activator, stress
ACSL5 Long-chain-fatty-acid–CoA ligase 5 -0.48 -1.53 -2.04 -1.79 Lipid metabolism
CFLAR CASP8 and FADD-like apoptosis re-
gulator
-0.53 -0.65 -1.32 -1.77 Inhibitor of apoptosis
COL4A1 Collagen alpha-1(IV) chain 0.00 -1.33 -2.13 -1.55 Angiogenesis, growth
PLK1 Serine/threonine-protein kinase PLK1 -0.89 -0.84 -1.38 -1.54 Cell cycle
Upregulated genes
GLYAT Glycine N-acyltransferase-like protein 0.00 0.50 1.68 2.80 Detoxification, acyl-
CoA metabolism
MYL9 Myosin regulatory light polypeptide 9 0.00 1.01 2.09 2.59 Motor protein
ULBP1 NKG2D ligand 1 0.00 0.61 1.62 2.29 Immune signaling
HMGCS2 Hydroxymethylglutaryl-CoA synthase 0.00 0.00 1.31 2.19 Lipid biosynthesis
TXNIP Thioredoxin-interacting protein 2.47 2.68 2.42 1.84 Repressor, cell cycle
CCPG1 Cell cycle progression protein 1 1.24 1.63 1.81 1.80 Cell cycle
CTNNA2 Catenin alpha-2 0.00 0.60 1.55 1.79 Development
LOXL2 Lysyl oxidase homolog 2 0.00 0.00 0.70 1.77 Chromatin regulator
ATOX1 Copper transport protein ATOX1 0.45 0.95 1.54 1.76 Ion transport
DGAT2 Diacylglycerol O-acyltransferase 2 0.00 0.81 1.27 1.70 Lipid biosynthesis
The strongest downregulation was detected for Paired mesoderm homeobox protein 1 (PRRX1)
with an M-value of -2.34 (fold change 0.19 relative to the reference) 36 hours upon butyrate
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additon. Six hours post butyrate addition PRRX1 showed downregulation by M = -0.77
(fold change 0.59), i.e. PRRX1 was increasingly downregulated over the course of sampling.
PRRX1 serves as a co-activator in developmental processes. As another example, Glycine
N-acyltransferase-like protein (GLYAT) was found to be the gene with the highest M-value of
2.80 (fold change 6.9 relative to the reference) 36 hours upon butyrate additon. Upregulation
of GLYAT was first detected 12 hours post butyrate addition with M = 0.5 (fold change
1.4). Strikingly, GLYAT is a mitochondrial acyltransferase and contributes to detoxification
processes and acyl-CoA-metabolism. Similar expression profiles were found for the other
genes, with maximum M-values of means of -2.0 and 2.0, respectively. Downregulated genes
had functions in growth, apoptosis and cell cycle control, whereas upregulated genes had
functions in signaling, lipid metabolism, cell cylce and chromatin modification.
In general, 2,724, 5,346, 6,610 and 7,672 genes were detected to be differentially expressed
upon butyrate addition at time points 6, 12, 24 and 36 hours (Fig. 4.11A). The Venn diagrams
in Fig. 4.11B show that most of the butyrate-responsive genes were expressed at more than
one time point with a majority being expressed at the ’36 h’ sampling point. When expression
profiles were analyzed by hierarchical cluster analysis, most genes indeed turned out to be
continuously up or downregulated over the time course of sampling (Fig. 4.11C).
Using k-means clustering, expression profiles could be grouped into 4 distinct clusters (Fig.
4.11D). Cluster I contained 929 genes that were upregulated during the first 12 hours of
butyrate treatment by a mean of two-fold (M = 1.0). In contrast, cluster II included 1014
genes that were downregulated during the first 12 hours by a mean of 0.5-fold (M = -1.0).
Gene Ontology annotations showed that the upregulated genes in cluster I were most signifi-
cantly related to energy generation (e.g. 33 genes contributing to ’generation of precursor
metabolites and energy’), transport (e.g. ’vesicle-mediated transport’, 53 genes) and response
reactions (e.g. ’response to endogenous stimulus’, 37 genes; see complete GO annotation in
Supplementary Tab. B.10). The downregulated genes in cluster II were most significantly
related to cell cycle regulation (e.g. ’cell cycle’, 106 genes), RNA processing (e.g. ’RNA
splicing’, 43 genes) and chromatin modification (e.g. ’chromosome organization’, 71 genes;
Supplementary Tab. B.11). 2861 genes in cluster III and 3039 genes in cluster IV showed
expression time courses that continuously, but only slightly, increased or decreased, with
minimum and maximum mean values of differential expression of 1.2-fold (M = 0.25) and
0.8-fold (M = -0.25). The continuously but weakly upregulated genes were most significantly
related to protein transport and protein catabolism (e.g. ’protein localization’, 227 genes
and ’proteolysis involved in cellular protein catabolic process’, 128 genes) as well as protein
synthesis (e.g. ’translational elongation’, 52 genes; Supplementary Tab. B.12). The down-
regulated genes were most significantly related to RNA metabolism and splicing (e.g. ’RNA
processing’, 196 genes), cell cycle regulation (e.g. ’mitotic cell cycle’, 132 genes) and gene
expression (e.g. ’transcription’, 425 genes; Supplementary Tab. B.13).
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Figure 4.11.: Analysis of differential gene expression data 6 to 36 hours after butyrate addition (mod-
ified from Wippermann et al. 2016). A Numbers of differentially expressed genes.
B Un-weighted Venn diagrams of genes showing up- and downregulated expression
6 hours to 36 hours after butyrate addition. C Hierarchical clustering of differential
gene expression data. A heatmap of gene expression data (fold changes color-coded
according to the legend) was generated using the ComplexHeatmap package in R. Cluster
analysis based was performed using euclidean clustering distance and Ward’s method for
agglomeration (Ward 2012). D Time courses of gene expression changes. By k-means
clustering 4 distinct general gene expression profiles were identified. Standard deviations
are represented in grey.
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When the changes in cellular pathways over time were examined by Generally Applicable
Gene-set Enrichment (GAGE; Luo et al. 2009) analysis (Fig. 4.12) in order to discriminate
early response reactions from potential secondary ones, genes related to the processes ’protein
amino acid acetylation’, ’regulation of transcription’, ’regulation of DNA replication’ and
’chromatin remodeling’ as well as processes related to differentiation (e.g. ’skeletal system
development’) were found to be specifically downregulated at the first sampling point.
4.1.4.2. Mapping of gene expression changes to cellular pathways
To get a detailed view on the time course of differential gene expression upon butyrate
treatment with regard to affected cellular pathways, significantly differentially expressed
genes were mapped to KEGG pathways (Kanehisa and Goto 2000) based on M-values.
Mapping was performed using the Bioconductor pathview package (Luo and Brouwer 2013)
that allows for visualization of multiple values for a single gene, i.e. enables representation
of time course data on KEGG pathway maps. According to the GO analysis, the pathways
’cell cycle’ and ’apoptosis’ were examined in detail. As butyrate was shown to have a major
impact on cellular energy generation and, importantly, a butyrate-induced switch from lactate
production to consumption could be observed during the experiment, the pathways ’citrate
cycle’ and ’glycolysis’ were also examined. The pathway ’spliceosome’ was examined more
closely, as butyrate addition affected several genes related to RNA processing. Additionally,
the impact of butyrate addition on the ’N-glycan biosynthesis’ pathway was analyzed to
account for the reports of changes in product glycosylation (see e.g. Hong et al. 2014).
The pathways ’RNA transport’, ’Aminoacyl tRNA biosynthsis’, ’Ribosome biogenesis’ and
’Ribosome’ were examined in detail in order to assess a potential impact of these processes
on recombinant protein production.
Impact of butyrate on cell cycle regulation 36 hours after butyrate addition a large part
of the genes involved in cell cycle regulation showed downregulated expression (Fig. 4.13).
These included key regulatory elements such as Proliferating cell nuclear antigen (PCNA)
or components of the Mini chromosome maintenance (MCM) complex. PCNA regulates
DNA replication and cell cycle by interacting with several proteins. It functions e.g. as a
platform for DNA polymerase during DNA replication and interaction of PCNA with the p21
protein stops DNA synthesis. Therefore, PCNA expression is correlated with cell proliferation
(Strzalka and Ziemienowicz 2011). The structurally related and highly conserved MCM
proteins 2 to 7, which form a hexameric complex that is recruited to replication origins during
G1 phase and functions as a helicase, are also associated with cell proliferation (Noseda and
Karsan 2006).
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Figure 4.12.: Generally Applicable Gene-set Enrichment (GAGE, Luo et al. 2009) analysis of signifi-
cantly differentially expressed genes after butyrate addition (Wippermann et al. 2016).
Heatmaps depict either significantly down- or upregulated cellular pathways (based on
Gene Ontology (GO) terms) over the time course of sampling.
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Expression time courses differed, as some genes were already downregulated 6 hours post
butyrate addition (e.g. PCNA) and for some genes downregulation was detected at later
time points (e.g. at the 36 hours sampling point for the MCM complex components). Some
central regulators of the pathway were furthermore upregulated, e.g. MYC, which showed
upregulated expression 6 to 12 hours post butyrate. MYC is associated with cell proliferation
as well, as it induces several positive cell cycle regulators and inhibits the activity of inhibitory
factors such as p21 (Bretones, Delgado, and León 2015). Further genes involved in the cell
cycle were GADD45A and GADD45B, which were found to be upregulated at all sampling
points. GADD45 expression has been shown to be induced by DNA damage and in response
to cellular stress associated with apoptosis and growth arrest. GADD45 action is mediated
via MAPK signaling (Salvador, Brown-Clay, and Fornace 2013).
For some genes differences in up- and downregulation of subunits or isoforms were detected,
e.g. including Anaphase-promoting complex (APC/C). ANAPC4 and ANAPC5 were down-
regulated after butyrate addition, whereas ANAPC11 and ANAPC13 were upregulated. The
APC/C complex regulates cell cycle transitions by controlling proteolysis of cell cycle proteins
and is regulated by specific cell cycle checkpoints (Chang and Barford 2014). Similarly, Mi-
totic spindle assembly checkpoint proteins MAD2A and MAD2B (MAD2L1 and MAD2L2)
were down- and upregulated, respectively.
As cell cycle regulation and WNT signaling are closely linked, differential gene expression
was analyzed for this pathway as well, which was found to exhibit both up- and downregulated
genes (Supplementary Fig. B.31).
Impact of butyrate on the induction of apoptotic pathways Several genes encoding
major regulators of apoptosis were upregulated upon butyrate addition, most of them already at
the first sampling point or 12 hours after butyrate addition at the latest (Fig. 4.14). These genes
included Caspase-3, Caspase-6 and Caspase-9 (CASP3, CASP6, CASP9), Apoptotic protease-
activating factor 1 (APAF-1) and Apoptosis regulator Bax (BAX). Caspases (= cysteine-
aspartic proteases) are proteases that are involved in cell death mediated by apoptosis and
also in non-apoptotic functions such as proliferation and differentiation. Within the intrinsic
pathway of apoptosis induction which is activated by cellular stress, the pro-apoptotic effectors
BAX and BAK induce the release of cytochrome c. APAF-1 then forms a complex with
cytochrome c and activates CASP9, which is a so-called initiator caspase that activates effector
caspases such as CASP3 and CASP6 (Shalini et al. 2015).
Further pro-apoptotic genes found to be upregulated upon butyrate addition were Bcl-2-like
protein 11 (BIM/BCL2L11) and C-Jun N-terminal kinase (JNK1/MAPK8). BIM was shown
to induce apoptosis in response to stimuli such as growth factor deprivation. It induces
conformational changes in BAX and thereby leads to its activation. It furthermore uncouples
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Figure 4.13.: Visualization of gene expression time course after butyrate addition for KEGG pathway
Cell Cycle (Kanehisa and Goto 2000). Pathway analysis and visualization of gene
expression changes based on M-values was performed using pathview (Luo and Brouwer
2013). Gene expression changes are color-coded according to the legend. Each node
is divided into four parts representing differential expression at sampling points ’6 h’
to ’36 h’. For nodes representing multiple proteins (isoforms, subunits etc.) maximal
absolute values are used as the summary/representative of a node.
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mitochondrial respiration and leads to the formation of reactive oxigen species. BIM was
also shown to affect cytoskeletal integrity (Sionov, Vlahopoulos, and Granot 2015). JNK1
also mediates cellular response reactions to stresses and is involved in apoptosis, but also in
processes such as proliferation and differentiation. JNKs in general belong to the Mitogen-
activated protein kinase (MAPK) familiy of proteins and are activated by the MAP2K proteins
MKK4 or MKK7, which are in turn activated by several MAP3K proteins that react to specific
signals. JNK proteins then upregulate pro-apoptotic genes by influencing transcription factors
or by direct phosphorylation events that impact the activity of further proteins (Dhanasekaran
and Reddy 2008).
Interestingly, Caspase-7, Caspase-8 and Caspase-12 (CASP7, CASP8 and CASP12) were
downregulated at all sampling points following butyrate addition. CASP8 represents the
initiator caspase of the extrinsic apoptotic pathway, which depends on ligand binding to
so-called death-receptors (McIlwain, Berger, and Mak 2013). While CASP7 belongs, like
CASP3 and CASP6, to the group of initiator caspases, CASP12 was shown to be involved in
apoptotic events due to ER stress which can be induced by chemicals (Lamkanfi, Kalai, and
Vandenabeele 2004).
According to the crosstalk of apoptotic processes with several signaling pathways, differential
gene expression was also found for the MAPK signaling pathway (largely upregulated, Supple-
mentary Fig. B.32), the calcium signaling pathway (both up- and downregulated components,
Supplementary Fig. B.33) and the p53 signaling pathway (both up- and downregulated
components as well, Supplementary Fig. B.34).
Butyrate-dependent changes in central energy metabolism Several genes encoding ma-
jor regulatory enzymes involved in glycolysis and the TCA cycle were upregulated upon
butyrate addition (Supplementary Fig. B.27 and 4.15). Interestingly, upregulation of gene
expression occurred earlier than downregulation, with several genes being not differentially
upregulated anymore 36 hours after butyrate addition. On the contrary, downregulation of
gene expression happened later and most genes were still found to be downregulated 36 hours
after butyrate addition.
Genes involved in glycolysis and gluconeogenesis that were upregulated upon butyrate ad-
dition comprised e.g. ADP-dependent glucokinase (ADPGK) and Acetyl-CoA synthetase
(ACSS2). Also, expression of key players involved in the citric acid cycle was upregulated,
including Pyruvate carboxylase (PC), ATP-citrate synthase (ACLY), Isocitrate deyhdrogenase
(IDH1) and Malate dehydrogenase (MDH1 and MDH2). Genes of the glycolysis path-
way that were downregulated at later sampling points included Hexokinase-1 (HK1) and
Glyceraldehyde-3-phosphate dehydrogenase (GAPDH). The only gene that was already down-
regulated 6 hours after butyrate addition was Lactate dehydrogenase (LDHA). Expression of
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Figure 4.14.: Visualization of gene expression time course after butyrate addition for KEGG pathway
Apoptosis (Kanehisa and Goto 2000). Pathway analysis was performed using pathview
(Luo and Brouwer 2013). Gene expression changes are color-coded according to the
legend. Please refer to legend of Fig. 4.13 for a more detailed description.
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TCA enzymes including Aconitate hydratase (ACO) and Succinyl-CoA ligase (SUCLG1 and
SUCLG2) was found to be downregulated 24 hours and/or 36 hours after butyrate addition as
well.
Only minor changes in gene expression within the pentose phosphate pathway were observed.
However, both purine and pyrimidine metabolism pathways were strongly affected upon
butyrate addition (Supplementary Figs. B.35 and B.36).
The effect of butyrate addition on splicing For a majority of genes involved in splicing
(Fig. 4.16) a similar behavior was observed, as most of the genes belonging to the small
nuclear ribonucleoprotein particles (snRNPs) U1, U2 and U4 to U6 were downregulated.
Differences were observed in the times regulation set in. In contrast, components of the PRP19
complex and PRP19 related genes showed either up- or downregulated expression. Briefly,
splicing begins with assembly of the small nuclear RNAs with the pre-mRNA, recognition of
the 5’ splice and branch sites and formation of the active splicing complex, which involves
association of PRP19 and related proteins (the NineTeen Complex, NTC). After several
rearrangements the catalytically active complex carries out the splicing reaction, which
includes the attack at the 5’ splice site by the branch site adenosine and the attack of the 3’
splice site be the 5’ exon, followed by exon joining and release of an intron-snRNP complex.
During this splicing cycle, modulation of the NTC and associated proteins are required for
spliceosome confirmations during slicing and disassembly (Almeida and O’Keefe 2015).
PRP19 also is involved in mediating cell survival after DNA damage and loss of PRP19 was
shown to result in accumulation of DNA double-strand breaks (Mahajan and Mitchell 2003).
Interestingly, an interaction of PRP19 complex components with the nucleotide excision
repair machinery and, additionally, with PCNA was found (Chanarat and Sträßer 2013; Chu
et al. 2006). Strikingly, the base excision repair pathway is linked to the regeneration of
unmodified cytosine during TET-mediated demethylation and DNMT1-PCNA-interaction is
essential for DNA maintenance methylation. As PCNA was also found to be downregulated,
this finding hints towards a complex system of butyrate-responsive cellular pathways.
Butyrate addition leads to changes in expression of genes relevant to glycosylation Bu-
tyrate was shown to be capable of influencing the quality and bioactivity of glycoproteins. For
example, Hong et al. showed that butyrate treatment resulted in changed galactosylation of
monoclonal antibodies (Hong et al. 2014), while Lee et al. showed that butyrate treatment led
to a reduction of the relative proportion of the sialic acid content of a recombinant glycoprotein
that was accompanied by altered expression of several genes related to glycosylation, such as
UDP-glucose pyrophosphorylase or Sialidase-2 (Lee et al. 2014). For this reason the gene
expression time course upon butyrate addition in CHO DP-12 cells for genes relevant for
N-glycan biosynthesis was examined in more detail (Fig. 4.17).
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Figure 4.15.: Visualization of gene expression time course after butyrate addition for KEGG pathway
Citrate Cycle (Kanehisa and Goto 2000; Wippermann et al. 2016). Pathway analysis
and visualization of gene expression changes based on M-values was performed using
pathview (Luo and Brouwer 2013). Gene expression changes are color-coded according
to the legend. Each node is divided into four parts representing differential expression
at sampling points ’6 h’ to ’36 h’ For nodes representing multiple proteins (isoforms,
subunits etc.) maximal absolute values are used as the summary/representative of a node.
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Figure 4.16.: Visualization of gene expression time course after butyrate addition for KEGG pathway
Spliceosome (Kanehisa and Goto 2000). Pathway analysis and visualization of gene
expression changes based on M-values was performed using pathview (Luo and Brouwer
2013). Gene expression changes are color-coded according to the legend. Each node
is divided into four parts representing differential expression at sampling points ’6 h’
to ’36 h’. For nodes representing multiple proteins (isoforms, subunits etc.) maximal
absolute values are used as the summary/representative of a node.
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Generally, N-glycosylation describes the attachment of glycans to polypeptides by an amide
linkage to asparagine (Asn) side chains (Moremen, Tiemeyer, and Nairn 2012). ALG glyco-
syltransferases catalyze the addition of monosaccharides to an N-glycan precursor, which is
attached to the nascent polypeptide chain during translation by the oligosaccharyltransferase
(OST) complex (Kelleher and Gilmore 2006). In the ER, glycoproteins are trimmed by glu-
cosidases. This process is important for ER-retention of such proteins until they are properly
folded and part of the quality control process. If folding fails nevertheless, glycoproteins are
targeted to ER-associated degradation (ERAD) by trimming of α1,2-linked mannose residues
(Lederkremer 2009). Glycoproteins that pass ER quality control are further processed to a
mature state by trafficking through the Golgi apparatus, resulting in distinct glycan profiles
(Moremen, Tiemeyer, and Nairn 2012).
Here, five genes of the N-glycosylation pathway were found to be upregulated after bu-
tyrate addition, including Alpha-1,3/1,6-mannosyltransferase (ALG2), Beta-1,4-N-acetyl-
glucosaminyltransferase (ALG14), Dolichyl-phosphate mannosyltransferase polypeptide 3
(DPM3), Dolichyl-diphosphooligosaccharide-protein glycosyltransferase subunit 1 (OST)
and Mannosyl-oligosaccharide 1,2-alpha-mannosidase IA (MAN1). On the contrary, Alpha-
1,3-mannosyltransferase (ALG3), Alpha-1,3-glucosyltransferase (ALG8), Alpha-1,2-glucosyl-
transferase (ALG10), Beta-1,4-N-acetylglucosaminyltransferase (ALG13) and Alpha-mannosi-
dase II (MAN2) were found to be downregulated post butyrate addition. Taken together,
butyrate-induced differential expression of genes related to N-glycosylation affected several
steps of the pathway, including the initial generation of the glycan precursor by ALGs, it’s
attachment to the nascent polypeptide by the OST complex, as well as the trimming process in
the ER and Golgi. Based on this, variations in glycosylation patterns of recombinant proteins
as described elsewhere could be expected.
Impact of butyrate on protein synthesis The productivity enhancing effect of butyrate on
CHO cells expressing recombinant proteins was shown in several cases (Palermo et al. 1991;
Jiang and Sharfstein 2008; Klausing, Krämer, and Noll 2011; Sung et al. 2004; Choi et al.
2005). However, the reason for this phenomenon is not entirely clear. As it was hypothesized
that butyrate might lead to increased productivity by eliciting an increase in cellular capacities
for translation, the gene expression time course data were analyzed regarding changes in
the pathways ’RNA transport’ (Supplementary Fig. B.28), ’Aminoacyl tRNA biosynthsis’
(data not shown), ’Ribosome biogenesis’ (Fig. 4.18) and ’Ribosome’ (Supplementary Fig.
B.29). No significant changes within the pathway ’Aminoacyl tRNA biosynthsis’ were found,
but RNA transport, ribosome biogenesis and ribosomal subunit expression were affected by
butyrate addition.
Ribosome biogenesis is considered one of the cellular processes that demand the largest
amount of energy and involves the action of many transiently associated proteins. Impor-
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Figure 4.17.: Visualization of gene expression time course after butyrate addition for KEGG pathway
N-glycan biosynthesis (Kanehisa and Goto 2000). Pathway analysis and visualization of
gene expression changes based on M-values was performed using pathview (Luo and
Brouwer 2013). Gene expression changes are color-coded according to the legend. Each
node is divided into four parts representing differential expression at sampling points ’6 h’
to ’36 h’. For nodes representing multiple proteins (isoforms, subunits etc.) maximal
absolute values are used as the summary/representative of a node.
tantly, the process of ribosome synthesis is linked to other central processes such as growth
and cell division (Thomson, Ferreira-Cerca, and Hurt 2013). It begins in the nucleolus by
co-transcription of rRNA genes through RNA polymerase I. Subsequently, several small nu-
cleolar ribonucleoparticles (snoRNPs) mediate co-transcriptional modification of the nascent
transcript, which forms ball-like structures at its 5’ end that are considered to represent the
earliest pre-ribosomes (Grandi et al. 2002). Subsequently, the rRNA transcript is cleaved co-
transcriptionally and the 90S pre-ribosome is separated into the pre-40S and pre-60S particles.
The pre-40S particles are then exported to the cytoplasm for maturation, whereas maturation
of the 60S is more complex and is mediated by several proteins within the nucleolus and
nucleus before 60S particles are exported as well (Thomson, Ferreira-Cerca, and Hurt 2013).
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Butyrate addition induced downregulation of several components of the pathway, including for
example GTP-binding nuclear protein RAN and Exportin-1 (CRM1), which are responsible
for the export of ribosomal subunits (Thomas and Kutay 2003). As another example, Nucleolar
protein 56 (NOP56), Nucleolar protein 58 (NOP58) and NHP2-like protein 1 (SNU13) were
downregulated. These proteins are essential for pre-rRNA processing (Gautier et al. 1997).
Upregulation was for example detected for RNA 3’-terminal phosphate cyclase-like protein
(RCL1), which was shown to associate with U3 snoRNP and to be required for 18S rRNA
biogenesis (Billy et al. 2000).
Taken together, the pathway exhibited mostly downregulated genes. A similar overall down-
regulation was found for the pathway ’RNA transport’. Several genes encoding ribosomal
subunits showed differential expression as well, with similar proportions of up- and down-
regulated genes. However, in summary these results suggest that the cellular capacities for
protein synthesis were limited instead of amplified upon butyrate addition, which contradicted
the hypothesis of an increase in gene expression potential on the level of translation.
Interestingly though, three genes with upregulated expression over the entire time course of
sampling were detected that contribute to protein export, namely Heat shock 70kDa protein
5 (BIP), Signal recognition particle subunit SRP54 and Signal peptidase SEC11. The ER
luminal chaperone BIP binds newly synthesized proteins to ensure proper folding, mediates
export of proteins destined for degradation and BIP expression was shown to increase in
response to the accumulation of unfolded proteins in the ER (Gething 1999). Strikingly, BIP
is known to be involved in the expression of monoclonal antibodies and increased productivity
was shown to be associated with increased BiP levels (Meleady 2007).
4.1.4.3. Comparison of DNA-microarray results with published gene expression
analyses in butyrate-treated CHO cells
In order to be able to estimate the reliability of the DNA-microarray experiment it was
compared to published data generated under similar conditions. Generally, microarray
analyses of gene expression changes depend on several factors such as the microarray type,
thresholds set for classification of genes as significantly differentially expressed and the
numbers of genes analyzed by the microarray. Other factors that make such comparisons
even more complex are, naturally, differences in cell types, cultivation parameters, sampling
points and various additional experimental conditions. Furthermore, most publications do
not contain complete lists of M-values for the entire group of differentially expressed genes.
Therefore, comparisons of microarray experiments need to be carefully assessed. Keeping
this in mind, studies that aimed to analyze butyrate-induced gene expression changes by
microarrays in cultured cells were compared regarding the extent to which butyrate was found
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Figure 4.18.: Visualization of gene expression time course after butyrate addition for KEGG pathway
Ribosome Biogenesis (Kanehisa and Goto 2000). Pathway analysis and visualization of
gene expression changes based on M-values was performed using pathview (Luo and
Brouwer 2013). Gene expression changes are color-coded according to the legend. Each
node is divided into four parts representing differential expression at sampling points ’6 h’
to ’36 h’. For nodes representing multiple proteins (isoforms, subunits etc.) maximal
absolute values are used as the summary/representative of a node.
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to change gene expression both on the global (i.e. numbers of genes) and gene specific (i.e.
M-values) scale.
The study closest related to the one performed here was done by Klausing et al., who analyzed
the butyrate effect (concentration 2 mM) in CHO DP-12 cells that were cultivated in batch
bioreactor experiments. They found a total of 1,461 genes to be differentially expressed upon
butyrate treatment (Klausing, Krämer, and Noll 2011). The array used for this analysis covered
38,310 transcripts. It has to be noted that not all of these transcripts were annotated at that
time and that the microarray was a preliminary version of the one used in this thesis. For this
reason only few expression values could be obtained. The second study used for comparison
was performed using a CHO cell line expressing two anti-apoptotic genes (Kantardjieff et al.
2010). Analyses of mRNA and protein levels were conducted for cells cultured with addition
of 2 mM butyrate at 33 °C using a microarray that covered 10,118 probe sets. A maximum of
994 differentially expressed genes were found in this experiment. In a third publication used
for comparison, gene expression changes after treatment with 10 mM butyrate were analyzed
in bovine kidney epithelial cells using a microarray that contained 45,383 unique cattle
sequences (Li and Li 2006a). In this experiment, 450 genes were detected to be significantly
differentially expressed.
Despite the differences in the experimental conditions or microarray types, all of these studies
showed a negative effect of butyrate addition on cell growth, too. Furthermore, common
functional groups of genes enriched within the respective datasets were, in accordance to
the GO analyses performed in the present study, related to cell cycle control, apoptosis,
metabolism and signaling. Li and Li as well as Kantardjieff et al. furthermore reported an
enrichment of genes related to the extracellular matrix such as Matrix metalloproteinases. A
similar enrichment was not observed in the present study.
Next, fold changes of gene expression for 99 cell cycle-related genes were compared between
the studies. Generally, 76 of these were also found to be differentially expressed in the present
study. Tab. 4.6 shows the M-values for selected examples (see Supplementary Tab. B.17 for a
complete list).
Cyclin A2 (CCNA2) was found to be downregulated by Li and Li (fold change 0.17), Kan-
tardjieff et al. (fold change 0.02) and also by the DNA-microarray experiments performed
in this thesis (fold change 0.39). Origin recognition complex subunit 1 (ORC1L) as well as
Minichromosome maintenance deficient 3 and 5 (MCM3 and MCM5) expression was shown
to be downregulated in all studies. Max interacting protein 1 (MXI1) was found to be strongly
upregulated by Li and Li (fold change 12.55) and was also found to be upregulated in the
present study (fold change 2.26). MYC expression was detected to be downregulated only in
CHO DP-12 cells by Klausing et al. (fold change 0.29) and by the present study (fold change
0.82). Taken together, gene-specific fold changes were generally comparable, especially
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Table 4.6.: Comparison of studies that analyzed gene expression in cultured cells under butyrate
treatment by microarrays (Kantardjieff et al. 2010; Klausing, Krämer, and Noll 2011; Li
and Li 2006a) with the results from the present study (’36 h’ sampling point). As fold
changes were indicated differently in these studies they were converted for comparability. A
complete list of fold changes for 99 cell cycle-related genes can be found in Supplementary
Tab. B.17.
Butyrate-induced gene expression fold changes measured by
Transcript Li and Li 2006 Klausing et al. 2011 Kantardjieff et al. 2010 Present study
CCNA2 0.17 n.d. 0.02 0.39
MCM3 0.10 0.86 0.05 0.41
MCM5 0.17 0.27 0.01 0.37
MXI1 12.55 n.d. n.d. 2.26
MYC n.d. 0.29 n.d. 0.82
ORC1L 0.23 0.27 0.07 0.52
those obtained by Klausing et al. and the present study. As the same cell line and microarray
type were used in both experiments this underlines the reliability of this study. The highest
changes in gene expression were measured by Kantardjieff at al., which may be due to the
combination of butyrate treatment with lower cultivation temperatures. For this reason the
highest discrepancy was found between these values and the ones found in the present study.
4.1.4.4. Genome-wide analysis of DNA methylation changes upon butyrate addition
In parallel to gene expression analyses, genomic regions showing butyrate-induced changes
in DNA methylation were identified and analyzed regarding their association with genes.
It has to be noted that, for this analysis, no discrimination was made between HMDs and
PMDs, as it is not entirely clear if gene regulation is indeed directly influenced by PMDs and,
importantly, PMD localization did not change in response to butyrate.
In the first analysis step, mean CpG methylation levels were compared (see Tab. 4.2 in section
4.1.2.4). Butyrate treatment was found to induce a maximum decrease in genome-wide mean
methylation levels from 61.09 % in the reference samples to 59.55 % at sampling point ’12 h’.
24 hours post butyrate the cells exhibited a mean methylation of 60.06 % and, at the ’36 h’
sampling point, of 61.23 %. Fig. 4.19A shows that butyrate addition furthermore did not
affect the general bimodal distribution of unmethylated and highly methylated CpGs. Also,
similarly small changes in mean methylation levels of CpG islands, microRNA (miRNA)
genes, coding sequences (CDSs), introns, untranslated regions (UTRs) and non-codingRNA
(ncRNA) genes were found (Fig. 4.19B–F). This indicated that differential DNA methylation
in response to butyrate was a site-specific and not an overall effect.
Next, differentially methylated genomic regions (DMRs) were identified based on compar-
isons between the methylomes of reference and butyrate-treated cultures. Accordingly, the
term ’hypomethylation’ refers to lower methylation levels of a genomic region in a given
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Figure 4.19.: Percent methylation of CpG dinucleotides and frequencies of mean methylation levels
of genomic features. A Frequency of single CpGs within methylation level intervals
(Wippermann et al. 2016). B–F Frequencies of mean methylation levels of the genomic
regions coding sequence (CDS, B) CpG island (CGI, C), intron (D), untranslated region
(UTR, E) and micro RNA (miRNA, F).
sample compared to the reference and the term ’hypermethylation’ refers to relatively higher
methylation levels. DMRs were subsequently grouped according to their position relative
to genes, if at least one base pair of an individual region overlapped with the DMR. For
this analysis isoforms of a gene were grouped and overlapping exons were merged. Four
individual regions were defined for each gene: (i) the 5’ regions ’1 kb upstream of the start
codon up to first intron’ (as regulatory DNA methylation at 5’ ends often affects CGIs, which
are mostly found in promoter regions and first exons; Brenet et al. 2011; Jones and Takai
2001), (ii) the intragenic regions ’second exon to last intron’, (iii) the 3’ regions ’last exon
to 1 kb downstream’ and, to get an idea about potential methylation events further upstream
of genes, (iv) the ’upstream region’ (1001 bp to 20 kb upstream). If an upstream region
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overlapped with another gene, the region was shortened. DMRs that could not be assigned to
any of these regions were grouped into the category ’intergenic’.
The total numbers of DMRs varied slightly over time with a maximum difference in the
numbers of hypomethylated regions between ’6 h’ (8113 DMRs) and ’12 h’ (8617 DMRs;
Tab. 4.7). For the hypermethylated regions sampling point ’36 h’ (5589 DMRs) exhibited a
maximum difference compared to the number of DMRs at the ’6 h’ sampling point (6524
DMRs). DMR sizes were found to range from about 2 to 8.5 kb for both hypomethylated and
hypermethylated DMRs at all sampling points.
Table 4.7.: Numbers of relatively hypomethylated and relatively hypermethylated DMRs with ≥ 1
significantly differentially methylated CpG 6, 12, 24 and 36 hours after butyrate addition in
comparison to the reference (Wippermann et al. 2016).
Sample Hypomethylated DMRs Hypermethylated DMRs
6 h 8,113 6,524
12 h 8,617 6,256
24 h 8,505 6,374
36 h 8,175 5,589
Fig. 4.20A shows the percentages of relatively hypomethylated and relatively hypermethylated
regions that were associated with genes or could not be associated with any genes for the ’6 h’
time point, as no significant differences in DMR-count per feature were found between the
sampling points (see pie charts for all sampling points in Supplementary Fig. B.24). 54 % of
the hypomethylated regions at the ’6 h’ sampling point were assigned to intergenic regions
and 46 % were associated with genes (23 % were associated with upstream regions, 10 % with
5’, 11 % intragenic and only 2 % with 3’ regions). Similarly, 57 % of the hypermethylated
regions were associated with intergenic regions and 43 % could be associated with genes.
As potential correlation of DNA methylation changes and differential gene expression were
supposed to be analyzed, DMRs that were not associated with genes were removed from
further analyses at this point and 6536, 6739, 6929 and 6327 DMRs, corresponding to 4739,
4721, 4967 and 4459 unique genes, remained for the sampling points ’6 h’, ’12 h’, ’24 h’
and ’36 h’, respectively. This indicated that several DMRs were associated with single
genes. The Venn diagrams in Fig. 4.20B furthermore show that differential methylation of
individual genes could be present at one or multiple time points. Additionally, both hypo- and
hypermethylation was detected for 30 % (2890) of the differentially methylated genes (Fig.
4.20C). For these genes associated with multiple DMRs, differential methylation occurred
both at the same region or at different regions and DMRs could also be present at either the
same or different time points.
Visual inspection of differentially methylated genomic regions in a genome browser illustrated
various dynamics of butyrate-induced DNA methylation changes. Fig. 4.21 shows 5’-
associated DMRs within CpG islands for the genes DNA-binding protein SATB2 (Satb2, e.g.
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Figure 4.20.: DNA methylation changes in CHO DP-12 cultures upon butyrate addition (Wippermann
et al. 2016). A Percentages of relatively hypomethylated and hypermethylated regions
associated with genes at the ’6 h’ sampling point. B,C Venn diagrams of differentially
methylated genes.
involved in chromatin remodeling; Gyorgy et al. 2008), Microtubule-associated protein 10
(Kiaa1338, e.g. involved in mitotic spindle assembly; Fong et al. 2013) and Oral-facial-digital
syndrome 1 protein (Ofd1, e.g. involved in cell cycle regulation; Singla et al. 2010). Satb2
represents an example of an exclusively hypomethylated gene and Kiaa1338 represents an
example of exclusive hypermethylation. Ofd1 was found to be associated with both kinds of
differential methylation which occurred next to each other.
DMRs were also visually examined in a higher resolution on the single-nucleotide scale (Fig.
4.22). Fig. 4.22A shows selected examples of genomic regions detected to be hypomethylated
(a set of each five exemplary regions per time point can be found in Supplementary Fig.
B.25). In several cases (16 of 20 inspected regions) differential hypomethylation was detected
exclusively for one time point. At the following time points methylation patterns were found
to be re-established and no significant differential methylation was detected anymore (notice
numbers of significantly differentially methylated CpGs).
The examination of relatively hypermethylated regions showed different dynamics of methyla-
tion changes over time (Fig. 4.22B and Supplementary Fig. B.26). For all of the hypermethy-
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Figure 4.21.: Exemplary display of 5’-associated differentially methylated regions within CpG islands
(Wippermann et al. 2016). Methylation data tracks were loaded into the GenDBE
genome browser (Rupp et al. 2014) to visually inspect selected genomic regions. Exons
are indicated by red rectangles and CpG islands by blue rectangles. Methylation levels
for each CpG are represented by green bars. Regions that were identified as significantly
hypo- or hypermethylated compared to the reference are marked by a red box and arrows
indicate decreasing or increasing methylation levels. All three genes are located on
the lagging strand. A Display of 3 kb of CHO K1 scaffold JH000295 including the 5’
region of DNA-binding protein SATB2 (Satb2). B Display of 3 kb of CHO K1 scaffold
JH000057 including the 5’ region of Microtubule-associated protein 10 (Kiaa1338).
C Display of 1 kb of scaffold JH001054 including the 5’ region of Oral-facial-digital
syndrome 1 protein (Ofd1).
lated regions examined (20 of 20), significant differential methylation was detected at more
than one time point and methylation patterns generally showed some variability. For example,
the hypermethylated DMR found to be present on scaffold JH000953 (Fig. 4.22B) showed
15 and 13 significantly differentially methylated CpGs 6 hours and 12 hours post butyrate
addition, only 4 significant CpGs 24 hours post butyrate addition and again 14 significant
CpGs 36 hours post butyrate.
To get an overview of the functional significance of genes that were affected by differential
methylation upon butyrate addition, gene ontology analyses were performed separately for
genes associated with both hypo- and hypermethylated DMRs as well as for genes exclusively
associated with either hypo- or hypermethylated DMRs. Generally, enriched functional
groups were very similar to those significantly enriched for the differentially expressed
genes. Genes that were both hypo- and hypermethylated were functionally related to protein
biosynthesis (e.g. ’translational elongation’, 36 genes), differentiation processes (e.g. ’skeletal
system development’, 62 genes) and RNA metabolism (e.g. ’negative regulation of RNA
metabolic process’, 67 genes; Supplementary Tab. B.14). Genes associated with exclusively
hypomethylated DMRs were most significantly enriched in functions related to cell cycle
regulation (e.g. ’cell cycle phase’, 101 genes), transcription (e.g. ’regulation of transcription
from RNA polymerase II promoter’, 157 genes), signaling (e.g. ’intracellular signaling
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Figure 4.22.: Screenshots of relatively hypomethylated (A) and hypermethylated (B) DMRs as visual-
ized in the GenDBE genome browser (Rupp et al. 2014). Methylation levels for each
CpG are represented by green bars. All regions are represented in the same scale (see
scale bar). Indicated are scaffold numbers as well as the numbers of CpGs detected as
significantly differentially methylated.
cascade’, 250 genes) and apoptosis (e.g. ’regulation of cell death’, 170 genes; Supplementary
Tab. B.15). Those genes that were exclusively associated with hypermethylated DMRs
(Supplementary Tab. B.16) were most significantly related to protein transport (e.g. ’protein
localization’, 110 genes) and RNA processing (e.g. ’RNA processing’, 66 genes).
4.1.4.5. Combination of DNA methylation and gene expression data
In order to combine the data generated by whole-genome bisulfite sequencing and gene
expression microarray analyses, potential correlations between DNA methylation and gene
expression profiles were analyzed. First, a general analysis was performed in order to assess
if up- or downregulation of gene expression was associated with specific methylation types
(simultaneous hypo- and hypermethylation or exclusive hypo- or hypermethylation). For this
purpose density plots of gene expression M-values were generated (Fig. 4.23). The majority
of genes associated with both hypo- and hypermethylated DMRs at different regions was not
differentially expressed (about 81 %, represented by the peak at M = 0 in the density plot).
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For genes associated with hypo- and hypermethylated DMRs at the same genomic region as
well as exclusively hypo- or hypermethylated DMRs the density curves showed significantly
lower percentages of genes that were not differentially expressed with about 38 %, 47 % and
48 %, respectively.
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Figure 4.23.: Density plots of gene expression M-values associated with different types of differentially
methylated genes.
In total, 973 genes (11 % of the differentially methylated genes) were found to be both
differentially methylated and expressed. A hierarchical cluster analysis was performed
for these genes to assess potential correlations between gene expression profiles and DNA
methylation changes. Five distinct clusters of DNA methylation and gene expression patterns
were detected (Fig. 4.24A). Inspection of the two main clusters (clusters 1 and 5) showed
that the majority of up- or downregulated genes was not associated with specific DNA
methylation profiles. However, three smaller clusters differed from the majority of genes.
Cluster 4 contained a group of genes associated with both hypo- and hypermethylation in
intragenic regions which was associated with both up- and downregulated gene expression,
but no significant enrichment of any gene functions was found for these genes. Cluster 2
showed hypomethylation of upstream regions, whereas cluster 3 exhibited hypermethylation
of upstream regions at multiple time points. Both clusters were associated with both up-
and downregulated genes as well. The genes of these clusters were significantly related
to ’translational elongation’ (p = 3.7 × 10-9), ’ribosome biogenesis’ (p = 1.2 × 10-3) and
’ribonucleoprotein complex biogenesis’ (p = 8.9 × 10-3). A search for protein associations
between the corresponding gene products using the STRING database revealed a network of
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strongly interacting ribosomal proteins and associated factors such as Heat shock cognate 71
kDa protein (HSPA8), mRNA turnover protein 4 (MRTO4) or Bystin (BYSL; Fig. 4.24B).
Most of the genes within this network were not differentially expressed at the ’6 h’ sampling
point, but were found to be differentially expressed 12 hours after butyrate addition or later
(Fig. 4.24C). A majority of the associated factors were downregulated, whereas most of
the ribosomal components were upregulated. Interestingly, HSPA8 showed a very different
expression profile as it was already 2.1-fold upregulated 6 hours post butyrate addition and
showed a maximum of 2.6-fold upregulation 12 hours post butyrate followed by a constant
decrease in differential expression.
For further exploration of mechanisms underlying the effects of butyrate addition on DNA
methylation and gene expression de novo motif discovery was performed using the motif
discovery algorithm DREME, which was designed to find short core motifs of eukaryotic
transcription factors (Bailey 2011). Significant enrichment of sequence motifs in DMRs was
calculated using the Fisher’s Exact Test in comparison to a ten-fold bigger set of randomly
chosen sequences with an equal length distribution (i.e. ten ’negative’ sequences per ’positive’
sequence). Very low p values with a minimum of 2.3 × 10-438 were calculated for the motif
5’-CGD-3’ (D = AGT). As DMRs naturally contain CpG dinucleotides and a lot of them
in high densities, the significant overrepresentation of CG-containing motifs was expected
and proofed the reliability of the sequence discovery method. De novo discovered motifs
were subsequently compared to human and mouse transcription factor databases using the
Tomtom algorithm (Gupta et al. 2007) in order to determine putative transcription factor
binding sites. Eight DNA sequence motifs were discovered in upstream regions which
significantly corresponded to 42 putative transcription factor binding sites. At 5’ ends
two motifs were found which corresponded to eight putative transcription factor binding
sites (see Supplementary Tab. B.9 for a list of DMR motifs and putatively corresponding
transcription factors). Strikingly, ten factors with putative binding sites in upstream regions
and five transcription factors with putative binding sites in 5’ regions were indeed found
to be differentially expressed when the gene expression microarray data were searched for
differential expression of transcription factors corresponding to these binding sites (Fig.
4.25). These included factors with upregulated expression such as Zinc finger and SCAN
domain containing protein 4 (ZSCAN4) and Forkhead box protein 1 (FOXO1) as well as
several factors showing downregulated expression such as Transcription factor AP-4 (TFAP4),
Transcription factor AP-2 gamma (TFAP2C), Ras-responsive element-binding protein 1
(RREB1), Transcription factor SP1 (SP1), Krueppel-like factor 13 (KLF13), Proto-oncogene
c-Rel (REL), Nuclear factor NF-kappa-B p65 subunit (RELA) and Nuclear factor NF-kappa-B
p105 subunit (NFKB1).
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Figure 4.24.: Integration of DNA methylation and gene expression data (Wippermann et al. 2016).
A Hierarchical cluster analysis of gene expression and DNA methylation profiles was
performed using Ward’s method for agglomeration (Ward 2012). Changes in gene
expression based on fold-changes and numbers of differentially methylated CpGs are
color-coded according to the legend. B Analysis of the genes comprised within clusters 2
and 3 using the STRING database (Szklarczyk et al. 2015) revealed a network of ribosomal
proteins and associated factors. C Gene expression fold-changes are represented for
ribosomal proteins (top diagram) and associated factors (bottom diagram).
109
Chapter 4. Results and discussion
TFAP4 TFAP2C
Eukar.
TF site
DMR
motif
ZSCAN4 FOXO1
P value
Position
Expression
4.2 × 10-5 6.5 × 10-5 1.7 × 10-5 4.2 × 10-4
upstream upstream upstream 5'
0.7-fold 1.2-fold 0.8-fold 1.4-fold
9.6 × 10-4
5'
0.7-fold
TF ID
TFAP2ASP1
NFKB1
Eukar.
TF site
DMR
motif
P value
Position
Expression
TF ID
Eukar.
TF site
DMR
motif
P value
Position
Expression
TF ID
RREB1
KLF13 MGA GLIS2
REL RELA
1.6 × 10-4 4.8 × 10-4 1.9 × 10-4 3.7 × 10-4
upstream upstream upstream upstream
0.7-fold 0.8-fold 0.6-fold 0.6-fold
1.1 × 10-4
upstream
0.6-fold
7.6 × 10-5 1.3 × 10-4 2.5 × 10-4
5' 5' 5'
0.7-fold 0.7-fold 0.8-fold
GLIS3 GLIS1
1.3 × 10-4
upstream
1.4-fold
2.3 × 10-4
upstream
1.4-fold
Figure 4.25.: Putative transcription factor binding-site motifs de novo discovered in DMRs upon
butyrate addition (Wippermann et al. 2016). Motif comparisons were performed using
Tomtom algorithm (Gupta et al. 2007). Shown are sequence logos and p values. It is
furthermore indicated whether the DMR was located within an upstream region or a 5’
region and if putative transcription factor expression was up- or downregulated.
4.1.4.6. Discussion: Butyrate-induced changes in gene expression
Functional analysis of differentially expressed genes upon butyrate addition showed that
cellular pathways such as cell cycle, apoptosis, signaling, protein transport, central energy
metabolism and RNA processing were significantly affected by butyrate. These processes
have been described to be affected by butyrate addition in CHO cells and other cell types
before (Blouin et al. 2011; Bordonaro, Lazarova, and Sartorelli 2008; Kantardjieff et al. 2010;
Klausing, Krämer, and Noll 2011; Li and Li 2006b; Scott, Longpre, and Loo 2008; Sun et al.
2012; Wu et al. 2012). A closer examination of specific pathways furthermore indicated
that butyrate induced downregulation of most cell cycle genes over the time course of 36
hours, potentially activated the intrinsic pathway of apoptosis and led to changes in glycolysis
and TCA cycle, which might indicate an increase in energetic resources. Furthermore,
several genes contributing to RNA splicing processes were found to be downregulated and
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some were hypothesized to be functionally linked to DNA methylation events through the
base excision repair pathway. Genes involved in protein biosynthesis were found to be
differentially expressed as well, although an overall downregulation of RNA transport and
ribosome biogenesis rather suggested reduced translational capacities than the opposite. As
ribosome biogenesis requires large amounts of energy (Thomson, Ferreira-Cerca, and Hurt
2013), downregulation of this process might contribute to an increase in energy resources
available for mAb production downstream of this process, for example during translation
itself. Strikingly, upregulated genes were found to be enriched for those contributing to
translational elongations and, additionally, a central factor relevant for protein export (BIP)
was found to be upregulated as well. BIP was shown to be related to high productivities in
CHO cells before (see e.g. Carlage et al. 2009). Finally, butyrate was shown to affect several
genes related to N-glycan biosynthesis, suggesting that its addition might very well contribute
to changes in the quality of recombinant proteins, as it has been reported before, too (Hong
et al. 2014; Lee et al. 2014).
The gene expression analysis furthermore showed that genes related to ’chromatin remodeling’
and ’protein amino acid acetylation’ as well as differentiation events were strongly affected
specifically at the first sampling point, indicating a potential role for these processes within
the early response to butyrate. As butyrate is known for its function as an inhibitor of
histone deacetylation (Boffa et al. 1978; Corfe 2012; Donohoe and Bultman 2012), an early
onset of processes related to chromatin remodeling could be expected. An involvement of
processes related to differentiation was less expected in the context of CHO-based production
of biopharmaceuticals, although butyrate has generally been shown to induce differentiation of
several cell types, including colonic T cells, adipocytes and medulloblastoma cells (Furusawa
et al. 2013; Li, Yao, and Jiang 2014; Nör et al. 2013).
4.1.4.7. Discussion: Transcription factor binding-site motifs in DMRs
Differentially methylated regions (DMRs) were found to be associated with genes related to
cellular processes similar to the ones significantly enriched within the group of differentially
expressed genes. Furthermore, DMRs were found to contain binding-site motifs of specific
transcription factors which were also differentially expressed and were therefore hypothesized
to represent regulatory sites closely connected to the cellular response to butyrate. The fact
that 973 genes were both differentially methylated and differentially expressed underlined the
hypothesis of these regions being active regulatory sites, although this number represented
only 11 % of the total differentially methylated genes. However, similarly small overlaps
between differential methylation and gene expression have been found in other studies as well,
even when RNA-sequencing was applied instead of gene expression analyses by microarrays
(see e.g. Kubo et al. 2015; Sadler et al. 2016). The presence of transcription factor binding-
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site motifs within DMRs furthermore underlined a potential involvement of differentiation
processes in the butyrate response, as many transcription factors with decreased expression
levels were related to cell growth, the regulation of apoptotic events and differentiation.
These included SP1, KLF13, TFAP2 and RREB1 as well as REL, RELA and NFKB1, which
represent three of the REL-like domain containing subunits of NFKB (Bragança et al. 2002;
Cruz-Topete et al. 2016; Guo et al. 2015a; Jiang et al. 2015; Perkins 2000; Vizcaíno, Mansilla,
and Portugal 2015).
On the contrary, transcription factors involved in pluripotency-related processes as well as cell
cycle arrest, cell death and energy homeostasis were upregulated. These included ZSCAN4,
which is involved in processes related to pluripotency by regulation of telomere elongation
(Lee and Gollahon 2015) and FOXO1, which is related to cell cycle arrest and cell death
(Martins, Lithgow, and Link 2016). FOXO1 was furthermore shown to be involved in the
regulation of energy metabolism by promotion of the expression of gluconeogenic enzymes
(Gross, Heuvel, and Birnbaum 2008). Strikingly, our results showed an increased expression
of pyruvate carboxylase (PC), which might indeed indicate an increase in gluconeogenesis.
The finding that processes related to central metabolism were potentially affected by butyrate
addition was confirmed on the phenotypic level by a switch from lactate production to
consumption that was visible 24 hours post butyrate addition. Interestingly, several studies
link upregulated expression of genes related to energy metabolism to increased productivities
in CHO cells, including Müller et al. who analyzed the effect of butyrate on the CHO cell
proteome by label-free MS quantification and found (amongst others) several proteins with
altered expression that were involved in glycolysis, TCA cycle and the pentose phosphate
pathway (Müller et al. 2016). These included proteins with increased expression levels such
as IDH1 and MDH1 as well as proteins showing decreased expression such as GAPDH, which
were found to be differentially expressed in this study, too. Bedoya-Lopez at al. furthermore
showed that CHO cell productivity increased due to temperature downshifts and that this was
accompanied by a significant upregulation of genes related to energy metabolism (Bedoya-
López et al. 2016). Meleady et al. could also identify changes in expression levels of genes
related to energy metabolism that were significantly associated with productivities (Meleady
et al. 2011). In the latter study HSPA8, which was found here within a network of genes
exhibiting constant differential methylation of upstream regions, was also amongst the genes
related to sustained productivity and has been found in similar contexts as well (Lee et al.
2009; Seth et al. 2007; Smales et al. 2004). Interestingly, HSPA8 is a member of the HSP70
family of chaperones with additional functions in the regulation of pluripotency (Geng et al.
2015; Stricher et al. 2013) and was significantly upregulated by butyrate addition already at
the first sampling point. This finding hints towards a specific, yet to be further elucidated role
of HSPA8 within the butyrate-responsive regulatory network.
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4.1.4.8. Discussion: Dynamics of DNA methylation changes upon butyrate addition
The genome-wide detection of differential DNA methylation in CHO DP-12 cells after
butyrate addition showed that the overall CHO DP-12 DNA methylation landscape did not
change significantly over the time course of 36 hours, as the general bimodal distribution of
either unmethylated and fully methylated CpGs did not change. Also, the location of partially
methylated domains (PMDs) was not affected by butyrate addition and mean methylation
levels of genomic features did not change. For this reason differential methylation was
analyzed site-specifically. When differentially methylated regions (DMRs) were detected,
no significant changes in their numbers or association with genomic features were found.
Nevertheless, DMRs showed a great variability regarding (i) different kinetics of the removal
of DNA methylation marks and (ii) multiple DNA methylation events affecting individual
genes at multiple time points. The differences in methylation kinetics observed between hypo-
and hypermethylated DMRs on the single-nucleotide level, which showed that hypomethylated
DMRs could be quickly established whereas hypermethylated DMRs were only slowly
removed, could be due to differences within the TET-based pathway for regeneration of
unmodified cytosine bases (see section 1.3.2 for a detailed description). Briefly, TET enzymes
are capable of oxidizing 5-methylcytosine and oxidation products can be removed passively
by being diluted in a DNA-replication dependent manner or by active removal mediated by
Thymine DNA glycosylase (TDG), which functions as a DNA repair enzyme capable of
removing thymines from T-G-mismatches, within the base excision repair (BER) pathway
(Kohli and Zhang 2013). The hypothesis that hypermethylated DMRs were passively removed
was underlined by the finding that DNA methylation patterns in the respective regions
were unstructured and variable, which possibly represented an uncoordinated process of
’dilution-by-replication’ due to the butyrate-induced cell cycle arrest. On the contrary, the
establishment of hypomethylated DMRs was found to occur precisely and quick, thereby
emphasizing a possible involvement of an active enzymatic process. The fact that, in both
cases, the establishment of hypermethylated states happened comparably quick adds to this
hypothesis, as the establishment of DNA methylation marks is only possible through an active
process. Variable DNA methylation at individual genes has been found in other biological
systems as well. For example, Wan et al. analyzed genome-wide DNA methylation and gene
expression patterns in different tissues and found that multiple DMRs can be associated with
one gene. Among 247 genes that were found in this study to be associated with more than
one tissue-specific DMR, 79 exhibited incoherent DMR sets (Wan et al. 2015).
4.1.4.9. Conclusion: Data integration allows for novel perspectives
The integrative analysis of time course DNA methylation and gene expression data from
butyrate-treated CHO cells proved the utility of integrating DNA methylation and gene
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expression data in a biotechnological context. Gene expression analyses proved that butyrate
addition affected pathways such as cell cycle or apoptosis, and regions that exhibited variable
DNA methylation in response to butyrate were associated with genes related to similar
functional groups. As a subset of genes furthermore exhibited both differential methylation
and expression and differentially methylated regions were found to contain potential binding-
site motifs of transcription factors putatively related to the observed phenotypic effects
of butyrate addition, these regions were hypothesized to represent regulatory sites closely
connected to the cellular response to butyrate addition. Generally, DNA methylation was
considered to reflect on-going gene activity. Obviously, questions remain regarding the
relevance of DNA methylation changes at genes that were not found to be differentially
expressed. As it is not clear how DNA methylation affects gene expression and if it occurs up-
or downstream of gene regulation (Schübeler 2015), answering these questions will require
further experiments. Further studies are required to assess the involvement of the transcription
factors putatively involved in the butyrate response as well. However, these results generally
underline the fact that integrating DNA methylation and gene expression data allows for a
novel perspective regarding target selection for rational cell line development. Taken together,
this experiment showed that integration of epigenetic and gene expression data allowed for
new insights into the butyrate effect on CHO cells and generally prove the benefit of this kind
of studies in the production of biopharmaceuticals.
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4.2. Comparison of whole-genome bisulfite sequencing and
CpG island microarray analysis
Although technological advances and reduced costs of whole-genome sequencing experiments
shifted DNA methylation analyses from gene-specific to genome-scale approaches, these
methods still require a sufficient sequencing depth and are not feasible for large numbers
of samples, which, for example, could be necessary to monitor DNA methylation changes
over a cultivation process. A more economical method is the analysis of DNA methylation
by microarrays, which employ the fact that methylated DNA fragments can be enriched
from sheared genomic DNA using a Methyl-CpG binding domain (MBD) protein. Enriched
fractions can subsequently be analyzed by hybridization to microarrays which contain probes
corresponding to pre-selected genomic loci. In the context of CHO-based production of re-
combinant proteins, CpG islands were considered to be of special interest, as CGI methylation
can cause stable transcriptional repression of linked genes and has been described to occur
during malignant transformation of several types of cancer (Park et al. 2011; Rauch et al.
2012). According to this fact it was hypothesized that CpG island methylation in CHO cells
might correlate with specific phenotypes or reactions to environmental conditions as well.
Generally, CpG island microarrays for human and mouse are commercially available. For
example, Agilents human CGI microarray covers 27,800 CGIs with 237,220 probes. As a
CGI microarray specifically designed for CHO cells did not exist, a CHO-specific array was
developed in a master thesis. This array covers 19,598 promoter-associated and intragenic
CGIs in the CHO genome (89 % of the total CGIs that were bioinformatically identified)
with 27,446 unique probes in a 60K format (62,976 probes per array; Wippermann 2012;
Wippermann et al. 2013). Fig. 4.26A shows a schematic representation of the location
of probes relative to genomic features. Due to this layout, the CHO-specific CpG island
microarray contains each probe at least twice, which results in at least four replicates when
microarray analyses are performed in dye swap pairs.
Fig. 4.27 outlines the experimental procedure of CpG island microarray analysis. Central
to the experiment was the enrichment of methylated DNA from a pool of DNA fragments,
which exhibited an average size of 500 bp and were generated by repeated cycles of sonica-
tion. Methylated DNA fragments were then enriched using a methyl-DNA-binding domain
(MBD) protein coupled to magnetic beads and the enrichment efficiency was controlled by
determining the ratio between the two previously identified control regions (Actb and Bcat1).
Enriched fractions of methylated DNA were subsequently labeled with fluorescent dyes and
comparatively hybridized to the microarray.
The CpG island microarray was applied to analyze the butyrate effect on CHO DP-12 cells
(Wippermann 2012) and the data generated by this means were functionally analyzed in
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Figure 4.26.: Schematic representation of CHO CpG island microarray probe distribution relative to
genomic features. Genomic features are color-coded according to the legend. Promoter
regions were defined as ’2.5 kb upstream to end of first exon’ as CHO transcription start
sites were not known at that point. For long CGIs probes were designed with average
distances of about 500 bp (please refer to Wippermann 2012 for details).
detail during this doctoral thesis. The results from this analysis were compared to the whole-
genome bisulfite sequencing results in order to assess microarray performance and identify
potential sources of bias. Additionally, exemplary results were confirmed by gene-specific
analysis of DNA methylation and CpG island microarray performance was controlled in
further hybridization experiments. Finally, putative central mediators of the butyrate effect
were identified based on the comparative data analysis and functionally analyzed in transient
RNAi experiments.
4.2.1. Analysis of the butyrate effect by CpG island microarrays
Cultivations (n = 4) were performed in the same way as for the analysis of the effect of butyrate
treatment by whole-genome bisulfite sequencing (Supplementary Fig. B.37) and a very similar
effect of butyrate on growth and productivity was observed. Briefly, reduced cell growth
could already be detected 24 hours after butyrate addition in treated cultures and the viability
started to decrease. The butyrate-treated cells reached a maximum of 31 × 105 cells/mL
48 hours after butyrate addition and enhanced cell specific productivities were observed on
day 5 with a maximum value of 17 pg/cell/day. The control cultures continued with normal
cell growth until a maximum viable cell density of 110 × 105 cells/mL was achieved. They
reached a maximum cell specific productivities of 9 pg/cell/day. Here, also, a butyrate-induced
switch to lactate consumption could be observed. Samples for DNA methylation analysis
by CpG island microarrays were taken before butyrate addition as well as 24 hours and 48
hours after butyrate addition from both the reference and butyrate-treated cultures. DNA was
extracted and sheared (see images of control agarose gels in Supplementary Fig. B.21) and
methylated DNA fragments were enriched. Per sampling point two CpG island microarrays
were hybridized as dye swap pairs. It has to be noted that the comparisons at each time point
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Figure 4.27.: Schematic representation of the experimental procedure of CpG island microarray anal-
ysis. After extraction, DNA is sonicated to an average fragment size of about 500 bp.
Methylated DNA fragments are enriched using a methyl-DNA-binding domain (MBD)
protein coupled to magnetic beads. The enriched methylated fractions are labeled with
Cyanine 3- and 5-dUTP and the samples are subsequently hybridized to the microarray.
were made directly between the reference cultures and the cultures that were treated with
butyrate, which is in contrast to the whole-genome bisulfite sequencing experiment. This
means that for the ’0 h’ time point the reference cultures were compared to the cultures that
were not yet treated with butyrate. Therefore, the comparison between the cultures at the ’0 h’
time point served as a control, as differences between identical cultures were not expected.
Data analysis was performed as described previously. Corresponding MA plots can be found
in Supplementary Fig. B.38.
The Venn diagrams in Fig. 4.28 illustrate the numbers of genes associated with differentially
methylated CpG islands that were found in this analysis and show that the effect of butyrate
on CpG island methylation was dynamic and reversible. Surprisingly, 42 genes were relatively
hypermethylated and 141 genes were relatively hypomethylated in a comparison between the
reference cultures and the cultures that were treated with butyrate later on (’0 h’ sampling
point; see discussion in section 4.2.5). These numbers and also the ratios between the
respective sampling points remained constant even after applying the most stringent statistical
parameters. Therefore, these genes were excluded from the ’24 h’ and ’48 h’ datasets before
further data analysis. Small numbers of differentially methylated genes were also found at
the end of the experiment (32 genes affected by relative hypermethylation and 110 genes
affected by hypomethylation). A strongly increased number of 1221 genes associated with
differentially methylated CpG islands was found 24 hours after butyrate supplementation,
with 342 genes showing relative hypermethylation of corresponding CGIs and 879 genes
being associated with relatively hypomethylated genomic regions. The greatest overlap in
the sampling points regarding affected genes existed between 24 hours and 48 hours (139
genes in total). Furthermore, 30 genes showed differential methylation both before butyrate
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treatment and 24 hours later. Only 10 genes were found being significantly differentially
methylated amongst all three time points and 5 differentially methylated genes were both
present at 0 and 48 hours.
24 h
48 h
0 h
141 1105
879
29
118
9
24 h
48 h
0 h
42
320
342
1
21
1
Relatively hypermethylated Relatively hypomethylated
Figure 4.28.: Significantly differentially methylated genes upon butyrate treatment (Wippermann et
al. 2013). Venn diagrams of genes associated with hypermethylated or hypomethylated
CpG islands prior to (0 h), 24 hours (24 h) and 48 hours (48 h) upon treatment of CHO
DP-12 cells with 3 mM butyrate.
Gene ontology analyses were carried out in order to gain an overview of affected cellular
processes and components (Fig. 4.29). In the dataset recorded before butyrate treatment it was
found that the protein group ’positive regulation of developmental process’ was significantly
overrepresented. The data of sampling point ’24 h’ suggested that the genes associated with
hypermethylated CGIs were related to the processes ’response to stimulus’, ’phosphorylation’
and ’biogenesis’, e.g. represented by the more specific functions ’DNA repair’, ’response
to organic substance’ or ’programmed cell death’. Within the group of genes associated
with hypomethylated CGIs the categories ’transcription’, ’chromatin’, ’signaling’, ’immune
response’, ’developmental process’ and ’phosphate metabolism’ were frequently affected,
e.g. comprising functions such as ’regulation of gene-specific transcription’, ’chromatin
modification’, ’regulation of MAP kinase activity’ or ’immune system development’ (also see
complete list of GO annotations for the ’24 h’ sampling point in Supplementary Tab. B.18
and B.18). Another 24 hours later (sampling point ’48 h’), genes related to ’carbohydrate
biosynthetic process’ were abundantly associated with hypermethylated CGIs. Hypomethy-
lated genes at the 48 hours sampling point could be clustered according to the functional
categories ’chromatin modification’, ’dendrite morphogenesis’, ’post-embryonic development’
or ’protein modification by small protein conjugation or removal’.
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Figure 4.29.: Gene ontology analysis of genes affected by butyrate-mediated differential methylation
of associated CpG islands (Wippermann et al. 2013). Log2 values of fold enrichment are
color-coded according to the legend, n.s.: not significantly enriched.
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4.2.2. Overlaps between the results of whole-genome bisulfite
sequencing and CpG island microarray analysis
The CpG island microarray results were compared to the whole-genome bisulfite sequencing
analysis in order to get an impression of the reliability of the custom-designed microarray.
Fig. 4.30 shows the comparison of genes detected to be differentially methylated by CpG
island microarray analysis with genes detected to be exclusively hypo- or hypermethylated,
genes that were found to be both hypo- and hypermethylated and, furthermore, genes that
were differentially expressed but not differentially methylated. The distinction between
the types of differential methylation was made because the presence of both hypo- and
hypermethylated cytosines within the same DNA fragment was suspected to potentially lead
to biased enrichment reactions. Therefore, genes both hypo- and hypermethylated were
hypothesized to be less frequently detected by the CpG island microarray.
448 genes (270 exclusively hypo- or hypermethylated genes and 178 genes both hypo- and
hypermethylated) that were detected to be differentially methylated by whole-genome bisulfite
sequencing were also detected by the CpG island microarray experiment. Obviously, the
hypothesis that genes both hypo- and hypermethylated would escape microarray detection
because of an indifferent behavior during methylated DNA enrichment did not prove to be true.
In summary about 32 % of the microarray result was confirmed by whole-genome bisulfite
sequencing. Although this number was apparently low, gene ontology analyses showed
enrichment of similar functional categories in both datasets, which included differentiation
processes, transcription, signaling and apoptosis.
Interestingly, 356 genes that were detected to be differentially expressed by DNA-microarray
analysis but were not found to be differentially methylated by whole-genome bisulfite sequenc-
ing were also found to be differentially methylated by the CpG island microarray. This finding
might be due to the fact that DNA methylation changes in response to butyrate potentially
reflected gene activity. It is obviously possible that gene activity-induced DNA methylation
changes were detected by the CpG island microarray but not the whole-genome approach.
4.2.3. Assessment of CpG microarray performance
In order to assess the reliability of differential DNA methylation detection by the CHO-specific
CpG island microarray in more detail, exemplary results from the analysis were verified by
Combined Bisulfite Restriction Analysis (COBRA; Xiong and Laird 1997). Furthermore,
control hybridization experiments were performed in order to be able to assess potential
sources of bias originating from the experimental procedure.
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Figure 4.30.: Comparison of genes detected to be differentially methylated and/or differentially ex-
pressed by different techniques. Purple: Genes detected to be differentially methylated
upon butyrate addition by CpG island microarray analysis. Red and blue: Genes detected
to be either exclusively hypo- or hypermethylated or both by whole-genome bisulfite
sequencing (including genes that were differentially expressed as well as those only
differentially methylated but not differentially expressed). Green: Genes detected to
be differentially expressed by DNA-microarrays but not associated with differential
methylation.
4.2.3.1. Assessment of CpG microarray performance by Combined Bisulfite
Restriction Analysis (COBRA)
Differentially methylated genes detected by CpG island microarrays were analyzed by CO-
BRA (Xiong and Laird 1997). Components of the WNT signaling pathway were selected
as examples for this analysis, because several genes that were found to be differentially
methylated upon butyrate addition by both CpG island microarray analysis and whole-genome
bisulfite sequencing were related to the ’intracellular signaling cascade’.
Butyrate-mediated CpG island methylation was detected within the canonical WNT/Beta-
catenin pathway ranging from members of WNT biogenesis and signal transduction in the
cytoplasm to transcriptional regulation in the nucleus. Briefly, Porcupine, an ER localized
membrane-spanning protein, mediates secretion and palmitoylation of WNT proteins (Haus-
mann, Bänziger, and Basler 2007; Janda et al. 2012). This modification is essential for their
interaction with the Frizzled seven-pass transmembrane protein family and the LDL receptor-
related proteins LRP5 and LRP6 (Janda et al. 2012). The formation of a WNT-FZD-LRP
complex leads to recruitment of the scaffolding protein Dishevelled, subsequent interaction
with the Axin complex and thereby stabilization of Beta-catenin (Logan and Nusse 2004).
Beta-catenin moves into the nucleus and regulates gene expression of WNT target genes
alongside the transcription factors TCF/LEF (Hoppler and Kavanagh 2007). The subsequent
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recruitment of several co-activators regulates a plethora of transcriptional events (MacDonald,
Tamai, and He 2009). For example, expression of the WNT responsive gene MYC is activated
by Beta-catenin (He et al. 1998). MYC has decisive influence on growth, proliferation and
differentiation (Massagué 2004). Its expression was previously shown to be influenced by
butyrate (Krupitza et al. 1995; Mariani et al. 2003) and a general influence of butyrate on
WNT signaling has been stated before on other cellular levels, e.g. by measuring WNT
activity or WNT target gene expression upon butyrate treatment (Bordonaro, Lazarova, and
Sartorelli 2008; Shin et al. 2012).
COBRA experiments depend on the presence of specific restriction endonuclease recognition
sites within the DNA region to be analyzed. These sites contain CpG dinucleotides that either
vanish after bisulfite conversion if the DNA was unmethylated at that specific position, or
remain within the DNA sequence if the respective base was methylated. Suitable restriction
enzymes are TaqI (recognition site 5’-TCGA-3’) and BstUI (recognition site 5’-CGCG-3’).
Due to this requirement not every gene can be analyzed by this technique. However, analysis
was possible for the genes Segment polarity dishevelled homolog DVL-1 (Dvl1), Frizzled-7
(Fzd7) and Myc proto-oncogene (Myc). Fzd7 and Dvl1 were only detected to be differentially
methylated by CpG island microarray analysis, whereas differential methylation of Myc was
detected by both techniques.
Dvl1
Ref But
- + - +TaqI
Fzd7
Ref But
- + - +TaqI
Myc
Ref But
BstUI - + - +
A B C
Figure 4.31.: Combined Bisulfite Restriction Analysis of Segment polarity dishevelled homolog DVL-1
(Dvl1, A), Frizzled-7 (Fzd7, B) and Myc proto-oncogene (Myc, C). Promoter regions
were amplified from bisulfite-treated DNA of reference and butyrate-treated CHO DP-12
cell cultures (24 h post butyrate). PCR products were digested with TaqI (recognition
site 5’-TCGA-3’) or BstUI (recognition site 5’-CGCG-3’). Undigested DNA was used to
control the signal strength.
Fig. 4.31 shows the COBRA results as a comparison of reference and butyrate-treated samples
at time point 24 hours. Undigested PCR products were used to enable a better estimation of
signal strength. For Fzd7, both the amplificates from reference and DNA from butyrate-treated
cultures were not cut by TaqI, which indicates that both DNA regions were not methylated
at the cytosine position that was analyzed. This was in accordance with the whole-genome
bisulfite sequencing analysis, but not with the CpG island microarray result. Differential DNA
methylation could be detected for Dvl1 and Myc, though, which indicated less methylation
upon butyrate treatment for Dvl1. For Myc the experiment indicated a higher methylation
level. Both results were in conformity with the changes in CpG island methylation that were
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detected by the microarray. On the contrary, differential Dvl1 methylation apparently escaped
the whole-genome bisulfite sequencing approach, while differential methylation of Myc was
also measured by this technique. Taken together, the gene specific analysis showed that
two of the three differentially methylated CpG islands that were examined indeed exhibited
differential methylation, which confirmed the CpG island microarray result in parts. The
results of whole-genome bisulfite sequencing, too, could be verified in parts by this analysis,
as two of three results were confirmed as well. Interestingly, this analysis did not allow for a
statement regarding a higher reliability of either of the two methods.
4.2.3.2. Assessment of CpG microarray performance by hybridization experiments
In order to be able to assess potential sources of bias originating from the experimental
procedure of CpG island microarray analysis, three hybridization experiments were performed
in dye swap pairs. The potential sources of bias that were identified in the experimental
procedure and which were addressed by this experiment were (i) incomplete purification of
DNA during the extraction by phenol-chloroform, (ii) inhomogeneities already present within
the input fractions of sheared DNA before enrichment (this experiment was performed during
the master studies (Wippermann 2012) but is included here for the sake of completeness) and
(iii) variations in the procedure of methylated DNA enrichment.
The first experiment addressed a potential variability introduced by DNA extraction using
phenol-chloroform. This step was suspected to be affected by several experimental factors
such as incomplete proteolysis by Proteinase K or impurities in the DNA samples due to
carryovers during phase separation. This could in turn lead to maintenance of histones or
other DNA-binding proteins at some DNA regions and affect the subsequent methylated DNA
enrichment reaction. According to this assumption, this experimental step was hypothesized to
be the one with the possibly strongest impact on the detection of differential DNA methylation.
In order to control the impact of DNA extraction on CpG island microarray results, two
separate DNA extractions were performed from the same sample of CHO DP-12 cells and
analyzed by the CHO-specific CpG island microarray. The MA plot in Fig. 4.32A shows the
result of this comparison. 40 probes indicated significant differences in signal intensities and
therefore falsely detected differential methylation. These probes exhibited A-values ≥ 7.0
and M-values ≥ 1.0 or ≤ -1.0. A-values represent the logarithmic product of red and green
signal intensities (log2RG), whereas M-values represent the signal ratio (log2R/G). That is, the
M-value represents the difference in enrichment of a specific region from two samples. The
threshold for M-values to be considered significant was generally set to M = 1.0 (representing
a two-fold difference in enrichment).
The second experiment addressed potential variations within input fraction of sheared DNA
from CHO DP-12 cells that were cultivated under different conditions. For this experiment
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DNA samples (see images of control agarose gels in Supplementary Fig. B.21) from reference
and butyrate-treated CHO DP-12 cell cultures were compared. No significant differences in
microarray signals were expected for this comparison, as each sample contained the entire
CHO DP-12 genome. Indeed, no significant differences between the two input fractions from
untreated and butyrate-treated CHO DP-12 cell cultures were detected (Tab. 4.8). The MA
plot in Fig. 4.32B shows that all values centered around a mean intensity of A = 10 and
M-values range from 0.5 to -0.5.
In the third experiment, two distinct enrichment reactions were performed from the same
sample of sheared DNA to control a potential bias introduced by methylated DNA enrichment.
As the sheared DNA samples contained 500 bp fragments of the genomes of millions of cells,
they were supposed to be very homogeneous regarding the distribution of fragments. There-
fore, it was expected that two individual enrichment reactions from the same sample would
lead to very similar fractions of enriched methylated DNA. According to this expectation, no
significantly differentially enriched CpG islands were found. The corresponding MA plot in
Fig. 4.32C shows only few signals above the threshold of A = 7.0 (represented in green or
red). According to the Student’s t-test these were not statistically significant.
Table 4.8.: Significant differences (p adjusted ≤ 0.05) between technical control hybridizations.
Sample 1 Sample 2 M ≥ 1.0 M ≤ -1.0
Input (untreated) Input (butyrate-treated) 0 0
Extraction 1 Extraction 2 40 0
Enrichment 1 Enrichment 2 0 0
In summary, the control experiments to asses the three variables suspected to be able to have
a strong impact on reliable CpG island microarray performance showed that only the DNA
extraction procedure led to false positive results. However, only a small number of probes
was falsely detected as differentially methylated (40 probes representing only 0.15 % of the
total number of probes present on the array). DNA extraction most probably has an effect
on binding of the MBD protein to specific DNA sites and not on the general composition
of the extracted DNA, as even sheared fractions from different samples were found to be
completely homogeneous. A general bias introduced by the enrichment procedure itself could
be excluded as well.
4.2.4. Discussion: Comparable overall results of CpG island
microarray and whole-genome methylation analyses
The analysis of differentially methylated regions by CpG island microarrays showed 1,221
genes to be affected 24 hours upon butyrate addition. When gene ontology analyses were
carried out to get an overview of involved cellular processes and components, the functions
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Figure 4.32.: MA plots of quality control hybridization experiments. Data analysis was performed
using EMMA2. Data were LOWESS normalized and Student’s t-tests were calculated.
MA plots were generated from these tests. M-values below the threshold of -1.0 (red)
represent de novo methylated regions. M-values above the threshold of 1.0 (green)
represent hypomethylated regions. The blue lines mark for each time point the 95 %
and 99 % confidence intervals of all observed M-values. The yellow line represents the
LOWESS fit. A Extraction control. Comparison of enriched methylated DNA fractions
from separately extracted DNA from the same cell sample. B Input control (Wippermann
2012). Comparison of input fractions from reference and butyrate-treated CHO DP-12
cell cultures without enrichment of methylated DNA. C Enrichment control. Comparison
of enriched methylated DNA fractions from the same sample of sheared DNA.
of genes found to be associated with differentially methylated CpG islands were similar
to those detected by whole-genome bisulfite sequencing and DNA-microarray analysis,
including response reactions, protein biosynthesis, cell death, DNA metabolism, transcription,
developmental processes, phosphate metabolism, signaling and transport. More than 50 % of
the genes found to be associated with differentially methylated CpG islands were also detected
to be either differentially methylated or differentially expressed or both by whole-genome
bisulfite sequencing and DNA-microarray analysis.
The presence of components of ’neuron development’, ’synaptic transmission’ or ’dendrite
morphogenesis’ within the genes found to be differentially methylated by CpG island mi-
croarray analysis was interesting, as similar functional groups were not found amongst the
genes detected to be differentially methylated by the whole-genome approach or the gene
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expression microarray. Though butyrate is able to induce differentiation of stem cells into
neural cells (Yao et al. 2010), an involvement of such specific factors in butyrate-treated CHO
cells has not been reported yet. On the one hand, this finding might be related to the fact that
genes involved in developmental processes were found to be both differentially methylated
and differentially expressed in the integrative, sequencing-based approach. On the other hand,
genes contributing to neuron development and related processes were found to be located
within partially methylated domains in CHO DP-12 cells. As methylation patterns are more
unstructured within these regions, it is possible that detection by enrichment and microarray
hybridization leads to some kind of bias for PMD-genes.
To the best of my knowledge, no publications can be found that show a direct comparison
of next generation bisulfite sequencing with enrichment based CpG island microarray hy-
bridization, which complicates an assessment of the CHO CGI-microarray performance in
comparison to the whole-genome approach. This lack of literature is probably due to the
plethora of factors that complicate such comparisons. However, some publications compare
bisulfite sequencing with the Illumina Infinium HumanMethylation27 assay, which is based on
bisulfite conversion of DNA followed by hybridization to a microarray containing 27,000 CpG
sites. In a comparison of the Infinium assay with different genome-wide, sequencing-based
methods Bock et al. showed that only about one-fifth of the differentially methylated re-
gions identified by whole-genome sequencing were detected by the microarray-based method.
Between different sequencing methods differences in DMR detection were also shown in
this publication (Bock et al. 2010). Interestingly, comparisons between sequencing- and
hybridization-based methods show only partial overlaps even when no enrichment procedure
is included into the experiment, which is the case for RNA sequencing (RNA-Seq) and
transcriptome analysis by microarrays. Zhao et al. analyzed gene expression profiles of
human T cells after activation and showed that, although a high correlation between gene
expression profiles was present, several genes were found to be differentially expressed only
by one method. For example, for the comparison ’0 h’ and ’2 h’ 602 genes were detected
as regulated by both methods, whereas 911 and 801 genes were uniquely detected by either
RNA-Seq or microarray hybridization (Zhao et al. 2014). Black et al. also compared these
techniques and applied them to the analysis of dose-response reactions in rats. In this study it
was also shown that the overlap between genes detected as differentially expressed was only
30–40 % (Black et al. 2014).
Another important finding of both experiments was the dynamic change of DNA methylation
in response to butyrate. CpG island microarray analysis showed that 48 hours upon butyrate
supplementation 91 % of the observed differential CpG island methylation that was present
at sampling point ’24 hours’ was not detectable anymore. This is obviously in contrast to
the whole-genome bisulfite sequencing analysis which, on the one hand, showed that DMRs
were variable and DNA methylation was highly dynamic as well, but, on the other hand, also
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showed that DMR numbers were still high 36 hours after butyrate addition. Although the
sampling point ’48 hours’ was used in the microarray experiment, which makes a comparison
obviously unprecise, the whole-genome approach allows for the guess that the number of
DMRs did not rapidly decrease between 36 and 48 hours post butyrate. Interestingly though,
in the whole-genome bisulfite sequencing experiment both genome-wide and region-specific
mean methylation levels were found to be decreased 12 hours post butyrate and increased
again at later time points as well. This effect might be caused by the hypothesized differences
in the kinetics of setting and removing DNA methylation marks. Importantly, the phenomenon
was also detected for CpG islands and might therefore be the reason for the apparent dynamics
detected by the CpG island microarray experiment.
4.2.5. Discussion: Variation in DNA methylation between identical
CHO cell cultures
One result of CpG island microarray analysis could not be compared to the whole-genome
approach, namely the occurrence of differentially methylated genes in a comparison between
identical cultures that were not treated with butyrate. There are several possible explanations
for this interesting finding. First, it could be possible that a statistically relevant occurrence
of (false positive) differentially methylated genes might be caused by a biased enrichment
reaction. Accordingly, the hybridization experiments for control of experimental parame-
ters showed that DNA extraction led to a small fraction of false positives. However, it is
furthermore known that within cell populations or even between individual cells a certain
degree of noise can occur within regulatory networks (Chalancon et al. 2012). It was shown
that switching between states of DNA methylation can contribute to this noise (Lim and
Oudenaarden 2007). The differentially methylated genes detected before butyrate treatment
may represent this effect, which could be further magnified by asynchronous cell growth or
minimal chronological differences in sampling. Interestingly, it is known that cultured cells
can behave very differently over the course of a production process even if they were treated
in the same way (Le et al. 2012). The reason for this differential behavior has not been found
yet.
The reason for the detection of differential methylation between identical cultures could not be
identified based on the data at hand. However, the genes found by the ’0 h’ comparison were
removed from the sets of differentially methylated genes at the ’24 h’ and ’48 h’ sampling
points, as they were suspected to be potentially unrelated to the butyrate-induced changes in
CpG island methylation.
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4.2.6. Conclusion: Perspectives of CHO-specific DNA methylation
microarrays
Taken together, the comparative analysis of DNA methylation changes upon butyrate addition
by CpG island microarrays and whole-genome bisulfite sequencing showed that both tech-
niques were suitable for DNA methylation detection. Although the sequencing-based method
was expected to be more reliable, COBRA experiments and control hybridizations proved
the reliability of the CpG island microarray as well. For this reason CpG island microarray
analyses might indeed be performed for economical reasons when sample numbers would
be to high for the whole-genome approach. In such experiments it could be advisable to
change the genomic sites covered by the array, as CpG islands are obviously not exclusively
targeted by DNA methylation changes, but rather keep their methylation state under many
conditions (Schübeler 2015). Besides the possibility of broadening the coverage to the whole
CHO genome or at least to regions with annotated genes, it would furthermore be possible to
create arrays for specific questions that could include genes and regulatory regions belonging
to certain pathways. An advantage of such an array would obviously be a higher coverage of
individual genes and thereby a higher statistical power. An exemplary application would be
the analysis of DNA methylation in regard to product properties like glycosylation, which
was shown here to be potentially influenced by butyrate addition. It would furthermore be
possible to add those promoters and enhancer regions to the array which are not associated
with CpG islands to achieve a more comprehensive view on gene regulation. Additionally,
sequences of recombinant genes and viral promoters should be added to analyze potential
changes in DNA methylation directly related to changes in productivity. As an alternative it
would also be possible to combine bisulfite-mediated conversion of DNA with microarrays
instead of using methylated DNA enrichment for sample preparation. The Illumina Infinium
HumanMethylation BeadChip Array represents an example of such a combination and is one
of the most popular DNA methylation microarray platforms today (see e.g. Daca-Roszak et al.
2015).
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4.3. Functional analysis of putative central mediators of the
butyrate effect
The analysis of the effect of butyrate on CHO DP-12 cells by both whole-genome bisulfite
sequencing and CpG island microarrays showed that DNA methylation patterns changed
dynamically. As hypothesized previously (please refer to section 4.1.4.7), these observed
dynamics of DNA methylation upon butyrate addition were potentially due to transcription
factor binding. However, an involvement of central components of the DNA methylation
machinery was considered to be necessary for these changes. Therefore, the CpG island
microarray and whole-genome bisulfite sequencing data were subjected to an analysis re-
garding regulatory components of this machinery. The genes Dnmt3a and Uhrf1, encoding
major mediators of de novo and maintenance methylation (Bostick et al. 2007; Cedar and
Bergman 2009), were found to be relatively hypomethylated by CpG island microarray analy-
sis at the 24 hours sampling point. Furthermore, the genes Gadd45g and Apobec2, encoding
mediators of DNA demethylation (Barreto et al. 2007; Rai et al. 2008) showed changes
in their promoter-methylation. Dnmt3a and Gadd45a were also found to be differentially
methylated in the whole-genome bisulfite sequencing experiment. The DNA-microarray
gene expression analysis furthermore showed that DNMT3A expression was downregulated,
whereas GADD45A expression was upregulated. As the hypothesis that DNMT3A could
have a key role in the cellular response to butyrate addition was strengthened by the fact that
silencing of DNMT3A in honey bee larvae led to the development into honey bee queens and,
strikingly, this developmental process is induced in nature by feeding a diet called royal jelly
(which contains phenyl butyrate; Kucharski et al. 2008), a putative role of DNMT3A in the
butyrate-response was analyzed more closely by transient knockdown in RNA interference
experiments.
In order to first confirm differential methylation of the Dnmt3a gene by a gene specific analysis
method, Combined Bisulfite Restriction Analysis (COBRA) was applied. Butyrate-induced
downregulation of DNMT3A expression was confirmed by Real-Time PCR and westernblot
analysis. Fig. 4.33A shows the COBRA result, which indicated a clear difference in DNA
methylation between reference and butyrate-treated cultures, although a higher level of methy-
lation was detected. As only single cytosine sites are analyzed by this method and differential
DNA methylation can be very variable anyway, this finding does not necessarily contradict
the results of whole-genome bisulfite sequencing and CpG island microarray analysis, which
indicated lower methylation of Dnmt3a upon butyrate treatment. The expression analysis (Fig.
4.33B and C) showed that DNMT3A abundance was decreased 24 hours as well as 48 hours
upon butyrate addition on both the mRNA and protein level by about 60 %. In the reference
cultures mRNA and protein levels did not change significantly over this period of time.
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Figure 4.33.: Confirmatory analysis of Dnmt3a methylation and expression changes upon butyrate
addition. A Combined bisulfite restriction analysis (COBRA). The promoter region was
amplified from bisulfite-treated DNA of reference and butyrate-treated CHO DP-12 cell
cultures (24 h post butyrate). PCR products were digested with BstUI (recognition site
5’-CGCG-3’). Undigested DNA was used to control the signal strength. B,C Gene
expression analysis of DNMT3A. B Real-Time PCR result. Error bars represent standard
deviations of triplicate measurements. C Westernblot analysis. Error bars represent
standard deviations of three separate westernblots from each replicate CHO DP-12
culture. An exemplary westernblot can be found in Supplementary Fig. B.39.
As differential methylation and downregulation of DNMT3A gene expression was confirmed,
DNMT3A was considered to be a promising target for RNAi-mediated knockdown. SiRNAs
targeting 3 different exons (exon 3, 8 and 20, see Fig. 4.34A) of the Dnmt3a gene were
designed and used to generate 60 nt shRNA-oligonucleotides which formed the typical
hairpin structure that is necessary for proper processing and subsequent silencing potential
of the released siRNA. Also, a scrambled control, i.e. an siRNA sequence similar in base
composition to the actual siRNAs but unspecific for the CHO genome, was used to assess
potential effects resulting from the general presence of siRNAs in the cells. The shRNA-
oligonucleotides were cloned into the pLVX-shRNA1 vector, which contains a human Pol
III-dependent U6 promoter upstream of the MCS for shRNA expression, and used for transient
transfection experiments.
In order to test the knockdown efficiency of the siRNAs designed to target DNMT3A, CHO
DP-12 cell cultures were transiently transfected by electroporation and grown for two days. A
reference culture was transfected with an empty vector. All cultures exhibited high viabilities
until the experiment was terminated. Samples were taken on both days to enable determination
of cell specific productivities compared to the reference culture and DNMT3A expression
levels were measured by qPCR on the second day. The qPCR analysis (Fig. 4.34B) showed
that shRNA2 had a very strong knockdown effect that resulted in the reduction of DNMT3A
mRNA levels by 90 %. Transfection of the pLVX-shRNA constructs 3 and 9 led to a reduction
in DNMT3A mRNA levels of about 20 %, although the measurements exhibited a large
standard deviation and may therefore be not significant. In the cultures transfected with the
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scrambled control a significant relative decrease of DNMT3A mRNA abundance by 35 %
was observed. Interestingly, the changes in cell specific productivities did not correlate with
knockdown efficiencies, as the cultures transfected with shRNA2 only showed an increase in
productivities of 2 pg mAB per cell and day compared to the reference, whereas the cultures
transfected with shRNAs 3 and 9 and the srcambled control showed a similar increase of
about 8 pg mAB per cell and day compared to the reference.
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Figure 4.34.: Knockdown of DNMT3A by RNA interference. A Schematic representation of Dnmt3a
gene and indication of exons that were targeted by shRNAs. B Relative DNMT3A mRNA
abundance in CHO DP12 cells transiently transfected with pU6-shRNA constructs.
Reference cultures were transfected with an empty pLVX-shRNA1 vector. Realtime PCR
measurements were performed 48 hours post transfection. Values were normalized to the
ACTB expression. Error bars represent standard deviations of triplicate measurements. C
Cell specific productivities were calculated based on antibody titers that were measured
by HPLC 24 hours and 48 hours post transfection.
4.3.1. Discussion: DNMT3A could be involved in butyrate-induced
hyperproductivity
Transient transfection of CHO DP-12 cell cultures with siRNA constructs targeting DNMT3A
led to an apparently successful knockdown of the gene. However, transfection experiments
with a scrambled control also had an effect on DNMT3A knockdown. This effect has already
been described previously for transient transfection experiments using the same cell line
but different target genes (see e.g. Klausing 2013). An explanation for this behavior has
not been found yet. However, it seems possible that DNMT3A as a protein involved in
many key regulatory processes is generally affected by the process of electroporation and/or
the introduction of siRNAs into the cell. Strikingly, a relationship of DNMT3A and small
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RNAs was reported in several publications that link the process of antisense RNA-mediated
transcriptional gene silencing to the epigenetic machinery (Weinberg and Morris 2016).
Most relevant to this experiment was the finding that decreased expression of DNMT3A, no
matter if it was induced by an actual siRNA or by the scrambled control, correlated with
an increase in cell specific productivities. Interestingly, the strong knockdown achieved by
shRNA2 was associated with the lowest increase in productivities, which might be due to the
fact that a drastic change in DNMT3A abundance is likely to affect several important pathways
and thereby probably leads to cell damage. A slight decrease in DNMT3A gene expression
might only cause a slight impairment of cellular processes and thereby allow for the cells to
remain functional. Therefore, shRNAs3 and 9 might by used in further experiments for stable
knockdown of DNMT3A. shRNA2 could be tested in an inducible expression system, as it is
possible that permanent expression of shRNA2 has a detrimental effect but that a short pulse
or controlled expression in specific growth phases might be suitable to enhance cell specific
productivities a lot more than observed in this experiment.
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Chinese hamster ovary (CHO) cells represent the major mammalian production cell line for
therapeutic proteins and improvement of CHO-based bioprocess performance and product
characteristics of biopharmaceuticals, e.g. by molecular engineering approaches, is of great
interest. An essential basis for this purpose is the CHO K1 genomic sequence (Xu et al.
2011) and transcriptome data (Becker et al. 2011) that became available in 2011. These data
furthermore enable investigations of genotype-phenotype relationships in CHO cells. In this
regard the analysis of DNA methylation is of special importance, as this epigenetic process is
linked to gene regulation and, importantly, changes in DNA methylation are often associated
with environmental factors such as nutrients or the exposure to chemicals (Ruiz-Hernandez
et al. 2015).
In order to study DNA methylation phenomena in CHO cell batch cultures, whole-genome
bisulfite sequencing was implemented here for the antibody-producing CHO DP-12 cell line.
This was achieved by customization of the publicly available CHO K1 genome, evaluation of
library qualities and selection of a suitable mapping algorithm. Methylome data generated in
this way were combined with gene expression measurements. This allowed for the first global
analysis of the CHO DNA methylation landscape as well as for the analysis of differential
DNA methylation upon butyrate addition. CHO DP-12 cells were found to exhibit global
hypomethylation compared to a majority of mammalian methylomes and hypermethylation
of CpG-dense regions at gene promoters called CpG islands. Also, partially methylated
domains were observed that covered 62% of the CHO DP-12 cell genome and contained
functional clusters of genes. Gene expression analysis showed these clusters to be either
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highly or weakly expressed with regard to CHO-specific characteristics. When whole-genome
bisulfite sequencing and DNA-microarray analyses were applied to analyze the time course
of cellular reactions upon butyrate addition, known butyrate-responsive pathways were found
to be affected, including cell cycle, splicing and apoptosis. Also, pathways potentially
involved in butyrate-induced hyperproductivity such as central energy metabolism and protein
biosynthesis were affected. Interestingly, the data suggested reduced biosynthetic capacities
but an increase in protein export. Differentially methylated regions were furthermore found to
contain binding-site motifs of specific transcription factors with a potentially central role in
the butyrate response. Similar effects of butyrate addition on DNA methylation were obtained
when data generated by a recently designed, CHO-specific microarray was analyzed.
5.1. Transgene integration into partially methylated
domains might be associated with production
instability or product heterogeneity
The partially methylated domains (PMDs) that were found in the CHO DP-12 cell methylome
represent epigenomic features similar to the methylomes of cancer and placenta cells (see
e.g. Schroeder and LaSalle 2013). The gene expression analysis strongly suggested these
features to be involved in the repression of tissue-specific genes, as it was e.g. shown for
placenta PMDs, too. Interestingly, the repressive effect of CHO DP-12 PMDs was not found
to affect genes relevant to CHO cell properties. To fully understand this relationship, it needs
to be elucidated how PMDs evolved, if they are generated in a dynamic manner and what
they look like on the cellular level. Also, potential functions of PMDs need to be analyzed
and the impact that they might have on cellular behavior. In the context of recombinant gene
expression it would also be interesting to elucidate if the integration of transgenes into PMDs
correlates with production stability or gene expression strength. To answer these questions,
single-cell epigenomic studies are necessary. Also, comparative site-directed integration of
recombinant genes into both highly methylated domains and partially methylated domains
could provide answers regarding a potential influence of the integration site on production
stability and possibly also on product heterogeneity.
Single-cell epigenomics are not as established as single-cell genomics studies, which are
e.g. employed for the analysis of genomes from unculturable microorganism or intra-tumor
genetic heterogeneity (Gawad, Koh, and Quake 2016; Marcy et al. 2007), or single-cell tran-
scriptomics, which e.g. enable the analysis of cell sub-populations in tumors or heterogeneity
in gene expression in dependency on circadian rhythms (Kanter and Kalisky 2015; Dalerba
et al. 2011; Shalek et al. 2013; Zopf et al. 2013). Nevertheless, single-cell epigenomics
methods are currently being implemented to elucidate DNA methylation dynamics during
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development or cell-to-cell heterogeneity in cell populations. The most critical factor in
this regard is the bisulfite conversion, which affects DNA integrity and thereby leads to
low genomic coverages. In 2015 first single-cell methylomes were produced by Farlik et
al., who implemented a whole-genome bisulfite sequencing-based protocol and established
a bioinformatical data analysis pipeline for the analysis of low-coverage methylome data
(Farlik et al. 2015). It was also shown that single-cell analyses of DNA methylation can
be combined with whole-genome amplification to achieve higher signals in sequencing, but
this combination obviously comes at the cost of introducing another source of bias into the
sequencing results (see e.g. Gravina, Ganapathi, and Vijg 2015).
5.2. Integrative analysis of butyrate-induced cellular
reactions raised further questions and allowed for
novel perspectives
Integration of DNA methylation and gene expression data in order to analyze the effect of
butyrate addition on epigenetic phenomena showed that 11% of the differentially methylated
genes were also found to be differentially expressed. Questions remain regarding the relevance
of DNA methylation changes at genes that were not found to be differentially expressed.
As it is not clear how DNA methylation affects gene expression and if it occurs up- or
downstream of gene regulation (Schübeler 2015), answering these questions will require
further experiments as well. Such experiments would include genome-wide profiling studies
of the epigenetic processes of DNA methylation, histone modifications and small RNA-
mediated regulation and their impact on gene expression changes. Furthermore, gene-specific
approaches would need to be applied to determine functional relationships between epigenetic
phenomena and gene regulation. It is also necessary to refine bioinformatics analysis pipelines
in order to be able to cope with the increasing amount of whole-genome data and to efficiently
integrate these data to create maps of multiple regulatory layers that might provide further
clues.
Generally, the integrative approach for data analysis allowed for a novel perspective regarding
the selection of potential target genes for rational cell line engineering, as it enabled identifi-
cation of transcription factors with potentially central roles within the butyrate-responsive
network. Follow-up experiments should address the roles of these transcription factors, e.g.
by mutagenization of binding sites (see e.g. Whitfield et al. 2012) or over-expression (see e.g.
Deniaud et al. 2009). Furthermore, DNA patterns at putative transcription factor binding sites
could be modified by the very recently developed technique of targeted DNA methylation.
Targeted DNA methylation repurposes the CRISPR/Cas9 system by using a deactivated Cas9
nuclease fused to the catalytic domain of DNMT3A, which is targeted to specific genomic
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loci through a co-expressed guide RNA (Vojta et al. 2016). Vojta and co-authors showed
that the system was capable of specific methylation of larger genomic regions by targeting
multiple adjacent sites, that the newly generated DNA methylation pattern was heritable
through mitosis and that it could repress gene activity. This system would be very suitable
for verification of direct regulatory functions of DNA methylation marks at specific genomic
sites.
Regarding a potential role of DNMT3A in the butyrate response and the inverse correlation of
DNMT3A expression and cell specific productivity, further experiments would be necessary.
These should, on the one hand, elucidate if DNMT3A is directly or indirectly affected
by butyrate addition and how its interaction network looks like. On the other hand, the
relationship between DNMT3A expression and cell specific productivity should be closer
examined by employment of inducible expression systems, stable integration of RNAi-
expression vectors for DNMT3A knockdown and characterization of cell behavior in fed-batch
or perfusion processes.
5.3. General considerations regarding CHO cell
metabolism, cultivation parameters and potential
epigenetic effects
The results of this thesis are suitable to serve as a basis for future studies of DNA methylation
in CHO cells. Results obtained by epigenomic studies might be useful for improvement of
production processes of biopharmaceuticals, as they could provide novel targets for rational
cell line development. DNA methylation marks might also serve as biomarkers useful for the
enrichment of stable, high producing clones during cell line development or to predict the
outcomes of production-scale processes (see e.g. Le et al. 2012). Lastly, epigenome-wide
studies might offer explanations for molecular mechanisms underlying the unique properties
of CHO cells, which are still poorly understood. This was underlined by the insights gained
from the establishment of the first DNA methylation map of a CHO cell line that was
performed here. The results obtained from the integrative analysis of DNA methylation and
gene expression in CHO cells furthermore underlined that environmental conditions might
be directly linked to epigenome-wide CHO cell characteristics and, thereby, influence CHO
cell metabolism and performance. In the following, general aspects regarding epigenetics,
metabolism and the influence of environmental conditions are considered more generally in
the context of the production of biopharmaceuticals.
An influence of metabolism on gene expression is an accepted phenomenon and epigenetic
processes were shown to be related to it several times. For example, patients suffering
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from type 2 diabetes exhibited several changes of DNA methylation in genomic regions
associated with genes relevant for carbohydrate metabolism and glycan degradation (Nilsson
et al. 2014). Prenatal malnutrition, as another example, was shown to be associated with
differential DNA methylation of genes related to growth and metabolism (Tobi et al. 2014).
In CHO cells metabolic capacities are obviously related to growth and productivity. In this
context it is interesting to have a closer look at lactate, a metabolite that has long been
known to affect the height of cell densities and final titers in production processes and is
generated from pyruvate during aerobic glycolysis (Lunt and Vander Heiden 2011). In this
thesis, a butyrate-induced switch from lactate formation to its consumption correlated with
changes in cell specific productivity, too. Variations in the rate of lactate formation and the
switch to its consumption between cultures of the same strain under the same conditions
were furthermore shown by Le et al., who applied multivariate analysis to a large amount
of bioprocess data from 243 bioreactor runs (Le et al. 2012). It was shown that the rate
of lactate formation and the switch to its consumption varied even between cultures of the
same strain under the same conditions. The hypothesis was raised that this finding was
a hint towards a predetermination of metabolic characteristics in early stages of culturing.
Adding to the hypothesis that epigenetic phenomena might be responsible for metabolic
changes in CHO cells is the fact that acetyl-CoA and other energy metabolites including
S-adenosyl methionine (SAM), nicotinamide adenine dinucleotide (NAD+) and adenosine
triphosphate (ATP) serve as co-factors for most epigenetic enzymes (Donohoe and Bultman
2012). ATP-citrate lyase (ACL)-dependent production of acetyl-CoA was e.g. shown to
contribute to increased histone acetylation in cells responding to growth factor stimulation
and during differentiation processes (Wellen et al. 2009). This effect is suspected to be due
to acetyl-CoAs regulatory effect on histone acetyl transferases (HATs), which play a key
role in cellular function. NAD+ is an essential co-factor for class III HDACs (Sauve and
Youn 2012). Glucose abundance leading to a high NADH/ NAD+ ratio therefore results in
decreased HDAC activity, enabling the epigenetic system to ’sense’ the nutritional cellular
state and respond to changing environmental conditions (Donohoe and Bultman 2012).
Taken together, studies linking epigenetic phenomena to central metabolism might be advis-
able in order to deepen the understanding of mammalian cultivation systems. Knowledge
gained in this way might then be employed for modulation of metabolic processes. In this
regard it appears possible to improve the production of biopharmaceuticals by using media
compositions or alternative supplements that alter methylation patterns in a way that leads
to increased growth and productivity, less apoptotic activity or a more efficient metabolism.
Underlining this hypothesis is the fact that addition of 5-azacytidine was shown to be re-
sponsible for activation of the CMV promoter in several cell types including CHO cells
(Radhakrishnan et al. 2008; Choi et al. 2005). Interestingly, several studies address the
question of an epigenetic effect of media components in the context of cultured human cell
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lines and reprogramming of stem cells. For example, an influence of supra-physiological
folic acid concentrations on in vitro cultured human cells was reported (Charles, Johnson, and
Belshaw 2012). The micronutrient folate is required for the generation of SAM, which is the
primary methyl group donor not only for DNA, but also for histone, RNA and phospholipid
methylation (Donohoe and Bultman 2012). At physiological doses (nanomolar range), an
effect of folate on global or gene-specific DNA methylation was not shown in non-transformed
cell lines. Strikingly, supra-physiological concentrations of folic acid (micromolar range),
as present in commercially available culture media, induced LINE-1 hypomethylation, CpG
island hypermethylation and decreased the intracellular SAM:SAH ratio, that is, caused
aberrant DNA methylation (Charles, Johnson, and Belshaw 2012). Interestingly, folate is
processed to the essential co-factor tetrahydrofolate (THF) by DHFR, which is used for gene
amplification in CHO cells (Jiang and Sharfstein 2009). Other studies addressing epigenetic
effects of media supplements focus on vitamin C (L-ascorbic acid), which harbors general
antioxidant properties but is rarely included in common cell culture media and supplements
(Monfort and Wutz 2013). Vitamin C was shown to facilitate the generation of induced
pluripotent stem cells with an improved differentiation potential by attenuating epigenetic
silencing of an imprinted gene cluster (Stadtfeld et al. 2012). Based on the current knowledge
it is speculated that this effect might be explained by a vitamin C-based enhancement of
key enzymes changing histone and DNA methylation patterns (Monfort and Wutz 2013). It
remains to be elucidated if absence of vitamin C in common cell culture media has an effect
on enzyme activities in production cell lines.
The cultivation temperature is another critical parameter in biopharmaceutical production
processes. Several lines of evidence establish mild hypothermia as a factor positively affecting
the production of recombinant proteins (Kou et al. 2011; Vergara et al. 2014). Interestingly, it
has been shown that an inverse correlation exists between global DNA methylation levels and
body temperature in fish (Varriale and Bernardi 2006). In plants an effect of temperature on
DNA methylation has been shown several times (Ste¸pin´ski 2012; Zhang et al. 2012; Chen
et al. 2014) - however, this might obviously be irrelevant for mammalian cells. In many
reptilian species, as another example, temperature is the major determinant of sex (Mork,
Czerwinski, and Capel 2014). In developing gonads derived from embryos of the American
alligator that were incubated at different temperatures, it was e.g. shown that genes playing a
critical role in sex determination were differentially methylated depending on the respective
incubation temperature (Parrott et al. 2014). Proof of temperature-dependent changes of DNA
methylation in mammalian cells is, to the best of my knowledge, still lacking. However,
analyzing the impact of temperature changes on epigenetic processes would be interesting,
especially in regard to pre-culture handling and potential effects of the culture history on
subsequent production processes.
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Abbreviations
% Percent
°C Degree Celsius
g Gravitational acceleration (9,81 m/s2)
µL Microliter
5caC 5-carboxylcytosine
5fC 5-formylcytosine
5hmC 5-hydroxymethylcytosine
5mC 5-methyl-cytosine
5mC 5-methylcytosine
A Log2RxG
A2UCOE Ubiquitously acting chromatin-opening element
AdoMet S-adenosyl-methionine
ATP Adenosine triphosphate
BER Base excision repair
bp Basepairs
Ca. Circa
CAB-Seq Chemical Modification-Assisted Bisulfite Sequencing
CDS Coding sequence
CGI CpG island
CH Chinese hamster
ChIRP-seq Chromatin Isolation by RNA Purification sequencing
Appendix A. Abbreviations
CHO Chinese hamster ovary
COBRA Combined Bisulfite Restriction Analysis
CpG Cytosine-Phosphate-Guanine (Dinucleotide)
Cy3-dUTP Cyanine3-5-(3-aminoallyl)-2’-deoxy-uridine-5’-triphosphate
Cy5-dUTP Cyanine5-5-(3-aminoallyl)-2’-deoxy-uridine-5’-triphosphate
d Day
DMH Differential methylation hybridization
DMH Differential Methylation Hybridization
DMR Differentially methylated region
DNA Desoxyribonucleic acid
DNase I Desoxyribonuclease I
DNMT DNA Methyltransferase
dNTP Desoxynucleotide triphosphat
EDTA Ethylendiamintetraacetate
EF-1a Elongation factor 1 alpha
ENCODE Encyclopedia of DNA Elements
ER Endoplasmic reticulum
ERAD ER-associated degradation
EtOH Ethanol
EWAS Epigenome-wide association studies
FDA Food and Drug Administration
Fig. Figure
g Gramm
GAGE Generally applicable gene-set enrichment
gDNA Genomic DNA
Glc Glucose
GO Gene ontology
h Hour
H3K27 Histone H3 lysine 27
HAT Histone acetyl transferase
HDAC Histone deacetylase
HepG2 Human liver cancer cell line HepG2
HMD Highly methylated domain
IL8 Interleukin 8
IMR90 Human foetal lung (IMR-90) cells
kb Kilobases
KEGG Kyoto Encyclopedia of Genes and Genomes
Lac Lactate
lncRNA long noncoding RNA
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M Log2R/G
mAB Monoclonal antibody
MBD Methyl-CpG-binding domain
MDR Methylation determining region
MeDIP Methylated DNA Immunoprecipitation
min Minutes
miRNA MicroRNA
miRNA microRNA
mL Milliliter
mRNA messenger RNA
MS-HRM Methylation-sensitive high-resolution melting
MSP Methylation-specific PCR
MSRE-PCR Methylation-Sensitive Restriction Enzyme Digestion PCR
NaBu Natriumbutyrate
ncRNA Non-coding RNA
ncRNA Non-coding RNA
NKCL Natural killer cell lymphoma
nt Nucleotides
o/e Observed/expected ratio
oxBS-Seq Oxidative Bisulfite Sequencing
p Probability
PCR Polymerase chain reaction
PMD Partially methylated domain
pri-miRNA Primary microRNA
Qp Cell specific productivity
qPCR Quantitative realtime PCR
redBS-Seq Reduced Bisulfite Sequencing
RISC RNA-induced silencing complex
RLU Relative light units
RNA Ribonucleic acid
RNAi RNA interference
RNAPII RNA polymerase II
RNase Ribonuclease
rpm Rounds per minute
rRNA Ribosomal RNA
RT Room temperature
SCFA Short chain fatty acid
SH-SY5Y Neuroblastoma cell line SH-SY5Y
siRNA Small interfering RNA
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snoRNA small nucleolar RNA
SNP Single nucleotide polymorphism
SV40 Simian virus 40 early region promoter
Tab. Table
TDG Thymine DNA glycosylase
TF Transcription factor
tRNA transfer RNA
TSS Transcription start site
TTS Transcription termination site
UTR Untranslated region
VCD Viable cell density
Viab Viability
WGA Whole genome amplification
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Supplementary material
In the following four sections experimental results are summarized that did not lead to a
satisfying final conclusion. First, the attempt to identify the transgene integration site within
the CHO DP-12 genome is described that was performed on the basis of whole-genome
sequencing of the CHO DP-12 cell genome. No reliable results could be obtained in this case
because the paired-end reads were too short for the stringent mapping procedure that would
have been necessary.
Second, the analysis of a putative involvement of microRNA 199a in the response of CHO
DP-12 cells to butyrate treatment is presented, which did not allow for a final answer as well
due to the complexity of the topic. However, a broader experimental setup was not possible
within the scope of this thesis.
In a third experiment, endogenous CHO cell promoters were tested regarding their expression
potential and capability to potentially replace the methylation prone CMV promoter. Generally,
the endogenous promoter sequences were found to be functional, but further studies need to
examine if these promoters are targeted by DNA methylation or histone modification events
as well.
Lastly, the CHO-specific CpG island microarray was applied to analyze and compare two
CHO-XL99 clones with differences in production characteristics that were kindly provided
by the Australian Institute of Bioengineering and Nanotechnology (AIBN). Unfortunately,
some microarrays were affected by hybridization artifacts that did not allow for a comparison
between some relevant samples.
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B.1. Attempt to identify transgene integration sites in the
CHO DP-12 genome
In order to assess the effect of butyrate treatment on DNA methylation of the IgG gene
integration site within the CHO DP-12 genome, the location of the recombinant gene needed
to be investigated. Therefore, the unmapped reads from the first sequencing run were aligned
to the sequence of the vector that was used to generate the CHO DP-12 cell line (Fig. B.1).
Surprisingly, in contrast to an average coverage of the genome (post trimming and mapping) of
about 34-fold, a coverage of the vector sequence of 350-fold was detected. This finding hints
towards multiple copies of the vector in the CHO DP-12 genome, which further complicated
identification of the integration site. The plot of coverages against the vector sequence also
shows that the coverage is significantly higher for the first 4000 bases, which represent the
coding region of the recombinant gene. In some cases the non-coding part of the vector
seemed to be removed from the genome.
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Figure B.1.: Coverage of the recombinant CHO DP-12 vector DNA by reads that could not be mapped
to the SNP-corrected CHO K1 genome. The region from 40 bp to 4300 bp represents the
sequence coding for heavy and light chain of the anti-IL8-antibody.
In an attempt to identifiy the integration site, the sequencing data generated from native
CHO DP-12 DNA was searched for paired-end reads that mapped to the vector sequence
with one read and to the CHO K1 genome with the corresponding second read. Hits were
supposed to accumulate around the putative integration site. Fig. B.2 shows an exemplary
mapping result for the recombinant vector sequence on the x-axis and a section of CHO
scaffold JH002371.1 on the y-axis. Positions were paired-end reads could be mapped to
both sequences are marked by a red cross. Interestingly, seven positions within this scaffold,
which co-localized with genes encoding IgG heavy chain regions, showed accumulation of
mapping hits at the beginning and end of the expression cassette. Similar results were found
for several other scaffolds as well with more or less clear accumulation patterns. Based on
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this mapping result it was speculated (i) that the short paired-end sequencing reads could lead
to a biased mapping process, which led to several false-positive hits within genes very similar
to the recombinant IgG gene or (ii) that the integration of the recombinant DNA, which was
performed randomly for CHO DP-12 cell line generation, happened by a mechanism similar
to homologous recombination. However, only repetition of sequencing with longer reads
that would allow for more stringent mapping procedures would have enabled us to reliably
exclude one or the other option.
As interpretation of the results for transgene integration site identification was not possible
by bioinformatics measures, a putative integration site was supposed to be analyzed by PCR.
For this, a Long PCR Enzyme Mix (ThermoFisher) was used, which is supposed to be able
to amplify extremely long DNA fragments of up to 46 kb. In this experiment CHO DP-12
DNA was compared to DNA from the Chinese hamster. Primers were designed that flanked a
putative integration region of 6504 bp, as the exact integration position could not be predicted.
Fig. B.3 shows a 0.6 % agarose gel used for separation of long-range PCR reactions that were
performed at 53 °C and 56 °C. At both temperatures amplificates of a size of about 6500
bp were generated from Chinese hamster DNA. This showed that the primers worked and
that, of course, no putative transgene was present in the host DNA. For CHO DP-12 DNA no
amplificate could be detected.
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Figure B.2.: Mapping of reads from libraries of native CHO DP-12 DNA to both the recombinant
vector sequence (x axis) and the SNP corrected CHO K1 genome (y axis). Each read that
could be mapped to both sequences is indicated by a red cross. The figure shows a cluster
of IgG V genes on scaffold JH002371.1 with 7 putative integration sites as an example.
There may be variuos reasons for this result. On the one hand it is possible that the prediction
of at least this specific integration site was correct, but that the recombinant vector integrated
multiple times. In this scenario the resulting genomic region would have been too long for
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amplification. On the other hand it is possible that the primers simply did not work, as a lot of
SNPs were detected between CHO K1 and CHO DP-12 cells and it is highly likely that even
more SNPs are present between DNA from a Chinese hamster and an antibody-producing
CHO cell line.
However, the attempt to identify trangene integration sites in the CHO DP-12 cell genome
was stopped at this point. A reliable identification would have been possible e.g. by a 2 × 300
bp Illumina MiSeq sequencing experiment which could not be performed within the scope of
this thesis.
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Figure B.3.: Attempt to verify a predicted transgene integration site in the CHO DP-12 genome by
long-range PCR. Primers flanked a putative integration site of a size of 6504 bp (i.e.
without integrated DNA). CHO DP-12 DNA was compared with C. griseus (Chinese
hamster) DNA. PCR was performed at annealing temperatures 53 °C and 56 °C.
B.2. Analysis of a putative involvement of microRNA 199a
in the response of CHO DP-12 cells to butyrate
treatment
As it has been shown that the expression of microRNAs can be regulated by changes in the
methylation status of their host genes and, additionally, butyrate has been shown to induce p21
protein expression by targeting the miR-106b family (Hu et al. 2011), a potential involvement
of the miRNA system in the CHO DP-12 cell response to butyrate addition was analyzed. For
this reasons, the DNA methylation data generated by the CpG island microarray experiment
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were searched for hints towards an effect of butyrate treatment on the microRNA system
and, in fact, several miRNA-containing genes were found to be differentially methylated
upon butyrate treatment. These included Coatomer subunit zeta-2 (Copz2), Ena/VASP-like
protein (Evl) and Dynamin-2 (Dnm2). Human Dnm2, a microtubule-associated GTPase
involved in clathrin-mediated endocytosis (Raimondi et al. 2011) contains the miR-199a gene
in intron 15 (Kim et al. 2008) and was selected to be analyzed regarding a potential effect of
butyrate addition on miRNA expression. For this purpose, DNM2 and primary microRNA (pri-
miRNA) 199a expression as well as the expression of two miR199a target genes, Prostaglandin
G/H synthase 2 (PTGS2) and NAD-dependent protein deacetylase sirtuin-1 (SIRT1) was
analyzed by qPCR 24 and 48 hours after butyrate addition (see schematic representation of
the regulatory system in Fig. B.4A).
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Figure B.4.: Analysis of putative effects of butyrate treatment on the expression of pri-miR199a and
miR-199a target genes. A Schematic representation of Dnm2 gene with CpG island
positions (black) and the pri-miR199a gene located at the 3’ terminus. Mature miR-199a
leads to repression of target genes SIRT1 and PTGS2. B Analysis of relative mRNA levels
of pri-miR199a, DNM2, PTGS2 and SIRT1 in butyrate treated cells by qPCR. Error bars
represent standard deviations of triplicate meaurements.
Fig. B.4B shows the qPCR results. Although decreased methylation of an intragenic Dnm2
region located before the miRNA gene was detected, no significant changes in pri-miRNA
expression upon butyrate treatment were measured by qPCR. DNM2 expression, however,
was found to be increased by more than 100 %. mRNA levels of the miR1992 targets PTGS2
and SIRT1 were found to be increased by 60 % and decreased by 80 %, respectively. Based on
these results, no direct effect of butyrate on miRNA199a-mediated regulation of the analyzed
target genes could be shown. As microRNAs regulated a plethora of target transcripts and
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several transcripts can be regulated by multiple microRNAs, this result does not allow for
a final answer. Further experiments would be necessary, which could for example combine
next generation sequencing of gene and microRNA expression after butyrate addition with
DNA methylation analyses. An experiment such big was not possible within the scope of this
thesis.
B.3. Analysing the expression strength of CHO cell
promoters by dual luciferase assays
Several publications show a DNA methylation-dependent silencing of viral promoters used
for recombinant gene expression in CHO cells. For example, when Kim et al. analyzed CMV
promoter methylation (29 CpG sites) by bisulfite sequencing in mAb producing CHO cell
lines during extended sub-culture in the presence of selective pressure, they revealed that the
instable, low generation number cell lines were affected by pCMV methylation that strongly
increased during sub-culturing (Kim et al. 2011). A correlation between pCMV methylation,
instability of productivity and its potential to be used as a biomarker was also addressed by
Osterlehner et al., who established a qPCR-based screening method which allows for the
enrichment of stable producers early in cell line development (Osterlehner, Simmeth, and
Göpfert 2011).
As it was hypothesized that endogenous CHO cell promoters might represent an alternative
to viral promoters in terms of either not being silenced as quickly or in response to different
conditions, the gene expression potential of 5 CHO promoters was analyzed by luciferase
reporter assays. This first estimation of promoter strength was possible because transcription
start sites were discovered in CHO cells by Jakobi et al. (Jakobi et al. 2014). The researchers
applied a dual-library RNA sequencing approach, which is based on the fact that intact
mRNA possess a 5’ cap that inhibits ligation of sequencing adapters. The actual peak library
was therefore treated with Tobacco acid pyrophosphatase (TAP) to remove 5’ caps prior to
adapter ligation, whereas a second library was not TAP-treated. In this second library only
fragmented mRNAs were sequenced and therefore represented the background noise that
could be substracted from the actual signals. By this approach 6,547 CHO cell transcription
starts sites were identified that were used to annotate putative promoter sequences and
allowed for a characterization of the CHO cell promoter landscape that was found to be,
accordingly to other mammalian cell types, characterized by the presence of broad and sharp
type transcription start sites. Furthermore, promoter regions were screened for common
regulatory elements such as TATA boxes.
For the analysis of promoter expression strength, 5 promoter sequences associated with high
expression levels (i.e. high abundance of reads) in the RNA sequencing experiment performed
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by Jakobi et al. were examined in dual-luciferase reporter assays regarding their recombinant
gene expression potential (Tab. B.1). Two of them could not be assigned to any gene, two
were associated with isoforms of Histone H4-like protein (Hist1h4n) and one was assigned
to Ribosomal protein S3 (Rps3). Besides the fact that all of the selected promoters were
associated with high expression levels, they varied regarding the types of expression initiation
(sharp or broad) and the presence of regulatory elements. These elements included the core
promoter motifs TATA box, downstream processing element (DPE), initiator region (INR)
and TFIIB recognition element (BRE), which represent sequence elements that can allow
for basal transcription from mammalian core promoters (Smales et al. 2004; see schematic
representation in Fig. B.5).
Table B.1.: Key features of 5 endogenous CHO promoters examined by dual luciferase assays regarding
the potential of recombinant gene expression (Jakobi et al. 2014). Indicated are CHO
scaffold numbers, assigned genes (if possible), heights of the peaks generated from mapping
of RNA sequencing reads to the reference genome, types of peaks (sharp or broad) and
identified regulatory elements. DPE = downstream processing element, INR = initiator
region, BRE = TFIIB recognition element. NA = not assigned, ND = not detected.
No. Source Gene Peak height Peak type Elements
1 Scaffold 157 NA 921,977 Sharp ND
2 Scaffold 115 NA 376,649 Broad TATA box, DPE
3 Scaffold 69 Hist1h4n 849,029 Sharp TATA box, INR
4 Scaffold 5 Rps3 159,343 Broad BRE
5 Scaffold 37 Hist1h4n 218,538 Sharp TATA box
Figure B.5.: Core promoter sequence motifs (Smales et al. 2004).
Reporter assays were performed by cloning of the selected promoter sequences into the
multiple cloning site of a Green Renilla Luciferase vector. Transient co-transfections of the
experimental promoters within the Renilla Luciferase plasmid and a normalization plasmid
that contained the Thymidine kinase (Tk) promoter within a Firefly Luciferase vector was
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performed using electroporation. Fig. B.6 outlines the experimental procedure. Central to
the experiment is the fact that the amount of relative light units (RLU) produced by Green
Renilla Luciferase depends on the expression strength of the endogenous CHO promoter,
whereas the luminescence signal from the constitutively expressed Tk promoter does not
change regardless of any intrinsic regulations, but depends on experimental conditions such
as the transfection efficiency. For this reason, Tk promoter-depended luciferase expression
can be used for normalization in dual luciferase assays, which are capable of measuring
both luciferase activities sequentially from a single sample. In the assay used here, Firefly
Luciferase activity was determined first by adding beetle luciferin and coenzyme A, which
results in a stable luminescence signal. The signal generated in this way is subsequently
quenched and the substrate for Renilla luciferase, coelenterate-luciferin, is added (Dual
Luciferase® Reporter Assay System protocol, Promega).
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Figure B.6.: Principle of dual luciferase reporter assays. Endogenous CHO promoter sequences
(’pExp’) were cloned into a plasmid encoding the Green Renilla Luciferase gene and
co-transfected into CHO K1 and CHO DP-12 cells simultaneously with a normalization
plasmid which contained the constitutive Tk promoter (’pTk’) and a Red Firefly Luciferase).
The luminescent signal produced by Renilla Luciferase abundance was normalized to the
Red Firefly signal in regard to varying experimental conditions such as the transfection
efficiency.
Experiments were performed using both CHO K1 and CHO DP-12 cells. The results of
luminescence measurements are shown in Fig. B.7. For both cell lines, untransfected control
cells (NTC) and cells transfected with the empty vector (MCS) showed reporter signals close
to the detection limit. Similarly low signals were observed for the endogenous CHO promoters
2 and 5, which showed expression potentials of less than 1 % of the CMV promoter strength.
The promoters 1 and 3 were found to be possess an expression strength of 11 % relative to
the CMV promoter in CHO DP-12, but not CHO K1 cells (0.5 % and 1.5 %, respectively).
Promoter 4 exhibited a comparable expression potentential in both cell lines with 5.5 % and
7.5 % of the CMV promoter expression capacity. Expression potential could not be related to
certain promoter types or specific functional elements, as both broad and sharp type promoters
were amongst the three functional promoters. Also, they were associated with either no
regulatory elements (promoter 1), with a TATA box and INR (promoter 3) or with a BRE box
(promoter 4).
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Figure B.7.: Reporter assay for measurement of the expression potential of endogenous CHO promoters
in comparison to the CMV promoter. ’MCS’ = CHO cultures transfected with the empty
Green Renilla vector, ’NTC’ = untransfected control cells. Error bars represent standard
deviations of triplicate measurements.
B.3.1. Discussion: Bioinformatically identified CHO promoters are
functional
The evaluation of expression potentials of newly discovered CHO cell promoters proved
that the annotated transcription start sites were indeed functional and could be employed
to mediate recombinant gene expression. Three of the five promoter sequences that were
tested showed an expression potential of about 1/10 of the CMV promoter strength in CHO
DP-12 cells and one of them in CHO K1 cells. Obviously, expression from endogenous CHO
promoters depends on intrinsic cellular pathways that are active or inactive in a specific CHO
cell line under given culturing conditions. This might be an explanation for the differences
found between CHO K1 and DP-12 cells, as CHO DP-12 cells were selected for a high
producer phenotype while CHO K1 cells do not produce any recombinant gene and were
not subjected to a selection process. Therefore, a general statement on the functionality
of endogenous CHO promoters might be impossible and promoters should be tested in the
specific CHO cell line they are supposed to be used in.
A more reliable screening for functional sequences with even higher expression potentials
than those found in this experiment would furthermore require examination of a larger number
of promoter sequences. Such an analysis would also possibly enable an estimation about
preferences regarding certain functional elements, which was not possible based on the small
number of promoters used here. However, this experiment shows that endogenous CHO
promoters could indeed be used to replace viral promoters, although optimization of culturing
conditions or the promoters themselves would possibly be required. Strong enhancement
of expression potentials was for example shown to be possible by artificial combination of
regulatory elements such as TATA box and Initiator Region (INR) in metazoans (??). In
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CHO cells expressing darbepoetin it was shown that a synthetic promoter in combination with
codon optimization of the recombinant gene was capable of achieving high expression levels
(Shukurov et al. 2014).
Endogenous CHO promoter elements might be capable of replacing methylation-prone viral
promoters, but further studies need to examine if these promoters are targeted by DNA
methylation or histone modification events as well. However, in general this experiment
provided a basis for further experiments and underlines the usefulness of a closer examination
of endogenous CHO cell promoters.
B.4. Comparative CpG island microarray analysis of CHO
clones with differences in productivity
The CHO-specific CpG island microarray was supposed to be applied in a second experiment
to analyze and compare two CHO-XL99 clones with differences in production characteristics
that were kindly provided by the Australian Institute of Bioengineering and Nanotechnology
(AIBN). The clones were derived from the original CHO K1 cell line by transfection with
a plasmid encoding the gene of a therapeutic IgG1 antibody, a puromycin resistance gene
and a glutamine synthetase gene. Antibody expressing cell pools (in the following referred
to as ’clones’ - however, it has to be noted that no single clones were isolated and analyses
were performed on polyclonal populations) were selected by puromycin and methionine
sulfoximine (MSX) and positive clones were either kept without selection pressure or with
supplementation of puromycin. Samples for CpG island microarray analysis of one clone with
poor production behavior and one clone with good production characteristics were taken from
a 7 day batch cultivation at day 4 or 5 and shipped to Bielefeld. A parallel batch cultivation
with identical sampling was performed for the host CHO K1 cell line in Bielefeld.
B.4.1. Confirmation of Actb and Bcat1 promoter regions as methylation
controls in CHO-XL99
The promoter regions of Actb and Bcat1 were previously identified as completely methylated
and unmethylated in CHO DP-12 cells, respectively. No changes in their DNA methylation
status could be detected upon butyrate addition. Therefore they were used as unmethylated
and methylated controls. To assess the potential of these promoter regions as methylation
controls in CHO-XL99 cells as well, their methylation status was determined by bisulfite
sequencing. The Actb promoter region exhibited completely unmethylated CpG dinucleotides,
whereas the Bcat1 promoter region was found to be completely methylated in CHO-XL99
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(Fig. B.8). Therefore, these regions could be used as methylation controls for the following
CpG island microarray experiments.
Actb
Bcat1
Figure B.8.: Confirmation of Actb and Bcat1 promoter regions as methylation controls in CHO-XL99
by bisulfite sequencing. Black circles represent a methylated CpG position, white circles
indicate unmethylated CpG positions.
B.4.2. Batch cultivation of CHO-XL99 clones
After transfection, mAB producing CHO-XL99 clones ’C’ and ’G’ were cultivated with
selection pressure by puromycin (’Early cell line development’ in Fig. B.9). Gene ampli-
fication was perfomred in a second round of selection with both puromycin addition and
MSX (’Mid cell line development’) and the clones were subsequently subjected to prolonged
passaging without selection pressure (’Late cell line development’). In all stages of cell line
development, the ’G’ clone showed lower maximum viable cell densities compared to the
’C’ clone, but higher mAb expression levels during early and mid cell line development (i.e.
when selection pressure was added; ’Combined expression levels’ in Fig. B.9). Without
selection pressure, mAB expression in the ’G’ clone was low. On the contrary, the ’C’ clone
showed comparatively high mAB expression only during early cell line development but mAB
production could not be increased by MSX selection and was also low without any selection
pressure. Therefore, the ’G’ clone is in the following referred to as ’the good producer’ and the
’C’ clone is referred to as ’the bad producer’. Sample generation for CpG island microarray
analysis was done by performing seven day batch cultivation with addition of puromycin only,
puromycin and MSX and without adding selection pressure. Also, the parental cells were
cultivated and samples from each were taken in triplicates in the middle of the exponential
growth phase.
B.4.3. CpG island microarray analysis of good and bad producing
clones in comparison to the CHO K1 host cell
DNA was extracted from three replicate samples of each the CHO K1 host cell samples
and the good and bad producer clones that were kept without selection pressure and with
selection pressure, respectively. DNA integrity was checked on agarose gels after DNA
extraction and no degradation was observed. DNAs were then sonicated (see images of
control agarose gels in Supplementary Fig. B.21) and methylated DNA fragments were
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Figure B.9.: VCDs, viabilities and mAB expression levels of CHO-XL99 clone cultivations during
early, mid and late cell line development.
enriched. Enrichment efficiencies were controlled by qPCR with pimers specific for Actb and
Bcat1, respectively. The enriched methylated DNA fractions of each three replicates were
pooled and compared to the CHO K1 host DNA by CpG island microarray analysis, which
was performed and controlled as described previously. Unfortunately, several microarrays
exhibited hybridization artifacts. Examples are shown in Fig. B.10. Hybridization artifacts
can occur due to difficulties in handling of microarrays in a 8 × format because the volume
of sample plus hybridization buffer is very small. Several arrays exhibited regions where air
bubbles stuck during hybridization or regions with low signal intensities in the middle part of
the array when too little hybridization mixture was present inside the chamber. These artifacts
were obtained regardless of the person setting up the array sandwich, even when a very well
trained person performed the experiments. Arrays exhibiting such artifacts were excluded
from the analysis and, consequently, also arrays from dye swap pairs when the statistical
power would have been too low for reliable calculations of probabilities. For this reason, all
samples generated from cells under both puromycin and MSX selection were excluded from
the analysis.
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Figure B.10.: Exemplary images of artifacts in hybridized CpG island microarrays after scanning and
applying Agilents Feature Extraction software. Top left: Array without artifacts. Top
right: Small air bubbles. Bottom left: Too little hybridization mixture too achieve good
signal intensities in the middle of the array. Bottom right: Weak signals at one side.
B.4.4. Data analysis
In a next step data were normalized and t-tests were calculated for each comparison (i.e. both
clones with and without selection pressure were compared to the parental cells). To get an
initial overview, MA plots were generated for these tests (Fig. B.11). Probes with M-values
between -1.0 and 1.0 (i.e. not significantly differentially methylated) are represented in black,
probes with M-values below -1.0 are represented in red (i.e. hypomethylation compared
to the host cells) and probes with M-values above 1.0 (i.e. hypermethylation compared to
the host cells) are represented in green. The probes represented in black, i.e. those without
a significant change in DNA methylation, showed the characteristic distribution that was
observed for other CHO cell lines as well: The majority was either unmethylated (low A
values/intensities) or methylated (high A values/intensities), a minority showed intermediate
methylation levels. Furthermore, the MA plots indicated that less genes were significantly
differentially methylated when both clones were cultivated without selection pressure. Under
selection with puromycin both clones exhibited a higher degree of differential methylation in
comparison to the host cells. According to the expectations, puromycin treatment resulted in
an increase in the numbers of differentially methylated CpG islands. For subsequent analyses
and in accordance with the established CpG island microarray analysis procedure, probes
with M-values of ≤ -1.0 and ≥ 1.0) were considered to be significant when they exhibited A
values of more than 7.0 and p adjusted values of less than 0.05.
Fig. B.12 shows the numbers of differentially methylated CpG islands present in the genomes
of the good and the bad producer when each of them was compared to the CHO K1 host
cell. Both clones had similar numbers of differentially methylated genes when they were kept
without selection pressure. The bad producer exclusively exhibited 377 hypomethylated and
108 hypermehylated genes, whereas 291 genes were exclusively hypomethylated and 152
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Figure B.11.: MA plots for the comparison of good and bad producing CHO-XL99 clones to the CHO
K1 host cell line. M-values below the threshold of -1.0 (red) represent hypomethylated
regions compared to the CHO K1 host cell line. M-values above the threshold of 1.0
(green) represent hypermethylated regions compared to the CHO K1 host cell line. The
blue lines mark for each time point the 95 % and 99 % confidence intervals of all
observed M-values. The yellow line represents the LOWESS fit.
genes were exclusively hypermethylated in the good producer in comparison to the CHO
K1 host cell. 83 genes were differentially hypomethylated and 17 genes were differentially
hypermethylated in both clones compared to the host cell. These differences represent the
effect of transfection, selection and gene amplification during cell line generation and are of
greatest relevance regarding the hypothesis that epigenetic states are established during this
procedure that can lead to unfavorable outcomes of production processes.
When both clones were subjected to puromycin selection, differential methylation increased
especially regarding the numbers of differentially hypomethylated genes. 1,140 genes were
hypomethylated in both clones, 1,128 were exclusively hypomethylated in the bad producer
and 331 were exclusively hypomethylated in the bad producer. The effect of puromycin
selection on differential hypermethylation was comparably small, with 182 hypermethylated
genes in the bad producer, 29 genes in the good producer and 6 overlapping genes.
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Figure B.12.: Significantly differentially methylated genes in good and bad producing CHO-XL99
clones with (’Puro’) and without (’w/o) selection pressure compared to the CHO K1
host cell line.
B.4.5. Functional annotation of differentially methylated genes in good
and bad producing CHO-XL99 clones
To assess if specific functional groups of genes were affected by differential DNA methy-
lation Gene Ontology analyses were performed with EASE scores below 0.05. The genes
that were identically differentially methylated in both clones were related to transport and
gene expression. Besides this, the clones differed significantly regarding the functions of
differentially methylated gens, as most of the functional groups enriched in the genes that
were detected to be exclusively differentially methylated in the good producer (Tab. B.2) were
related to cellular response reactions, including e.g. response reactions to hormones, vitamins
or nutrients. This finding raises the possibility that in this case selection resulted in growth
of a cell pool more responsive to components of the culture medium than other clones, i.e
a beneficial phenotype that could possibly be related to the good performance of the good
producer.
In the bad producer (Tab B.3), genes related to cytoskeleton organization, biosynthetic and
metabolic processes were found to be differentially methylated. Also, genes contributing to
the response to hypoxia were overrepresented. This is interesting as it was shown in human
cancer cells that hypoxia-related genes encode proteins that contribute to processes such as
glucose transport, proliferation and apoptosis (Chi et al. 2006). Strikingly, cell death-related
191
Appendix B. Supplementary material
Table B.2.: Gene Ontology analysis of genes associated with differentially methylated CpG islands in
replicate cultures of the good producing CHO-XL99 cell line without selection pressure.
GO term (category ’biological process’) % Fold enrichment p value Benjamini p value
Response to estrogen stimulus 2.42 4.07 0.004 0.997
Response to nutrient levels 3.32 2.99 0.004 0.960
Response to vitamin 1.81 4.86 0.008 0.986
Response to extracellular stimulus 3.32 2.67 0.008 0.969
Response to hormone stimulus 4.53 2.19 0.009 0.951
Regulation of wnt receptor signaling pathway 1.51 5.81 0.010 0.945
Translational elongation 2.11 3.71 0.012 0.910
RNA processing 5.74 1.86 0.014 0.927
Response to nutrient 2.42 3.06 0.016 0.931
Response to endogenous stimulus 4.53 1.98 0.020 0.922
Response to retinoic acid 1.21 6.48 0.023 0.938
cAMP biosynthetic process 0.91 11.46 0.027 0.943
Response to steroid hormone stimulus 2.72 2.51 0.028 0.935
Response to organic substance 6.65 1.63 0.029 0.932
Sulfur amino acid biosynthetic process 0.91 10.69 0.031 0.937
Cyclic nucleotide metabolic process 1.21 5.63 0.033 0.941
Detection of mechanical stimulus 0.91 10.03 0.035 0.941
Negative regulation of catalytic activity 3.32 2.12 0.035 0.933
Cellular response to hormone stimulus 2.11 2.81 0.038 0.941
Regulation of gene-specific transcription 2.11 2.79 0.039 0.939
RNA splicing 3.32 2.07 0.040 0.936
Negative regulation of specific transcription from
RNA polymerase II promoter
1.21 5.22 0.041 0.930
Response to vitamin A 1.21 5.09 0.043 0.934
genes were significantly overrepresented, including some major cellular regulators such as
Myc or Death-associated protein kinase 1 (Dapk1). As an epigenetic ’predisposition’ toward
apoptotic processes that results from the procedure of cell line generation could be a reason
for the variable performance of CHO production cell lines, the network of differentially
methylated apoptotic genes was analyzed more closely (Section B.4.6).
Upon puromycin treatment 1,140 genes became hypomethylated in both the good and bad
producing CHO-XL99 clones. These genes were related to the functional groups of ’phosphate
metabolism/phosphorylation’, ’calcium ion transport’, ’chromatin modification’, ’signaling’
and ’cell death’ (Tab. B.4). As puromycin treatment induces cell death in those cells that
do not carry the resistance gene (anymore) or maybe integrated the gene at a silent locus
within the genome, apoptotic processes could be expected. The occurrence of genes related to
the processes phosphorylation, calcium signaling and chromatin modification might be an
indication for growth and protein production within those cells that are resistant to puromycin.
Fewer genes were found to be uniquely differentially methylated in the good producer upon
puromycin treatment in comparison to the bad producing clone. However, both groups com-
prised the functional categories ’gene expression’ and ’signaling’. Differentially methylated
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genes in the bad producer furthermore belonged to the categories ’metabolism’, ’macro-
molecule biosynthesis’, ’transport’ and ’exocytosis’ (data not shown).
Table B.3.: Gene Ontology analysis of genes associated with differentially methylated CpG islands in
replicate cultures of the bad producing CHO-XL99 cell line without selection pressure.
GO term (category ’biological process’) % Fold enrichment p value Benjamini p value
Actin filament-based process 3.61 2.74 0.003 0.988
Cell death 7.22 1.84 0.004 0.951
Death 7.22 1.83 0.004 0.885
Actin cytoskeleton organization 3.33 2.70 0.005 0.858
Response to oxygen levels 2.50 3.25 0.007 0.819
Auditory receptor cell development 0.83 21.80 0.008 0.813
Ubiquitin-dependent protein catabolic process 3.33 2.52 0.008 0.800
Programmed cell death 6.11 1.83 0.009 0.789
Triglyceride biosynthetic process 0.83 16.95 0.013 0.805
Apoptosis 5.83 1.77 0.015 0.812
Phospholipid biosynthetic process 1.94 3.49 0.015 0.792
Regulation of RNA metabolic process 13.61 1.37 0.017 0.796
Regulation of transcription, DNA-dependent 13.33 1.38 0.018 0.775
Response to protein stimulus 1.94 3.33 0.019 0.768
Neutral lipid biosynthetic process 0.83 12.71 0.022 0.795
Acylglycerol biosynthetic process 0.83 12.71 0.022 0.795
Cytoskeleton organization 4.44 1.87 0.025 0.819
Glycerol ether biosynthetic process 0.83 11.74 0.026 0.817
Negative regulation of molecular function 3.61 1.98 0.032 0.846
Phospholipid metabolic process 2.50 2.41 0.034 0.850
Organophosphate metabolic process 2.50 2.29 0.043 0.875
Response to hypoxia 1.94 2.66 0.048 0.882
Regulation of transcription from rna polymerase ii
promoter
6.11 1.54 0.048 0.875
B.4.6. Differential methylation of apoptotic networks in bad producing
clones
Gene Ontology analyses showed a significant overrepresentation of cell death-related genes in
the bad producer without application of selection pressure. As an epigenetic ’predisposition’
toward unfavorable cellular processes resulting from the procedure of cell line generation
or due to differences in culture handling was previously suspected to be responsible for the
variable performance of CHO production cell lines (Le et al. 2012), the significant presence of
differential methylation of genes relevant for apoptotic processes was analyzed more closely.
An analysis using the STRING database (Szklarczyk et al. 2015) showed two clusters of
associated gene-products with known or predicted interactions. The first cluster comprised
the proteins Inositol 1,4,5-trisphosphate receptor type 1 (ITPR1) and Rho guanine nucleotide
exchange factor 16 and 17 (ARHGEF16 and ARHGEF17) that interact with Rho-related GTP-
binding protein RhoB (RHOB) to mediate apoptosis in response to DNA damage (Srougi
and Burridge 2011). The second cluster of associated proteins encoded by differentially
193
Appendix B. Supplementary material
Table B.4.: Gene Ontology analysis of genes affected by puromycin induced differential methylation
of associated CpG islands.
GO term (category ’biological process’) % Fold enrichment p value Benjamini p value
Di-, tri-valent inorganic cation transport 2.41 2.43 0.000 0.425
Phosphate metabolic process 8.26 1.51 0.000 0.265
Phosphorylation 6.69 1.49 0.001 0.623
Calcium ion transport 1.88 2.36 0.002 0.606
Chromatin modification 2.93 1.90 0.002 0.568
Regulation of small GTPase mediated signal trans-
duction
2.72 1.92 0.002 0.616
Protein amino acid phosphorylation 5.65 1.51 0.003 0.616
Cell death 5.96 1.48 0.003 0.589
Death 5.96 1.46 0.004 0.612
Embryonic morphogenesis 3.03 1.76 0.004 0.652
Ephrin receptor signaling pathway 0.42 10.63 0.005 0.649
Proline biosynthetic process 0.42 10.63 0.005 0.649
Positive regulation of apoptosis 3.87 1.60 0.005 0.683
Cellular amino acid biosynthetic process 0.94 3.28 0.005 0.659
Positive regulation of programmed cell death 3.87 1.59 0.006 0.651
Positive regulation of cell death 3.87 1.58 0.007 0.657
Programmed cell death 5.02 1.46 0.008 0.709
Nitrogen compound biosynthetic process 3.03 1.66 0.009 0.721
Apoptosis 4.92 1.45 0.010 0.729
methylated genes comprised cellular key regulators such as MYC, Tumor protein p73 (TP73)
and Caspase-7 (CASP7) as well as 5 additional proteins. Strikingly, all of these proteins
interact with hypoxia inducible factors within the cellular response to low oxygen levels. In
hypoxic conditions Hypoxia-inducible factor 1 (HIF1) inhibits MYC to induce cell-cycle
arrest (Dang et al. 2008). P73 not only controls proapoptotic genes, but was shown to be
involved in the response to hypoxic conditions by promoting ubiquitin-dependent degradation
of Hypoxia-inducible factor 1-alpha (Amelio et al. 2015). CASP7 was shown to be induced
by Hypoxia-inducible factor 2-alpha in response to UV-induced apoptosis (Turchi et al. 2008).
In the bad producer (without selection pressure) all genes encoding these proteins (except for
Proteasome activator complex subunit 3 (Psme3) and Myc) were hypomethylated compared
to the XL99 host. For most of them, differential methylation was even detected at consec-
utive loci (e.g CpG islands 1, 2 and 3 of Casp7). When selection pressure by puromycin
supplementation was applied, differential methylation of Myc, Tp73, Ddx41, Ube4b and
Ddit4 increased in the bad producer. For example, Ubeb4b became hypomethylated at one
additional CpG island (two differentially methylated CGIs without selection pressure, three
CGIs under puromycin selection) and the relative methylation of the Tp73 CGI decreased
from 0.34 to 0.02. Interestingly, differential methylation of Myc reversed from a mean relative
methylation value of 4 to a mean value of 0.2.
None of the genes encoding the cell death related proteins comprised within the potentially
hypoxia-responsive protein cluster were significantly differentially methylated in the good
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producer without selection pressure. When selection pressure was applied, this clone also
exhibited hypomethylation of Myc, Tp73, Ube4b and Ddit4 with fold methylation changes
comparable to the bad producer (e.g. a fold methylation change of 0.02 was detected for the
Tp73 CGI in both clones.)
B.4.7. Discussion: Possible maintenance of detrimental
hypoxia-induced epigenetic marks through cell line generation
This experiment showed that the bad producing CHO-XL99 clone possessed several differ-
entially methylated CpG islands associated with hypoxia-inducible, apoptosis-related genes
even when kept without selection pressure and, most importantly, while maintaining high
viabilities. This finding supports the hypothesis that the process of cell line generation could
have an effect on DNA methylation without immediately resulting in a specific phenotype
and, thereby, bearing the chance of selecting unfavorable clonal populations. In this scenario
only the addition of additional cellular stress would cause the cells to switch into unwanted
phenotypes.
The cluster of apoptotic genes found to be associated with differentially methylated CpG
islands was closely related to the cellular reaction to hypoxic conditions. Strikingly, the
dissolved oxygen concentration represents a critical parameter in production processes. Distur-
bances of this parameter can lead to significantly impaired growth and productivity. Therefore,
oxygen transport is a major limitation in large-scale mammalian cell culture (Miller, Wilke,
and Blanch 1987). As it is well accepted that environmental factors interact with the human
epigenome to adjust gene expression to specific conditions, an influence of oxygen and oxida-
tive processes on epigenetic events is, based on the current knowledge, reasonable to assume.
Demethylation of DNA is in mammals linked to oxidative processes by the involvement of
the ten eleven translocation (TET) dioxygenases, which convert 5-methylcytosine (5mC)
to 5-hydroxymethylcytosine (5hmC) (Tahiliani et al. 2009). Furthermore, histone lysine
demethylation is mediated by oxygen-dependent enzymes, too. Lysine Specific Demethylase
1 (LSD1) catalyzes oxidation of the methylamine group to the imine state, thereby allowing
hydrolysis and release of the former methyl carbon atom as formaldehyde (Shi et al. 2004;
Jeltsch 2013). Another group of protein lysine demethylases harbors a Jumonji C (JmjC)
domain and uses, similar to TET enzymes, alpha-ketoglutarate as a co-substrate in an oxida-
tion reaction to remove all methylation states (Donohoe and Bultman 2012; Tsukada et al.
2006; Hou and Yu 2010). The removal of epigenetic marks therefore requires molecular
oxygen as a highly reactive reaction partner and the oxygenases involved in this reactions
need to be optimized for a certain oxygen pressure (Jeltsch 2013). Thus, setting up reversible
epigenetic patterns might depend on proper environmental oxygen levels. Adding to this
hypothesis is recent research that shows a major effect of hypoxia on transcription, maturation
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and function of a specific group of miRNAs (termed âC˜hypoxamirsâC™; Nallamshetty,
Chan, and Loscalzo 2013). Furthermore, hypoxia inducible factors (HIFs) are known to
regulate energy metabolism in hypoxic conditions by triggering a switch from oxidative
phosphorylation to anaerobic glycolysis and inhibit the conversion of pyruvate to acetyl-coA,
a process that has already been described in the context of the butyrate experiments in tis
thesis and that is linked to epigenetic processes on several levels (Koh and Powis 2012; Goda
and Kanai 2012).
However, it has to be kept in mind that this experiment was performed using a polyclonal
cell population and differential DNA methylation as detected by the CHO-specific CpG
island microarray is therefore difficult to assess, especially regarding the variability of DNA
methylation that was reported in the main part of this thesis.
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Listing B.1: R script for import of CHO CpG island microarray data into limma and generation of
quality plots.
# I n s t a l l a t i o n
s o u r c e ( " h t t p : / / www. b i o c o n d u t o r . o rg / b i o c L i t e . R" )
b i o c L i t e ( )
b i o c L i t e ( " limma " )
b i o c L i t e ( " s t a t m o d " )
# S e t working d i r e c t o r y
se twd ( "C : \ \ Use r s \ \ . . . " )
# Load package
l i b r a r y ( limma )
# I m p o r t t a r g e t t x t− f i l e ( Columns : ’ FileName ’ , ’Cy3 ’ , ’Cy5 ’ ,
’Name ’ ( o f sample ) )
t a r g e t s <− r e a d T a r g e t s ( " T a r g e t s . t x t " , row . names ="Name " )
# I m p o r t m i c r o a r r a y d a t a f i l e s
RG <− r e a d . maimages ( t a r g e t s , s o u r c e =" a g i l e n t " , columns = l i s t (G =
" gMedianS igna l " , Gb = " gBGMedianSignal " , R = " r M e d i a n S i g n a l " , Rb =
" rBGMedianSignal " ) , a n n o t a t i o n = c ( " Row " , " Col " , " FeatureNum " ,
" Con t ro lType " , " ProbeName " , " genes " ) , names = t a r g e t s $ N a m e )
# G e n e r a t i o n o f b o x p l o t s t h a t a r e saved as PDF f i l e s i n working
d i r e c t o r y
pdf ( " GBackground . pdf " )
b o x p l o t ( d a t a . f rame ( log2 (RG$Gb ) ) , main =" Green background " )
pdf ( " RBackground . pdf " )
b o x p l o t ( d a t a . f rame ( log2 (RG$Rb ) ) , main ="Red background " )
pdf ( " GSigna l . pdf " )
b o x p l o t ( d a t a . f rame ( log2 (RG$G ) ) , main =" Green s i g n a l " )
pdf ( " RSigna l . pdf " )
b o x p l o t ( d a t a . f rame ( log2 (RG$R ) ) , main ="Red s i g n a l " )
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# G e n e r a t i o n o f i n t e n s i t y p l o t s f o r each a r r a y
f o r ( i i n 1 : 8 ) {
name . Gb <− p a s t e ( i , " imageplo tGb . pdf " , sep = " " )
pdf ( name . Gb )
i m a g e p l o t ( l og 2 (RG$Gb [ , i ] ) , RG$pr in t e r , main =
p a s t e ( " I m a g e p l o t Gb Array " , i ) )
name .G <− p a s t e ( i , " imagep lo tG . pdf " , sep = " " )
pdf ( name .G)
i m a g e p l o t ( l og 2 (RG$G[ , i ] ) , RG$pr in t e r , main =
p a s t e ( " I m a g e p l o t G Array " , i ) )
name . Rb <− p a s t e ( i , " imagep lo tRb . pdf " , sep = " " )
pdf ( name . Rb )
i m a g e p l o t ( l og 2 (RG$Rb [ , i ] ) , RG$pr in t e r , main =
p a s t e ( " I m a g e p l o t Gb Array " , i ) )
name . R <− p a s t e ( i , " imagep lo tR . pdf " , sep = " " )
pdf ( name . R)
i m a g e p l o t ( l og 2 (RG$R[ , i ] ) , RG$pr in t e r , main =
p a s t e ( " I m a g e p l o t R Array " , i ) )
}
# G e n e r a t i o n o f one d e n s i t y p l o t f o r a l l a r r a y s
MA <− n o r m a l i z e W i t h i n A r r a y s (RG, method =" none " , bc . method =" none " )
pdf ( " P l o t D e n s i t i e s M A . pdf " )
p l o t D e n s i t i e s (MA)
Listing B.2: R script for import of CHO gene expression microarray data into limma as well as
normalization and calculation of statistics for the comparison of data sets of interest.
# I n s t a l l a t i o n
s o u r c e ( " h t t p : / / www. b i o c o n d u t o r . o rg / b i o c L i t e . R" )
b i o c L i t e ( )
b i o c L i t e ( " limma " )
b i o c L i t e ( " s t a t m o d " )
# S e t working d i r e c t o r y
se twd ( "C : \ \ Use r s \ \ . . . " )
# Load package
l i b r a r y ( limma )
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# I m p o r t t a r g e t t x t− f i l e ( Columns : ’ SampleNumber ’ , ’ FileName ’ ,
’ C o n d i t i o n ’ )
t a r g e t s <− r e a d T a r g e t s ( " t a r g e t s . t x t " )
x <− r e a d . maimages ( t a r g e t s , s o u r c e =" a g i l e n t " , g r e e n . on ly =TRUE)
# Normal i ze w i t h i n and between a r r a y s
y <− b a c k g r o u n d C o r r e c t ( x , method =" normexp " , o f f s e t =16)
y <− n o r m a l i z e B e t w e e n A r r a y s ( y , method =" q u a n t i l e " )
y . ave <− a v e r e p s ( y , ID=y$genes$ProbeName )
# B u i l d a d e s i g n ma t r i x , pe r fo rm l i n e a r model ing
f <− f a c t o r ( t a r g e t s $ C o n d i t i o n , l e v e l s = u n i q u e ( t a r g e t s $ C o n d i t i o n ) )
d e s i g n <− model . m a t r i x (~0 + f )
co lnames ( d e s i g n ) <− l e v e l s ( f )
f i t <− l m F i t ( y . ave , d e s i g n )
# Compare d a t a s e t s o f i n t e r e s t , e . g . d a t a o f t i m e p o i n t s ’0 h ’ and ’6h ’
c o n t r a s t . m a t r i x <− m a k e C o n t r a s t s ( " zero−s i x " , l e v e l s = d e s i g n )
f i t 2 <− c o n t r a s t s . f i t ( f i t , c o n t r a s t . m a t r i x )
f i t 2 <− eBayes ( f i t 2 )
# G e n e r a t e t x t f i l e c o n t a i n i n g s t a t i s t i c s
t o p T a b l e ( f i t 2 , a d j u s t ="BH" , c o e f =" zero−s i x " , g e n e l i s t =y . ave$genes )
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Figure B.13.: Agarose gel for integrity control of genomic DNA extracted from reference and butyrate
treated CHO DP-12 cells for whole-genome bisulfite sequencing.
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Figure B.14.: Quality of libraries for whole genome bisulfite sequencing was checked using High
Sensitivity DNA Chips on a Bioanalyzer. At first (A), all samples showed an additional
peak at about 85 bp that disappeared after a second cleanup procedure with AMPURE
beads (B).
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Figure B.15.: Evaluation of an effect of shearing on library generation from bisulfite treated DNA. A
Library generated from native bisulfite-treated DNA. B Library generated from sheared
bisulfite-treated DNA.
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Figure B.16.: Comparison of mapping results for exemplary CpG islands obtained with the MethPipe
mapping tool (Song et al. 2013) and BS-Seeker2 (Guo et al. 2013). Red boxes mark the
CpG island regions that were analyzed regarding their methylation level. A CpG island
of Lanosterol 14-alpha demethylase (Cyp51a1) gene. B CpG island of Protein HEXIM1
(Hexim1) gene.
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Figure B.17.: Methylation data tracks were loaded into the GenDBE genome browser (Rupp et al.
2014) to check for consistency of whole-genome bisulfite sequencing results between the
sampling points. Exons of the exemplary Dnah14 gene are indicated by red rectangles.
Methylation levels for each CpG are represented by green bars.
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Figure B.18.: Denaturing agarose gels for control of integrity of RNAs used for gene expression
microarray experiments. RNA extraction was performed separately for replicate cultures
at time points 0h (reference) and 6h to 36h post butyrate addition. Indicated are the 28S
and 18S rRNA bands and also the position of RNAs smaller than 200 bp (’sRNA’) that
are additionally captured by the preparation columns that were used.
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Figure B.19.: Artificial images of spatial signal distributions of gene expression microarrays. Images
were generated by the Feature Extraction software. Sampling points of hybridized RNAs
are indicated as well as internal slide numbers.
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Figure B.20.: Boxplots of signal intensities for gene expression microarrays before and after back-
ground correction and quantile normalization for 4 reference (’0 h’) and each 3 microar-
rays for time points 6, 12, 24 and 36 hours. Signal intensities (log2E) were corrected for
the background signals (log2Eb) and normalized (see R script in B.2).
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Figure B.21.: Agarose gels for the control of sheared DNA samples for CpG island microarray analysis.
Per lane, 300 ng of DNA were separated to control if the samples exhibited the desired
fragment size of about 500 bp.
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Figure B.22.: Examplary display of quality plots from CHO CpG island microarray data. A Imageplots
were generated to control the spatial distribution of signals on the slide. B Densities of
red and green signals were plotted and expected to show a generally bimodal distribution,
which corresponds to either unmethylated or methylated CpG islands. C Red and green
signals and background signals were controlled in order to exclude main signals that
were too low or background signals that were too high to allow for a discrimination
between foreground and background.
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Figure B.23.: Display of SNP-corrected CHO K1 scaffolds JH000001 to JH000009 (Wippermann et
al. 2015). CHO DP-12 DNA methylation levels for 1 kb windows were plotted along
the scaffolds and color-coded according to the legend. Also shown are exons and CpG
islands (CGI) in black. Regions identified as CHO DP-12 PMDs are marked by green
bars.
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Figure B.24.: Percentages of relatively hypomethylated and relatively hypermethylated DMRs with
≥ 1 significantly differentially methylated CpG 6, 12, 24 and 36 hours after butyrate
addition, which were assigned to the genomic features upstream region, 5’ and 3’ end,
intergenic and intragenic region (Wippermann et al. 2016).
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Figure B.25.: Screenshots of relatively hypomethylated DMRs as visualized in the GenDBE genome
browser (Rupp et al. 2014). All regions are represented in the same scale.
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Figure B.26.: Screenshots of relatively hypermethylated DMRs as visualized in the GenDBE genome
browser (Rupp et al. 2014). All regions are represented in the same scale.
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Figure B.27.: Visualisation of gene expression time course after butyrate addition for KEGG pathway
Glycolysis (Kanehisa and Goto 2000). Pathway analysis and visualization of gene
expression changes based on M-values was performed using pathview (Luo and Brouwer
2013). Gene expression changes are color-coded according to the legend.
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Figure B.28.: Visualisation of gene expression time course after butyrate addition for KEGG pathway
RNA Transport (Kanehisa and Goto 2000). Pathway analysis and visualization of gene
expression changes based on M-values was performed using pathview (Luo and Brouwer
2013). Gene expression changes are color-coded according to the legend.
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Figure B.29.: Visualisation of gene expression time course after butyrate addition for KEGG pathway
Ribosome (Kanehisa and Goto 2000). Pathway analysis and visualization of gene
expression changes based on M-values was performed using pathview (Luo and Brouwer
2013). Gene expression changes are color-coded according to the legend.
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Figure B.30.: Visualisation of gene expression time course after butyrate addition for KEGG pathway
Regulation of Actin Cytoskeleton (Kanehisa and Goto 2000). Pathway analysis and
visualization of gene expression changes based on M-values was performed using
pathview (Luo and Brouwer 2013). Gene expression changes are color-coded according
to the legend.
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Figure B.31.: Visualisation of gene expression time course after butyrate addition for KEGG pathway
Regulation of Wnt Signaling (Kanehisa and Goto 2000). Pathway analysis and visualiza-
tion of gene expression changes based on M-values was performed using pathview (Luo
and Brouwer 2013). Gene expression changes are color-coded according to the legend.
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Figure B.32.: Visualisation of gene expression time course after butyrate addition for KEGG pathway
MAPK Signaling (Kanehisa and Goto 2000). Pathway analysis and visualization of gene
expression changes based on M-values was performed using pathview (Luo and Brouwer
2013). Gene expression changes are color-coded according to the legend.
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Figure B.33.: Visualisation of gene expression time course after butyrate addition for KEGG pathway
Regulation of Calcium Signaling (Kanehisa and Goto 2000). Pathway analysis and
visualization of gene expression changes based on M-values was performed using
pathview (Luo and Brouwer 2013). Gene expression changes are color-coded according
to the legend.
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Figure B.34.: Visualisation of gene expression time course after butyrate addition for KEGG pathway
Regulation of p53 Signaling (Kanehisa and Goto 2000). Pathway analysis and visualiza-
tion of gene expression changes based on M-values was performed using pathview (Luo
and Brouwer 2013). Gene expression changes are color-coded according to the legend.
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Figure B.35.: Visualisation of gene expression time course after butyrate addition for KEGG pathway
Purine Metabolism (Kanehisa and Goto 2000). Pathway analysis and visualization of
gene expression changes based on M-values was performed using pathview (Luo and
Brouwer 2013). Gene expression changes are color-coded according to the legend.
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Figure B.36.: Visualisation of gene expression time course after butyrate addition for KEGG pathway
Pyrimidine Metabolism (Kanehisa and Goto 2000). Pathway analysis and visualization
of gene expression changes based on M-values was performed using pathview (Luo and
Brouwer 2013). Gene expression changes are color-coded according to the legend.
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Figure B.37.: Cell growth and IgG production as well as glucose and lactate concentrations of butyrate
treated and control CHO DP-12 cell cultures (Wippermann 2012, Wippermann et al.
2013). Shown are the mean values of each four replicate cultures, error bars represent
standard deviations. A Mean viable cell density (continuous lines) and viability (dashed
lines). Addition of 3 mM butyrate is marked by a red vertical line, sampling points for
microarray analyses are marked by grey arrows. B Mean IgG titer (continuous lines) and
cell specific productivity (dashed lines) of butyrate and reference cultures. C Glucose
(Glc) and lactate (Lac) concentrations.
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Figure B.38.: MA plots for the indicated sampling points (Wippermann 2012, Wippermann et al. 2013).
M-values below the threshold of -1.0 (red) represent de novo methylated regions upon
butyrate treatment. M-values above the threshold of 1.0 (green) represent hypomethy-
lated regions upon butyrate treatment. The blue lines mark for each time point the 95 %
and 99 % confidence intervals of all observed M-values. The yellow line represents the
LOWESS fit.
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Figure B.39.: Exemplary westernblot for measurement of DNMT3A expression in reference and
butyrate treated CHO DP-12 cell cultures. Expression strength was normalized to
whole-protein abundance as determined by coomassie staining of the membranes. A
PageRuler™ Prestained Protein Ladder was used as a size standard.
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Table B.5.: Complete GO annotation for highly expressed CHO DP-12 PMD genes (1261) with
Benjamini p values ≤ 0.05 (Wippermann et al. 2015).
GO term (category ’biological process’) % Fold enrichment p value Benjamini p value
Translation 11.7 5.78 4.54E-76 1.41E-72
Translational elongation 6.1 9.92 7.25E-64 1.13E-60
RNA processing 9.3 2.78 6.47E-25 6.72E-22
Ribosome biogenesis 4 5.33 1.14E-23 8.88E-21
Ribonucleoprotein complex biogenesis 4.8 4.34 6.73E-23 4.19E-20
Nuclear mRNA splicing, via spliceosome 4 4.25 9.30E-19 4.83E-16
RNA splicing, via transesterification reactions 4 4.25 9.30E-19 4.83E-16
RNA splicing, via transesterification reactions with
bulged adenosine as nucleophile
4 4.25 9.30E-19 4.83E-16
rRNA processing 2.9 5.23 2.61E-17 1.16E-14
RNA splicing 5.4 3.11 2.84E-17 1.11E-14
rRNA metabolic process 2.9 5.01 1.31E-16 3.84E-14
mRNA processing 5.6 2.84 2.09E-15 6.57E-13
Oxidative phosphorylation 2.9 4.78 2.32E-15 6.60E-13
ncRNA metabolic process 4.4 3.17 1.47E-14 3.83E-12
Generation of precursor metabolites and energy 5.2 2.74 7.95E-14 1.91E-11
mRNA metabolic process 5.8 2.57 1.12E-13 2.50E-11
ncRNA processing 3.7 3.27 7.37E-13 1.53E-10
Energy coupled proton transport, down electrochemical
gradient
1.4 5.85 1.61E-09 3.14E-07
ATP synthesis coupled proton transport 1.4 5.85 1.61E-09 3.14E-07
Ribosomal small subunit biogenesis 0.8 11.83 4.30E-09 7.88E-07
Mitotic cell cycle 4.9 2.18 8.82E-09 1.53E-06
Ribosomal large subunit biogenesis 0.7 11.71 4.62E-08 7.57E-06
Cellular respiration 2.1 3.49 4.84E-08 7.55E-06
Ion transmembrane transport 1.4 4.78 6.09E-08 9.04E-06
Negative regulation of protein modification process 2.3 3.17 6.51E-08 9.22E-06
Translational initiation 1.3 4.91 1.00E-07 1.36E-05
Mitochondrial electron transport, NADH to ubiquinone 1.3 4.96 2.36E-07 3.06E-05
Intracellular transport 7 1.74 2.92E-07 3.63E-05
Electron transport chain 2.1 3.08 3.68E-07 4.41E-05
Proton transport 1.5 4.05 4.10E-07 4.74E-05
Cell cycle process 6.2 1.8 4.69E-07 5.22E-05
Positive regulation of ubiquitin-protein ligase activity
during mitotic cell cycle
1.6 3.83 5.05E-07 5.42E-05
Protein folding 2.8 2.57 5.14E-07 5.34E-05
ATP synthesis coupled electron transport 1.4 4.18 5.49E-07 5.51E-05
Mitochondrial ATP synthesis coupled electron transport 1.4 4.18 5.49E-07 5.51E-05
Proteasomal protein catabolic process 2 3.19 5.61E-07 5.46E-05
Proteasomal ubiquitin-dependent protein catabolic pro-
cess
2 3.19 5.61E-07 5.46E-05
Hydrogen transport 1.5 3.92 6.99E-07 6.60E-05
Negative regulation of cellular protein metabolic pro-
cess
2.8 2.53 7.73E-07 7.08E-05
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Positive regulation of ubiquitin-protein ligase activity 1.6 3.72 8.25E-07 7.34E-05
Cell cycle 7.8 1.64 9.03E-07 7.81E-05
Respiratory electron transport chain 1.5 3.86 9.03E-07 7.61E-05
Macromolecular complex assembly 6.9 1.7 9.64E-07 7.90E-05
Positive regulation of protein ubiquitination 1.7 3.41 9.79E-07 7.82E-05
Regulation of ubiquitin-protein ligase activity during
mitotic cell cycle
1.6 3.66 1.05E-06 8.15E-05
Anaphase-promoting complex-dependent proteasomal
ubiquitin-dependent protein catabolic process
1.5 3.8 1.16E-06 8.82E-05
Negative regulation of ubiquitin-protein ligase activity
during mitotic cell cycle
1.5 3.8 1.16E-06 8.82E-05
Positive regulation of ligase activity 1.6 3.56 1.66E-06 1.23E-04
Negative regulation of ubiquitin-protein ligase activity 1.5 3.69 1.88E-06 1.36E-04
Negative regulation of ligase activity 1.5 3.69 1.88E-06 1.36E-04
Negative regulation of protein metabolic process 2.8 2.43 1.91E-06 1.35E-04
Cellular macromolecular complex assembly 4 2.05 1.99E-06 1.38E-04
Energy derivation by oxidation of organic compounds 2.3 2.62 4.00E-06 2.71E-04
Regulation of ubiquitin-protein ligase activity 1.6 3.34 4.83E-06 3.20E-04
Purine ribonucleotide biosynthetic process 2 2.78 7.44E-06 4.83E-04
Negative regulation of protein ubiquitination 1.5 3.34 8.73E-06 5.55E-04
Regulation of ligase activity 1.6 3.21 8.74E-06 5.45E-04
Macromolecular complex subunit organization 6.9 1.59 1.35E-05 8.22E-04
Purine ribonucleoside triphosphate biosynthetic process 1.7 2.92 1.35E-05 8.09E-04
Purine nucleoside triphosphate biosynthetic process 1.7 2.89 1.59E-05 9.36E-04
Ribonucleoside triphosphate biosynthetic process 1.7 2.89 1.59E-05 9.36E-04
Protein targeting 2.9 2.18 1.74E-05 0.001
Regulation of protein ubiquitination 1.7 2.86 1.87E-05 0.001
Ribonucleotide biosynthetic process 2 2.62 2.08E-05 0.001
Cellular macromolecular complex subunit organization 4 1.86 2.36E-05 0.001
Nucleoside triphosphate biosynthetic process 1.7 2.81 2.57E-05 0.001
Oxidation reduction 6.3 1.61 2.59E-05 0.001
Protein targeting to mitochondrion 1 4.59 2.86E-05 0.001
Protein localization in mitochondrion 1 4.59 2.86E-05 0.001
ATP biosynthetic process 1.6 2.92 3.63E-05 0.002
Purine ribonucleotide metabolic process 2.1 2.45 4.53E-05 0.002
DNA metabolic process 5.2 1.67 4.76E-05 0.002
Mitochondrial transport 1.3 3.2 5.14E-05 0.002
Purine ribonucleoside triphosphate metabolic process 1.8 2.56 7.16E-05 0.003
Ribonucleoside triphosphate metabolic process 1.8 2.54 8.18E-05 0.004
NADH metabolic process 0.5 9.76 1.22E-04 0.006
ATP metabolic process 1.7 2.6 1.25E-04 0.006
Ribonucleotide metabolic process 2.1 2.3 1.31E-04 0.006
Purine nucleoside triphosphate metabolic process 1.8 2.45 1.36E-04 0.006
Cell cycle phase 4.3 1.7 1.54E-04 0.007
Intracellular protein transport 4 1.74 1.55E-04 0.007
Protein transport 6.9 1.49 1.70E-04 0.007
Ribonucleoprotein complex assembly 1.3 3.02 1.90E-04 0.008
Cofactor metabolic process 2.5 2.07 1.93E-04 0.008
Establishment of protein localization 6.9 1.47 2.33E-04 0.009
Cellular amide metabolic process 1.1 3.25 2.52E-04 0.01
Regulation of cellular protein metabolic process 4.7 1.62 2.57E-04 0.01
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Response to unfolded protein 1.3 2.93 2.65E-04 0.01
Purine nucleotide biosynthetic process 2 2.2 3.71E-04 0.014
Nucleoside triphosphate metabolic process 1.8 2.28 3.90E-04 0.015
Cellular protein localization 4.1 1.65 4.34E-04 0.016
Protein complex assembly 4.8 1.57 4.44E-04 0.017
Protein complex biogenesis 4.8 1.57 4.44E-04 0.017
M phase of mitotic cell cycle 2.6 1.92 4.70E-04 0.017
Ribosome assembly 0.5 7.8 4.81E-04 0.017
Cellular macromolecule localization 4.1 1.63 5.13E-04 0.018
Nitrogen compound biosynthetic process 3.4 1.72 5.99E-04 0.021
Nicotinamide metabolic process 0.9 3.58 6.90E-04 0.024
Nicotinamide nucleotide metabolic process 0.9 3.58 6.90E-04 0.024
protein localization in organelle 1.9 2.14 7.39E-04 0.026
M phase 3.4 1.7 7.65E-04 0.026
Nucleobase, nucleoside and nucleotide biosynthetic
process
2.3 1.95 8.11E-04 0.027
Nucleobase, nucleoside, nucleotide and nucleic acid
biosynthetic process
2.3 1.95 8.11E-04 0.027
Negative regulation of macromolecule metabolic pro-
cess
6.4 1.44 8.27E-04 0.028
Alkaloid metabolic process 0.9 3.49 8.51E-04 0.028
Protein localization 7.5 1.39 9.47E-04 0.031
Purine nucleotide metabolic process 2.2 1.96 9.87E-04 0.032
Table B.6.: Complete GO annotation for weakly or not expressed CHO DP-12 PMD-genes (2360)
with Benjamini p values ≤ 0.05 (Wippermann et al. 2015).
GO term (category ’biological process’) % Fold enrichment p value Benjamini p value
Cell adhesion 6.30 1.63 6.01E-10 1.23E-06
Synaptic transmission 3.10 1.85 2.02E-07 2.77E-04
Transmission of nerve impulse 3.40 1.78 2.25E-07 2.31E-04
Behavior 4.20 1.60 1.70E-06 0.001
Elevation of cytosolic calcium ion concentration 1.40 2.37 2.23E-06 0.002
Calcium ion homeostasis 2.10 2.00 2.45E-06 0.001
Neurological system process 9.00 1.34 2.48E-06 0.001
Cellular calcium ion homeostasis 2.00 2.01 2.61E-06 0.001
Cellular di-, tri-valent inorganic cation homeostasis 2.30 1.86 5.97E-06 0.002
Cellular metal ion homeostasis 2.10 1.92 8.43E-06 0.003
Response to wounding 4.50 1.52 8.63E-06 0.003
Cytosolic calcium ion homeostasis 1.40 2.21 1.18E-05 0.004
Cellular chemical homeostasis 3.40 1.62 1.27E-05 0.004
Cellular ion homeostasis 3.40 1.62 1.28E-05 0.003
Metal ion homeostasis 2.10 1.87 1.38E-05 0.004
Di-, tri-valent inorganic cation homeostasis 2.40 1.80 1.39E-05 0.003
Cell-cell signaling 4.80 1.45 3.90E-05 0.009
Cellular cation homeostasis 2.40 1.72 4.26E-05 0.009
Regulation of system process 2.80 1.64 5.03E-05 0.01
Positive regulation of hydrolase activity 1.80 1.84 8.70E-05 0.017
Ion homeostasis 3.40 1.52 1.03E-04 0.019
Cell surface receptor linked signal transduction 12.50 1.22 1.13E-04 0.02
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Regulation of G-protein coupled receptor protein signal-
ing pathway
0.80 2.71 1.53E-04 0.026
Chemical homeostasis 4.10 1.44 1.88E-04 0.03
Regulation of phospholipase activity 0.90 2.38 1.88E-04 0.029
Activation of phospholipase C activity by G-protein
coupled receptor protein signaling pathway coupled to
IP3 second messenger
0.80 2.66 2.00E-04 0.03
Regulation of lipase activity 1.10 2.20 2.22E-04 0.032
Embryonic skeletal system development 1.00 2.29 2.32E-04 0.032
G-protein coupled receptor protein signaling pathway 7.90 1.27 2.88E-04 0.039
Locomotory behavior 2.40 1.60 3.52E-04 0.046
Positive regulation of phospholipase activity 0.90 2.34 3.56E-04 0.045
Metal ion transport 3.70 1.44 4.10E-04 0.05
Table B.7.: Motif enrichment in DMRs 6, 12, 24 and 36 hours after butyrate addition identified by
DREME (Bailey 2011). A = Adenine, T = Thymine, C = Cytosine, G = Guanine, N "Any
base" = ACGT, V "Not T" = ACG, H "Not G" = ACT, D "Not C" = AGT, B "Not A" = CGT,
M "Amino" = AC, R "Purine" = AG, W "Weak" = AT, S "Strong" = CG ,Y "Pyrimidine" =
CT, K "Keto" = GT, U = T. Significantly enriched DNA motifs are displayed separately for
upstream, 5’, intragene and 3’ regions. Also indicated are the corresponding p values.
Sample Upstream region 5’ Intragene 3’
Motif (5’→3’) p value Motif (5’→3’) p value Motif (5’→3’) p value Motif (5’→3’) p value
6 h CGD 3.7E-338 CGD 6.60E-48 CGD 5.70E-107 CGB 2.10E-10
CGC 6.80E-29 CGC 1.20E-16 CGC 2.40E-12
CCWSCC 1.90E-23 GGSC 9.00E-07 CCCWGSAG 4.80E-11
GRGGGS 1.40E-15 GGTCTAYC 1.00E-06 CCTSCAG 5.00E-10
CAGGGB 1.60E-11 GGGRCC 5.30E-09
GGACAS 8.20E-11 CCTCMYC 6.00E-10
GAGKTCCC 8.70E-11 CACASMC 9.20E-09
GAGGGAGM 1.60E-09 GRGTCAC 5.90E-08
BCCCAG 1.50E-09 GGCTKCC 6.90E-08
GRGSC 2.10E-08 CATGGGGA 1.10E-07
ATWCCATC 6.30E-08 CTVCTGTC 1.40E-08
AKGAWGGG 2.20E-07 CAGGSAC 9.30E-08
ACWCCTG 2.30E-07 AGWSCCC 3.10E-07
CACAGASA 3.40E-07 GGTGSC 5.00E-07
GGAGATSA 7.40E-07
AKCCTGG 7.50E-07
ACCYACAG 1.10E-06
12 h CGD 1.6E-328 CGD 1.30E-139 CGW 1.40E-50 CGB 7.70E-10
CGC 9.50E-28 CGC 3.00E-17 CGS 5.10E-36 ATTCCWGK 1.90E-08
CHCCHCC 1.70E-16 CTGNCCC 6.10E-12
SCCAGS 1.90E-14 CMCASCC 1.80E-11
GCCYCC 1.00E-10 CCCTSCTS 1.90E-11
CCAGGR 9.80E-09 GGKGACY 9.00E-11
CTCTGRG 8.50E-08 CCWGAGAS 3.90E-10
GAGGGAYA 5.30E-07 AGGGSWC 1.50E-09
ARACCAG 1.00E-06 CCCCARG 6.20E-09
STGTCAGA 9.70E-07 GCCMCWC 1.20E-08
CAGGGK 1.10E-06 GASTCAC 4.00E-08
ATCCCTKC 1.10E-06 GCCASC 6.80E-08
BCTGCTGC 7.70E-08
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CCTSCAG 1.50E-07
CTCMYCC 4.90E-07
STGGGGA 5.80E-07
CCWGGAY 9.20E-07
AKCTSTGG 1.50E-06
24 h CGD 1.9E-312 CGD 5.10E-126 CGD 1.30E-100 CGB 1.40E-10
CGC 6.90E-26 CGC 4.00E-15 CCWGSAG 1.10E-11
GRGGGS 2.40E-16 GGAAMTCC 1.10E-06 CGCGCGC 2.40E-11
CCWGSC 4.00E-14 CGC 1.40E-09
GGAAVTCC 2.20E-09 CCCAGRGR 6.50E-09
CCCAGS 3.90E-09 RGGGMCA 9.50E-09
CTAKGAAC 7.20E-08 CCAGSYC 2.20E-08
CCHCC 7.40E-08 CMCACHC 1.80E-08
GGWGATCA 4.60E-08 GGKGAC 3.40E-08
GGASWCC 2.50E-07 GASTCAC 1.00E-07
AMTGATCC 4.20E-07 CTGCMC 6.50E-07
ACAGSTGA 4.90E-07 CTACCTAG 1.10E-06
GTACYCCA 7.30E-07 GAGCCYTA 1.50E-06 ACCCARTC
CCAAKAYC 8.10E-07
CTCTCAYC 1.40E-06
ACCCARTC 1.50E-06
36 h CGD 1.80E-298 CGD 5.10E-137 CGD 3.20E-103 CGY 8.40E-08
CGC 1.60E-24 CGC 3.90E-18 CGC 2.80E-14 GATAGASA 3.60E-07
GRGGS 5.30E-16 AGGGSYC 2.00E-12
CCCWGS 2.00E-11 CAGCTCAK 2.40E-09
CCAGGM 1.70E-10 CCTGCWG 2.00E-09
GTACTCCA 6.90E-08 CMCASAC 3.00E-09
CCTSAACA 8.30E-08 CCYASAGC 6.10E-09
CTGGATCW 9.60E-08 CCTGAGAS 1.80E-08
GGTMCAGA 1.70E-07 CCCCTYC 2.60E-08
AGATCWG 1.20E-06 SCCTGGR 6.10E-08
CTCCTSAA 1.70E-06 GRGTCAC 1.60E-07
GAGGCTSC 2.10E-07
GTRAGGGA 3.10E-07
ACCCWGC 3.20E-07
CCAGDGAC 3.20E-07
CCTGTSYC 6.50E-07
CCTGGRC 1.10E-06
GCCAKGCC 1.40E-06
CTGTGGYC 1.40E-06
Table B.8.: Motifs enriched in hypomethylated DMRs 6, 12, 24 and 36 hours after butyrate addition
identified by DREME (Bailey 2011). A = Adenine, T = Thymine, C = Cytosine, G =
Guanine, N "Any base" = ACGT, V "Not T" = ACG, H "Not G" = ACT, D "Not C" =
AGT, B "Not A" = CGT, M "Amino" = AC, R "Purine" = AG, W "Weak" = AT, S "Strong"
= CG ,Y "Pyrimidine" = CT, K "Keto" = GT, U = T. Significantly enriched DNA motifs
are displayed separately for upstream, 5’, intragene and 3’ regions. Also indicated are the
corresponding p values.
Sample Upstream region 5’ Intragene 3’
Motif (5’→3’) p value Motif (5’→3’) p value Motif (5’→3’) p value Motif (5’→3’) p value
6 h CGD 2.9e-426 CGH 1.60E-153 CGD 4.00E-132 CGH 6.50E-14
CGC 3.60E-39 CCG 8.00E-26 CGC 2.10E-12
CCWGGDC 8.80E-26 BCCAGC 2.30E-11 GGGCWSC 9.10E-12
GSTGGS 1.00E-21 CCHCC 3.40E-09 CACWGGS 2.40E-11
GCCYCY 3.60E-18 ARCCCTG 6.40E-07 CCMCMCCC 8.70E-11
CCCTGB 3.40E-14 CTGGGBC 7.40E-07 CWCCTGS 2.60E-10
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CCCCMC 1.20E-12 GCWGTGSC 2.90E-11
CCWGSC 2.10E-11 CTGARGCC 8.80E-10
TTCCTGGR 2.30E-09 CYCCAGC 2.80E-09
GCHC 2.70E-09 CAGRGYC 4.40E-09
AGGGGWC 1.00E-07 CAKCTGCA 9.10E-09
CAGACWGG 1.20E-07 CCTGRKG 4.70E-08
GATCCTR 4.70E-07 GGGACAS 2.80E-08
CCAGGW 7.70E-07 CCWGGCY 9.00E-08
GGTCYAC 8.40E-07 CAGGGS 3.80E-08
GKGTGTS 2.00E-06 CCTTGRCC 3.30E-07
RGCACCY 3.20E-07
CAGMCACA 5.10E-07
GGTGGMCW 4.90E-08
AGGAYCCC 1.20E-06
CHCTTGGA 1.10E-06
CWGCTCTC 1.70E-06
12 h CGD 5.9e-459 CGD 6.30E-184 CGH 1.40E-126 CGB 2.20E-13
CGC 1.60E-49 CGC 5.50E-17 CCG 2.40E-18 CCTCTTAG 1.10E-06
BCCAGS 2.10E-26 CTGSCY 6.20E-13 CHCAGCC 1.10E-12 GAAACTTA 1.50E-06
GGDGGB 4.00E-22 CCAGS 1.20E-08 CTGBCCC 3.10E-12
CCTGYC 1.80E-13 CCCMCMC 4.20E-07 AGCYCAGR 5.10E-12
SAGGS 1.30E-12 GGTATACA 1.20E-06 CWCAGRGC 3.40E-11
CACMCC 4.50E-11 CYCCWGC 1.10E-10
CHCAGAG 1.10E-09 GGWGCY 3.00E-09
CAGGWGTY 4.50E-09 CCWGKGAC 3.00E-10
GWTCWGGA 3.90E-08 GAGHCCC 5.80E-09
GGGAYACC 6.10E-08 GCAGSY 1.10E-08
BAGACC 2.00E-07 CARGYCC 2.60E-09
ACWCCC 3.20E-07 CTBAGGGA 2.70E-08
CCAGGS 3.60E-08
GAGRGGMC 4.20E-09
CTGSCC 4.40E-08
CACWGGAG 2.10E-07
AMCCCCAG 2.80E-07
CWGWGCC 3.40E-07
GATGAGWC 3.80E-07
CCCCWTCC 5.00E-07
CACCYCC 9.50E-07
CYCAATGC 1.40E-06
24 h CGD 3.7e-446 CGD 2.00E-190 CGD 7.40E-153 CGB 4.10E-15
CGC 4.60E-47 CGC 1.30E-24 CGC 2.20E-16 CAAKATCC 7.30E-07
CCWGGS 1.10E-28 SCAGGS 6.00E-11 CTGGGSY 8.00E-13
CCASCMC 1.30E-23 CCHCC 1.40E-09 CMCMCMC 1.10E-11
GCCYCY 4.40E-20 GCTGGS 1.80E-07 CTSAGMC 1.10E-11
CAGGGTKK 8.80E-15 ARCCC 1.70E-06 GCASCC 3.50E-11
CYCMC 1.00E-13 HCAGGGY 4.00E-11
GGSCY 5.30E-12 CAVCTCC 2.60E-10
ASACCWG 7.90E-11 CCMCAGM 3.00E-10
TCCAGGA 1.50E-10 CASWGGG 3.60E-09
CTGCCY 4.30E-08 CTGCCCY 2.70E-08
GGSTS 5.90E-08 GCCTGS 4.70E-09
GAGATRCC 4.00E-07 ASCTGCAS 3.20E-09
GGTGS 9.80E-07 CCCTSCWG 5.00E-08
GGTGTCCM 9.20E-07 CCCCTR 4.30E-07
GGSACACA 7.70E-07
CCAGAWGR 8.00E-07
AGWGAGC 1.30E-06
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AGGRGCC 1.40E-06
36 h CGD 2.3e-483 CGB 3.00E-196 CGD 4.30E-156 CGD 4.60E-14
CGC 1.40E-49 CGA 3.60E-21 CGC 1.60E-13 ATTCYACC 1.40E-07
CCWGSCY 1.20E-33 CCWGCC 4.10E-12 CCAGGSH 4.00E-12 ACAGGAAY 4.80E-07
GGDGGB 4.60E-23 CCCMMCC 3.00E-10 KCTGGGS 1.10E-11 GTTGAGGK 8.30E-07
CCWGGRS 1.80E-16 CTCTGRG 8.00E-08 CCTGWGRC 4.40E-11
AVWCCC 4.40E-14 CTGTAGMC 1.20E-07 GCYCTGA 9.40E-11
GGBCY 1.30E-10 AGGGTTB 1.30E-07 CTGKCCC 3.00E-10
GGCAS 1.10E-08 CCAGGM 1.20E-06 CTSAGCC 3.20E-10
CTCTGWG 2.10E-08 AGTVACCC 4.20E-07 CTGCTCWS 1.20E-09
GGGAYAC 8.00E-08 CWCTGGS 1.10E-09
GACTYCTC 2.60E-07 CTGAGGHC 6.60E-09
CAGGATS 3.60E-07 ABTGTGGG 6.40E-09
BTGGGG 1.30E-06 GRGKCAC 6.10E-09
RCACCTCA 1.80E-06 GCCCCY 1.00E-08
CWCCYCC 7.80E-09
CAGGWS 1.20E-08
AGGACYC 1.60E-07
CAGTGTGS 1.70E-07
AGKCCATG 3.90E-07
CCACCHAA 5.90E-07
GGCTTSA 1.00E-06
GCTGCAS 1.30E-06
GCAGTGTY 1.70E-06
Table B.9.: DNA motifs de novo discovered in DMRs upon butyrate addition were compared to human
and mouse transcription factor databases (Wippermann et al. 2016). Motif comparisons
were performed using Tomtom (Gupta et al. 2007). P values are indicated for both the
motif discovery and motif comparison. Seed and wobble bases: A = adenine, T = thymine,
C = cytosine, G = guanine, M "amino" = AC, R "purine" = AG, W "weak" = AT, S "strong"
= CG ,Y "pyrimidine" = CT. Also shown are gene expression values as determined by
CHO-specific DNA-microarrays as fold-changes. n.a. = gene not present on the microarray;
n.d. = gene present on microarray but not significantly differentially expressed.
DMR motif (5’→3’) Genomic position p value DREME Putative TF ID p value Tomtom TF expression
(CHO DNA-
microarray)
ACCCARTC Upstream 1.50E-06 DUXL 6.27E-05 n.a.
CCWGGRS Upstream 1.80E-16 EBF1 2.04E-05 n.d.
CCTGYC Upstream 1.80E-13 ID4 4.22E-05 n.a.
CCTGYC Upstream 1.80E-13 SNAI2 4.69E-05 n.d.
GCCYCY Upstream 4.40E-20 SP2 2.79E-05 n.d.
GCCYCY Upstream 4.40E-20 SP1 1.58E-04 0.7-fold
GCCYCY Upstream 4.40E-20 KLF13 4.83E-04 0.8-fold
CACMCC Upstream 4.50E-11 TBX15 6.74E-05 n.d.
CACMCC Upstream 4.50E-11 TBX1 9.65E-05 n.d.
CACMCC Upstream 4.50E-11 TBX20 1.35E-04 n.d.
CACMCC Upstream 4.50E-11 TBX21 1.61E-04 n.d.
CACMCC Upstream 4.50E-11 TBR1 1.93E-04 n.d.
CACMCC Upstream 4.50E-11 MGA 1.93E-04 0.6-fold
CACMCC Upstream 4.50E-11 TBX5 1.93E-04 n.d.
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CACMCC Upstream 4.50E-11 HIC1 2.14E-04 n.d.
CACMCC Upstream 4.50E-11 SREBF2 2.14E-04 n.d.
CACMCC Upstream 4.50E-11 TBX4 2.27E-04 n.d.
CACMCC Upstream 4.50E-11 EOMES 3.42E-04 n.d.
ACAGSTGA Upstream 4.90E-07 TFAP4 4.23E-05 0.7-fold
ACAGSTGA Upstream 4.90E-07 MEIS3 2.84E-04 n.d.
ACAGSTGA Upstream 4.90E-07 MEIS2 2.84E-04 n.d.
ACAGSTGA Upstream 4.90E-07 PKNOX1 3.34E-04 n.d.
ACAGSTGA Upstream 4.90E-07 PKNOX2 3.54E-04 n.d.
ACAGSTGA Upstream 4.90E-07 TGIF2 3.97E-04 n.d.
GRGGS Upstream 5.30E-16 TFAP2C 1.69E-05 0.8-fold
GRGGS Upstream 5.30E-16 TFAP2A 3.73E-04 0.6-fold
CCCCMC Upstream 1.20E-12 ZNF740 3.66E-05 n.d.
CCCCMC Upstream 1.20E-12 ZFP281 4.37E-05 n.a.
CCCCMC Upstream 1.20E-12 ZFP740 7.21E-05 n.d.
CCCCMC Upstream 1.20E-12 FOXO4 1.01E-04 n.d.
CCCCMC Upstream 1.20E-12 GLIS2 1.07E-04 0.6-fold
CCCCMC Upstream 1.20E-12 ZIC1 1.07E-04 n.d.
CCCCMC Upstream 1.20E-12 ZIC3 1.19E-04 n.d.
CCCCMC Upstream 1.20E-12 FOXO3 1.23E-04 n.d.
CCCCMC Upstream 1.20E-12 GLIS3 1.30E-04 1.4-fold
CCCCMC Upstream 1.20E-12 FOXO1 1.43E-04 n.d.
CCCCMC Upstream 1.20E-12 PLAGL1 1.73E-04 n.d.
CCCCMC Upstream 1.20E-12 FOXO6 1.84E-04 n.d.
CCCCMC Upstream 1.20E-12 GLIS1 2.25E-04 1.4-fold
CCCCMC Upstream 1.20E-12 ZIC4 4.84E-04 n.d.
GKGTGTS Upstream 2.00E-06 ZSCAN4 6.47E-05 1.2-fold
GKGTGTS Upstream 2.00E-06 KLF1 2.20E-04 n.d.
GGAAMTCC 5’ 1.10E-06 FLI1 3.05E-05 n.d.
GGAAMTCC 5’ 1.10E-06 ERG 4.06E-05 n.d.
GGAAMTCC 5’ 1.10E-06 REL 7.60E-05 0.7-fold
GGAAMTCC 5’ 1.10E-06 RELA 1.29E-04 0.7-fold
GGAAMTCC 5’ 1.10E-06 NFKB1 2.51E-04 0.8-fold
CCMCMC 5’ 4.20E-07 GLI2 5.74E-05 n.d.
CCMCMC 5’ 4.20E-07 RREB1 9.56E-05 0.7-fold
CCMCMC 5’ 4.20E-07 FOXO1 4.16E-04 1.4-fold
Table B.10.: Gene ontology (GO) classification of differentially expressed genes (929) with expression
profiles belonging to cluster I (Wippermann et al. 2016).
GO ID GO term Count p value
GO:0055114 oxidation reduction 62 9.61E-08
GO:0016192 vesicle-mediated transport 53 4.67E-06
GO:0006091 generation of precursor metabolites and energy 33 3.16E-05
GO:0048193 Golgi vesicle transport 19 4.14E-05
GO:0046907 intracellular transport 54 8.53E-05
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GO:0009719 response to endogenous stimulus 37 1.89E-04
GO:0006119 oxidative phosphorylation 15 1.91E-04
GO:0010035 response to inorganic substance 23 2.67E-04
GO:0006892 post-Golgi vesicle-mediated transport 11 3.36E-04
GO:0008610 lipid biosynthetic process 30 6.62E-04
GO:0019220 regulation of phosphate metabolic process 40 7.72E-04
GO:0051174 regulation of phosphorus metabolic process 40 7.72E-04
GO:0010033 response to organic substance 54 8.27E-04
GO:0045859 regulation of protein kinase activity 31 9.07E-04
GO:0031667 response to nutrient levels 21 0.001
GO:0010038 response to metal ion 16 0.001
GO:0009725 response to hormone stimulus 32 0.001
GO:0051338 regulation of transferase activity 32 0.002
GO:0043549 regulation of kinase activity 31 0.002
GO:0006886 intracellular protein transport 32 0.002
GO:0006368 RNA elongation from RNA polymerase II promoter 9 0.002
GO:0009991 response to extracellular stimulus 22 0.002
GO:0051348 negative regulation of transferase activity 13 0.002
GO:0019318 hexose metabolic process 20 0.002
GO:0006979 response to oxidative stress 18 0.002
GO:0030384 phosphoinositide metabolic process 11 0.002
GO:0015986 ATP synthesis coupled proton transport 8 0.002
GO:0015985 energy coupled proton transport, down electrochemical
gradient
8 0.002
GO:0042325 regulation of phosphorylation 37 0.002
GO:0006354 RNA elongation 9 0.002
GO:0006469 negative regulation of protein kinase activity 12 0.002
GO:0022900 electron transport chain 14 0.003
GO:0015980 energy derivation by oxidation of organic compounds 16 0.003
GO:0033673 negative regulation of kinase activity 12 0.003
GO:0008219 cell death 51 0.004
GO:0006650 glycerophospholipid metabolic process 14 0.004
GO:0034613 cellular protein localization 33 0.004
GO:0032870 cellular response to hormone stimulus 15 0.004
GO:0016265 death 51 0.004
GO:0046486 glycerolipid metabolic process 17 0.004
GO:0070727 cellular macromolecule localization 33 0.004
GO:0005996 monosaccharide metabolic process 21 0.004
GO:0006796 phosphate metabolic process 64 0.006
GO:0006793 phosphorus metabolic process 64 0.006
GO:0007584 response to nutrient 15 0.006
GO:0009206 purine ribonucleoside triphosphate biosynthetic process 12 0.006
GO:0033554 cellular response to stress 41 0.007
GO:0009201 ribonucleoside triphosphate biosynthetic process 12 0.007
GO:0009145 purine nucleoside triphosphate biosynthetic process 12 0.007
GO:0008202 steroid metabolic process 19 0.007
GO:0034220 ion transmembrane transport 8 0.008
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GO:0019217 regulation of fatty acid metabolic process 8 0.008
GO:0009142 nucleoside triphosphate biosynthetic process 12 0.008
GO:0009141 nucleoside triphosphate metabolic process 14 0.009
GO:0006754 ATP biosynthetic process 11 0.009
GO:0009205 purine ribonucleoside triphosphate metabolic process 13 0.009
GO:0010243 response to organic nitrogen 9 0.009
GO:0045454 cell redox homeostasis 9 0.009
GO:0006818 hydrogen transport 9 0.009
GO:0009199 ribonucleoside triphosphate metabolic process 13 0.01
GO:0022904 respiratory electron transport chain 9 0.01
Table B.11.: Gene ontology (GO) classification of differentially expressed genes (1014) with expression
profiles belonging to cluster II (Wippermann et al. 2016).
GO ID GO term Count p value
GO:0007049 cell cycle 106 8.21E-19
GO:0000278 mitotic cell cycle 68 1.07E-18
GO:0022402 cell cycle process 86 3.68E-18
GO:0022403 cell cycle phase 68 5.17E-16
GO:0000087 M phase of mitotic cell cycle 48 6.53E-16
GO:0000280 nuclear division 47 1.61E-15
GO:0007067 mitosis 47 1.61E-15
GO:0048285 organelle fission 47 7.86E-15
GO:0000279 M phase 57 1.74E-14
GO:0051276 chromosome organization 71 4.75E-14
GO:0051301 cell division 50 2.05E-12
GO:0006325 chromatin organization 57 6.45E-12
GO:0006396 RNA processing 71 1.64E-11
GO:0008380 RNA splicing 43 3.18E-09
GO:0000375 RNA splicing, via transesterification reactions 30 3.23E-09
GO:0000377 RNA splicing, via transesterification reactions with bulged
adenosine as nucleophile
30 3.23E-09
GO:0000398 nuclear mRNA splicing, via spliceosome 30 3.23E-09
GO:0034622 cellular macromolecular complex assembly 45 1.07E-08
GO:0006323 DNA packaging 25 1.47E-08
GO:0065003 macromolecular complex assembly 73 1.49E-08
GO:0034621 cellular macromolecular complex subunit organization 48 1.66E-08
GO:0006333 chromatin assembly or disassembly 26 1.78E-08
GO:0043933 macromolecular complex subunit organization 76 2.13E-08
GO:0031497 chromatin assembly 21 3.14E-08
GO:0065004 protein-DNA complex assembly 21 7.02E-08
GO:0007017 microtubule-based process 37 1.16E-07
GO:0008283 cell proliferation 51 4.84E-07
GO:0034728 nucleosome organization 20 5.01E-07
GO:0051726 regulation of cell cycle 42 7.23E-07
GO:0006397 mRNA processing 41 8.45E-07
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GO:0016071 mRNA metabolic process 45 8.83E-07
GO:0032886 regulation of microtubule-based process 14 1.44E-06
GO:0048145 regulation of fibroblast proliferation 12 1.47E-06
GO:0010605 negative regulation of macromolecule metabolic process 72 1.52E-06
GO:0006334 nucleosome assembly 18 2.28E-06
GO:0016568 chromatin modification 36 2.33E-06
GO:0007346 regulation of mitotic cell cycle 25 2.38E-06
GO:0000226 microtubule cytoskeleton organization 24 4.51E-06
GO:0031399 regulation of protein modification process 37 4.85E-06
GO:0010604 positive regulation of macromolecule metabolic process 78 8.71E-06
GO:0070507 regulation of microtubule cytoskeleton organization 12 1.06E-05
GO:0032268 regulation of cellular protein metabolic process 50 1.19E-05
GO:0051172 negative regulation of nitrogen compound metabolic pro-
cess
53 1.54E-05
GO:0016481 negative regulation of transcription 48 2.30E-05
GO:0007059 chromosome segregation 16 2.74E-05
GO:0010558 negative regulation of macromolecule biosynthetic process 54 3.22E-05
GO:0031327 negative regulation of cellular biosynthetic process 55 3.28E-05
GO:0010564 regulation of cell cycle process 19 4.27E-05
GO:0045934 negative regulation of nucleobase, nucleoside, nucleotide
and nucleic acid metabolic process
51 4.45E-05
GO:0048146 positive regulation of fibroblast proliferation 9 4.90E-05
GO:0045449 regulation of transcription 185 5.24E-05
GO:0009890 negative regulation of biosynthetic process 55 5.79E-05
GO:0051247 positive regulation of protein metabolic process 30 5.99E-05
GO:0032270 positive regulation of cellular protein metabolic process 29 7.12E-05
GO:0031400 negative regulation of protein modification process 19 7.63E-05
GO:0008284 positive regulation of cell proliferation 43 7.66E-05
GO:0007093 mitotic cell cycle checkpoint 11 8.15E-05
GO:0031401 positive regulation of protein modification process 25 8.21E-05
GO:0022613 ribonucleoprotein complex biogenesis 24 1.23E-04
GO:0007051 spindle organization 11 1.23E-04
GO:0042516 regulation of tyrosine phosphorylation of Stat3 protein 7 1.90E-04
GO:0010629 negative regulation of gene expression 48 2.23E-04
GO:0050658 RNA transport 16 2.31E-04
GO:0051236 establishment of RNA localization 16 2.31E-04
GO:0050657 nucleic acid transport 16 2.31E-04
GO:0006260 DNA replication 24 2.76E-04
GO:0042127 regulation of cell proliferation 67 2.97E-04
GO:0045596 negative regulation of cell differentiation 26 3.07E-04
GO:0006403 RNA localization 16 3.25E-04
GO:0051173 positive regulation of nitrogen compound metabolic pro-
cess
57 3.57E-04
GO:0051253 negative regulation of RNA metabolic process 37 3.58E-04
GO:0015931 nucleobase, nucleoside, nucleotide and nucleic acid trans-
port
17 4.07E-04
GO:0070271 protein complex biogenesis 47 4.39E-04
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GO:0006461 protein complex assembly 47 4.39E-04
GO:0045935 positive regulation of nucleobase, nucleoside, nucleotide
and nucleic acid metabolic process
55 5.04E-04
GO:0040001 establishment of mitotic spindle localization 5 5.15E-04
GO:0045892 negative regulation of transcription, DNA-dependent 36 5.32E-04
GO:0012501 programmed cell death 54 5.37E-04
GO:0051603 proteolysis involved in cellular protein catabolic process 53 6.17E-04
GO:0006915 apoptosis 53 6.67E-04
GO:0044257 cellular protein catabolic process 53 6.89E-04
GO:0033043 regulation of organelle organization 25 7.77E-04
GO:0009891 positive regulation of biosynthetic process 59 7.80E-04
GO:0006259 DNA metabolic process 46 8.17E-04
GO:0045787 positive regulation of cell cycle 11 9.20E-04
GO:0042254 ribosome biogenesis 17 9.58E-04
GO:0051781 positive regulation of cell division 9 0.001
GO:0042509 regulation of tyrosine phosphorylation of STAT protein 8 0.001
GO:0001932 regulation of protein amino acid phosphorylation 21 0.001
GO:0007018 microtubule-based movement 16 0.001
GO:0019941 modification-dependent protein catabolic process 50 0.001
GO:0043632 modification-dependent macromolecule catabolic process 50 0.001
GO:0016569 covalent chromatin modification 17 0.001
GO:0051329 interphase of mitotic cell cycle 15 0.001
GO:0030163 protein catabolic process 53 0.001
GO:0051340 regulation of ligase activity 13 0.001
GO:0051653 spindle localization 5 0.001
GO:0051293 establishment of spindle localization 5 0.001
GO:0001933 negative regulation of protein amino acid phosphorylation 8 0.001
GO:0045941 positive regulation of transcription 49 0.001
GO:0010557 positive regulation of macromolecule biosynthetic process 55 0.001
GO:0051439 regulation of ubiquitin-protein ligase activity during mi-
totic cell cycle
12 0.002
GO:0031328 positive regulation of cellular biosynthetic process 57 0.002
GO:0006511 ubiquitin-dependent protein catabolic process 26 0.002
GO:0051098 regulation of binding 19 0.002
GO:0008219 cell death 59 0.002
GO:0051254 positive regulation of RNA metabolic process 43 0.002
GO:0022415 viral reproductive process 11 0.002
GO:0051325 interphase 15 0.002
GO:0051351 positive regulation of ligase activity 12 0.002
GO:0032269 negative regulation of cellular protein metabolic process 21 0.002
GO:0016265 death 59 0.002
GO:0044265 cellular macromolecule catabolic process 59 0.002
GO:0006913 nucleocytoplasmic transport 19 0.002
GO:0010627 regulation of protein kinase cascade 26 0.002
GO:0051169 nuclear transport 19 0.002
GO:0045893 positive regulation of transcription, DNA-dependent 42 0.003
GO:0051028 mRNA transport 13 0.003
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GO:0032259 methylation 12 0.003
GO:0010628 positive regulation of gene expression 49 0.003
GO:0006351 transcription, DNA-dependent 29 0.003
GO:0009792 embryonic development ending in birth or egg hatching 32 0.003
GO:0070647 protein modification by small protein conjugation or re-
moval
19 0.003
GO:0051294 establishment of spindle orientation 4 0.003
GO:0034508 centromere complex assembly 4 0.003
GO:0000132 establishment of mitotic spindle orientation 4 0.003
GO:0042532 negative regulation of tyrosine phosphorylation of STAT
protein
4 0.003
GO:0046425 regulation of JAK-STAT cascade 8 0.003
GO:0051248 negative regulation of protein metabolic process 21 0.003
GO:0006338 chromatin remodeling 10 0.003
GO:0006350 transcription 143 0.003
GO:0009967 positive regulation of signal transduction 29 0.003
GO:0032774 RNA biosynthetic process 29 0.003
GO:0051438 regulation of ubiquitin-protein ligase activity 12 0.003
GO:0051302 regulation of cell division 9 0.004
GO:0051437 positive regulation of ubiquitin-protein ligase activity dur-
ing mitotic cell cycle
11 0.004
GO:0034660 ncRNA metabolic process 24 0.004
GO:0000075 cell cycle checkpoint 13 0.004
GO:0043414 biopolymer methylation 11 0.004
GO:0010563 negative regulation of phosphorus metabolic process 9 0.004
GO:0045936 negative regulation of phosphate metabolic process 9 0.004
GO:0051640 organelle localization 13 0.004
GO:0006364 rRNA processing 13 0.004
GO:0051100 negative regulation of binding 10 0.004
GO:0043009 chordate embryonic development 31 0.004
GO:0051443 positive regulation of ubiquitin-protein ligase activity 11 0.004
GO:0019221 cytokine-mediated signaling pathway 11 0.004
GO:0051129 negative regulation of cellular component organization 17 0.005
GO:0010941 regulation of cell death 63 0.005
GO:0060216 definitive hemopoiesis 4 0.005
GO:0006474 N-terminal protein amino acid acetylation 4 0.005
GO:0046426 negative regulation of JAK-STAT cascade 4 0.005
GO:0010639 negative regulation of organelle organization 12 0.005
GO:0016032 viral reproduction 11 0.005
GO:0044092 negative regulation of molecular function 31 0.005
GO:0006917 induction of apoptosis 30 0.005
GO:0012502 induction of programmed cell death 30 0.005
GO:0033135 regulation of peptidyl-serine phosphorylation 5 0.006
GO:0031365 N-terminal protein amino acid modification 5 0.006
GO:0031398 positive regulation of protein ubiquitination 12 0.006
GO:0016072 rRNA metabolic process 13 0.006
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GO:0031110 regulation of microtubule polymerization or depolymer-
ization
7 0.006
GO:0043392 negative regulation of DNA binding 9 0.006
GO:0006275 regulation of DNA replication 10 0.006
GO:0051101 regulation of DNA binding 15 0.006
GO:0009057 macromolecule catabolic process 60 0.007
GO:0016570 histone modification 15 0.007
GO:0043067 regulation of programmed cell death 62 0.007
GO:0034470 ncRNA processing 20 0.007
GO:0006473 protein amino acid acetylation 9 0.007
GO:0051252 regulation of RNA metabolic process 123 0.007
GO:0030307 positive regulation of cell growth 8 0.007
GO:0043623 cellular protein complex assembly 18 0.007
GO:0046605 regulation of centrosome cycle 4 0.007
GO:0046784 intronless viral mRNA export from host nucleus 4 0.007
GO:0007052 mitotic spindle organization 5 0.007
GO:0010647 positive regulation of cell communication 30 0.007
GO:0043193 positive regulation of gene-specific transcription 12 0.008
GO:0006730 one-carbon metabolic process 14 0.008
GO:0042981 regulation of apoptosis 61 0.008
GO:0007569 cell aging 7 0.008
GO:0045937 positive regulation of phosphate metabolic process 13 0.008
GO:0031396 regulation of protein ubiquitination 13 0.008
GO:0010562 positive regulation of phosphorus metabolic process 13 0.008
GO:0031145 anaphase-promoting complex-dependent proteasomal
ubiquitin-dependent protein catabolic process
10 0.008
GO:0031055 chromatin remodeling at centromere 3 0.009
GO:0006366 transcription from RNA polymerase II promoter 23 0.009
GO:0051052 regulation of DNA metabolic process 14 0.009
GO:0007026 negative regulation of microtubule depolymerization 5 0.009
GO:0031114 regulation of microtubule depolymerization 5 0.009
Table B.12.: Gene ontology (GO) classification of differentially expressed genes (2861) with expression
profiles belonging to cluster III (Wippermann et al. 2016).
GO ID GO term Count p value
GO:0008104 protein localization 227 1.61E-20
GO:0015031 protein transport 203 3.43E-20
GO:0045184 establishment of protein localization 203 1.05E-19
GO:0006414 translational elongation 52 4.95E-18
GO:0046907 intracellular transport 171 7.89E-16
GO:0070727 cellular macromolecule localization 115 7.64E-13
GO:0034613 cellular protein localization 114 1.08E-12
GO:0006886 intracellular protein transport 105 4.16E-12
GO:0006412 translation 90 9.97E-10
GO:0006605 protein targeting 64 8.39E-09
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GO:0009057 macromolecule catabolic process 162 4.50E-07
GO:0044265 cellular macromolecule catabolic process 152 5.69E-07
GO:0043632 modification-dependent macromolecule catabolic process 124 1.46E-06
GO:0019941 modification-dependent protein catabolic process 124 1.46E-06
GO:0051603 proteolysis involved in cellular protein catabolic process 128 1.91E-06
GO:0044257 cellular protein catabolic process 128 2.49E-06
GO:0006793 phosphorus metabolic process 189 4.51E-06
GO:0006796 phosphate metabolic process 189 4.51E-06
GO:0030163 protein catabolic process 130 4.73E-06
GO:0016192 vesicle-mediated transport 122 4.93E-06
GO:0070647 protein modification by small protein conjugation or re-
moval
44 2.10E-05
GO:0016310 phosphorylation 156 2.84E-05
GO:0033554 cellular response to stress 116 3.98E-05
GO:0032446 protein modification by small protein conjugation 36 1.59E-04
GO:0007264 small GTPase mediated signal transduction 68 1.68E-04
GO:0042274 ribosomal small subunit biogenesis 8 2.35E-04
GO:0048193 Golgi vesicle transport 35 3.03E-04
GO:0006612 protein targeting to membrane 14 3.48E-04
GO:0016567 protein ubiquitination 32 5.11E-04
GO:0016044 membrane organization 79 5.22E-04
GO:0033365 protein localization in organelle 37 5.91E-04
GO:0017038 protein import 34 6.56E-04
GO:0009144 purine nucleoside triphosphate metabolic process 32 8.06E-04
GO:0032869 cellular response to insulin stimulus 21 9.74E-04
GO:0006119 oxidative phosphorylation 27 0.001
GO:0019637 organophosphate metabolic process 46 0.001
GO:0006974 response to DNA damage stimulus 76 0.001
GO:0009116 nucleoside metabolic process 20 0.001
GO:0008286 insulin receptor signaling pathway 14 0.001
GO:0006644 phospholipid metabolic process 44 0.001
GO:0009141 nucleoside triphosphate metabolic process 33 0.001
GO:0022613 ribonucleoprotein complex biogenesis 42 0.001
GO:0032870 cellular response to hormone stimulus 33 0.002
GO:0008654 phospholipid biosynthetic process 27 0.002
GO:0045333 cellular respiration 26 0.002
GO:0016197 endosome transport 18 0.002
GO:0042981 regulation of apoptosis 144 0.003
GO:0043067 regulation of programmed cell death 145 0.003
GO:0051656 establishment of organelle localization 20 0.003
GO:0010941 regulation of cell death 145 0.003
GO:0007243 protein kinase cascade 73 0.003
GO:0006468 protein amino acid phosphorylation 121 0.004
GO:0043068 positive regulation of programmed cell death 83 0.004
GO:0006281 DNA repair 58 0.004
GO:0010942 positive regulation of cell death 83 0.005
GO:0051650 establishment of vesicle localization 12 0.005
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GO:0032483 regulation of Rab protein signal transduction 15 0.005
GO:0032313 regulation of Rab GTPase activity 15 0.005
GO:0043065 positive regulation of apoptosis 82 0.005
GO:0018105 peptidyl-serine phosphorylation 11 0.005
GO:0034976 response to endoplasmic reticulum stress 12 0.006
GO:0006916 anti-apoptosis 44 0.006
GO:0009150 purine ribonucleotide metabolic process 32 0.006
GO:0007242 intracellular signaling cascade 211 0.006
GO:0032868 response to insulin stimulus 25 0.006
GO:0007259 JAK-STAT cascade 13 0.007
GO:0018209 peptidyl-serine modification 13 0.007
GO:0009205 purine ribonucleoside triphosphate metabolic process 28 0.007
GO:0009060 aerobic respiration 12 0.008
GO:0000209 protein polyubiquitination 10 0.008
GO:0000737 DNA catabolic process, endonucleolytic 10 0.008
GO:0016072 rRNA metabolic process 24 0.008
GO:0006508 proteolysis 179 0.008
GO:0006650 glycerophospholipid metabolic process 28 0.008
GO:0009199 ribonucleoside triphosphate metabolic process 28 0.008
GO:0016558 protein import into peroxisome matrix 6 0.008
GO:0006163 purine nucleotide metabolic process 40 0.008
GO:0006308 DNA catabolic process 17 0.009
GO:0051187 cofactor catabolic process 11 0.009
GO:0009259 ribonucleotide metabolic process 33 0.009
GO:0006364 rRNA processing 23 0.009
Table B.13.: Gene ontology (GO) classification of differentially expressed genes (3039) with expression
profiles belonging to cluster IV (Wippermann et al. 2016).
GO ID GO term Count p value
GO:0006396 RNA processing 196 7.05E-32
GO:0000278 mitotic cell cycle 132 2.16E-21
GO:0016071 mRNA metabolic process 132 2.16E-21
GO:0008380 RNA splicing 108 5.47E-20
GO:0007049 cell cycle 219 5.51E-20
GO:0006397 mRNA processing 117 6.97E-20
GO:0048285 organelle fission 90 7.57E-18
GO:0006259 DNA metabolic process 154 2.31E-17
GO:0022402 cell cycle process 165 2.20E-16
GO:0022403 cell cycle phase 131 3.48E-16
GO:0007067 mitosis 84 1.07E-15
GO:0000280 nuclear division 84 1.07E-15
GO:0000087 M phase of mitotic cell cycle 85 1.08E-15
GO:0000279 M phase 106 8.98E-14
GO:0051276 chromosome organization 138 6.31E-13
GO:0034470 ncRNA processing 68 9.61E-12
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GO:0051301 cell division 92 3.36E-11
GO:0006260 DNA replication 67 6.56E-11
GO:0007059 chromosome segregation 38 1.63E-10
GO:0000377 RNA splicing, via transesterification reactions with bulged
adenosine as nucleophile
57 1.88E-10
GO:0000398 nuclear mRNA splicing, via spliceosome 57 1.88E-10
GO:0000375 RNA splicing, via transesterification reactions 57 1.88E-10
GO:0022613 ribonucleoprotein complex biogenesis 62 1.06E-9
GO:0006350 transcription 425 1.29E-9
GO:0016568 chromatin modification 83 1.60E-9
GO:0006281 DNA repair 85 1.89E-9
GO:0043933 macromolecular complex subunit organization 171 2.74E-9
GO:0006357 regulation of transcription from RNA polymerase II pro-
moter
174 3.22E-9
GO:0006974 response to DNA damage stimulus 103 4.19E-9
GO:0006913 nucleocytoplasmic transport 54 1.18E-8
GO:0034621 cellular macromolecular complex subunit organization 98 1.44E-8
GO:0051169 nuclear transport 54 1.93E-8
GO:0034660 ncRNA metabolic process 70 2.81E-8
GO:0010605 negative regulation of macromolecule metabolic process 171 3.42E-8
GO:0044265 cellular macromolecule catabolic process 169 4.01E-8
GO:0065003 macromolecular complex assembly 157 5.43E-8
GO:0051236 establishment of RNA localization 38 6.44E-8
GO:0050658 RNA transport 38 6.44E-8
GO:0050657 nucleic acid transport 38 6.44E-8
GO:0000819 sister chromatid segregation 21 7.98E-8
GO:0051028 mRNA transport 35 1.09E-7
GO:0006403 RNA localization 38 1.61E-7
GO:0015931 nucleobase, nucleoside, nucleotide and nucleic acid trans-
port
41 2.06E-7
GO:0009057 macromolecule catabolic process 176 2.44E-7
GO:0000070 mitotic sister chromatid segregation 20 2.79E-7
GO:0010604 positive regulation of macromolecule metabolic process 188 6.25E-7
GO:0042254 ribosome biogenesis 42 7.20E-7
GO:0045449 regulation of transcription 491 8.39E-7
GO:0070271 protein complex biogenesis 121 9.73E-7
GO:0006461 protein complex assembly 121 9.73E-7
GO:0006325 chromatin organization 96 1.04E-6
GO:0051254 positive regulation of RNA metabolic process 116 1.19E-6
GO:0045893 positive regulation of transcription, DNA-dependent 115 1.35E-6
GO:0016569 covalent chromatin modification 42 1.86E-6
GO:0016570 histone modification 41 1.99E-6
GO:0051329 interphase of mitotic cell cycle 36 3.44E-6
GO:0010628 positive regulation of gene expression 133 3.61E-6
GO:0016072 rRNA metabolic process 34 4.88E-6
GO:0045941 positive regulation of transcription 129 5.37E-6
GO:0008033 tRNA processing 29 5.54E-6
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GO:0034622 cellular macromolecular complex assembly 81 6.99E-6
GO:0051325 interphase 36 7.15E-6
GO:0010629 negative regulation of gene expression 117 7.49E-6
GO:0030163 protein catabolic process 139 8.11E-6
GO:0051173 positive regulation of nitrogen compound metabolic pro-
cess
143 8.45E-6
GO:0006412 translation 83 1.00E-5
GO:0033554 cellular response to stress 128 1.05E-5
GO:0031328 positive regulation of cellular biosynthetic process 150 1.09E-5
GO:0051603 proteolysis involved in cellular protein catabolic process 134 1.24E-5
GO:0019941 modification-dependent protein catabolic process 129 1.33E-5
GO:0043632 modification-dependent macromolecule catabolic process 129 1.33E-5
GO:0017038 protein import 41 1.40E-5
GO:0006364 rRNA processing 32 1.48E-5
GO:0045935 positive regulation of nucleobase, nucleoside, nucleotide
and nucleic acid metabolic process
138 1.52E-5
GO:0044257 cellular protein catabolic process 134 1.60E-5
GO:0010557 positive regulation of macromolecule biosynthetic process 143 1.92E-5
GO:0006511 ubiquitin-dependent protein catabolic process 64 2.10E-5
GO:0009891 positive regulation of biosynthetic process 150 2.40E-5
GO:0006605 protein targeting 58 2.91E-5
GO:0010558 negative regulation of macromolecule biosynthetic process 122 3.37E-5
GO:0032774 RNA biosynthetic process 74 3.55E-5
GO:0006351 transcription, DNA-dependent 73 4.03E-5
GO:0045944 positive regulation of transcription from RNA polymerase
II promoter
88 5.00E-5
GO:0051168 nuclear export 23 5.96E-5
GO:0016481 negative regulation of transcription 104 7.09E-5
GO:0022618 ribonucleoprotein complex assembly 25 7.49E-5
GO:0051436 negative regulation of ubiquitin-protein ligase activity dur-
ing mitotic cell cycle
24 7.76E-5
GO:0033365 protein localization in organelle 42 9.42E-5
GO:0045934 negative regulation of nucleobase, nucleoside, nucleotide
and nucleic acid metabolic process
113 1.06E-4
GO:0006261 DNA-dependent DNA replication 22 1.08E-4
GO:0051170 nuclear import 29 1.19E-4
GO:0051172 negative regulation of nitrogen compound metabolic pro-
cess
114 1.20E-4
GO:0043123 positive regulation of I-kappaB kinase/NF-kappaB cas-
cade
31 1.23E-4
GO:0051444 negative regulation of ubiquitin-protein ligase activity 24 1.32E-4
GO:0051352 negative regulation of ligase activity 24 1.32E-4
GO:0010498 proteasomal protein catabolic process 32 1.37E-4
GO:0043161 proteasomal ubiquitin-dependent protein catabolic process 32 1.37E-4
GO:0030261 chromosome condensation 13 1.51E-4
GO:0031327 negative regulation of cellular biosynthetic process 121 1.63E-4
GO:0009890 negative regulation of biosynthetic process 123 1.78E-4
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GO:0043543 protein amino acid acylation 22 1.87E-4
GO:0031145 anaphase-promoting complex-dependent proteasomal
ubiquitin-dependent protein catabolic process
23 2.32E-4
GO:0006405 RNA export from nucleus 17 2.60E-4
GO:0022411 cellular component disassembly 20 2.63E-4
GO:0051248 negative regulation of protein metabolic process 49 2.75E-4
GO:0051439 regulation of ubiquitin-protein ligase activity during mi-
totic cell cycle
24 3.50E-4
GO:0000059 protein import into nucleus, docking 10 4.14E-4
GO:0006399 tRNA metabolic process 34 4.72E-4
GO:0040029 regulation of gene expression, epigenetic 25 4.99E-4
GO:0006606 protein import into nucleus 27 5.04E-4
GO:0006338 chromatin remodeling 20 5.85E-4
GO:0046907 intracellular transport 135 5.97E-4
GO:0051438 regulation of ubiquitin-protein ligase activity 25 6.15E-4
GO:0006473 protein amino acid acetylation 19 6.16E-4
GO:0016573 histone acetylation 18 6.41E-4
GO:0031397 negative regulation of protein ubiquitination 24 6.77E-4
GO:0051443 positive regulation of ubiquitin-protein ligase activity 23 7.43E-4
GO:0043122 regulation of I-kappaB kinase/NF-kappaB cascade 31 7.99E-4
GO:0006406 mRNA export from nucleus 14 8.74E-4
GO:0034504 protein localization in nucleus 28 9.57E-4
GO:0043623 cellular protein complex assembly 42 9.98E-4
GO:0000079 regulation of cyclin-dependent protein kinase activity 19 0.001
GO:0006366 transcription from RNA polymerase II promoter 56 0.001
GO:0045892 negative regulation of transcription, DNA-dependent 79 0.001
GO:0032984 macromolecular complex disassembly 12 0.001
GO:0034623 cellular macromolecular complex disassembly 12 0.001
GO:0051340 regulation of ligase activity 25 0.001
GO:0051253 negative regulation of RNA metabolic process 80 0.001
GO:0000122 negative regulation of transcription from RNA polymerase
II promoter
62 0.001
GO:0051437 positive regulation of ubiquitin-protein ligase activity dur-
ing mitotic cell cycle
22 0.001
GO:0051351 positive regulation of ligase activity 23 0.001
GO:0032269 negative regulation of cellular protein metabolic process 45 0.001
GO:0007010 cytoskeleton organization 93 0.001
GO:0045184 establishment of protein localization 152 0.001
GO:0000082 G1/S transition of mitotic cell cycle 19 0.002
GO:0007076 mitotic chromosome condensation 8 0.002
GO:0006401 RNA catabolic process 21 0.002
GO:0042176 regulation of protein catabolic process 18 0.002
GO:0009451 RNA modification 17 0.002
GO:0031398 positive regulation of protein ubiquitination 25 0.002
GO:0042177 negative regulation of protein catabolic process 9 0.002
GO:0015031 protein transport 149 0.003
GO:0022614 membrane to membrane docking 5 0.003
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GO:0051101 regulation of DNA binding 32 0.003
GO:0006289 nucleotide-excision repair 18 0.003
GO:0000226 microtubule cytoskeleton organization 37 0.004
GO:0006730 one-carbon metabolic process 30 0.004
GO:0051252 regulation of RNA metabolic process 325 0.004
GO:0010608 posttranscriptional regulation of gene expression 49 0.004
GO:0016458 gene silencing 18 0.004
GO:0032479 regulation of type I interferon production 8 0.005
GO:0031396 regulation of protein ubiquitination 27 0.005
GO:0006302 double-strand break repair 19 0.006
GO:0009156 ribonucleoside monophosphate biosynthetic process 10 0.006
GO:0006809 nitric oxide biosynthetic process 7 0.006
GO:0007017 microtubule-based process 56 0.006
GO:0006417 regulation of translation 34 0.007
GO:0022616 DNA strand elongation 5 0.007
GO:0051098 regulation of binding 37 0.007
GO:0006270 DNA replication initiation 8 0.007
GO:0006413 translational initiation 15 0.007
GO:0051099 positive regulation of binding 22 0.008
GO:0009411 response to UV 18 0.008
GO:0051090 regulation of transcription factor activity 27 0.008
GO:0045089 positive regulation of innate immune response 15 0.009
GO:0031400 negative regulation of protein modification process 30 0.009
GO:0006308 DNA catabolic process 18 0.009
GO:0006886 intracellular protein transport 77 0.009
GO:0046209 nitric oxide metabolic process 7 0.009
GO:0031050 dsRNA fragmentation 7 0.009
GO:0031047 gene silencing by RNA 12 0.009
Table B.14.: Gene ontology (GO) classification of genes both hypomethylated and hypermethylated
upon butyrate addition (2890; Wippermann et al. 2016).
GO ID GO term Count p value
GO:0006414 translational elongation 36 1.55E10-9
GO:0009952 anterior/posterior pattern formation 38 1.49E10-6
GO:0007389 pattern specification process 58 5.48E10-6
GO:0048706 embryonic skeletal system development 24 1.67E10-5
GO:0003002 regionalization 45 1.96E10-5
GO:0001501 skeletal system development 62 8.77E10-5
GO:0051253 negative regulation of RNA metabolic process 67 1.93E10-4
GO:0006364 rRNA processing 24 3.36E10-4
GO:0045892 negative regulation of transcription, DNA-dependent 65 3.59E10-4
GO:0042254 ribosome biogenesis 29 3.77E10-4
GO:0016072 rRNA metabolic process 24 6.44E10-4
GO:0048704 embryonic skeletal system morphogenesis 17 6.79E10-4
GO:0045926 negative regulation of growth 26 8.83E10-4
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GO:0007155 cell adhesion 111 9.24E10-4
GO:0022610 biological adhesion 111 9.75E10-4
GO:0022613 ribonucleoprotein complex biogenesis 37 0.001
GO:0051270 regulation of cell motion 39 0.001
GO:0015031 protein transport 118 0.002
GO:0010605 negative regulation of macromolecule metabolic process 114 0.002
GO:0008361 regulation of cell size 40 0.002
GO:0034470 ncRNA processing 37 0.002
GO:0045184 establishment of protein localization 118 0.002
GO:0030308 negative regulation of cell growth 22 0.002
GO:0001558 regulation of cell growth 38 0.002
GO:0031056 regulation of histone modification 7 0.002
GO:0045792 negative regulation of cell size 23 0.002
GO:0030334 regulation of cell migration 34 0.002
GO:0032535 regulation of cellular component size 49 0.003
GO:0048705 skeletal system morphogenesis 25 0.003
GO:0016481 negative regulation of transcription 75 0.003
GO:0010629 negative regulation of gene expression 81 0.003
GO:0034101 erythrocyte homeostasis 14 0.004
GO:0035051 cardiac cell differentiation 10 0.004
GO:0043433 negative regulation of transcription factor activity 13 0.005
GO:0045934 negative regulation of nucleobase, nucleoside, nucleotide
and nucleic acid metabolic process
81 0.005
GO:0031057 negative regulation of histone modification 5 0.005
GO:0031058 positive regulation of histone modification 5 0.005
GO:0008104 protein localization 130 0.005
GO:0042274 ribosomal small subunit biogenesis 6 0.006
GO:0030097 hemopoiesis 42 0.007
GO:0051172 negative regulation of nitrogen compound metabolic pro-
cess
81 0.007
GO:0051130 positive regulation of cellular component organization 34 0.007
GO:0034660 ncRNA metabolic process 41 0.008
GO:0006986 response to unfolded protein 17 0.008
GO:0051318 G1 phase 8 0.008
GO:0051090 regulation of transcription factor activity 22 0.008
GO:0006412 translation 55 0.008
GO:0048534 hemopoietic or lymphoid organ development 45 0.009
GO:0001667 ameboidal cell migration 11 0.009
Table B.15.: Gene ontology (GO) classification of hypomethylated genes upon butyrate addition (3886;
Wippermann et al. 2016).
GO ID GO term Count p value
GO:0022403 cell cycle phase 101 1.09E-05
GO:0000279 M phase 84 1.12E-05
GO:0022402 cell cycle process 129 2.01E-05
244
B.7. Supplementary tables
GO:0000087 M phase of mitotic cell cycle 61 2.79E-05
GO:0006357 regulation of transcription from RNA polymerase II pro-
moter
157 5.59E-05
GO:0007067 mitosis 59 6.15E-05
GO:0000280 nuclear division 59 6.15E-05
GO:0048285 organelle fission 60 1.07E-04
GO:0000278 mitotic cell cycle 88 1.12E-04
GO:0007242 intracellular signaling cascade 250 1.29E-04
GO:0006396 RNA processing 121 1.55E-04
GO:0060627 regulation of vesicle-mediated transport 31 1.58E-04
GO:0010941 regulation of cell death 170 1.78E-04
GO:0043067 regulation of programmed cell death 169 2.08E-04
GO:0032891 negative regulation of organic acid transport 8 2.11E-04
GO:0006397 mRNA processing 77 2.36E-04
GO:0007049 cell cycle 162 2.51E-04
GO:0042981 regulation of apoptosis 167 2.56E-04
GO:0016071 mRNA metabolic process 86 3.03E-04
GO:0044265 cellular macromolecule catabolic process 152 3.19E-04
GO:0008380 RNA splicing 69 3.51E-04
GO:0043632 modification-dependent macromolecule catabolic process 124 3.56E-04
GO:0019941 modification-dependent protein catabolic process 124 3.56E-04
GO:0060191 regulation of lipase activity 28 3.75E-04
GO:0060193 positive regulation of lipase activity 25 4.72E-04
GO:0009057 macromolecule catabolic process 161 4.76E-04
GO:0051051 negative regulation of transport 38 5.62E-04
GO:0016192 vesicle-mediated transport 122 8.80E-04
GO:0051603 proteolysis involved in cellular protein catabolic process 126 9.97E-04
Table B.16.: Gene ontology (GO) classification of hypermethylated genes upon butyrate treatment
(1737; Wippermann et al. 2016).
GO ID GO term Count p value
GO:0008104 protein localization 110 2.89E-8
GO:0045184 establishment of protein localization 97 1.27E-7
GO:0015031 protein transport 95 3.04E-7
GO:0008380 RNA splicing 43 9.63E-6
GO:0006397 mRNA processing 45 4.03E-5
GO:0046907 intracellular transport 77 4.25E-5
GO:0006396 RNA processing 66 6.89E-5
GO:0016071 mRNA metabolic process 49 7.58E-5
GO:0051028 mRNA transport 18 1.65E-4
GO:0050657 nucleic acid transport 19 2.12E-4
GO:0051236 establishment of RNA localization 19 2.12E-4
GO:0050658 RNA transport 19 2.12E-4
GO:0006403 RNA localization 19 3.15E-4
GO:0015931 nucleobase, nucleoside, nucleotide and nucleic acid trans-
port
20 5.32E-4
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GO:0048193 Golgi vesicle transport 22 5.39E-4
GO:0070727 cellular macromolecule localization 50 5.76E-4
GO:0000398 nuclear mRNA splicing, via spliceosome 24 7.61E-4
GO:0000377 RNA splicing, via transesterification reactions with bulged
adenosine as nucleophile
24 7.61E-4
GO:0000375 RNA splicing, via transesterification reactions 24 7.61E-4
GO:0034613 cellular protein localization 49 8.70E-4
Table B.17.: Comparison of studies that aimed to analyze butyrate-induced gene expression changes
by microarrays in cultured cells (Klausing, Krämer, and Noll 2011; Kantardjieff et al.
2010; Li and Li 2006a). Fold changes of expression of cell cycle-related genes were, if
necessary, converted to enable comparability. n.d. = significant change in gene expression
not detected in the respective microarray experiment.
Butyrate-induced gene expression fold changes measured by
Transcript Li and Li 2006 Klausing et al. 2011 Kantardjieff et al. 2010 Present study
ATR n.d. 0.53 0.06 0.77
AURKA 0.17 n.d. n.d. 0.46
AURKAIP1 0.19 n.d. n.d. n.d.
AURKB 0.18 n.d. n.d. 0.50
BUB1 0.10 n.d. 0.18 n.d.
BUB1B 0.06 n.d. n.d. 0.50
CBX5 0.10 n.d. n.d. 0.50
CCAR1 0.17 n.d. n.d. 0.70
CCNA2 0.17 n.d. 0.02 0.39
CCNA2 0.17 n.d. n.d. 0.39
CCNB1 n.d. n.d. 0.01 0.43
CCNB1 0.06 n.d. n.d. 0.43
CCNB2 0.22 n.d. 0.02 0.48
CCNB2 0.22 n.d. n.d. 0.48
CCNG1 0.07 n.d. n.d. n.d.
CDC20 n.d. n.d. 0.01 0.35
CDC20 0.10 n.d. n.d. 0.35
CDC25A 0.11 n.d. n.d. 0.59
CDC2A n.d. n.d. 0.05 n.d.
CDC45l 0.09 n.d. n.d. 0.57
CDCA2 0.08 n.d. n.d. 0.58
CDCA8 0.17 n.d. n.d. 0.38
CDK1 0.12 n.d. n.d. n.d.
CDK11B 0.04 n.d. n.d. n.d.
CDK4 0.15 n.d. n.d. n.d.
CDKN2C 0.22 n.d. n.d. n.d.
CENPA 0.09 n.d. n.d. 0.32
CENPF 0.06 n.d. n.d. 0.69
CHAF1A 0.20 n.d. n.d. 0.81
CHD3 0.14 n.d. n.d. 0.54
CHEK1 0.16 n.d. n.d. 0.79
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CHEK2 n.d. 1.43 0.04 n.d.
CKS1B 0.09 n.d. n.d. 0.65
CKS2 0.02 n.d. n.d. 0.72
CYCD n.d. 2.49 n.d. n.d.
DKC1 0.11 n.d. n.d. 0.40
DLGAP5 0.22 n.d. n.d. 0.52
DSCC1 0.06 n.d. n.d. 0.55
DTYMK 0.15 n.d. n.d. 0.68
E2F4 0.11 n.d. n.d. 0.66
E2F6 n.d. n.d. 2.60 0.63
ESCO2 0.13 n.d. n.d. n.d.
ESPL1 0.08 n.d. n.d. 0.63
FEN1 0.18 n.d. n.d. 0.63
GTF3C2 0.24 n.d. n.d. 0.71
GTSE1 0.23 n.d. n.d. 0.57
H2AFZ 0.08 n.d. n.d. 0.54
HDAC7A n.d. 0.71 0.18 0.78
HDAC8 0.15 n.d. n.d. n.d.
HELLS 0.13 n.d. n.d. 0.60
KIF11 0.23 n.d. n.d. n.d.
KIF14 0.20 n.d. n.d. 0.66
KIF20A 0.12 n.d. n.d. 0.52
KIF20B 0.13 n.d. n.d. 0.51
KIF22 0.09 n.d. n.d. 0.39
KIF23 0.07 n.d. n.d. 0.51
KIF2c 0.19 n.d. n.d. 0.65
LMNB1 0.05 n.d. n.d. 0.67
MAD2L1 0.07 n.d. n.d. 0.72
MAP126 0.04 n.d. n.d. n.d.
MCM3 0.10 0.86 0.05 0.41
MCM4 0.14 n.d. n.d. 0.50
MCM5 0.17 0.27 0.01 0.37
MCM6 0.09 n.d. n.d. 0.65
MCM7 n.d. n.d. 0.11 0.51
MND1 0.07 n.d. n.d. n.d.
MSH3 0.24 n.d. n.d. n.d.
MSH6 0.21 n.d. n.d. 0.64
MXI1 12.55 n.d. n.d. 2.26
MYC n.d. 0.29 n.d. 0.82
NCAPG 0.06 n.d. n.d. 0.52
NCL 0.10 n.d. n.d. 0.66
NDC80 0.15 n.d. n.d. 0.63
NEK2 0.13 n.d. n.d. 0.57
NUCKS1 0.19 n.d. n.d. 0.53
NUSAP1 0.08 n.d. n.d. 0.41
ORC1L 0.23 0.27 0.07 0.52
PBK 0.15 n.d. n.d. 0.50
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PCNA 0.09 n.d. n.d. 0.44
PES1 0.17 n.d. n.d. n.d.
PKMYT1 n.d. 0.41 0.01 0.58
PLK1 n.d. n.d. 0.05 0.34
PRC1 0.07 n.d. n.d. 0.54
PRKDC n.d. n.d. 1.10 n.d.
PSMB8 0.14 n.d. n.d. 0.35
RAD51 0.11 n.d. n.d. n.d.
RAD51AP1 0.21 n.d. n.d. 0.70
REXO4 0.21 n.d. n.d. 0.62
SAFB2 0.20 n.d. n.d. n.d.
SMC4 0.13 n.d. n.d. 0.46
SPC25 0.14 n.d. n.d. 0.59
TCERG1 0.09 n.d. n.d. 0.61
UEB2C 0.14 n.d. n.d. 0.39
UBE2K 0.25 n.d. n.d. 0.59
WEE1 0.16 n.d. n.d. n.d.
YWHAG n.d. n.d. 0.18 n.d.
Table B.18.: Gene Ontology analysis (p values ≤ 0.01.) of genes affected by butyrate-mediated
differential hypomethylation of associated CpG islands 24 hours upon butyrate addition
(Wippermann et al. 2013). Genes detected without treatment with 3 mM butyrate (’0 h’
sampling point) were removed from the dataset before ontology analysis.
GO ID GO term Count p value
GO:0010605 negative regulation of macromolecule metabolic process 70 4.98E-06
GO:0010629 negative regulation of gene expression 53 6.06E-06
GO:0045934 negative regulation of nucleobase, nucleoside, nucleotide
and nucleic acid metabolic process
53 9.53E-06
GO:0016481 negative regulation of transcription 49 9.66E-06
GO:0051172 negative regulation of nitrogen compound metabolic pro-
cess
53 1.38E-05
GO:0016310 phosphorylation 73 1.40E-05
GO:0006468 protein amino acid phosphorylation 63 2.12E-05
GO:0010558 negative regulation of macromolecule biosynthetic process 54 2.83E-05
GO:0031327 negative regulation of cellular biosynthetic process 55 2.92E-05
GO:0006793 phosphorus metabolic process 83 3.87E-05
GO:0006796 phosphate metabolic process 83 3.87E-05
GO:0009890 negative regulation of biosynthetic process 55 5.17E-05
GO:0045892 negative regulation of transcription, DNA-dependent 39 5.20E-05
GO:0051253 negative regulation of RNA metabolic process 39 7.45E-05
GO:0007242 intracellular signaling cascade 100 8.44E-05
GO:0051056 regulation of small GTPase mediated signal transduction 30 1.07E-04
GO:0000904 cell morphogenesis involved in differentiation 29 1.47E-04
GO:0048667 cell morphogenesis involved in neuron differentiation 26 1.73E-04
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GO:0030030 cell projection organization 38 2.22E-04
GO:0048666 neuron development 35 4.12E-04
GO:0030182 neuron differentiation 42 4.68E-04
GO:0002366 leukocyte activation during immune response 9 5.69E-04
GO:0002263 cell activation during immune response 9 5.69E-04
GO:0000122 negative regulation of transcription from RNA polymerase
II promoter
29 6.15E-04
GO:0051051 negative regulation of transport 18 0.001
GO:0007169 transmembrane receptor protein tyrosine kinase signaling
pathway
25 0.001
GO:0030520 estrogen receptor signaling pathway 5 0.002
GO:0002285 lymphocyte activation during immune response 6 0.002
GO:0046578 regulation of Ras protein signal transduction 23 0.002
GO:0032583 regulation of gene-specific transcription 17 0.002
GO:0035023 regulation of Rho protein signal transduction 14 0.003
GO:0048812 neuron projection morphogenesis 23 0.003
GO:0045851 pH reduction 5 0.003
GO:0032989 cellular component morphogenesis 36 0.003
GO:0031175 neuron projection development 26 0.003
GO:0007167 enzyme linked receptor protein signaling pathway 32 0.004
GO:0032582 negative regulation of gene-specific transcription 9 0.004
GO:0007409 axonogenesis 21 0.004
GO:0002520 immune system development 27 0.004
GO:0033500 carbohydrate homeostasis 9 0.005
GO:0042593 glucose homeostasis 9 0.005
GO:0010551 regulation of specific transcription from RNA polymerase
II promoter
13 0.005
GO:0006357 regulation of transcription from RNA polymerase II pro-
moter
57 0.005
GO:0045860 positive regulation of protein kinase activity 23 0.005
GO:0021904 dorsal/ventral neural tube patterning 5 0.006
GO:0007389 pattern specification process 26 0.006
GO:0010553 negative regulation of specific transcription from RNA
polymerase II promoter
8 0.006
GO:0019637 organophosphate metabolic process 21 0.006
GO:0007268 synaptic transmission 28 0.006
GO:0000902 cell morphogenesis 32 0.006
GO:0030004 cellular monovalent inorganic cation homeostasis 6 0.007
GO:0060122 inner ear receptor stereocilium organization 4 0.007
GO:0033674 positive regulation of kinase activity 23 0.007
GO:0006644 phospholipid metabolic process 20 0.008
GO:0048534 hemopoietic or lymphoid organ development 25 0.008
GO:0035295 tube development 22 0.009
GO:0032147 activation of protein kinase activity 14 0.009
GO:0019226 transmission of nerve impulse 31 0.009
GO:0043406 positive regulation of MAP kinase activity 13 0.009
GO:0042592 homeostatic process 57 0.010
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Table B.19.: Gene Ontology analysis (p values ≤0.01.) of genes affected by butyrate-mediated dif-
ferential hypermethylation of associated CpG islands 24 hours upon butyrate addition
(Wippermann et al. 2013). Genes detected without treatment with 3 mM butyrate (’0 h’
sampling point) were removed from the dataset before ontology analysis.
GO ID GO term Count p value
GO:0051348 negative regulation of transferase activity 10 9.97E-05
GO:0006469 negative regulation of protein kinase activity 9 2.77E-04
GO:0033673 negative regulation of kinase activity 9 3.50E-04
GO:0006974 response to DNA damage stimulus 19 3.53E-04
GO:0006281 DNA repair 16 4.33E-04
GO:0065003 macromolecular complex assembly 27 5.25E-04
GO:0043933 macromolecular complex subunit organization 28 6.24E-04
GO:0010033 response to organic substance 28 7.91E-04
GO:0006461 protein complex assembly 22 8.43E-04
GO:0070271 protein complex biogenesis 22 8.43E-04
GO:0051338 regulation of transferase activity 18 9.45E-04
GO:0045859 regulation of protein kinase activity 17 0.001
GO:0033554 cellular response to stress 23 0.002
GO:0043549 regulation of kinase activity 17 0.002
GO:0010605 negative regulation of macromolecule metabolic process 27 0.002
GO:0043086 negative regulation of catalytic activity 14 0.003
GO:0016192 vesicle-mediated transport 22 0.004
GO:0042325 regulation of phosphorylation 19 0.004
GO:0043069 negative regulation of programmed cell death 16 0.004
GO:0060548 negative regulation of cell death 16 0.004
GO:0006259 DNA metabolic process 20 0.005
GO:0043407 negative regulation of MAP kinase activity 5 0.005
GO:0044092 negative regulation of molecular function 15 0.006
GO:0051172 negative regulation of nitrogen compound metabolic pro-
cess
20 0.006
GO:0019220 regulation of phosphate metabolic process 19 0.006
GO:0051174 regulation of phosphorus metabolic process 19 0.006
GO:0051235 maintenance of location 6 0.008
GO:0009890 negative regulation of biosynthetic process 21 0.008
GO:0043066 negative regulation of apoptosis 15 0.009
GO:0010629 negative regulation of gene expression 19 0.009
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